data_1j3s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j3s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.231 0.538 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.72 -11.82 60.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.37 -52.47 5.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.893 . . . . 0.0 109.693 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' CD1' ' A' ' 9' ' ' ILE . . . -56.03 -34.71 62.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 2.5 ttpt -51.08 -42.11 60.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -1.156 . . . . 0.0 109.612 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -77.08 -25.47 52.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.654 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.527 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 12.2 mt -66.58 -62.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.572 ' CE1' HG11 ' A' ' 20' ' ' VAL . 54.6 t80 -62.76 -40.25 96.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.09 -1.006 . . . . 0.0 108.951 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.501 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 84.3 mt -66.52 -14.63 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.464 -0.773 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 5.0 ttt -119.07 5.17 11.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.007 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -120.79 -64.25 1.26 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.044 -1.035 . . . . 0.0 109.805 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 37.83 3.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 108.895 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.2 t -91.73 4.34 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.447 -0.783 . . . . 0.0 109.904 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.43 -46.67 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 108.973 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 11.0 m -90.64 -29.53 17.71 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.319 -0.863 . . . . 0.0 108.936 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.674 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 69.1 m-70 -114.72 84.51 2.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -84.93 97.98 10.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.931 -1.106 . . . . 0.0 109.12 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG11 ' CE1' ' A' ' 10' ' ' PHE . 2.5 m -85.71 17.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -149.15 31.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -97.59 -77.04 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.53 52.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.23 16.62 35.04 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.85 124.01 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -1.153 . . . . 0.0 109.348 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -124.71 95.48 4.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -82.11 -73.85 0.37 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.097 -1.002 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 48.2 m -84.79 -63.08 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.04 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -88.48 152.18 23.14 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.3 Cg_endo -66.78 134.32 34.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.577 2.185 . . . . 0.0 110.969 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 17.2 t-20 -53.03 103.02 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 109.692 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD21 ' CG ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.06 51.5 1.96 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.665 -0.647 . . . . 0.0 109.826 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.412 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 4.1 t60 -93.46 -8.54 41.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 102' ' ' THR . . . -162.01 31.07 0.31 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.516 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -55.48 -28.13 52.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.044 . . . . 0.0 109.85 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 29.9 m-85 -72.28 113.83 9.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.197 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.85 51.03 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -101.61 136.54 41.28 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.056 -1.261 . . . . 0.0 110.075 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' CG ' ' N ' ' A' ' 40' ' ' THR . 30.5 ttmt -82.45 167.52 18.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.024 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.543 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -61.72 165.18 5.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.918 . . . . 0.0 109.946 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 65.4 94.47 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.6 tp-100 -149.05 -48.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -1.216 . . . . 0.0 109.645 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 46' ' ' TYR . . . -61.55 146.4 89.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 109.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.72 -60.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.776 2.317 . . . . 0.0 110.758 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.24 52.77 4.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -160.01 118.5 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -1.098 . . . . 0.0 108.888 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.9 t -83.33 70.99 10.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 30' ' ' PRO . 2.3 m-85 -44.26 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.684 -0.635 . . . . 0.0 109.747 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.56 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -50.85 -40.62 56.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.435 -0.791 . . . . 0.0 109.219 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.535 ' HB1' ' CG2' ' A' ' 75' ' ' ILE . . . -52.45 -72.51 0.05 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.587 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -37.2 -49.35 0.91 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -53.79 -48.32 69.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -0.928 . . . . 0.0 110.678 -178.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -65.04 -45.18 86.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.103 -0.998 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -21.03 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.161 -0.962 . . . . 0.0 109.68 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.84 43.94 48.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG23 HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -99.34 137.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.993 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -98.54 115.62 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 35' ' ' LEU . 11.8 m95 -59.02 111.11 1.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -136.42 -158.74 8.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.78 -74.12 0.23 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.197 -1.178 . . . . 0.0 109.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -36.91 78.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 110.13 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -44.97 92.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.367 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.7 OUTLIER -68.97 -24.97 64.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.242 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.8 tpp -59.75 -44.84 93.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -56.91 5.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 34.3 t80 -51.34 -28.65 12.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.987 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.7 tp -84.02 -31.48 25.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -58.76 -26.09 63.68 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 7.7 m120 -171.84 102.46 0.37 Allowed Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.42 -32.72 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.075 1.85 . . . . 0.0 110.045 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -27.97 31.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.456 -0.777 . . . . 0.0 109.734 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -83.75 -33.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' CE2' HD12 ' A' ' 75' ' ' ILE . 7.8 t80 -79.51 -68.41 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.914 . . . . 0.0 108.817 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.587 ' CD1' ' ND2' ' A' ' 52' ' ' ASN . 4.4 mm -102.96 111.18 64.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 70.43 7.23 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.292 1.994 . . . . 0.0 109.711 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -172.98 -40.29 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.528 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 11.2 t -42.58 151.55 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 109.843 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -111.78 7.12 20.1 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.557 -0.715 . . . . 0.0 109.103 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.542 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 5.7 ptm -86.0 117.79 25.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.931 -1.105 . . . . 0.0 109.695 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.89 50.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 27.4 t80 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 121.52 0.676 . . . . 0.0 110.197 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.127 0.489 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 7.4 mmt180 -62.06 -44.86 95.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.399 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.68 79.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.979 -1.076 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' A' ' 9' ' ' ILE . 8.2 m-20 -65.61 -26.41 67.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 9' ' ' ILE . 28.6 mt -66.58 -59.92 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 108.856 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 4.8 mm -50.52 -32.53 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.428 -0.795 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.3 78.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -64.28 -50.33 68.33 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.092 -1.005 . . . . 0.0 109.724 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.1 mm? -64.67 -18.49 65.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.805 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 4.8 mttt -80.86 -25.68 37.48 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.001 -1.062 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 5.5 tptp -78.02 -37.66 46.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.94 -54.8 3.81 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 98' ' ' LEU . 19.3 p -92.69 16.23 12.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.055 -1.028 . . . . 0.0 111.149 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 32.0 t-20 -156.82 29.03 0.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.923 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.483 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 14.1 mm-40 -72.21 -7.41 49.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.695 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -55.24 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.796 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.81 -49.31 59.91 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.8 tttt -62.49 -13.63 32.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.9 mmtt -85.46 -54.14 4.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.048 -1.033 . . . . 0.0 109.355 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 70.8 mt -57.22 -53.7 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.499 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 10.1 t80 -60.26 -42.3 95.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 5.2 mt -58.34 -24.42 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.325 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ptm -123.35 18.25 9.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.163 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.64 -48.09 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.05 -1.031 . . . . 0.0 109.725 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -133.72 20.6 3.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.937 -1.102 . . . . 0.0 109.517 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.7 t -85.3 8.4 18.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.497 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -100.31 -43.87 6.12 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 35.5 m -93.39 -27.93 16.45 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 76.2 m-70 -112.94 84.28 1.96 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 109.798 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -78.53 84.05 4.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 108.364 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.499 HG12 ' CZ ' ' A' ' 10' ' ' PHE . 3.3 m -83.93 31.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 110.692 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 22.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 109.818 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -99.85 6.04 45.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.431 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.16 -22.14 12.56 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.16 7.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 142.1 39.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.16 . . . . 0.0 109.279 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.431 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -127.22 172.77 10.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 109.659 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 -72.63 0.17 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 109.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.485 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 16.8 m -85.28 -55.41 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.302 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -95.7 153.23 20.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.624 ' HA ' ' CE2' ' A' ' 46' ' ' TYR . 32.3 Cg_endo -69.1 128.25 16.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.032 1.822 . . . . 0.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 30' ' ' PRO . 14.8 t-20 -44.22 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.529 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.25 41.21 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.481 ' HA ' ' CG2' ' A' ' 102' ' ' THR . 55.0 t-80 -87.12 -16.64 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.336 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.96 37.93 0.81 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 64' ' ' LEU . 6.6 tp -67.49 -33.98 76.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.557 -0.966 . . . . 0.0 110.167 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.2 m-85 -64.07 130.26 43.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.981 . . . . 0.0 110.09 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 20.81 76.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -148.0 121.1 8.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.019 -1.283 . . . . 0.0 109.783 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.06 160.02 29.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.223 -0.923 . . . . 0.0 109.148 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 53' ' ' LYS . 11.3 t -65.05 -174.84 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.906 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 57.23 79.58 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -156.39 -56.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . . . -43.2 135.37 3.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.686 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.65 134.01 11.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.505 2.136 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 -11.55 60.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.624 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -133.71 76.22 1.65 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 109.718 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -68.56 92.24 0.45 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 5.7 m-30 -46.17 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.873 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.4 m -59.67 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.401 -0.812 . . . . 0.0 109.358 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -35.71 -31.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.529 ' O ' ' ND2' ' A' ' 54' ' ' ASN . . . -32.3 -59.71 0.3 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.373 0.606 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.638 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 t30 -62.23 -54.17 44.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 109.328 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG2' ' A' ' 40' ' ' THR . 5.3 ttpp -41.94 -27.94 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 110.295 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 51' ' ' ALA . 7.3 p30 -94.94 -33.55 12.73 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.002 -1.061 . . . . 0.0 109.991 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 19.8 tptp -53.11 -20.02 3.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.033 -1.042 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.91 75.07 0.79 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG21 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -150.41 127.35 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 110.472 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -90.04 101.78 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.651 ' CH2' ' CG ' ' A' ' 67' ' ' TYR . 5.4 m95 -42.41 107.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.352 -0.843 . . . . 0.0 110.216 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.16 -154.8 7.97 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -76.58 -75.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -1.213 . . . . 0.0 109.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 65' ' ' MET . 21.2 t70 -62.32 -37.46 85.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -55.2 35.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 35' ' ' LEU . 2.3 tt -63.49 -19.73 65.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.328 -0.858 . . . . 0.0 109.298 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.482 ' HG2' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -64.78 -46.36 82.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -49.93 66.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.187 -0.945 . . . . 0.0 109.758 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.651 ' CG ' ' CH2' ' A' ' 59' ' ' TRP . 7.9 t80 -53.35 -41.02 65.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.105 -0.997 . . . . 0.0 109.352 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -69.98 -33.81 72.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.781 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.7 -24.13 63.72 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 21.1 t-20 -170.98 97.27 0.42 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 29.7 Cg_endo -74.75 -37.52 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.219 1.946 . . . . 0.0 110.769 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -72.84 -9.09 58.29 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.086 -1.009 . . . . 0.0 109.209 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 14.4 tptt -94.17 -57.69 2.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -62.91 -62.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.599 HG12 ' CE1' ' A' ' 67' ' ' TYR . 3.2 mm -80.45 117.23 66.78 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.9 Cg_endo -75.61 74.87 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.165 1.91 . . . . 0.0 110.685 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.42 26.84 1.74 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.453 ' HA ' HG22 ' A' ' 49' ' ' THR . 11.1 t -49.94 160.7 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.414 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 0.95 37.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 108.813 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 8.8 ptm -113.46 122.25 46.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 81' ' ' ILE . 16.0 tt -91.04 58.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 55.3 t80 . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.566 -0.709 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.482 ' CD ' ' HG2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -50.0 -36.1 27.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.223 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.86 89.22 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.253 -0.905 . . . . 0.0 109.174 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.68 -35.44 42.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.0 -55.88 16.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.409 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 96' ' ' ALA . 16.7 mm -53.51 -69.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.543 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -39.98 -39.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.81 -0.556 . . . . 0.0 110.244 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.03 -50.36 72.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.562 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 2.7 mm? -75.22 -3.48 33.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 -12.18 20.64 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.216 -0.927 . . . . 0.0 109.748 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -113.96 -43.55 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 110.123 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.96 -33.4 61.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -128.54 46.15 2.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.061 -1.024 . . . . 0.0 109.957 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -177.5 45.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.303 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.217 0.532 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -62.62 -22.62 66.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.889 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -84.39 -49.75 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.877 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -52.12 -45.56 57.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HG2' HD13 ' A' ' 11' ' ' ILE . 17.6 tttp -59.9 -37.36 79.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.912 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -21.69 61.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.867 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' LYS . 32.1 mm -75.09 -63.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 15' ' ' SER . 30.6 t80 -56.22 -45.61 79.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.213 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 18.6 mt -58.93 -30.66 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.6 ttp -116.77 21.9 13.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -134.14 -65.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -115.58 30.83 7.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.106 -0.996 . . . . 0.0 109.564 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 4.3 t -89.68 -14.95 33.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.114 . . . . 0.0 109.466 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -82.43 -44.18 16.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 108.911 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.3 m -90.08 -35.08 15.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 108.869 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 68.6 m-70 -114.02 80.36 1.38 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.039 -1.038 . . . . 0.0 109.934 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.475 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.5 p -79.69 94.55 5.74 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.663 -1.273 . . . . 0.0 108.781 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 32' ' ' LEU . 2.9 m -84.57 -5.56 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.19 26.5 9.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.3 -51.39 3.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.4 60.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.76 24.99 72.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -96.34 115.55 27.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -1.106 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -131.57 89.88 2.77 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.46 -68.5 0.71 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 0.0 109.773 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 99.8 m -90.19 -59.81 2.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.722 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -90.41 149.0 19.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.7 Cg_endo -65.84 136.03 43.68 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.51 2.14 . . . . 0.0 111.232 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 9.5 t-20 -52.4 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.774 -0.579 . . . . 0.0 110.286 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -82.15 70.07 9.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.729 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 14.8 t60 -88.86 -45.65 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.599 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.52 38.93 1.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' A' ' 59' ' ' TRP . 5.5 tp -54.03 -28.28 37.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -1.131 . . . . 0.0 109.601 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.6 m-85 -66.29 136.75 56.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.81 17.23 57.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 1.8 ttt-85 -133.87 135.68 43.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -1.203 . . . . 0.0 109.326 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -64.68 -174.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.877 . . . . 0.0 109.925 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' LYS . 4.6 p -53.5 -169.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -133.3 175.11 20.33 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.879 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -161.82 54.3 0.25 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.954 . . . . 0.0 108.666 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.34 169.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 109.666 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 43' ' ' ALA . 35.0 Cg_endo -75.12 -66.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.64 2.226 . . . . 0.0 110.585 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.96 6.86 61.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -131.04 103.89 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -1.135 . . . . 0.0 109.403 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' TYR . 34.7 t -75.14 83.89 2.34 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-30 -44.19 176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.731 -0.606 . . . . 0.0 110.186 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -59.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.906 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -52.61 -38.75 60.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.604 -0.685 . . . . 0.0 109.227 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . . . -49.26 -70.57 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.394 -0.817 . . . . 0.0 108.847 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.576 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -43.97 -54.18 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.603 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 52' ' ' ASN . 10.1 tptp -40.03 -46.56 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.213 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.67 -34.47 60.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 9.6 tptt -53.65 -17.85 2.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.996 -1.065 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.43 54.34 32.75 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.509 HG21 ' ND2' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -108.24 138.42 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.997 . . . . 0.0 110.251 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -98.13 104.21 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.6 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 6.6 m95 -49.04 103.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.068 -1.02 . . . . 0.0 110.263 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.86 -164.11 11.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.92 -55.79 5.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.022 -1.281 . . . . 0.0 109.712 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -73.77 -38.93 64.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.157 -0.964 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -37.86 79.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.058 -1.026 . . . . 0.0 109.521 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -77.38 -35.96 53.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.182 -0.949 . . . . 0.0 109.125 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.443 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 46.1 ttm -56.77 -28.53 61.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 108.831 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -53.22 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.6 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 19.9 t80 -58.78 -17.72 25.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -36.19 11.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 108.919 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 65' ' ' MET . 21.6 tt0 -59.31 -23.65 62.63 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -176.0 88.52 0.28 Allowed Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.4 Cg_endo -74.59 -37.54 2.28 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.378 2.052 . . . . 0.0 110.274 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -67.63 -14.07 62.63 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.17 -0.956 . . . . 0.0 108.654 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -98.74 -31.66 11.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.227 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.544 ' CD2' HD13 ' A' ' 75' ' ' ILE . 13.1 t80 -83.37 -72.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 108.629 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.592 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.5 mm -83.87 115.4 59.65 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 84.26 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.286 1.991 . . . . 0.0 110.396 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 140.18 -7.37 2.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.458 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 12.0 t -44.43 144.67 0.99 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.245 . . . . 0.0 109.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 17.18 24.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.442 ' HE1' ' HB2' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.44 124.47 20.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.871 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 81' ' ' ILE . 6.6 mt -92.05 21.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HE1' ' A' ' 80' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.419 0.628 . . . . 0.0 110.193 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.244 0.545 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -53.04 -36.13 60.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.91 -49.16 60.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.438 ' HB3' HG13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -62.92 -24.58 67.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 110.028 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 9' ' ' ILE . 75.8 mt -68.29 -59.52 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.564 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 1.1 mp -61.74 -32.47 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.85 46.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' HB2' ' C ' ' A' ' 6' ' ' GLY . 32.7 t80 -66.84 -44.27 81.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.963 -1.086 . . . . 0.0 109.814 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.5 mm? -75.91 -4.01 38.54 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.56 -15.13 17.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.197 -0.939 . . . . 0.0 109.14 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 9.0 tttp -103.71 -31.1 10.02 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.23 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.59 -0.694 . . . . 0.0 110.983 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 103' ' ' ASN . 4.6 t -91.06 -48.62 6.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 0.0 110.855 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.548 ' N ' ' CG2' ' A' ' 102' ' ' THR . 7.8 t-20 -69.66 -4.26 18.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.871 -1.143 . . . . 0.0 110.029 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 8.4 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.599 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -74.8 -45.93 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 9' ' ' ILE . 2.0 tppm? -76.97 -41.39 43.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.18 94.15 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HD3' ' CE1' ' A' ' 97' ' ' TYR . 3.2 ttpt -61.03 -32.85 72.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -1.158 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -67.44 -25.33 65.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 5.2 mm -76.98 -68.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.551 ' CG ' HD21 ' A' ' 98' ' ' LEU . 48.8 t80 -53.35 -46.66 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 12' ' ' MET . 12.9 tt -56.01 -43.54 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 110.054 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.515 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.21 14.52 31.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.44 -68.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.072 -1.017 . . . . 0.0 109.592 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -113.59 37.16 3.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 2.9 t -93.51 -48.16 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.881 -1.137 . . . . 0.0 109.835 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.4 -33.79 45.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 36.4 m -98.24 -37.72 9.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.109 -0.994 . . . . 0.0 109.159 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.668 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 67.6 m-70 -115.51 74.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.85 -1.156 . . . . 0.0 108.992 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.4 96.83 5.45 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.696 -1.253 . . . . 0.0 109.168 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 32' ' ' LEU . 3.0 m -87.53 25.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.475 -0.766 . . . . 0.0 109.879 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -140.08 9.29 2.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -85.23 -86.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.8 38.04 0.61 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.52 13.84 63.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -98.66 169.59 9.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -1.13 . . . . 0.0 109.269 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.31 117.51 9.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -91.41 -73.15 0.55 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.283 -0.886 . . . . 0.0 109.158 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 20.7 m -93.24 -59.88 1.92 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -92.31 153.36 21.72 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.668 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.2 Cg_endo -66.57 147.57 82.19 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.403 2.069 . . . . 0.0 111.254 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.45 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 16.2 t-20 -64.61 100.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 110.328 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.88 38.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -90.91 36.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 109.093 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.56 37.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 59' ' ' TRP . 4.2 tp -79.04 -24.39 43.64 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.356 -1.084 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 27.5 m-85 -74.4 127.28 32.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 109.549 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 14.12 82.92 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 11.7 ttt-85 -134.18 134.55 42.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.154 . . . . 0.0 109.516 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 4.0 mttt -73.78 -177.36 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.455 ' CG2' ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -92.61 -175.5 3.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 59.48 89.05 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.5 tp-100 -147.98 -43.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 109.72 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 48' ' ' TYR . . . -73.53 136.35 78.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.327 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 45' ' ' GLY . 35.2 Cg_endo -77.28 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.08 -30.02 0.37 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.526 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -80.59 125.53 30.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.433 -1.039 . . . . 0.0 109.109 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -86.49 57.3 4.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-85 -36.42 158.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.286 0.565 . . . . 0.0 110.066 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -61.0 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.84 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -46.03 -35.89 5.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . . . -49.0 -61.2 2.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -55.94 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 109.592 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 52' ' ' ASN . 6.7 ttpm? -39.99 -30.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.53 0.681 . . . . 0.0 109.338 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLY . 86.1 m-20 -92.23 -39.67 11.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.448 -0.783 . . . . 0.0 109.687 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -56.9 92.72 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.934 -1.104 . . . . 0.0 108.252 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' ASN . . . -38.19 91.52 0.01 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -143.65 145.75 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 110.015 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -118.61 100.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.679 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 6.9 m95 -37.56 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.793 0.806 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -122.38 -164.45 12.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -1.146 . . . . 0.0 109.705 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.05 -27.21 66.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.457 ' OG1' ' CA ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -60.88 -40.69 93.97 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -76.26 -32.49 58.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -37.09 67.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.67 -56.81 4.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.679 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 9.5 t80 -56.07 -19.11 11.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 109.992 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -92.33 -36.31 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.033 -1.042 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.99 -25.16 63.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 5.1 t-20 -168.8 85.46 0.67 Allowed Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -75.01 -26.39 10.95 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.462 2.108 . . . . 0.0 109.766 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 2.2 tttt -74.3 -19.18 60.57 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 43.2 tptt -88.79 -45.06 10.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.501 -0.749 . . . . 0.0 109.438 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 8.1 t80 -71.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.116 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.618 ' CD1' ' CD2' ' A' ' 74' ' ' TYR . 2.6 mm -96.2 107.81 37.5 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.703 -0.623 . . . . 0.0 109.654 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -79.13 81.68 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.375 2.05 . . . . 0.0 110.347 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.23 -18.25 0.71 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.5 t -44.97 132.21 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 109.938 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 23.76 5.01 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -59.2 120.0 8.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.607 -0.683 . . . . 0.0 109.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.9 mt -93.29 26.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 121.625 0.726 . . . . 0.0 110.663 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' CD ' HD23 ' A' ' 68' ' ' LEU . 8.0 ttp85 -55.04 -44.75 74.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.958 . . . . 0.0 109.125 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.52 66.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 0.0 109.23 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.46 -36.63 84.81 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.264 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 66.7 mt -61.97 -29.78 70.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -0.864 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mm -79.15 -46.91 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.351 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.08 -46.78 65.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.219 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.541 ' CD2' HD23 ' A' ' 98' ' ' LEU . 28.1 t80 -70.66 -47.52 59.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.993 -1.067 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.1 mm? -71.7 -3.36 21.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -87.0 -55.9 3.62 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -28.58 61.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.59 50.28 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.389 -0.82 . . . . 0.0 109.68 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 102' ' ' THR . 3.1 t -124.38 41.41 3.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.855 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 99' ' ' LYS . 2.9 t-20 179.78 50.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.388 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.185 0.517 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.47 -27.68 69.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.663 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HB3' ' OD2' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -58.25 -62.16 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.64 -37.17 94.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.6 ttmm -58.47 -26.45 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -1.176 . . . . 0.0 109.811 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -82.2 -40.5 21.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 109.994 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HB ' HD22 ' A' ' 94' ' ' LEU . 12.9 mm -61.48 -58.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 0.0 110.123 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.435 ' CE1' HG12 ' A' ' 20' ' ' VAL . 18.8 t80 -62.12 -41.06 97.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.005 -1.06 . . . . 0.0 109.758 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 18.3 mm -68.21 -11.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.7 ttm -133.31 19.47 4.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 110.215 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 5.8 tptt -131.76 -43.25 1.0 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 109.199 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.07 25.33 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.7 t -85.59 10.42 13.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -43.5 6.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 108.748 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.542 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 34.4 m -99.61 -22.02 15.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.136 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.684 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 76.8 m-70 -117.43 79.42 1.34 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -79.53 100.08 7.58 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.827 -1.17 . . . . 0.0 108.781 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG12 ' CE1' ' A' ' 10' ' ' PHE . 3.9 m -83.81 13.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.887 . . . . 0.0 109.742 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -121.94 17.95 10.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.407 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.37 179.44 6.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.7 53.92 4.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.1 7.52 76.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -97.92 159.5 14.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.119 . . . . 0.0 109.356 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.576 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -140.33 109.27 6.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.905 . . . . 0.0 108.706 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.562 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 30.8 m -87.42 -96.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -50.12 158.83 1.55 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 35.5 Cg_endo -69.38 151.92 71.24 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.363 2.042 . . . . 0.0 111.427 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.576 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.0 t-20 -62.41 102.99 0.36 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -82.07 54.86 2.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.121 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -99.51 43.54 1.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 108.888 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA2' ' CG2' ' A' ' 102' ' ' THR . . . 132.01 48.5 0.11 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.621 ' CD2' ' CG ' ' A' ' 59' ' ' TRP . 3.6 tt -65.92 -33.78 76.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -1.027 . . . . 0.0 110.35 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 21.3 m-85 -60.08 140.58 56.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 0.0 109.847 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.04 20.0 74.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 38' ' ' ARG . 16.5 ttp85 -133.36 98.95 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 169.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -70.08 172.95 7.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.658 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 72.15 72.8 0.9 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.449 ' HG3' ' HG2' ' A' ' 38' ' ' ARG . 66.2 mm-40 -135.53 -53.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 109.806 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB2' ' NE2' ' A' ' 26' ' ' HIS . . . -71.11 137.96 84.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.625 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -79.73 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.696 2.264 . . . . 0.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.28 -33.73 1.41 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.91 121.76 25.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -1.089 . . . . 0.0 109.429 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -84.64 65.4 9.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-30 -37.88 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.617 0.723 . . . . 0.0 111.12 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 45.1 p -68.44 88.8 0.34 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 109.466 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.74 -33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -51.28 -65.06 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.528 ' ND2' HG13 ' A' ' 75' ' ' ILE . 2.6 m-20 -39.72 -55.08 1.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.435 -0.791 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -42.31 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.75 -27.33 67.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.278 -0.889 . . . . 0.0 109.852 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 6.1 tptt -73.45 -0.22 14.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.17 -0.956 . . . . 0.0 109.668 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.59 27.26 2.0 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' C ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -81.0 125.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.994 . . . . 0.0 110.085 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -94.05 100.46 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.621 ' CG ' ' CD2' ' A' ' 35' ' ' LEU . 17.2 m95 -37.39 109.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -130.76 -155.09 8.14 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.02 -60.64 2.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -1.191 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.32 -35.24 73.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.493 HG21 ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -65.35 -48.56 72.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.74 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 68' ' ' LEU . 1.3 tt -69.53 -32.59 71.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.103 -0.998 . . . . 0.0 109.533 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.419 ' HG2' ' HD2' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -59.88 -34.15 72.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 108.89 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -77.8 -53.4 7.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.518 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.595 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 38.9 t80 -57.65 -16.34 10.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -92.37 -40.34 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.563 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.95 -22.53 60.23 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 70' ' ' ASN . 22.4 p30 -172.57 95.91 0.37 Allowed Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -73.34 -40.23 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.255 1.97 . . . . 0.0 110.541 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -69.41 -9.36 53.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.995 -1.065 . . . . 0.0 108.948 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -54.41 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.559 ' CE1' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -69.16 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.147 -0.971 . . . . 0.0 108.837 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 67' ' ' TYR . 4.8 mm -98.19 106.82 37.68 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.653 -0.654 . . . . 0.0 109.553 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.5 75.77 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.159 1.906 . . . . 0.0 109.583 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 170.36 -22.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.538 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 13.8 t -36.96 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -1.052 . . . . 0.0 110.329 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.89 13.46 31.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.549 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 6.3 ptm -114.54 123.07 48.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 110.079 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.41 44.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 19.9 t80 . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.653 -0.654 . . . . 0.0 109.766 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.419 ' HD2' ' HG2' ' A' ' 65' ' ' MET . 10.2 ttp85 -58.52 -52.43 65.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 108.918 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.84 73.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -63.75 -30.69 71.76 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.476 HD22 ' HB ' ' A' ' 9' ' ' ILE . 18.3 mt -64.66 -55.75 18.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -63.43 -31.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.27 87.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.73 -49.41 70.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.017 -1.052 . . . . 0.0 109.973 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 3.4 mm? -66.34 -16.33 63.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.727 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -77.64 -51.03 11.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.121 -0.987 . . . . 0.0 109.608 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.8 -22.34 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.76 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.44 -55.73 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 110.222 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.502 ' CG2' ' HA2' ' A' ' 34' ' ' GLY . 3.3 t -110.71 -32.23 6.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.99 -1.069 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.544 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 6.7 t30 -81.4 8.41 9.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 110.017 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.32 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 14.5 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.38 -10.15 59.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -96.3 -49.71 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 9' ' ' ILE . . . -75.11 -33.3 54.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HD2' ' CE1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -69.67 -36.15 75.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 109.605 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -32.03 58.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.524 HG22 ' CD2' ' A' ' 94' ' ' LEU . 53.9 mt -67.92 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.262 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.569 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.7 t80 -54.35 -39.16 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 15' ' ' SER . 5.0 mm -57.09 -37.91 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -107.04 10.54 30.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.065 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -109.79 -60.03 1.84 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.102 -0.999 . . . . 0.0 109.527 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -132.07 40.81 3.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.313 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.2 t -87.25 -1.15 57.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -100.83 -49.07 4.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 38.3 m -87.75 -13.19 43.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.876 . . . . 0.0 109.357 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.619 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 82.2 m-70 -134.23 81.87 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 110.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.0 p -78.67 90.21 4.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.9 -1.125 . . . . 0.0 108.003 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.1 m -82.85 35.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.625 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 23.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.869 -1.144 . . . . 0.0 110.211 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -95.74 -15.63 22.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.884 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.89 -25.4 4.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 136.53 -6.26 3.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -67.21 141.17 57.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -1.126 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.431 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -112.87 115.3 28.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 109.088 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.63 -79.94 0.32 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.761 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.527 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 7.0 m -98.97 -53.54 3.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 175.14 31.99 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -73.52 125.04 9.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.823 2.349 . . . . 0.0 110.94 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 24' ' ' GLY . 15.6 t-20 -49.37 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -78.8 76.54 5.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 -66.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -110.4 27.19 11.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.558 ' HG ' ' CD1' ' A' ' 59' ' ' TRP . 1.9 tt -43.56 -30.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -1.079 . . . . 0.0 109.556 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.1 m-85 -74.91 128.95 36.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.58 66.26 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -120.77 123.6 43.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.406 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -60.09 -177.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' GLY . 2.3 p -80.47 178.43 8.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.51 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 52.83 104.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -155.16 -62.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.279 . . . . 0.0 110.005 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -61.08 139.33 94.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.95 -173.82 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.744 2.296 . . . . 0.0 110.509 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 45.99 25.25 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.623 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -157.16 112.11 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 108.96 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -78.35 77.25 4.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.6 m-85 -46.77 179.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.557 ' CG2' ' CA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.49 88.11 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.105 -0.997 . . . . 0.0 108.871 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.12 -41.75 12.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.77 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -51.03 -66.75 0.33 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.301 -0.875 . . . . 0.0 108.959 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.566 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.25 -42.36 4.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.465 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 5.5 tttt -43.41 -72.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.95 -15.79 60.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -60.42 -13.22 12.2 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.013 -1.055 . . . . 0.0 109.39 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.52 51.51 32.19 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.534 HG23 ' ND2' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -110.82 123.73 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.53 -0.983 . . . . 0.0 110.215 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -87.27 116.39 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 35' ' ' LEU . 12.6 m95 -56.55 96.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.299 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -117.68 -176.57 17.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -64.21 -59.69 4.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.108 -1.231 . . . . 0.0 110.073 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.45 -38.35 77.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 109.922 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.427 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.59 -35.6 74.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -77.77 -29.81 51.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.071 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.443 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -58.68 -35.0 71.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.33 -0.856 . . . . 0.0 109.105 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.48 -58.61 3.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 52' ' ' ASN . 56.1 t80 -48.69 -28.81 3.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.163 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.68 -39.27 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 0.0 109.487 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 65' ' ' MET . 10.8 tt0 -60.54 -21.22 62.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 1.8 m120 -169.21 89.61 0.59 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -76.76 -41.44 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.612 2.208 . . . . 0.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -31.98 57.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.34 -0.85 . . . . 0.0 109.973 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 1.6 mmpt? -83.19 -26.25 31.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.554 ' CD2' HG12 ' A' ' 75' ' ' ILE . 7.1 t80 -83.94 -72.24 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.004 -1.06 . . . . 0.0 109.045 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 22.4 mm -93.73 119.37 67.12 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 109.669 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.8 60.22 7.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.475 2.116 . . . . 0.0 110.134 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 51' ' ' ALA . . . -158.31 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.557 ' CA ' ' CG2' ' A' ' 49' ' ' THR . 9.7 t -59.83 161.96 5.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 109.758 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 11.41 5.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' MET . 7.7 ptm -77.75 114.05 16.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.316 1.055 . . . . 0.0 109.752 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 tt -95.16 33.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.976 -179.446 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.231 0.539 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -53.32 -30.17 37.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.15 -52.67 17.9 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -59.16 -22.03 60.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.61 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD2' HG22 ' A' ' 9' ' ' ILE . 27.4 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 4.9 mm -57.25 -38.58 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.325 -0.859 . . . . 0.0 109.413 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.28 82.46 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.545 -0.722 . . . . 0.0 109.86 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.555 ' CE1' ' HD2' ' A' ' 7' ' ' LYS . 23.4 t80 -61.99 -34.95 77.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 109.611 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.3 mm? -83.32 -13.35 55.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -95.05 -9.32 34.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.315 -0.865 . . . . 0.0 109.682 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.98 -52.08 2.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 109.46 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.14 71.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.97 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -128.53 40.41 3.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.826 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 102' ' ' THR . 6.0 t-20 178.85 51.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG23 ' HE2' ' A' ' 100' ' ' LYS . 4.3 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.64 -36.9 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.595 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 9' ' ' ILE . 5.7 mmtt -74.94 -45.26 43.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 93' ' ' ASP . . . -42.27 -52.64 5.07 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 4.1 ttmm -64.16 -36.49 84.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -1.17 . . . . 0.0 109.666 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 11' ' ' ILE . 3.1 tptt -62.56 -23.43 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.073 -1.017 . . . . 0.0 109.915 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 5' ' ' LYS . 17.9 mm -82.65 -67.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.892 -1.13 . . . . 0.0 109.829 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.551 ' CE2' HG23 ' A' ' 20' ' ' VAL . 23.2 t80 -49.99 -31.55 12.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 109.524 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.544 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 3.2 tt -69.73 -40.65 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 ttm -111.77 29.61 7.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.378 -0.826 . . . . 0.0 109.973 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -140.73 -39.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.007 . . . . 0.0 109.951 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -146.48 16.53 1.3 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.967 -1.083 . . . . 0.0 109.938 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.544 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 28.2 t -85.44 7.94 20.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.893 -1.129 . . . . 0.0 109.594 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -100.1 -43.32 6.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 57.9 m -95.98 -32.83 12.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.67 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 71.4 m-70 -108.18 84.53 1.96 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 109.472 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 91.35 5.28 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.723 -1.235 . . . . 0.0 108.817 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG23 ' CE2' ' A' ' 10' ' ' PHE . 11.8 m -85.12 8.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.433 -0.792 . . . . 0.0 110.133 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 2.6 mt-10 -146.13 24.95 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 110.383 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -96.74 -58.31 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.057 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.8 54.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.38 20.01 3.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -100.81 82.66 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.448 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.85 150.11 30.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 109.373 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -133.77 -85.37 0.44 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.526 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 49.8 m -81.91 -15.6 53.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -132.44 150.26 19.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.67 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.8 Cg_endo -66.36 131.72 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.202 . . . . 0.0 111.108 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.1 t-20 -53.17 102.79 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.486 ' CB ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -81.97 42.69 0.73 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 110.166 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.432 ' ND1' ' CG2' ' A' ' 102' ' ' THR . 22.6 t-80 -89.0 58.43 4.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 108.993 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.85 23.67 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -56.52 -22.19 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.038 -1.272 . . . . 0.0 109.237 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 19.6 m-85 -70.85 134.37 47.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.876 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.77 10.5 61.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -123.64 120.31 32.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -1.202 . . . . 0.0 109.421 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 161.64 16.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.081 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -67.45 176.37 2.37 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 61.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -157.93 -58.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.185 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -53.24 129.79 50.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 0.0 109.862 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.56 145.14 18.23 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.598 2.198 . . . . 0.0 110.386 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.1 -47.02 3.7 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -81.24 113.83 19.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.958 . . . . 0.0 108.766 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -77.35 77.55 3.88 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.665 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-85 -46.6 177.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.647 . . . . 0.0 109.335 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.67 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 109.278 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -47.24 -41.67 19.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.242 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.567 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -47.8 -68.38 0.19 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' ND2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -40.47 -47.12 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.688 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER -48.15 -60.03 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.858 . . . . 0.0 110.044 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.2 -20.63 66.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 110.065 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -63.84 -8.75 11.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.088 -1.008 . . . . 0.0 109.96 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.08 52.56 34.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.53 HG22 ' ND2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -114.29 135.77 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.51 -0.994 . . . . 0.0 110.436 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -97.98 114.45 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.493 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 10.6 m95 -54.59 109.03 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.98 -163.15 10.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.87 -62.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.283 . . . . 0.0 109.839 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.1 93.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.098 -1.001 . . . . 0.0 109.937 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.53 -38.17 80.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.804 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -76.32 -32.79 58.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.765 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.6 ttt -55.79 -39.55 71.44 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -75.21 -48.6 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.27 -0.894 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 30.4 t80 -59.55 -18.33 39.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 109.737 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 HD11 HD21 ' A' ' 64' ' ' LEU . 1.2 mp -92.71 -38.92 11.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -22.2 62.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . 10.3 m-20 -172.25 94.17 0.39 Allowed Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 78' ' ' THR . 31.2 Cg_endo -76.26 -30.78 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 0.0 110.022 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -82.15 -26.94 33.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.381 -0.824 . . . . 0.0 109.711 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -80.9 -44.34 18.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.259 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' CG ' ' A' ' 73' ' ' LYS . 2.4 t80 -72.08 -66.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.567 HG23 ' CB ' ' A' ' 51' ' ' ALA . 31.3 mm -98.43 110.28 55.97 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.479 -0.763 . . . . 0.0 109.62 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -79.35 67.07 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.459 2.106 . . . . 0.0 109.863 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -165.65 -47.65 0.02 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.537 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.0 t -47.57 167.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -1.233 . . . . 0.0 109.692 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -134.72 11.51 3.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.534 ' O ' ' HG3' ' A' ' 80' ' ' MET . 6.6 ptm -77.65 118.83 20.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.9 33.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 2.4 t80 . . . . . 0 C--N 1.302 -1.499 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 1.4 mpt_? -55.44 -45.88 76.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.126 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.58 89.75 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 4.3 m-20 -57.87 -29.13 64.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.279 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 91' ' ' ARG . 27.2 mt -66.96 -47.71 70.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.6 mm -65.84 -59.2 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.388 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.2 -42.25 6.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.904 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.01 -52.07 58.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 110.003 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.556 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.2 mm? -75.39 -0.42 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -95.87 -25.1 16.14 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 110.088 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE2' HG23 ' A' ' 3' ' ' VAL . 5.6 mtpp -108.7 -36.41 6.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.32 67.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.432 ' CG2' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -136.0 49.41 2.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.998 -1.064 . . . . 0.0 110.082 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.9 t30 -178.14 34.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.559 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG21 ' HD2' ' A' ' 100' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.055 0.455 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.65 -46.75 44.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.634 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -29.05 70.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.793 -1.192 . . . . 0.0 109.758 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . -72.43 -51.08 13.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 2.7 tttp -43.84 -35.18 1.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.023 -1.281 . . . . 0.0 110.082 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -74.25 -46.05 44.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 109.965 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.1 mt -56.86 -50.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.421 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 13.3 t80 -63.56 -46.41 86.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 110.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -53.21 -37.23 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.968 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.415 ' HE1' ' HA ' ' A' ' 9' ' ' ILE . 11.5 ptt? -107.29 5.72 27.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.831 -1.168 . . . . 0.0 110.448 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.7 tppt? -109.03 -69.47 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.895 -1.128 . . . . 0.0 109.733 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -117.11 40.8 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.146 -0.971 . . . . 0.0 108.599 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 8.2 t -87.99 -53.94 4.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.757 -1.214 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 17' ' ' CYS . 9.5 pt20 -55.95 -38.62 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.831 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.486 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 8.7 m -86.96 -24.52 24.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.128 -0.983 . . . . 0.0 108.978 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.663 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 71.7 m-70 -131.76 76.8 1.73 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.978 -1.076 . . . . 0.0 109.58 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -76.89 92.52 3.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.23 24.44 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 110.531 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 18.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 108.645 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -22.21 51.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.496 -0.753 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.73 -17.18 8.84 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.31 -7.24 3.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.13 155.79 21.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -1.225 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.67 141.71 34.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 0.0 109.568 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 28' ' ' THR . 2.6 ttmt -113.7 -85.07 0.59 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 19.4 m -79.13 -76.68 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -74.68 155.89 48.88 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.663 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 34.3 Cg_endo -70.14 138.01 35.65 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.236 1.958 . . . . 0.0 110.74 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -48.82 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.897 . . . . 0.0 109.604 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -82.5 53.08 2.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.743 . . . . 0.0 110.181 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -99.81 77.5 2.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 0.0 109.336 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 102' ' ' THR . . . 113.41 11.69 12.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -54.01 -27.99 35.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.601 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 2.8 m-85 -61.96 150.03 38.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 109.908 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.02 17.55 23.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' CZ ' ' O ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -138.66 162.48 34.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -1.161 . . . . 0.0 109.422 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -92.93 -156.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.543 ' O ' ' CZ ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -59.65 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -145.85 -176.04 19.41 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.9 36.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.433 -1.039 . . . . 0.0 109.4 -179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.441 ' CB ' ' NE2' ' A' ' 26' ' ' HIS . . . -41.46 160.89 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.94 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.29 154.69 36.71 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.662 2.241 . . . . 0.0 109.962 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.33 20.04 20.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.551 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -153.87 104.48 2.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.932 . . . . 0.0 109.054 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 82.8 p -77.67 81.47 4.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 m-85 -44.65 174.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.662 -0.649 . . . . 0.0 109.309 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.06 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.03 -1.044 . . . . 0.0 109.495 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -55.17 -42.03 72.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.538 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -49.27 -72.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.594 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 1.3 m120 -38.45 -48.63 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.506 -0.746 . . . . 0.0 109.615 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 13.2 tttt -42.81 -69.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 0.0 110.671 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 55' ' ' LYS . 38.7 p30 -63.48 -17.96 63.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -62.44 -12.17 20.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 46.02 81.74 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.486 HG21 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -105.63 134.66 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.386 -1.067 . . . . 0.0 109.804 -179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.46 HD13 ' CD ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -96.32 96.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 0.0 108.597 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.528 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 8.0 m95 -42.06 103.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -126.12 -164.01 11.68 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.06 -70.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.0 109.383 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -61.02 -36.63 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.432 -0.792 . . . . 0.0 109.748 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -36.23 75.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.5 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -77.08 -33.73 57.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.335 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 tpt -54.69 -38.75 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.98 -58.15 3.49 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.404 -0.81 . . . . 0.0 109.491 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 53.6 t80 -52.9 -18.92 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.925 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.5 tp -92.33 -38.84 11.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.557 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -59.48 -22.55 61.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 8.3 p30 -178.58 88.98 0.22 Allowed Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HB2' HG22 ' A' ' 78' ' ' THR . 32.8 Cg_endo -75.55 -43.25 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.466 2.111 . . . . 0.0 110.292 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -21.69 65.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.227 -0.921 . . . . 0.0 108.833 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -89.09 -38.91 13.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.389 -0.819 . . . . 0.0 109.227 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.469 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 3.9 t80 -75.76 -68.73 0.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.594 ' CD1' ' ND2' ' A' ' 52' ' ' ASN . 12.1 mm -93.0 109.8 41.79 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.541 -0.724 . . . . 0.0 109.335 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 34.5 Cg_endo -76.23 87.8 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.218 1.945 . . . . 0.0 110.541 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 153.37 -27.14 0.78 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -42.24 145.51 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -1.099 . . . . 0.0 110.023 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -107.26 18.9 21.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.442 ' HE2' ' HB2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -61.59 127.28 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 110.016 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.7 mt -95.86 27.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HE2' ' A' ' 80' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.546 0.689 . . . . 0.0 110.385 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.49 ' CA ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.301 0.572 . . . . 0.0 109.594 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.85 -40.04 75.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.2 77.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' CB ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -63.08 -32.91 74.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.829 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt -64.91 -53.15 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 2.3 mm -60.21 -38.64 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.5 83.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.996 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.26 -53.41 57.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.2 -0.938 . . . . 0.0 109.571 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.6 mm? -65.23 -15.8 62.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.389 -0.819 . . . . 0.0 109.809 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -80.56 -28.76 37.16 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.003 -1.061 . . . . 0.0 110.158 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -102.0 -56.05 2.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.866 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.79 65.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -142.85 46.76 1.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.002 -1.061 . . . . 0.0 110.151 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 102' ' ' THR . 7.1 t30 174.12 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.019 . . . . 0.0 110.03 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 3.3 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.324 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.26 -12.61 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -91.26 -54.08 4.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.83 -39.91 79.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 26.6 tttp -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 0.0 109.538 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -74.51 -27.77 60.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.525 HG23 ' CD2' ' A' ' 94' ' ' LEU . 80.5 mt -61.22 -63.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.14 -0.975 . . . . 0.0 109.023 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 14' ' ' CYS . 40.1 t80 -62.69 -42.21 99.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 108.728 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 9.2 mm -61.5 -18.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.747 . . . . 0.0 109.297 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.43 ' O ' ' HG3' ' A' ' 12' ' ' MET . 4.6 tpt -128.52 18.54 6.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 109.618 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -131.64 -50.42 0.98 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -126.51 23.23 6.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.126 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.6 t -87.84 -2.28 58.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.821 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -92.28 -45.79 8.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 108.488 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.4 m -90.94 -35.65 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.67 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 65.1 m-70 -110.63 85.01 2.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.063 -1.023 . . . . 0.0 110.339 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 15' ' ' SER . 2.8 p -79.84 99.39 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.75 -1.219 . . . . 0.0 108.821 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG12 ' CB ' ' A' ' 32' ' ' LEU . 3.4 m -86.95 33.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 21.71 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.28 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -63.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.26 64.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.09 13.23 40.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -100.12 156.92 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.613 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -152.69 119.91 5.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.369 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -93.3 -86.0 0.26 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 22.2 m -87.93 -43.41 11.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.799 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -101.2 153.29 19.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.67 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.1 Cg_endo -66.71 132.81 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.947 2.431 . . . . 0.0 111.692 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -49.58 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.44 0.638 . . . . 0.0 109.909 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.52 HD23 ' CB ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.89 69.93 7.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.509 -0.745 . . . . 0.0 110.677 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.433 ' O ' ' OG1' ' A' ' 102' ' ' THR . 10.0 t-80 -100.5 -59.46 1.7 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.053 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.76 36.72 4.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 59' ' ' TRP . 14.3 tp -48.87 -30.03 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.096 . . . . 0.0 109.768 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 76.5 m-85 -75.56 124.49 27.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.961 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.03 69.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.38 107.8 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.023 -1.281 . . . . 0.0 109.576 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' THR . 4.3 pttt -61.3 150.13 35.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -46.74 176.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 109.886 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 55.99 91.96 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 2.0 tp-100 -151.52 -43.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -1.169 . . . . 0.0 109.644 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB1' ' CE1' ' A' ' 48' ' ' TYR . . . -58.29 146.09 72.33 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.618 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.77 -62.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.794 2.329 . . . . 0.0 110.761 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.33 46.51 3.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -160.79 114.03 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.176 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 48' ' ' TYR . 25.4 m -79.15 77.27 5.66 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.2 m-85 -46.23 -179.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.752 -0.593 . . . . 0.0 109.787 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.555 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.68 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.995 . . . . 0.0 108.971 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.46 -38.94 64.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.54 ' HB1' ' CG2' ' A' ' 75' ' ' ILE . . . -49.72 -64.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.608 ' ND2' ' CH2' ' A' ' 59' ' ' TRP . 2.4 t-20 -53.51 -41.16 66.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.868 -1.145 . . . . 0.0 109.373 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.536 ' N ' HG22 ' A' ' 40' ' ' THR . 24.5 tttm -52.1 -37.0 52.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -82.07 -23.44 35.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 110.33 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 28.9 tttt -76.4 3.07 11.87 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.985 -1.072 . . . . 0.0 109.671 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.2 11.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -103.8 132.01 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -96.67 112.41 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 108.648 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.608 ' CH2' ' ND2' ' A' ' 52' ' ' ASN . 6.1 m95 -59.95 105.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 110.047 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.99 -157.83 8.81 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.78 -63.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -1.118 . . . . 0.0 109.567 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -37.71 85.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.927 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.45 -45.07 92.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.827 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -66.78 -34.27 77.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.993 . . . . 0.0 109.271 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.51 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 2.5 tmm? -54.26 -38.41 65.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.397 -0.815 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.01 -60.81 2.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CD1' HG12 ' A' ' 75' ' ' ILE . 39.0 t80 -54.42 -17.71 3.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.781 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.1 tp -90.74 -31.22 16.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.023 -1.048 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.74 -27.34 66.42 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -177.75 100.61 0.22 Allowed Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 32.6 Cg_endo -76.34 -40.71 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.356 2.037 . . . . 0.0 110.262 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 9.5 tptm -70.84 -12.11 61.35 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -102.32 -35.66 8.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.965 . . . . 0.0 109.314 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 11.8 t80 -76.84 -69.35 0.53 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 108.618 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 5.6 mm -95.2 111.09 53.73 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.901 . . . . 0.0 109.214 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.15 70.24 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.289 1.993 . . . . 0.0 110.385 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -177.47 -38.3 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.555 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 13.4 t -44.71 158.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -108.54 -2.8 18.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.17 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' MET . 8.9 ptm -88.83 121.99 31.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.067 -1.021 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.24 45.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CB ' ' CE ' ' A' ' 80' ' ' MET . 48.4 t80 . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.51 ' NH1' ' HG2' ' A' ' 65' ' ' MET . 1.4 mtp180 -65.62 -47.47 75.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.168 -0.957 . . . . 0.0 109.089 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.58 65.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.888 . . . . 0.0 109.28 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -30.46 66.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.408 -0.807 . . . . 0.0 109.342 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.525 ' CD2' HG23 ' A' ' 9' ' ' ILE . 43.5 mt -65.46 -58.33 6.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 3.3 mm -66.14 -29.09 45.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 109.221 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.57 94.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.603 -0.685 . . . . 0.0 109.929 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.492 ' CD2' HD23 ' A' ' 98' ' ' LEU . 22.6 t80 -73.12 -52.94 12.35 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.109 -0.994 . . . . 0.0 109.245 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.529 ' O ' ' CG2' ' A' ' 102' ' ' THR . 1.4 mm? -60.43 -16.97 41.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.416 -0.803 . . . . 0.0 109.921 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -82.76 -48.04 11.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.883 -1.135 . . . . 0.0 109.463 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.29 77.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.9 -50.03 11.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 98' ' ' LEU . 13.8 t -120.27 40.33 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.948 -1.095 . . . . 0.0 110.368 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 10.9 t-20 -167.97 39.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.481 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.466 ' CG2' ' HE2' ' A' ' 100' ' ' LYS . 9.9 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.304 0.574 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 5' ' ' LYS . 15.4 pt-20 -53.47 -36.26 61.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 0.0 109.75 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -97.64 -14.11 21.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.06 -41.21 97.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 20.0 ttmt -61.94 -22.38 65.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.067 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -78.81 -40.41 33.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.086 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' CG2' HD21 ' A' ' 94' ' ' LEU . 42.8 mt -62.36 -50.95 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 108.798 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 34.5 t80 -62.55 -39.22 92.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 6.7 mm -61.48 -22.2 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.42 -0.8 . . . . 0.0 108.872 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.04 13.28 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 4.1 tptt -126.86 -55.74 1.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.188 . . . . 0.0 110.381 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -130.68 22.36 5.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.821 -1.174 . . . . 0.0 110.216 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 40.0 t -86.41 7.37 26.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.935 -1.103 . . . . 0.0 109.461 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -100.53 -54.58 2.81 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 10.5 m -82.85 -27.41 30.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.6 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 73.6 m-70 -115.2 88.8 2.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.135 -0.978 . . . . 0.0 110.059 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.2 p -78.7 83.37 4.86 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.045 -1.035 . . . . 0.0 108.457 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.432 HG13 ' CZ ' ' A' ' 10' ' ' PHE . 2.7 m -84.02 30.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 110.304 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.18 19.57 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.324 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -97.43 -61.1 1.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.23 62.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.54 16.1 54.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -92.0 144.7 25.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -1.155 . . . . 0.0 109.532 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.492 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.79 133.19 19.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 109.683 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 -77.13 0.58 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.511 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 52.5 m -90.53 -40.14 12.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.529 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.509 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -104.99 152.63 17.33 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HA ' ' CE2' ' A' ' 46' ' ' TYR . 31.4 Cg_endo -68.04 133.15 28.12 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.385 2.057 . . . . 0.0 111.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.445 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.4 t-20 -49.1 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.475 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.93 67.69 8.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.545 -0.722 . . . . 0.0 109.49 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 102' ' ' THR . 5.4 t-160 -98.24 -6.93 30.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 109.874 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.82 61.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -78.69 -30.98 46.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.27 -1.136 . . . . 0.0 109.858 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 83.6 m-85 -67.97 124.33 23.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.98 28.62 62.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.03 120.56 9.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.523 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 173.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.962 . . . . 0.0 109.212 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.495 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -85.57 175.44 8.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 60.67 96.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.86 -55.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.853 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -44.32 133.24 4.52 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.21 139.62 15.01 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.578 2.185 . . . . 0.0 110.605 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.07 -49.96 4.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.09 104.51 12.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.462 -1.022 . . . . 0.0 108.84 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.62 80.59 4.09 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 6.6 m-30 -44.35 173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -62.89 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.129 -0.982 . . . . 0.0 108.435 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -41.52 -37.83 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -0.763 . . . . 0.0 109.856 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . . . -39.78 -64.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.702 -0.624 . . . . 0.0 109.4 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.522 ' ND2' HG13 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -45.83 -51.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.868 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.493 ' CA ' ' OG1' ' A' ' 40' ' ' THR . 25.2 tttt -49.93 -41.45 46.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -71.46 -32.17 67.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.011 -1.055 . . . . 0.0 110.127 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.75 2.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.039 -1.038 . . . . 0.0 109.736 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.27 52.58 46.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.35 132.92 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -1.019 . . . . 0.0 110.371 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -95.29 97.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CD1' HD11 ' A' ' 35' ' ' LEU . 10.1 m95 -37.16 122.77 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.634 0.73 . . . . 0.0 111.127 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -143.04 -164.06 10.03 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -76.08 -73.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 0.0 109.617 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.53 -33.59 72.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.691 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -47.22 86.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 108.835 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -61.69 -35.83 79.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.46 -0.775 . . . . 0.0 109.005 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ttt -55.79 -35.12 65.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.412 -0.805 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' OE2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 tm-20 -71.94 -60.02 2.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.793 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.62 ' CD1' HG12 ' A' ' 75' ' ' ILE . 24.8 t80 -54.79 -21.17 10.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -88.02 -33.21 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.444 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.91 -23.92 66.63 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 9.9 t-20 -177.82 96.54 0.22 Allowed Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 32.2 Cg_endo -74.34 -30.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.446 2.097 . . . . 0.0 110.182 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -13.34 60.54 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 108.646 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -95.58 -46.32 6.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.117 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' OE2' ' A' ' 66' ' ' GLU . 13.2 t80 -71.46 -64.05 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.006 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.62 HG12 ' CD1' ' A' ' 67' ' ' TYR . 4.2 mm -79.31 126.44 81.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.7 Cg_endo -74.98 74.24 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.122 1.882 . . . . 0.0 110.692 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.39 33.37 1.62 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 71' ' ' PRO . 14.0 t -50.48 162.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.342 . . . . 0.0 108.929 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.62 12.35 35.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.949 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.538 ' O ' ' HG3' ' A' ' 80' ' ' MET . 6.3 ptm -130.57 128.64 41.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 81' ' ' ILE . 9.1 tp -109.41 40.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.302 -1.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.451 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -59.85 -50.67 72.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.161 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 -39.99 75.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.429 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -29.55 69.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.587 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.479 HD21 ' CG2' ' A' ' 9' ' ' ILE . 20.6 mt -64.25 -47.4 79.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.877 . . . . 0.0 109.186 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 3.6 mm -71.2 -30.84 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.137 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.03 79.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 101' ' ' ALA . 13.1 t80 -69.61 -33.59 72.89 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 108.951 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -78.63 -9.5 59.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.363 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.11 -16.52 17.81 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HE2' ' CG2' ' A' ' 3' ' ' VAL . 3.3 mtpt -108.9 -20.14 13.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . . . -91.08 -43.45 9.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.384 -0.822 . . . . 0.0 109.935 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.461 ' OG1' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -104.0 -59.27 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.677 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 5.2 t30 -53.2 -26.76 18.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 100' ' ' LYS . 29.5 tp10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.455 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.323 0.582 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -63.87 -15.83 59.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -82.15 -72.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -53.77 -28.2 38.14 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 35.4 tttt -65.98 -37.77 86.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 109.858 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -75.21 -26.07 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.528 ' CG2' HD22 ' A' ' 94' ' ' LEU . 33.4 mm -64.3 -60.79 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.506 ' CD1' HD22 ' A' ' 98' ' ' LEU . 39.5 t80 -61.28 -38.3 86.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 7' ' ' LYS . 49.4 mt -64.13 -22.49 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 tpp -122.84 16.03 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.126 -0.984 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 6.6 tppt? -127.57 -49.01 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.091 -1.006 . . . . 0.0 109.553 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 28.69 4.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.982 . . . . 0.0 108.88 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.1 t -86.66 -4.16 59.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -95.23 -43.48 8.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.246 -0.908 . . . . 0.0 108.917 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.489 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 7.0 m -91.26 -44.19 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.963 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.663 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 59.6 m-70 -101.92 81.81 2.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.047 . . . . 0.0 109.772 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 p -79.66 95.51 5.95 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.826 -1.171 . . . . 0.0 108.877 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 32' ' ' LEU . 3.0 m -82.37 13.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.867 . . . . 0.0 109.859 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.32 17.15 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 110.057 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -89.95 -23.94 21.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 109.709 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.35 60.36 0.55 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.71 9.53 52.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 3.5 tttp -91.61 130.76 37.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -1.166 . . . . 0.0 109.536 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.486 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.01 104.85 5.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 -82.03 0.13 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.13 -0.981 . . . . 0.0 110.181 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.404 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 10.8 m -89.9 -30.86 17.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -108.65 150.4 17.05 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.666 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -67.29 129.05 19.52 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.79 2.327 . . . . 0.0 111.103 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.486 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.0 t-20 -48.68 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.64 -0.663 . . . . 0.0 110.128 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.491 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -83.64 62.27 6.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 9.3 p80 -100.26 52.78 0.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.311 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 38' ' ' ARG . . . 118.74 64.49 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -78.3 -26.42 46.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -1.071 . . . . 0.0 110.269 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 7.1 m-30 -71.88 125.63 27.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.076 . . . . 0.0 110.981 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.07 -6.51 69.19 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.203 -0.999 . . . . 0.0 111.281 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.13 134.59 54.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.658 -1.495 . . . . 0.0 110.287 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -70.76 150.42 45.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.501 ' OG1' ' NE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -60.95 163.77 5.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.018 . . . . 0.0 110.212 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.66 99.27 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -160.78 -34.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.258 . . . . 0.0 110.026 179.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.62 128.7 85.14 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.065 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.7 149.73 21.03 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.531 2.154 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.49 -14.2 55.82 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -126.02 111.64 14.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -1.073 . . . . 0.0 108.3 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' TYR . 2.0 p -74.27 78.84 1.82 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.666 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.8 m-85 -48.18 179.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.528 HG22 ' CA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.9 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.16 -40.76 11.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.623 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -53.88 -67.85 0.23 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.449 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.581 ' N ' HG22 ' A' ' 75' ' ' ILE . 2.1 m120 -36.26 -53.8 0.82 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.443 -0.785 . . . . 0.0 111.078 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -55.37 -59.49 4.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.931 -1.106 . . . . 0.0 110.176 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.04 -12.43 11.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.347 -0.846 . . . . 0.0 110.675 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -79.31 5.75 11.68 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.861 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.16 45.88 10.23 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.39 114.06 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -1.125 . . . . 0.0 109.868 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.35 108.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.551 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 4.9 m95 -46.74 113.63 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.52 179.24 17.24 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.1 -60.49 2.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.277 . . . . 0.0 109.535 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.49 -41.72 98.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.676 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.58 -32.44 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.694 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 HD13 HD22 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -78.58 -32.73 47.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.753 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 tpp -60.54 -35.76 76.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -54.07 7.53 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.562 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 45.6 t80 -56.13 -26.5 50.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.1 tp -81.97 -39.54 23.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -59.87 -23.18 63.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 9.3 m120 -168.33 96.22 0.58 Allowed Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 32.0 Cg_endo -77.08 -29.91 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.417 2.078 . . . . 0.0 110.44 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -85.29 -31.87 22.83 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.318 -0.863 . . . . 0.0 109.516 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 3.6 mmmt -78.57 -35.29 46.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.001 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.566 ' CE2' HD12 ' A' ' 75' ' ' ILE . 22.1 t80 -75.81 -69.05 0.52 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 52' ' ' ASN . 5.6 mm -101.16 117.73 61.68 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 61.37 8.21 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.428 2.086 . . . . 0.0 110.017 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.45 -48.3 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.528 ' CA ' HG22 ' A' ' 49' ' ' THR . 7.4 t -50.68 167.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.283 . . . . 0.0 109.847 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -135.48 10.19 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.544 ' CE ' ' HB3' ' A' ' 82' ' ' PHE . 6.8 ptm -76.41 123.33 25.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mt -97.87 35.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 4.4 t80 . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.539 . . . . 0.0 109.888 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.129 0.49 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.19 66.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 0.0 109.04 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.61 79.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 109.213 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -59.37 -35.9 74.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' A' ' 9' ' ' ILE . 38.1 mt -58.67 -46.42 87.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 3.2 mm -67.85 -49.03 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 0.0 110.039 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.19 -39.19 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.435 -0.79 . . . . 0.0 110.394 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 36.7 t80 -70.51 -50.67 35.4 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.999 -1.063 . . . . 0.0 110.085 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 10' ' ' PHE . 2.3 mm? -72.23 -4.49 29.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -99.49 -20.46 16.41 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.157 -0.964 . . . . 0.0 109.883 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -107.28 -20.08 13.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.647 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.92 -36.34 12.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 110.003 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 47.38 2.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.638 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 6.4 t-20 -171.93 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 109.35 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 12.7 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.24 0.543 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 3.8 mt-10 -64.55 -19.9 65.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' HG12 ' A' ' 9' ' ' ILE . 9.9 mttt -91.55 -33.26 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.48 -20.55 75.54 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 25.4 ttpt -70.58 -32.98 70.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -1.118 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' HA ' ' HB ' ' A' ' 11' ' ' ILE . 6.6 mttp -85.46 -31.8 22.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.543 ' CG2' HD23 ' A' ' 94' ' ' LEU . 29.4 mm -57.62 -57.33 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.009 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.524 ' CD2' HD22 ' A' ' 98' ' ' LEU . 20.6 t80 -67.33 -41.65 84.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 108.989 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 8.7 mm -55.85 -18.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 109.108 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 ttt -119.21 -5.89 10.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.94 -62.03 1.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.586 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -126.49 41.92 3.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.028 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -95.45 -1.1 51.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.828 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.17 -35.26 9.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 108.764 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.7 m -99.96 -21.43 15.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.605 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 76.0 m-70 -126.15 80.42 1.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 0.0 109.742 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -79.0 90.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.514 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.7 8.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 110.394 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -164.94 23.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.927 -1.108 . . . . 0.0 109.9 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 22' ' ' LYS . 2.9 tmtp? -100.62 37.47 1.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.133 -0.979 . . . . 0.0 109.199 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.63 -30.45 8.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.19 8.64 40.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -95.32 117.63 30.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.209 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -90.69 172.05 8.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.052 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -160.01 -91.62 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.372 -0.83 . . . . 0.0 108.912 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 11.5 m -65.2 -59.76 3.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 108.741 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -95.86 153.9 20.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 33.2 Cg_endo -69.49 134.42 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.176 1.917 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' HIS . 6.9 t-20 -46.55 101.4 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.8 41.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 109.911 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -91.33 70.85 6.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' N ' HG22 ' A' ' 102' ' ' THR . . . 117.36 19.37 5.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.598 ' CD2' ' CD1' ' A' ' 59' ' ' TRP . 17.9 tp -53.77 -29.81 41.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.142 . . . . 0.0 109.508 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' HB3' ' OD1' ' A' ' 103' ' ' ASN . 14.4 m-85 -69.85 135.56 49.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.29 83.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.496 ' NH1' HD12 ' A' ' 35' ' ' LEU . 31.2 ttp85 -155.21 123.75 6.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.257 . . . . 0.0 109.599 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -61.7 164.86 5.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.195 -0.94 . . . . 0.0 109.063 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 5.8 t -101.53 169.6 8.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.515 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.496 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 88.93 67.43 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -161.8 -32.07 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.138 -1.213 . . . . 0.0 110.739 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -36.39 141.15 0.37 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.785 . . . . 0.0 110.331 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.58 128.21 9.34 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.626 2.217 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.46 -47.35 3.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -100.5 63.84 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.482 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 m -62.9 95.46 0.08 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 30' ' ' PRO . 1.5 m-30 -50.91 -179.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.756 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.2 p -59.58 90.37 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.001 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -31.4 -35.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.701 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -39.7 -62.93 0.63 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.554 ' CB ' HG22 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -38.78 -69.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 110.665 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.458 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 2.3 tmtt? -43.12 -38.97 2.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -66.14 -41.91 89.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 110.488 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HG2' ' CE2' ' A' ' 74' ' ' TYR . 45.4 tptt -50.68 -20.42 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 109.123 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.57 39.47 97.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' C ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -103.88 119.04 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.605 -0.938 . . . . 0.0 110.373 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -82.17 100.78 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 6.3 m95 -38.81 118.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 111.05 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.13 -159.61 9.61 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HA ' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -77.41 -63.02 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.11 -1.229 . . . . 0.0 109.735 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.28 -35.79 71.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.172 -0.955 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -46.27 89.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.095 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -70.22 -36.08 74.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.27 45.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.76 -50.07 59.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.51 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.618 ' CD1' HG12 ' A' ' 75' ' ' ILE . 54.3 t80 -54.87 -21.86 12.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.756 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.73 -38.11 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.25 -23.51 62.41 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.27 95.04 0.23 Allowed Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.5 Cg_endo -73.7 -36.34 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.354 2.036 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -70.37 -9.06 55.2 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 108.927 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -91.91 -50.21 5.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' CD2' HD12 ' A' ' 75' ' ' ILE . 7.0 t80 -71.89 -64.93 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.618 HG12 ' CD1' ' A' ' 67' ' ' TYR . 4.7 mm -91.35 108.93 32.41 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.6 Cg_endo -77.76 73.15 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.311 2.007 . . . . 0.0 110.291 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.489 ' C ' ' CG2' ' A' ' 49' ' ' THR . . . 171.34 -28.97 0.11 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.924 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 t -50.4 134.1 23.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.849 -1.383 . . . . 0.0 109.45 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.78 12.0 37.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.565 ' O ' ' HG3' ' A' ' 80' ' ' MET . 5.3 ptm -87.23 123.16 31.94 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.94 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 81' ' ' ILE . 37.4 mm -109.44 36.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HB3' ' HE3' ' A' ' 80' ' ' MET . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.976 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.199 0.523 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -52.51 -42.54 64.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 109.341 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.61 87.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -30.11 70.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.543 HD23 ' CG2' ' A' ' 9' ' ' ILE . 42.2 mt -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 2.3 mm -75.23 -34.39 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.566 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -47.13 81.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 109.947 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -70.16 -44.21 69.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.524 HD22 ' CD2' ' A' ' 10' ' ' PHE . 1.5 mm? -71.38 -7.7 48.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.1 -1.0 . . . . 0.0 109.434 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.08 -16.93 17.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.776 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -104.11 -26.44 12.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 110.14 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.7 -45.74 9.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.146 -0.971 . . . . 0.0 110.295 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.497 HG22 ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -114.2 38.51 3.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.699 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' LYS . 1.2 t30 -176.41 61.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 6.5 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 4.0 tm-20 -59.06 -24.36 62.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.383 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.2 tptm -75.12 -53.44 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 97' ' ' TYR . . . -72.18 -67.66 1.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -39.66 -35.27 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.44 -1.035 . . . . 0.0 110.305 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.55 -44.29 57.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 0.0 109.53 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -72.42 -65.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.705 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 15' ' ' SER . 18.3 t80 -46.05 -40.83 11.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.726 -1.234 . . . . 0.0 109.803 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 15' ' ' SER . 6.9 mm -62.05 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.023 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -107.51 20.12 19.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.129 -0.982 . . . . 0.0 109.842 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -126.96 -61.33 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.772 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 1.9 m -113.3 5.07 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 0.0 110.161 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -88.79 27.23 1.35 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.809 -1.182 . . . . 0.0 109.244 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.32 -61.08 1.46 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.444 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.3 m -80.02 -30.83 39.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.646 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 66.4 m-70 -102.18 173.56 6.32 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.044 0.926 . . . . 0.0 109.46 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 18' ' ' HIS . 20.9 p -161.85 92.77 0.87 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 32' ' ' LEU . 3.5 m -84.14 34.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.78 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.416 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 8.9 tptt -101.23 35.89 2.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.85 -35.28 4.03 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.76 0.18 6.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 137.92 37.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.534 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -120.04 102.53 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.01 . . . . 0.0 110.475 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.72 -74.58 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.59 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 66.4 m -89.77 -99.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 17' ' ' CYS . . . -51.73 150.62 7.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.646 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.4 Cg_endo -69.81 156.67 62.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 111.417 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.534 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -63.26 102.1 0.36 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 30' ' ' PRO . 3.7 mp -79.05 71.17 5.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 109.997 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -100.51 -57.71 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.044 . . . . 0.0 109.013 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -111.24 23.1 19.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.3 tt -44.25 -36.02 2.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -1.082 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 4.4 m-30 -65.81 142.1 58.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.371 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 15.28 61.47 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 5.4 tmm_? -136.76 142.77 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -1.152 . . . . 0.0 109.589 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -82.07 -171.54 3.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -92.92 -176.73 4.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.873 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 51.09 101.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -157.92 -77.1 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.238 . . . . 0.0 110.193 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -40.84 136.51 1.53 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.966 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.59 152.27 29.45 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.707 2.271 . . . . 0.0 110.265 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.63 -53.03 4.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.7 OUTLIER -99.35 69.86 1.7 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.421 -1.046 . . . . 0.0 108.621 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 p -67.8 97.72 0.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 30' ' ' PRO . 1.4 m-30 -53.52 -175.72 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.769 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.3 t -60.9 88.02 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -36.84 -32.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.313 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . . . -45.13 -63.03 1.02 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.718 -0.613 . . . . 0.0 109.464 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.526 ' CA ' HG21 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.75 -52.99 6.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.973 . . . . 0.0 109.404 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -50.52 -42.32 54.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 109.664 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.56 -42.83 99.79 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.865 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -49.71 -21.13 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.049 -1.032 . . . . 0.0 109.272 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.3 46.48 78.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.497 HD12 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -104.05 123.12 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.531 -0.982 . . . . 0.0 110.249 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -87.71 100.9 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 7.4 m95 -40.2 116.72 0.7 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.825 0.822 . . . . 0.0 110.82 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -148.19 -154.09 6.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -77.68 -74.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.262 . . . . 0.0 109.588 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.45 -34.72 78.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 110.301 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -64.42 -56.13 16.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.274 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -64.94 -21.88 66.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.9 ttt -67.14 -32.66 73.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.315 -0.865 . . . . 0.0 109.021 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -54.42 6.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.412 -0.805 . . . . 0.0 109.794 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.667 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 4.9 t80 -54.99 -36.89 65.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.926 -1.109 . . . . 0.0 109.168 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.68 -27.85 50.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.36 -26.66 65.25 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.555 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.28 101.95 0.24 Allowed Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' A' ' 67' ' ' TYR . 30.6 Cg_endo -74.56 -27.09 11.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.372 2.048 . . . . 0.0 109.838 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -78.27 -19.33 53.88 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.598 -0.689 . . . . 0.0 109.371 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -97.53 -29.92 13.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.024 -1.048 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 67' ' ' TYR . 3.7 t80 -80.81 -70.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 67' ' ' TYR . 1.6 mm -85.63 119.2 71.88 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 33.4 Cg_endo -73.25 82.83 1.54 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 110.482 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 113.02 26.24 4.16 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLY . 14.7 t -43.99 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.039 -1.271 . . . . 0.0 109.293 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 10.6 mmtm -93.9 0.75 56.32 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.783 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.536 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 2.5 ptt? -118.1 119.31 34.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.07 -1.019 . . . . 0.0 109.727 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.4 mm -89.51 49.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.286 -0.883 . . . . 0.0 108.919 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 35.1 t80 . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.371 -0.831 . . . . 0.0 109.183 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.206 0.526 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.73 -39.04 57.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.584 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.6 75.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.469 ' OD2' ' CG ' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -66.43 -28.89 68.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.0 mt -73.82 -62.04 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 95' ' ' ILE . 4.2 mm -61.06 -30.42 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.85 77.69 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 110.35 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.467 ' HB2' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t80 -63.53 -47.47 81.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.034 -1.042 . . . . 0.0 110.442 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mm? -63.25 -29.2 70.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.596 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HG2' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -66.27 -36.8 83.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.023 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.27 -18.48 36.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.95 47.08 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.907 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.5 HG21 ' N ' ' A' ' 103' ' ' ASN . 6.7 t -132.85 -43.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.067 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.512 ' CB ' ' HG2' ' A' ' 99' ' ' LYS . 7.2 t-20 -63.43 -11.83 26.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 0.0 109.546 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 4' ' ' GLU . 11.4 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.266 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 3' ' ' VAL . 39.1 mt-10 -76.23 -31.23 58.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.651 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' HD13 ' A' ' 9' ' ' ILE . 3.7 tppt? -73.14 -55.37 6.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.73 97.45 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 3.3 ttpm? -65.06 -18.82 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -40.7 54.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.512 HG22 ' CG ' ' A' ' 94' ' ' LEU . 2.9 mp -67.26 -60.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' SER . 38.9 t80 -52.03 -44.78 64.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.115 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.5 HD12 ' CG ' ' A' ' 7' ' ' LYS . 20.2 mt -56.68 -38.01 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 24.8 12.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.043 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -130.23 -62.31 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.285 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -120.6 26.43 9.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.206 -0.934 . . . . 0.0 108.81 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 3.0 t -82.81 4.73 24.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 3.6 tp-100 -99.83 -54.52 2.89 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 108.712 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 44.7 m -83.21 -22.26 33.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.653 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 72.8 m-70 -123.31 89.34 3.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.894 . . . . 0.0 109.861 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -93.42 96.28 9.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.96 -1.087 . . . . 0.0 108.806 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.2 m -85.29 31.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.384 -0.823 . . . . 0.0 109.941 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.98 7.19 2.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.017 -1.052 . . . . 0.0 109.708 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -149.47 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.01 36.73 3.92 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.16 80.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.94 159.16 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -141.04 140.77 34.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 -60.88 1.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 HG22 ' SG ' ' A' ' 17' ' ' CYS . 85.0 m -100.17 -61.28 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -93.49 156.29 22.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 29.9 Cg_endo -66.77 135.78 39.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.62 2.213 . . . . 0.0 111.335 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.62 103.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 109.534 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.576 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.35 46.1 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 46.1 t60 -96.06 69.34 2.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 108.822 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 102' ' ' THR . . . 117.98 16.33 5.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.505 HD13 ' NH1' ' A' ' 38' ' ' ARG . 23.0 tp -52.58 -30.69 32.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.507 -0.996 . . . . 0.0 109.872 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 3.3 m-85 -60.9 141.04 57.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.443 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.34 70.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 3.4 tmm_? -135.28 125.63 26.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -1.128 . . . . 0.0 109.382 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 19.1 mttp -72.3 173.39 8.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -74.05 170.26 15.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.738 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 67.03 108.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' NE2' ' HD2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -160.95 -63.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.976 -1.308 . . . . 0.0 109.91 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -41.75 150.63 0.35 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.266 -0.896 . . . . 0.0 109.906 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.4 -75.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.836 2.357 . . . . 0.0 110.587 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.72 66.02 3.96 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -160.58 120.97 2.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 108.998 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.52 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 40.4 t -84.07 70.55 10.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.9 m-85 -44.69 179.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.701 -0.625 . . . . 0.0 110.174 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -57.79 88.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 108.886 179.407 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.54 -41.4 66.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.54 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -51.48 -70.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 108.77 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.584 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -40.28 -47.28 2.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 110.062 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.95 -57.25 6.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.28 -33.62 75.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.533 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -14.07 6.3 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.114 -0.992 . . . . 0.0 109.824 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 40.81 97.02 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 HG21 ' ND2' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -95.29 133.34 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 0.0 110.034 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.54 112.48 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.617 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 10.0 m95 -54.17 101.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 110.245 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.46 -164.88 12.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -73.97 -67.67 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.01 89.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.872 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -36.31 76.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.7 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -80.24 -27.28 38.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttt -57.03 -47.03 81.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 0.0 109.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.32 -51.56 20.12 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.378 -0.827 . . . . 0.0 109.823 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.617 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 51.9 t80 -54.09 -22.7 11.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 109.664 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.6 tp -90.35 -29.77 17.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.0 109.178 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.75 -24.75 65.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.552 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -175.75 102.27 0.25 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.7 Cg_endo -76.61 -37.47 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.35 2.033 . . . . 0.0 110.258 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -75.13 -17.82 60.34 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.334 -0.853 . . . . 0.0 110.266 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.552 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -94.39 -37.65 11.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.856 -1.152 . . . . 0.0 109.581 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CE2' HD13 ' A' ' 75' ' ' ILE . 1.9 t80 -76.6 -66.06 0.86 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.869 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' CD1' ' ND2' ' A' ' 52' ' ' ASN . 8.1 mm -101.06 106.47 44.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.362 -0.836 . . . . 0.0 109.532 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.86 71.18 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.391 2.06 . . . . 0.0 110.024 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -173.42 -42.12 0.04 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.546 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 14.6 t -43.49 158.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 3.69 21.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.489 -0.757 . . . . 0.0 109.411 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.567 ' O ' ' HG3' ' A' ' 80' ' ' MET . 9.8 ptm -92.87 118.14 30.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.992 . . . . 0.0 109.934 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mm -92.66 48.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.547 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 15.3 t80 . . . . . 0 C--N 1.301 -1.5 0 CA-C-O 121.514 0.673 . . . . 0.0 110.173 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.245 0.545 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.462 ' HA ' HD11 ' A' ' 94' ' ' LEU . 7.8 ttp180 -56.6 -45.43 81.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.96 -49.38 70.54 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.235 -0.916 . . . . 0.0 109.596 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -21.43 60.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.767 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.512 ' CG ' HG22 ' A' ' 9' ' ' ILE . 22.2 mt -72.68 -59.64 2.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.404 ' N ' HD11 ' A' ' 95' ' ' ILE . 5.3 mm -56.57 -49.79 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.403 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.94 70.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.611 -0.68 . . . . 0.0 109.633 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 4.5 t80 -53.07 -49.82 65.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.255 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 1.1 mt -82.65 -12.97 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.3 ttmt -79.34 -10.94 59.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.169 -0.957 . . . . 0.0 108.906 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -110.55 -40.06 4.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.91 -55.6 4.86 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.263 -0.898 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.569 ' CG2' ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -99.56 30.48 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 9.3 t-20 -165.01 64.85 0.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.389 179.784 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 4' ' ' GLU . 9.7 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.214 0.53 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' N ' HG12 ' A' ' 3' ' ' VAL . 4.1 mm-40 -67.15 -40.34 86.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -49.67 -34.77 21.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -57.83 -45.11 86.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -1.138 . . . . 0.0 109.737 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.62 -27.58 60.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.636 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 93' ' ' ASP . 51.1 mt -60.25 -53.8 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 6.9 t80 -73.76 -46.6 44.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.257 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 11' ' ' ILE . 22.7 mm -56.42 -16.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -120.73 -6.66 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 15.8 tppt? -101.98 -65.81 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 109.858 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -112.04 29.4 7.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.8 t -89.9 -1.15 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.733 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -94.78 -35.6 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.241 -0.912 . . . . 0.0 108.724 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 16.9 m -103.43 -26.28 12.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.654 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 75.4 m-70 -117.51 78.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.035 -1.041 . . . . 0.0 109.649 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.1 p -78.66 94.8 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.178 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -82.16 22.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 0.0 110.519 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -151.21 20.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.902 -1.124 . . . . 0.0 109.467 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.48 -17.97 27.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.65 -27.1 3.11 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.56 -0.94 3.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -88.34 164.68 15.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.076 -1.25 . . . . 0.0 109.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.539 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.994 -1.066 . . . . 0.0 110.234 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -71.02 -75.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 108.867 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.459 HG21 ' SG ' ' A' ' 17' ' ' CYS . 93.7 m -99.81 -58.89 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 108.713 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -83.2 155.53 32.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.8 Cg_endo -67.88 143.36 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.498 2.132 . . . . 0.0 111.048 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.4 t-20 -56.25 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 110.075 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -85.02 55.44 3.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.403 -0.81 . . . . 0.0 109.826 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -96.99 48.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.269 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.43 62.26 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.4 tp -79.91 -31.22 40.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.395 -1.062 . . . . 0.0 109.872 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -60.32 137.21 58.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.047 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.4 27.98 73.08 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 58.1 ttp85 -139.96 123.59 17.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.983 -1.304 . . . . 0.0 109.742 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.524 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -64.45 175.59 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.156 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 53' ' ' LYS . 7.5 t -94.81 -173.92 3.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.11 -0.994 . . . . 0.0 109.82 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 91.61 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.637 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 2.2 pm0 -159.44 -36.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.182 -1.187 . . . . 0.0 109.807 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -70.17 137.4 86.88 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 109.566 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.35 173.98 12.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.45 2.1 . . . . 0.0 110.359 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.37 5.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -145.61 121.19 10.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.11 . . . . 0.0 109.12 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -85.04 66.16 9.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.637 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.9 m-85 -43.97 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.722 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -67.28 86.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -44.22 -34.97 2.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . . . -51.17 -59.99 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.62 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 19.4 t-20 -52.85 -52.97 55.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.45 ' N ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.85 -33.44 7.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.318 -0.864 . . . . 0.0 109.297 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -77.87 -35.71 50.62 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.383 -0.823 . . . . 0.0 109.772 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -61.11 -11.96 10.59 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.072 -1.018 . . . . 0.0 109.574 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.98 35.93 78.53 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -87.51 125.45 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.667 -0.902 . . . . 0.0 110.324 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -87.15 95.33 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 5.3 m95 -34.87 121.79 0.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -142.87 -166.51 11.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -65.26 0.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -1.201 . . . . 0.0 109.779 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -60.45 -38.83 85.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.946 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -36.46 75.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 109.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.9 OUTLIER -76.24 -24.09 54.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.172 -0.955 . . . . 0.0 109.347 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -42.02 78.49 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.19 -50.94 13.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 75' ' ' ILE . 23.6 t80 -49.72 -44.99 48.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.379 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.451 HD23 ' NH1' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -73.59 -32.15 63.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -25.8 63.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.58 84.11 0.34 Allowed Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 33.0 Cg_endo -76.4 -22.13 12.72 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.645 2.23 . . . . 0.0 109.354 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -75.59 -16.56 60.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -101.45 -38.69 7.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.457 -0.777 . . . . 0.0 109.239 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 11.4 t80 -73.47 -66.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 4.3 mm -97.53 106.72 34.77 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.75 83.46 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.259 1.973 . . . . 0.0 110.595 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 149.91 -14.37 1.02 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 8.1 t -43.68 132.38 4.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.239 . . . . 0.0 109.908 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 23.8 4.37 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.3 mmm -59.17 125.4 23.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.753 -0.592 . . . . 0.0 109.81 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 mm -89.09 17.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.611 -0.681 . . . . 0.0 109.929 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.341 0.591 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -67.86 -51.84 43.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.89 80.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 109.237 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 9' ' ' ILE . 96.1 m-20 -60.48 -28.96 68.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.384 -0.823 . . . . 0.0 109.592 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 18.0 mt -65.05 -51.92 58.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.6 mm -59.59 -37.59 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.58 99.63 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.582 -0.699 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.1 -46.63 76.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.086 -1.009 . . . . 0.0 109.673 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 98' ' ' LEU . 2.0 mm? -72.89 -15.21 61.59 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 2.0 ttpt -76.81 -32.95 57.97 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -38.83 13.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.891 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.43 -56.77 6.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.64 35.85 4.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.25 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -160.77 47.43 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.698 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.344 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.77 -41.47 37.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -40.65 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 9' ' ' ILE . . . -67.11 -50.86 42.91 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.573 ' HA ' ' CG ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -56.39 -27.2 55.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -79.25 -33.84 43.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 0.0 109.216 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 12.7 mt -60.98 -57.1 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.3 t80 -59.59 -46.24 89.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.093 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 15.1 mm -57.81 -22.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.807 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 ttt -122.31 10.75 9.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 22.4 tptt -122.94 -56.52 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.072 . . . . 0.0 109.591 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -118.47 22.0 12.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -84.96 2.86 41.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.986 . . . . 0.0 109.597 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -100.11 -41.66 7.05 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.871 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 13.1 m -95.18 -26.36 16.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.621 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 73.9 m-70 -115.09 81.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -0.891 . . . . 0.0 109.808 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 p -78.69 83.27 4.86 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.083 -1.01 . . . . 0.0 108.553 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 4.5 m -82.78 45.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.169 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -165.96 24.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.003 -1.06 . . . . 0.0 109.785 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 25' ' ' LYS . 42.7 tttp -100.22 -73.22 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.48 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.95 52.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 4.98 51.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 9.3 tppt? -91.21 144.86 25.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 109.213 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -133.04 114.88 14.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.901 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.92 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.328 -0.857 . . . . 0.0 109.28 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -99.9 -47.65 4.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.229 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -84.27 153.4 29.08 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 30.6 Cg_endo -68.74 133.53 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.672 2.248 . . . . 0.0 111.256 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.4 t-20 -50.92 99.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.47 0.652 . . . . 0.0 109.59 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.487 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -80.93 70.87 7.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 109.78 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 28.1 p-80 -100.59 -48.99 4.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 109.901 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 33' ' ' HIS . . . -120.96 30.78 5.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.58 -40.09 8.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -1.193 . . . . 0.0 109.043 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 65.0 m-85 -68.61 147.44 51.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.29 17.59 11.95 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' NH1' ' HB3' ' A' ' 42' ' ' GLN . 7.3 ttp85 -147.2 116.08 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -1.211 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -59.39 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 108.94 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -79.53 -164.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.614 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA3' ' CD ' ' A' ' 53' ' ' LYS . . . 53.99 101.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -154.45 -30.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.24 . . . . 0.0 110.558 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.479 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -95.38 135.93 22.9 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.719 -1.238 . . . . 0.0 109.552 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.89 136.96 13.62 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.607 2.204 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.29 -24.45 13.8 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -99.2 108.63 21.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -1.053 . . . . 0.0 108.673 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -76.18 80.17 2.98 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 1.8 m-85 -47.96 -179.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.655 -0.653 . . . . 0.0 109.242 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 78' ' ' THR . 0.1 OUTLIER -58.19 88.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.13 -37.31 61.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.459 -0.776 . . . . 0.0 109.707 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.508 ' HB3' HG23 ' A' ' 75' ' ' ILE . . . -59.15 -46.29 88.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.586 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.642 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 21.9 t-20 -64.37 -54.55 31.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.041 . . . . 0.0 110.008 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.421 ' CD ' ' HA3' ' A' ' 41' ' ' GLY . 6.2 tttt -50.81 -38.24 47.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.104 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -81.32 -24.1 37.38 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.621 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -65.31 -10.42 32.49 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.141 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.24 63.99 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.545 HD12 HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.07 121.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -1.117 . . . . 0.0 110.256 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -84.66 99.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 m95 -37.82 110.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.606 0.717 . . . . 0.0 110.839 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -129.76 -168.16 12.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.91 -57.22 4.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -1.183 . . . . 0.0 109.877 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.14 -42.18 80.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.291 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -38.39 77.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.999 -1.063 . . . . 0.0 109.286 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -71.59 -33.34 68.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 108.82 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.0 ttp -54.04 -38.22 64.96 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.408 -0.807 . . . . 0.0 109.317 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.95 -57.02 4.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 39.1 t80 -49.16 -31.27 8.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 64' ' ' LEU . 1.1 mp -81.83 -38.14 25.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.052 -1.03 . . . . 0.0 109.266 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -59.08 -22.69 61.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.8 p30 -179.6 99.0 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -74.22 -33.72 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.403 2.069 . . . . 0.0 110.257 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -13.99 60.26 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.896 . . . . 0.0 108.933 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 2.8 tptm -92.71 -45.11 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.5 t80 -72.2 -67.59 0.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 18.3 mm -95.74 107.48 34.08 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.6 Cg_endo -77.57 78.12 3.63 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.244 1.963 . . . . 0.0 110.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 164.8 -23.09 0.15 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.477 ' HA ' HG22 ' A' ' 49' ' ' THR . 13.7 t -43.63 155.49 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.008 -1.289 . . . . 0.0 109.768 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -111.04 8.49 21.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.012 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 80' ' ' MET . 5.7 ptm -96.4 118.05 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.94 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.1 mm -84.03 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.484 -0.76 . . . . 0.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' HB3' ' HG3' ' A' ' 71' ' ' PRO . 9.6 t80 . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 108.984 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -56.66 8.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 109.635 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.51 30.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.25 -42.31 99.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -0.809 . . . . 0.0 110.126 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 90' ' ' GLU . 6.5 mt -56.25 -44.92 80.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.553 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -65.83 -42.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.67 16.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.687 . . . . 0.0 110.004 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.573 ' CG ' ' HA ' ' A' ' 7' ' ' LYS . 20.8 t80 -73.85 -46.28 45.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.07 -1.019 . . . . 0.0 109.425 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -71.4 -4.38 26.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.321 -0.862 . . . . 0.0 109.812 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.9 -46.61 8.08 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -79.45 -33.64 42.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.472 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 97' ' ' TYR . . . -68.8 -53.81 19.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 19.3 p -104.03 -37.85 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.959 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 16.0 t30 -85.05 19.43 2.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 10.0 tt0 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.07 . . . . 0.0 109.477 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.173 0.511 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -62.28 -44.07 97.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.612 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -71.52 -32.77 68.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.775 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -56.57 19.17 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 7.5 ttmt -54.8 -26.58 35.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.302 -1.117 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.78 -36.19 65.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.296 -0.878 . . . . 0.0 108.909 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 43.4 mm -58.21 -59.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 108.718 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 15' ' ' SER . 30.6 t80 -58.66 -41.3 85.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 109.099 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.557 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -54.26 -30.97 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.112 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.458 ' N ' HG23 ' A' ' 11' ' ' ILE . 3.4 ttt -114.88 7.32 15.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.245 -0.909 . . . . 0.0 110.954 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.21 -61.33 1.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.214 . . . . 0.0 110.275 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -127.44 24.71 6.2 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.065 . . . . 0.0 109.78 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.557 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 38.7 t -88.2 2.65 51.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.139 . . . . 0.0 109.824 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -100.59 -55.11 2.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 34.0 m -81.0 -25.52 37.19 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.644 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 72.8 m-70 -119.39 89.49 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.106 -0.996 . . . . 0.0 109.766 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.7 p -78.43 83.64 4.64 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.5 m -80.9 36.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.457 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -161.6 21.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.072 -1.017 . . . . 0.0 109.244 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -73.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.88 55.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.5 18.52 67.88 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.63 132.28 45.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -1.21 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.533 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -127.09 101.04 6.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 110.069 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -70.0 -63.71 1.03 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.522 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 20.4 m -104.69 -76.76 0.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -71.26 159.34 53.85 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.644 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.9 Cg_endo -68.99 142.89 52.66 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.447 2.098 . . . . 0.0 110.901 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -58.86 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.833 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.587 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -81.68 73.65 8.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.459 -0.776 . . . . 0.0 109.825 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.74 -62.94 1.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.26 28.03 11.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.402 HD21 ' HG ' ' A' ' 32' ' ' LEU . 47.9 tp -49.66 -26.37 3.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -1.059 . . . . 0.0 109.835 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 102' ' ' THR . 13.1 m-85 -72.78 130.92 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.24 79.64 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' ARG . 7.1 ttp85 -133.97 126.99 31.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.136 -1.214 . . . . 0.0 109.667 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -61.82 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.515 HG21 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -97.55 -179.31 4.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -0.928 . . . . 0.0 109.769 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.44 97.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.583 ' OE1' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -160.74 -33.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.986 -1.302 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.21 138.49 96.04 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.973 -1.079 . . . . 0.0 109.601 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.45 -34.4 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.63 2.22 . . . . 0.0 110.676 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.93 49.08 1.04 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -160.21 128.37 4.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.027 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -86.29 54.24 3.08 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.1 m-85 -31.59 149.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.29 0.567 . . . . 0.0 110.19 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.474 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -58.76 90.76 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.6 -34.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.275 0.559 . . . . 0.0 109.556 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . . . -56.03 -64.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.476 -0.765 . . . . 0.0 109.495 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.553 ' OD1' ' CG2' ' A' ' 75' ' ' ILE . 3.6 m120 -36.52 -40.29 0.24 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -47.12 63.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.63 -17.13 63.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -66.45 -7.09 17.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.47 49.29 33.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 ' O ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -116.53 145.15 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -100.93 96.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.703 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 8.1 m95 -40.91 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.419 -0.8 . . . . 0.0 110.492 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -123.22 -153.88 8.87 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG2' HG22 ' A' ' 95' ' ' ILE . 2.0 mt-10 -76.13 -70.83 0.42 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -1.129 . . . . 0.0 109.724 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -37.36 86.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -49.17 78.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.091 -1.006 . . . . 0.0 109.511 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CD2' HD12 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -67.51 -31.96 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.181 -0.949 . . . . 0.0 109.382 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -31.87 66.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -77.91 -54.95 5.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.703 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 5.4 t80 -57.98 -19.7 32.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.514 HD12 ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -93.25 -34.47 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.912 -1.117 . . . . 0.0 109.842 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -58.84 -24.86 62.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 20.4 t-20 -170.6 95.67 0.45 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -74.59 -40.58 1.02 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.352 2.034 . . . . 0.0 110.257 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -8.11 41.1 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.274 -0.892 . . . . 0.0 108.922 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -104.05 -34.53 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.429 -0.794 . . . . 0.0 109.251 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.569 ' CD2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 t80 -76.52 -70.0 0.48 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.543 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 67' ' ' TYR . 2.7 mm -86.05 117.11 68.13 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.76 81.36 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.264 1.976 . . . . 0.0 110.742 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.7 -4.26 2.71 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.452 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 15.2 t -54.21 163.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.784 -1.421 . . . . 0.0 109.546 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.11 21.18 7.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.472 ' HE2' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -58.77 109.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.04 43.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' HB3' ' HE2' ' A' ' 80' ' ' MET . 11.2 t80 . . . . . 0 N--CA 1.488 1.429 0 O-C-N 121.724 -0.61 . . . . 0.0 110.542 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.288 0.566 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -54.33 -40.8 68.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.703 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.2 96.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.914 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -34.34 75.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.028 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.447 HD22 HG22 ' A' ' 9' ' ' ILE . 92.7 mt -60.83 -51.5 69.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 4.6 mm -67.38 -36.78 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.38 57.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.607 -0.683 . . . . 0.0 110.129 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -73.47 -43.32 60.46 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.998 -1.064 . . . . 0.0 109.948 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -67.15 -7.22 21.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.953 . . . . 0.0 109.977 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 1.8 ttpt -96.01 -36.17 11.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.646 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 9.3 tttm -81.14 -31.63 34.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.11 2.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.21 -0.932 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.52 ' CG2' ' CD1' ' A' ' 36' ' ' PHE . 6.4 t -102.41 25.27 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.054 -1.029 . . . . 0.0 110.422 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -160.94 61.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.959 -1.088 . . . . 0.0 109.533 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' A' ' 100' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.282 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' HD11 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -93.43 -48.3 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.315 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -57.09 -35.6 70.34 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -66.42 -44.37 83.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -1.068 . . . . 0.0 109.387 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -26.23 68.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' CG2' HD23 ' A' ' 94' ' ' LEU . 7.1 mt -73.53 -66.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 20' ' ' VAL . 45.3 t80 -55.68 -25.26 38.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 108.988 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.505 ' CD1' ' HG3' ' A' ' 7' ' ' LYS . 7.4 mt -70.9 -40.38 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.847 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.5 ptm -107.34 18.1 22.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.593 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -120.58 -62.54 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.967 . . . . 0.0 109.536 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 30.01 6.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.122 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 1.3 t -86.1 7.34 25.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -100.98 -54.31 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 3.2 m -84.41 -32.52 24.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.661 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 63.2 m-70 -114.15 93.34 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.11 -0.994 . . . . 0.0 109.992 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.6 p -91.3 97.25 10.99 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.872 -1.142 . . . . 0.0 108.559 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 20' ' ' VAL . 3.0 m -83.97 47.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 110.061 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 3.0 mt-10 -173.34 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.921 -1.112 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 0.56 39.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.549 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.13 -10.46 40.03 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.1 10.86 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -89.82 160.46 16.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -1.18 . . . . 0.0 109.365 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -138.44 167.9 20.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -141.37 -87.04 0.17 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.523 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 38.1 m -94.47 -25.03 17.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 108.98 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -115.6 150.49 18.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.682 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.7 Cg_endo -65.98 131.76 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.444 2.096 . . . . 0.0 111.031 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -49.98 101.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.49 -0.756 . . . . 0.0 110.198 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.01 63.41 6.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 109.717 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.489 ' O ' ' CG2' ' A' ' 102' ' ' THR . 2.2 t60 -94.25 -21.46 19.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.997 . . . . 0.0 109.993 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 38' ' ' ARG . . . -156.19 22.73 0.51 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 5.8 tt -41.61 -35.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -1.053 . . . . 0.0 110.288 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -70.36 131.7 44.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.129 -0.982 . . . . 0.0 110.545 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.02 -13.03 64.28 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -126.71 151.87 47.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.897 -1.355 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 177.83 6.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.818 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 2.6 p -64.5 -164.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.29 94.0 0.01 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.25 -47.27 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -1.148 . . . . 0.0 109.5 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.31 142.75 55.01 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -78.64 -90.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.691 2.26 . . . . 0.0 110.941 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.42 -33.02 0.83 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.61 111.44 18.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -1.109 . . . . 0.0 109.067 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 1.6 p -77.37 78.32 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-85 -46.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 109.668 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -58.66 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 109.208 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.61 -42.93 68.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.53 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -54.16 -73.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.549 ' HB3' ' CG2' ' A' ' 40' ' ' THR . 1.9 m-20 -35.45 -40.97 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.137 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -55.36 -59.17 5.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.883 . . . . 0.0 110.049 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -64.08 -20.66 66.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.79 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -65.36 -8.16 17.13 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.64 45.47 59.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.37 117.48 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -1.014 . . . . 0.0 109.979 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -84.46 111.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.636 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 8.1 m95 -50.26 101.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.944 -1.097 . . . . 0.0 110.271 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -122.41 -167.63 13.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' OE2' ' CG2' ' A' ' 95' ' ' ILE . 19.7 mm-40 -65.47 -74.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -62.95 -35.11 79.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 110.268 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -42.87 93.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.671 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -73.42 -33.79 65.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.446 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 35.7 tpp -59.11 -27.32 65.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.171 -0.956 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.41 -64.48 1.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.881 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.636 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 28.5 t80 -49.08 -28.26 4.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.956 . . . . 0.0 109.996 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -32.79 21.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 65' ' ' MET . 4.0 tt0 -59.42 -24.7 63.71 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -177.25 88.69 0.25 Allowed Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -73.82 -36.53 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.32 -17.21 64.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.061 -1.024 . . . . 0.0 108.363 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 2.4 ttmt -99.57 -25.76 14.32 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 75' ' ' ILE . 11.8 t80 -88.0 -70.26 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.249 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.531 ' CD1' ' OD1' ' A' ' 52' ' ' ASN . 2.6 mm -99.52 106.66 41.09 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.366 -0.834 . . . . 0.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.98 83.76 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.374 2.049 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 158.42 -30.31 0.46 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.472 ' HA ' HG22 ' A' ' 49' ' ' THR . 10.0 t -44.39 160.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.955 -1.32 . . . . 0.0 109.785 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 15.98 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.6 mmm -59.2 118.31 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.799 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 tp -92.32 18.83 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.411 0.624 . . . . 0.0 110.133 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.209 0.528 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -62.15 -38.16 87.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.812 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.6 71.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.31 -25.58 67.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD23 ' CG2' ' A' ' 9' ' ' ILE . 29.2 mt -69.75 -52.5 24.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.722 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.501 HD11 ' N ' ' A' ' 95' ' ' ILE . 3.3 mm -62.26 -47.76 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.928 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.76 71.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.79 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' CD2' HD22 ' A' ' 98' ' ' LEU . 33.3 t80 -61.74 -44.63 96.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 97' ' ' TYR . 4.0 mm? -81.95 -2.7 52.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 1.6 tmmt? -97.0 -13.83 22.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.162 -0.961 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -119.97 -39.9 2.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.56 -32.78 60.52 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.28 -0.888 . . . . 0.0 110.387 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -127.87 23.19 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.05 -1.031 . . . . 0.0 110.321 -179.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 4.1 t-20 -149.34 14.45 0.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.023 -1.048 . . . . 0.0 109.818 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.268 0.556 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.5 -12.81 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.853 . . . . 0.0 109.942 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.424 ' O ' HG12 ' A' ' 9' ' ' ILE . 23.7 mttt -91.88 -54.31 3.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.091 -1.006 . . . . 0.0 109.848 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.59 -30.18 55.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -70.32 -46.7 63.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -1.109 . . . . 0.0 109.728 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -70.48 -18.98 62.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.7 mm -73.18 -64.6 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 108.792 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 98' ' ' LEU . 11.5 t80 -49.23 -42.34 40.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 108.621 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 55.3 mt -56.23 -42.41 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.01 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' A' ' 12' ' ' MET . 3.3 ppp? -107.12 20.06 19.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.49 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.49 -54.59 1.77 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.738 -1.226 . . . . 0.0 109.866 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -133.89 25.65 3.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.136 -0.977 . . . . 0.0 109.468 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.6 t -80.12 3.39 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -56.87 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.345 -0.847 . . . . 0.0 108.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.49 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 23.1 m -82.14 -17.9 44.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.415 -0.803 . . . . 0.0 109.13 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.645 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 75.3 m-70 -125.15 84.03 2.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.795 -1.191 . . . . 0.0 110.239 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 15.7 p -79.29 81.53 5.54 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.52 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 4.1 m -79.84 12.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -137.0 24.33 3.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 0.0 109.867 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.7 tmtt? -98.96 -46.98 5.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.567 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.49 67.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.4 22.53 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' CB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 tptt -98.8 140.64 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 0.0 109.588 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.17 128.61 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.436 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -72.5 0.72 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 96.7 m -93.84 -53.94 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.407 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -91.4 160.22 26.69 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 35.1 Cg_endo -70.53 134.36 26.2 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.367 2.045 . . . . 0.0 110.54 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.416 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 11.7 t-20 -48.27 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.32 43.59 0.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.421 -0.799 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' VAL . 2.0 t-160 -98.62 77.82 2.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -0.975 . . . . 0.0 108.827 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.86 7.61 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -54.2 -30.53 50.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.422 -1.046 . . . . 0.0 109.727 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CE2' HG22 ' A' ' 95' ' ' ILE . 4.4 m-85 -65.3 143.15 57.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.905 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.54 13.62 61.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 40.4 ttp85 -138.52 129.91 27.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -1.131 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -74.39 174.43 8.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -71.94 175.7 5.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.715 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 76.51 94.94 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -150.14 -73.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.32 141.25 2.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.7 Cg_endo -79.72 -92.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.691 2.261 . . . . 0.0 111.425 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.38 -29.99 0.76 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -79.78 113.01 17.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -1.057 . . . . 0.0 108.991 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -77.98 77.93 4.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-30 -46.09 178.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.608 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.71 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -43.66 -42.72 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -54.39 -70.54 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.884 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.584 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 0.7 OUTLIER -38.92 -40.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 110.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -57.41 -70.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.197 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.45 -10.56 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.333 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -66.03 -7.64 18.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.83 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.14 50.66 33.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -118.83 118.79 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -1.059 . . . . 0.0 109.727 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG23 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -78.33 121.35 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.023 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 9.0 m95 -64.99 95.08 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.272 -0.892 . . . . 0.0 110.007 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -115.5 -170.7 16.22 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.61 -68.39 0.4 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.089 -1.242 . . . . 0.0 109.69 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.03 -37.22 86.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.882 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -49.03 79.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.074 -1.016 . . . . 0.0 109.315 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 1.2 tt -63.47 -32.61 74.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 109.311 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.1 ttp -56.27 -40.87 74.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.379 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.58 -54.91 13.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.318 -0.864 . . . . 0.0 109.78 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CE1' ' OD1' ' A' ' 52' ' ' ASN . 86.4 t80 -49.18 -34.08 13.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.3 -37.01 58.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 109.472 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.37 -23.31 62.45 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -170.41 93.0 0.48 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.68 -43.36 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.373 2.049 . . . . 0.0 110.008 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -79.27 -22.26 44.95 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -92.26 -36.19 13.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.4 t80 -73.62 -66.6 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 13.6 mm -96.38 113.2 62.05 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.43 -0.793 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.76 70.24 7.04 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.255 1.97 . . . . 0.0 109.747 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.42 -46.69 0.03 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.544 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.7 t -58.09 163.75 2.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.281 . . . . 0.0 109.651 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.32 9.03 5.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.569 ' O ' ' HG3' ' A' ' 80' ' ' MET . 8.1 ptm -74.48 115.82 14.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.879 -1.129 . . . . 0.0 109.513 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 81' ' ' ILE . 41.8 mm -94.13 35.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.54 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 4.9 t80 . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.807 -0.558 . . . . 0.0 110.167 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.307 0.575 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -53.51 -43.77 68.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 109.263 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.73 -34.31 71.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.381 -0.824 . . . . 0.0 109.701 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.1 -28.82 66.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.117 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 9' ' ' ILE . 55.7 mt -71.13 -63.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 109.418 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 1.1 mp -59.66 -32.01 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 108.996 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.71 91.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 109.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.2 -48.42 62.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.352 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 10' ' ' PHE . 2.0 mm? -67.13 -16.29 64.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -72.49 -49.26 34.3 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.312 -0.867 . . . . 0.0 109.862 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 6.8 tttt -79.88 -27.4 40.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.31 -59.15 3.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 110.376 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -29.89 7.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.46 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.503 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t30 -81.61 10.96 5.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.508 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.268 0.556 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -13.03 26.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' HG13 ' A' ' 9' ' ' ILE . 6.9 ttmt -77.44 -63.07 1.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.28 -32.78 60.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 34.9 tttt -64.67 -33.7 76.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -77.08 -24.13 51.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 5' ' ' LYS . 17.9 mt -69.62 -55.94 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 108.838 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 9.7 t80 -62.84 -40.15 96.53 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.324 -0.86 . . . . 0.0 108.921 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 14.5 mt -58.06 -28.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.38 -0.825 . . . . 0.0 109.001 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -114.92 6.89 15.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 110.015 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -113.68 -66.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -115.07 31.18 6.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.965 -1.084 . . . . 0.0 109.459 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.8 t -90.16 8.74 31.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.2 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -101.44 -48.2 4.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 0.0 108.956 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 96.9 m -93.57 -25.52 17.52 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.419 -0.8 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.639 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 79.1 m-70 -113.87 82.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 110.249 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 19' ' ' THR . 5.1 p -78.86 88.4 4.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 108.448 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.5 m -79.88 9.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -137.75 18.01 2.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.046 . . . . 0.0 109.433 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 4.8 tptt -88.9 -57.27 2.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.36 63.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.43 17.63 33.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.93 73.47 1.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -1.192 . . . . 0.0 109.368 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.513 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -78.47 128.9 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 109.964 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' NZ ' HG22 ' A' ' 19' ' ' THR . 0.0 OUTLIER -101.69 -80.39 0.5 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 96.3 m -91.8 -33.33 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.363 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -108.56 156.91 15.51 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.9 Cg_endo -68.68 136.33 35.68 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.543 2.162 . . . . 0.0 110.849 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 6.2 t-20 -51.38 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.812 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.6 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.64 70.25 7.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.494 -0.754 . . . . 0.0 109.456 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.463 ' O ' ' HB ' ' A' ' 102' ' ' THR . 31.3 t-80 -100.2 -49.58 4.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 109.098 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -122.81 37.67 2.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 ' C ' ' CD2' ' A' ' 35' ' ' LEU . 3.1 tt -49.52 -50.52 41.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.992 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -60.37 137.94 58.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.855 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.92 24.21 76.55 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD2' ' HG2' ' A' ' 42' ' ' GLN . 24.2 ttp85 -145.78 118.11 8.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -1.231 . . . . 0.0 109.797 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -70.68 164.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.91 169.07 4.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.866 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 73.13 83.39 0.29 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -148.61 -39.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -1.148 . . . . 0.0 109.882 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . . . -79.84 136.35 54.87 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 109.693 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.5 Cg_endo -79.15 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.59 2.193 . . . . 0.0 110.972 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -40.13 -37.91 1.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -80.13 125.07 29.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -1.061 . . . . 0.0 108.979 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 48' ' ' TYR . 93.9 p -86.34 57.35 4.44 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m-30 -31.8 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.113 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 31.0 p -63.19 93.4 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.642 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -36.93 -37.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.568 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -41.15 -69.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.576 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 28.6 m-20 -45.1 -45.26 11.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 109.852 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.7 -74.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.93 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.57 -14.03 2.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.885 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HG2' ' CG1' ' A' ' 75' ' ' ILE . 1.8 tptp -59.17 -13.83 8.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.0 109.926 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.94 58.78 12.39 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.73 120.33 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.491 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.07 102.15 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.047 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.465 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 6.7 m95 -41.16 106.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.42 -159.87 10.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.9 -59.45 2.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.11 -1.229 . . . . 0.0 109.868 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.96 -38.12 64.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.846 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.98 -52.1 66.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 1.4 tt -62.94 -37.32 86.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -53.36 -37.9 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE1' ' CD1' ' A' ' 74' ' ' TYR . 7.5 tm-20 -69.87 -57.11 5.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.574 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.6 t80 -60.87 -13.41 15.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 109.526 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.09 -49.79 7.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.058 . . . . 0.0 109.073 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 6.9 tt0 -59.21 -22.08 60.49 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 69' ' ' GLU . 1.2 m-80 -161.27 92.34 1.48 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 32.8 Cg_endo -76.0 -52.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.0 110.878 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.128 -0.982 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 15.5 mtpt -77.09 -39.91 47.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' A' ' 75' ' ' ILE . 22.8 t80 -68.05 -63.23 1.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -114.21 125.3 29.48 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 71.19 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.239 1.959 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . -160.57 -58.47 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.4 t -41.81 152.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -1.132 . . . . 0.0 110.164 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.11 5.18 13.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.597 ' CE ' ' CB ' ' A' ' 82' ' ' PHE . 8.5 ptm -77.58 119.29 20.93 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.071 -1.018 . . . . 0.0 109.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.4 mt -90.11 55.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.597 ' CB ' ' CE ' ' A' ' 80' ' ' MET . 48.7 t80 . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.579 -0.7 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -44.07 92.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.43 96.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.348 -0.845 . . . . 0.0 109.388 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.4 -37.45 62.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.09 -53.23 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 96' ' ' ALA . 19.9 mm -61.99 -79.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -33.76 -38.35 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.285 0.564 . . . . 0.0 110.698 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 1.2 t80 -56.62 -57.04 14.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 0.0 109.177 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.68 -13.69 60.65 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.461 -0.774 . . . . 0.0 109.48 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -75.78 -15.81 60.21 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -112.36 -24.36 9.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.609 -0.682 . . . . 0.0 109.215 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.06 -48.78 6.07 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.133 -0.979 . . . . 0.0 110.058 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -109.59 32.03 5.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.923 . . . . 0.0 109.928 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t-20 -154.73 -46.14 0.09 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.171 -0.956 . . . . 0.0 109.376 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.65 173.75 16.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.168 -1.195 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.5 t -98.93 -49.15 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.575 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.72 -11.82 60.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.37 -52.47 5.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.893 . . . . 0.0 109.693 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' CD1' ' A' ' 9' ' ' ILE . . . -56.03 -34.71 62.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 2.5 ttpt -51.08 -42.11 60.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -1.156 . . . . 0.0 109.612 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -77.08 -25.47 52.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.654 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.527 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 12.2 mt -66.58 -62.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.572 ' CE1' HG11 ' A' ' 20' ' ' VAL . 54.6 t80 -62.76 -40.25 96.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.09 -1.006 . . . . 0.0 108.951 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.501 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 84.3 mt -66.52 -14.63 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.464 -0.773 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 5.0 ttt -119.07 5.17 11.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.007 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -120.79 -64.25 1.26 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.044 -1.035 . . . . 0.0 109.805 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.576 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.64 37.83 3.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 108.895 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.2 t -91.73 4.34 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.447 -0.783 . . . . 0.0 109.904 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.43 -46.67 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 108.973 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 11.0 m -90.64 -29.53 17.71 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.319 -0.863 . . . . 0.0 108.936 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.674 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 69.1 m-70 -114.72 84.51 2.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -84.93 97.98 10.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.931 -1.106 . . . . 0.0 109.12 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG11 ' CE1' ' A' ' 10' ' ' PHE . 2.5 m -85.71 17.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -149.15 31.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -97.59 -77.04 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.53 52.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.23 16.62 35.04 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.85 124.01 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -1.153 . . . . 0.0 109.348 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -124.71 95.48 4.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -82.11 -73.85 0.37 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.097 -1.002 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 48.2 m -84.79 -63.08 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.04 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -88.48 152.18 23.14 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.3 Cg_endo -66.78 134.32 34.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.577 2.185 . . . . 0.0 110.969 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 17.2 t-20 -53.03 103.02 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 109.692 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 HD21 ' CG ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.06 51.5 1.96 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.665 -0.647 . . . . 0.0 109.826 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.412 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 4.1 t60 -93.46 -8.54 41.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 102' ' ' THR . . . -162.01 31.07 0.31 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.516 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -55.48 -28.13 52.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.044 . . . . 0.0 109.85 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 29.9 m-85 -72.28 113.83 9.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.197 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.85 51.03 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -101.61 136.54 41.28 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.056 -1.261 . . . . 0.0 110.075 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' CG ' ' N ' ' A' ' 40' ' ' THR . 30.5 ttmt -82.45 167.52 18.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.024 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.543 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -61.72 165.18 5.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.918 . . . . 0.0 109.946 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 65.4 94.47 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.6 tp-100 -149.05 -48.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -1.216 . . . . 0.0 109.645 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 46' ' ' TYR . . . -61.55 146.4 89.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 109.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.72 -60.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.776 2.317 . . . . 0.0 110.758 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.24 52.77 4.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -160.01 118.5 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -1.098 . . . . 0.0 108.888 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.9 t -83.33 70.99 10.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 30' ' ' PRO . 2.3 m-85 -44.26 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.684 -0.635 . . . . 0.0 109.747 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.56 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -50.85 -40.62 56.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.435 -0.791 . . . . 0.0 109.219 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.535 ' HB1' ' CG2' ' A' ' 75' ' ' ILE . . . -52.45 -72.51 0.05 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.587 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -37.2 -49.35 0.91 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -53.79 -48.32 69.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -0.928 . . . . 0.0 110.678 -178.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -65.04 -45.18 86.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.103 -0.998 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -21.03 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.161 -0.962 . . . . 0.0 109.68 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.84 43.94 48.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG23 HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -99.34 137.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.993 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -98.54 115.62 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.626 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 11.8 m95 -59.02 111.11 1.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -136.42 -158.74 8.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.78 -74.12 0.23 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.197 -1.178 . . . . 0.0 109.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -36.91 78.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 110.13 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -44.97 92.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.367 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.7 OUTLIER -68.97 -24.97 64.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.242 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.8 tpp -59.75 -44.84 93.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -56.91 5.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 34.3 t80 -51.34 -28.65 12.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.987 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' CD1' ' CMB' ' A' ' 105' ' ' HEC . 2.7 tp -84.02 -31.48 25.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -58.76 -26.09 63.68 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 7.7 m120 -171.84 102.46 0.37 Allowed Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.42 -32.72 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.075 1.85 . . . . 0.0 110.045 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -27.97 31.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.456 -0.777 . . . . 0.0 109.734 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -83.75 -33.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' CE2' HD12 ' A' ' 75' ' ' ILE . 7.8 t80 -79.51 -68.41 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.914 . . . . 0.0 108.817 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.587 ' CD1' ' ND2' ' A' ' 52' ' ' ASN . 4.4 mm -102.96 111.18 64.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 70.43 7.23 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.292 1.994 . . . . 0.0 109.711 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -172.98 -40.29 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.528 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 11.2 t -42.58 151.55 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 109.843 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HG2' ' O2D' ' A' ' 105' ' ' HEC . 6.2 mmmt -111.78 7.12 20.1 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.557 -0.715 . . . . 0.0 109.103 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.734 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 5.7 ptm -86.0 117.79 25.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.931 -1.105 . . . . 0.0 109.695 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.89 50.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CZ ' HBB3 ' A' ' 105' ' ' HEC . 27.4 t80 -59.53 149.83 28.79 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.52 0.676 . . . . 0.0 110.197 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.21 149.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.86 143.13 48.54 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 2.2 mp -70.32 142.56 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -1.143 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -131.93 16.82 4.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 109.411 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.29 86.9 0.82 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.593 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -29.29 58.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -55.41 -52.84 62.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.322 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.39 -32.98 72.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.301 -0.874 . . . . 0.0 109.8 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 7.4 mmt180 -62.06 -44.86 95.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.399 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.68 79.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.979 -1.076 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' A' ' 9' ' ' ILE . 8.2 m-20 -65.61 -26.41 67.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 9' ' ' ILE . 28.6 mt -66.58 -59.92 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 108.856 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 4.8 mm -50.52 -32.53 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.428 -0.795 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.3 78.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -64.28 -50.33 68.33 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.092 -1.005 . . . . 0.0 109.724 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.1 mm? -64.67 -18.49 65.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.805 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 4.8 mttt -80.86 -25.68 37.48 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.001 -1.062 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 5.5 tptp -78.02 -37.66 46.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.94 -54.8 3.81 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 98' ' ' LEU . 19.3 p -92.69 16.23 12.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.055 -1.028 . . . . 0.0 111.149 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 32.0 t-20 -156.82 29.03 0.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.923 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.483 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.734 ' C1D' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 11.1 m-20 -114.77 162.93 16.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -1.152 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.59 -36.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.943 . . . . 0.0 109.51 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 14.1 mm-40 -72.21 -7.41 49.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.695 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -93.11 -55.24 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.796 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.81 -49.31 59.91 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.8 tttt -62.49 -13.63 32.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.9 mmtt -85.46 -54.14 4.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.048 -1.033 . . . . 0.0 109.355 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 70.8 mt -57.22 -53.7 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.499 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 10.1 t80 -60.26 -42.3 95.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 5.2 mt -58.34 -24.42 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.325 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ptm -123.35 18.25 9.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.163 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.64 -48.09 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.05 -1.031 . . . . 0.0 109.725 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.571 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -133.72 20.6 3.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.937 -1.102 . . . . 0.0 109.517 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.7 t -85.3 8.4 18.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.497 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -100.31 -43.87 6.12 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 35.5 m -93.39 -27.93 16.45 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 76.2 m-70 -112.94 84.28 1.96 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 109.798 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -78.53 84.05 4.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 108.364 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.499 HG12 ' CZ ' ' A' ' 10' ' ' PHE . 3.3 m -83.93 31.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 110.692 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 22.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 109.818 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -99.85 6.04 45.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.431 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.16 -22.14 12.56 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.16 7.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 142.1 39.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.16 . . . . 0.0 109.279 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -127.22 172.77 10.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 109.659 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 -72.63 0.17 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 109.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.485 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 16.8 m -85.28 -55.41 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.302 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -95.7 153.23 20.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.624 ' HA ' ' CE2' ' A' ' 46' ' ' TYR . 32.3 Cg_endo -69.1 128.25 16.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.032 1.822 . . . . 0.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 30' ' ' PRO . 14.8 t-20 -44.22 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.529 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.25 41.21 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.481 ' HA ' ' CG2' ' A' ' 102' ' ' THR . 55.0 t-80 -87.12 -16.64 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.336 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.96 37.93 0.81 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 64' ' ' LEU . 6.6 tp -67.49 -33.98 76.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.557 -0.966 . . . . 0.0 110.167 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.2 m-85 -64.07 130.26 43.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.981 . . . . 0.0 110.09 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 20.81 76.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -148.0 121.1 8.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.019 -1.283 . . . . 0.0 109.783 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.06 160.02 29.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.223 -0.923 . . . . 0.0 109.148 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 53' ' ' LYS . 11.3 t -65.05 -174.84 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.906 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 57.23 79.58 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -156.39 -56.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . . . -43.2 135.37 3.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.686 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.65 134.01 11.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.505 2.136 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 -11.55 60.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.624 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -133.71 76.22 1.65 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 109.718 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -68.56 92.24 0.45 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 5.7 m-30 -46.17 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.873 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.522 ' CB ' HBD1 ' A' ' 105' ' ' HEC . 7.4 m -59.67 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.401 -0.812 . . . . 0.0 109.358 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -35.71 -31.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.529 ' O ' ' ND2' ' A' ' 54' ' ' ASN . . . -32.3 -59.71 0.3 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.373 0.606 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.638 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 t30 -62.23 -54.17 44.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 109.328 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG2' ' A' ' 40' ' ' THR . 5.3 ttpp -41.94 -27.94 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 110.295 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 51' ' ' ALA . 7.3 p30 -94.94 -33.55 12.73 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.002 -1.061 . . . . 0.0 109.991 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 19.8 tptp -53.11 -20.02 3.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.033 -1.042 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.91 75.07 0.79 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG21 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -150.41 127.35 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 110.472 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -90.04 101.78 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.651 ' CH2' ' CG ' ' A' ' 67' ' ' TYR . 5.4 m95 -42.41 107.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.352 -0.843 . . . . 0.0 110.216 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.16 -154.8 7.97 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -76.58 -75.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -1.213 . . . . 0.0 109.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 65' ' ' MET . 21.2 t70 -62.32 -37.46 85.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -55.2 35.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 35' ' ' LEU . 2.3 tt -63.49 -19.73 65.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.328 -0.858 . . . . 0.0 109.298 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.482 ' HG2' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -64.78 -46.36 82.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -49.93 66.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.187 -0.945 . . . . 0.0 109.758 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.651 ' CG ' ' CH2' ' A' ' 59' ' ' TRP . 7.9 t80 -53.35 -41.02 65.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.105 -0.997 . . . . 0.0 109.352 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.535 ' CD2' HMB2 ' A' ' 105' ' ' HEC . 0.9 OUTLIER -69.98 -33.81 72.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.781 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.7 -24.13 63.72 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 21.1 t-20 -170.98 97.27 0.42 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 29.7 Cg_endo -74.75 -37.52 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.219 1.946 . . . . 0.0 110.769 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -72.84 -9.09 58.29 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.086 -1.009 . . . . 0.0 109.209 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 14.4 tptt -94.17 -57.69 2.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -62.91 -62.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.599 HG12 ' CE1' ' A' ' 67' ' ' TYR . 3.2 mm -80.45 117.23 66.78 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.9 Cg_endo -75.61 74.87 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.165 1.91 . . . . 0.0 110.685 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.42 26.84 1.74 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.453 ' HA ' HG22 ' A' ' 49' ' ' THR . 11.1 t -49.94 160.7 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.414 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.503 ' CB ' HMD2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -101.57 0.95 37.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 108.813 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.743 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.8 ptm -113.46 122.25 46.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 81' ' ' ILE . 16.0 tt -91.04 58.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.608 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 55.3 t80 -75.57 154.67 36.61 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.566 -0.709 . . . . 0.0 109.907 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 p -99.12 149.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.486 -0.759 . . . . 0.0 109.246 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.48 120.07 5.16 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.4 mt -74.51 131.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -1.158 . . . . 0.0 109.183 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -74.49 -48.09 29.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 109.383 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 96.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -33.12 69.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.688 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.7 -53.47 18.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.31 -45.27 93.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.256 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.482 ' CD ' ' HG2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -50.0 -36.1 27.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.223 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.86 89.22 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.253 -0.905 . . . . 0.0 109.174 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.68 -35.44 42.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.0 -55.88 16.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.409 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 96' ' ' ALA . 16.7 mm -53.51 -69.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.543 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -39.98 -39.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.81 -0.556 . . . . 0.0 110.244 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.03 -50.36 72.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.562 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 2.7 mm? -75.22 -3.48 33.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 -12.18 20.64 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.216 -0.927 . . . . 0.0 109.748 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -113.96 -43.55 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 110.123 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.96 -33.4 61.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -128.54 46.15 2.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.061 -1.024 . . . . 0.0 109.957 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -177.5 45.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.303 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.743 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -108.48 152.69 24.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -1.097 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.32 -37.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.76 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -62.62 -22.62 66.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.889 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -84.39 -49.75 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.877 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -52.12 -45.56 57.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HG2' HD13 ' A' ' 11' ' ' ILE . 17.6 tttp -59.9 -37.36 79.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.912 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -21.69 61.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.867 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' LYS . 32.1 mm -75.09 -63.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 15' ' ' SER . 30.6 t80 -56.22 -45.61 79.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.213 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 18.6 mt -58.93 -30.66 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.6 ttp -116.77 21.9 13.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -134.14 -65.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.577 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.58 30.83 7.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.106 -0.996 . . . . 0.0 109.564 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 4.3 t -89.68 -14.95 33.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.114 . . . . 0.0 109.466 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -82.43 -44.18 16.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 108.911 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.3 m -90.08 -35.08 15.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 108.869 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.677 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 68.6 m-70 -114.02 80.36 1.38 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.039 -1.038 . . . . 0.0 109.934 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.475 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.5 p -79.69 94.55 5.74 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.663 -1.273 . . . . 0.0 108.781 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 32' ' ' LEU . 2.9 m -84.57 -5.56 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.19 26.5 9.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.3 -51.39 3.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.4 60.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.76 24.99 72.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -96.34 115.55 27.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -1.106 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -131.57 89.88 2.77 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.46 -68.5 0.71 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 0.0 109.773 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 99.8 m -90.19 -59.81 2.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.722 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -90.41 149.0 19.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.7 Cg_endo -65.84 136.03 43.68 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.51 2.14 . . . . 0.0 111.232 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 9.5 t-20 -52.4 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.774 -0.579 . . . . 0.0 110.286 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -82.15 70.07 9.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.729 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 14.8 t60 -88.86 -45.65 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.599 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.52 38.93 1.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' A' ' 59' ' ' TRP . 5.5 tp -54.03 -28.28 37.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -1.131 . . . . 0.0 109.601 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.6 m-85 -66.29 136.75 56.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.81 17.23 57.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 1.8 ttt-85 -133.87 135.68 43.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -1.203 . . . . 0.0 109.326 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -64.68 -174.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.877 . . . . 0.0 109.925 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 39' ' ' LYS . 4.6 p -53.5 -169.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -133.3 175.11 20.33 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.879 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -161.82 54.3 0.25 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.954 . . . . 0.0 108.666 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.34 169.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 109.666 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 43' ' ' ALA . 35.0 Cg_endo -75.12 -66.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.64 2.226 . . . . 0.0 110.585 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.96 6.86 61.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -131.04 103.89 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -1.135 . . . . 0.0 109.403 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' TYR . 34.7 t -75.14 83.89 2.34 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-30 -44.19 176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.731 -0.606 . . . . 0.0 110.186 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.478 ' OG1' HAD2 ' A' ' 105' ' ' HEC . 0.3 OUTLIER -59.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.906 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -52.61 -38.75 60.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.604 -0.685 . . . . 0.0 109.227 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . . . -49.26 -70.57 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.394 -0.817 . . . . 0.0 108.847 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.576 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -43.97 -54.18 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.603 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 52' ' ' ASN . 10.1 tptp -40.03 -46.56 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.213 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.67 -34.47 60.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 9.6 tptt -53.65 -17.85 2.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.996 -1.065 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.43 54.34 32.75 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.509 HG21 ' ND2' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -108.24 138.42 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.997 . . . . 0.0 110.251 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -98.13 104.21 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.6 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 6.6 m95 -49.04 103.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.068 -1.02 . . . . 0.0 110.263 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.86 -164.11 11.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.92 -55.79 5.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.022 -1.281 . . . . 0.0 109.712 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -73.77 -38.93 64.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.157 -0.964 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -37.86 79.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.058 -1.026 . . . . 0.0 109.521 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -77.38 -35.96 53.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.182 -0.949 . . . . 0.0 109.125 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.443 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 46.1 ttm -56.77 -28.53 61.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 108.831 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -53.22 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.6 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 19.9 t80 -58.78 -17.72 25.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.467 HD23 HMB3 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -96.08 -36.19 11.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 108.919 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 65' ' ' MET . 21.6 tt0 -59.31 -23.65 62.63 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -176.0 88.52 0.28 Allowed Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.4 Cg_endo -74.59 -37.54 2.28 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.378 2.052 . . . . 0.0 110.274 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -67.63 -14.07 62.63 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.17 -0.956 . . . . 0.0 108.654 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -98.74 -31.66 11.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.227 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.544 ' CD2' HD13 ' A' ' 75' ' ' ILE . 13.1 t80 -83.37 -72.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 108.629 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.592 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.5 mm -83.87 115.4 59.65 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 84.26 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.286 1.991 . . . . 0.0 110.396 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 140.18 -7.37 2.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.458 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 12.0 t -44.43 144.67 0.99 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.245 . . . . 0.0 109.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HB2' ' CGD' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -104.77 17.18 24.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.442 ' HE1' ' HB2' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.44 124.47 20.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.871 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.511 ' HB ' ' CBC' ' A' ' 105' ' ' HEC . 6.6 mt -92.05 21.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HE1' ' A' ' 80' ' ' MET . 0.5 OUTLIER -59.72 160.28 7.62 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.419 0.628 . . . . 0.0 110.193 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.93 -37.75 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.238 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.84 101.85 1.71 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 mm -101.85 142.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 108.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.24 10.43 3.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.055 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 122.81 42.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.048 -1.032 . . . . 0.0 109.245 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -17.7 9.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.61 -61.34 2.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.68 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 -49.05 79.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -53.04 -36.13 60.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.91 -49.16 60.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.438 ' HB3' HG13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -62.92 -24.58 67.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 110.028 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 HD11 ' CBB' ' A' ' 105' ' ' HEC . 75.8 mt -68.29 -59.52 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.564 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 1.1 mp -61.74 -32.47 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.85 46.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' HB2' ' C ' ' A' ' 6' ' ' GLY . 32.7 t80 -66.84 -44.27 81.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.963 -1.086 . . . . 0.0 109.814 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.5 mm? -75.91 -4.01 38.54 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.56 -15.13 17.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.197 -0.939 . . . . 0.0 109.14 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 9.0 tttp -103.71 -31.1 10.02 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.23 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.59 -0.694 . . . . 0.0 110.983 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 103' ' ' ASN . 4.6 t -91.06 -48.62 6.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 0.0 110.855 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.548 ' N ' ' CG2' ' A' ' 102' ' ' THR . 7.8 t-20 -69.66 -4.26 18.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.871 -1.143 . . . . 0.0 110.029 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 8.4 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.599 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.592 ' CMD' HBD1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -79.86 121.5 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -1.123 . . . . 0.0 109.497 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.82 -29.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -74.8 -45.93 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 9' ' ' ILE . 2.0 tppm? -76.97 -41.39 43.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.18 94.15 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HD3' ' CE1' ' A' ' 97' ' ' TYR . 3.2 ttpt -61.03 -32.85 72.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -1.158 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -67.44 -25.33 65.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 5.2 mm -76.98 -68.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.551 ' CG ' HD21 ' A' ' 98' ' ' LEU . 48.8 t80 -53.35 -46.66 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 12' ' ' MET . 12.9 tt -56.01 -43.54 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 110.054 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.515 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.21 14.52 31.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.44 -68.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.072 -1.017 . . . . 0.0 109.592 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -113.59 37.16 3.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 2.9 t -93.51 -48.16 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.881 -1.137 . . . . 0.0 109.835 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.4 -33.79 45.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 36.4 m -98.24 -37.72 9.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.109 -0.994 . . . . 0.0 109.159 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.668 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 67.6 m-70 -115.51 74.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.85 -1.156 . . . . 0.0 108.992 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.4 96.83 5.45 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.696 -1.253 . . . . 0.0 109.168 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 32' ' ' LEU . 3.0 m -87.53 25.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.475 -0.766 . . . . 0.0 109.879 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -140.08 9.29 2.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -85.23 -86.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.8 38.04 0.61 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.52 13.84 63.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -98.66 169.59 9.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -1.13 . . . . 0.0 109.269 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.31 117.51 9.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -91.41 -73.15 0.55 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.283 -0.886 . . . . 0.0 109.158 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 20.7 m -93.24 -59.88 1.92 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -92.31 153.36 21.72 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.668 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.2 Cg_endo -66.57 147.57 82.19 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.403 2.069 . . . . 0.0 111.254 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.45 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 16.2 t-20 -64.61 100.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 110.328 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.88 38.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -90.91 36.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 109.093 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.56 37.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD13 ' CGA' ' A' ' 105' ' ' HEC . 4.2 tp -79.04 -24.39 43.64 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.356 -1.084 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 27.5 m-85 -74.4 127.28 32.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 109.549 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 14.12 82.92 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 11.7 ttt-85 -134.18 134.55 42.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.154 . . . . 0.0 109.516 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 4.0 mttt -73.78 -177.36 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.455 ' CG2' ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -92.61 -175.5 3.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 59.48 89.05 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.5 tp-100 -147.98 -43.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 109.72 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 48' ' ' TYR . . . -73.53 136.35 78.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.327 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 45' ' ' GLY . 35.2 Cg_endo -77.28 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.08 -30.02 0.37 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.526 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -80.59 125.53 30.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.433 -1.039 . . . . 0.0 109.109 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -86.49 57.3 4.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-85 -36.42 158.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.286 0.565 . . . . 0.0 110.066 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -61.0 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.84 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -46.03 -35.89 5.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . . . -49.0 -61.2 2.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -55.94 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 109.592 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 52' ' ' ASN . 6.7 ttpm? -39.99 -30.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.53 0.681 . . . . 0.0 109.338 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLY . 86.1 m-20 -92.23 -39.67 11.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.448 -0.783 . . . . 0.0 109.687 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -56.9 92.72 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.934 -1.104 . . . . 0.0 108.252 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' ASN . . . -38.19 91.52 0.01 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -143.65 145.75 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 110.015 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -118.61 100.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.679 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 6.9 m95 -37.56 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.793 0.806 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -122.38 -164.45 12.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -1.146 . . . . 0.0 109.705 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.05 -27.21 66.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.457 ' OG1' ' CA ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -60.88 -40.69 93.97 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -76.26 -32.49 58.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -37.09 67.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.67 -56.81 4.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.679 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 9.5 t80 -56.07 -19.11 11.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 109.992 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.549 ' CD2' HMB1 ' A' ' 105' ' ' HEC . 0.7 OUTLIER -92.33 -36.31 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.033 -1.042 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.99 -25.16 63.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 5.1 t-20 -168.8 85.46 0.67 Allowed Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -75.01 -26.39 10.95 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.462 2.108 . . . . 0.0 109.766 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 2.2 tttt -74.3 -19.18 60.57 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 43.2 tptt -88.79 -45.06 10.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.501 -0.749 . . . . 0.0 109.438 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 8.1 t80 -71.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.116 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.618 ' CD1' ' CD2' ' A' ' 74' ' ' TYR . 2.6 mm -96.2 107.81 37.5 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.703 -0.623 . . . . 0.0 109.654 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -79.13 81.68 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.375 2.05 . . . . 0.0 110.347 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.23 -18.25 0.71 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.5 t -44.97 132.21 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 109.938 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 23.76 5.01 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -59.2 120.0 8.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.607 -0.683 . . . . 0.0 109.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.466 ' HB ' HBC1 ' A' ' 105' ' ' HEC . 10.9 mt -93.29 26.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 0.3 OUTLIER -60.04 162.3 5.85 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.625 0.726 . . . . 0.0 110.663 -179.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 p -100.63 -33.11 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.35 93.82 2.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.15 125.9 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.156 . . . . 0.0 109.502 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -97.87 25.48 5.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.239 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -135.55 107.13 6.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.575 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -61.03 -25.88 67.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.425 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.8 -39.38 76.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.772 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.81 -51.15 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' CD ' HD23 ' A' ' 68' ' ' LEU . 8.0 ttp85 -55.04 -44.75 74.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.958 . . . . 0.0 109.125 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.52 66.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 0.0 109.23 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.46 -36.63 84.81 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.264 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 66.7 mt -61.97 -29.78 70.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -0.864 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mm -79.15 -46.91 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.351 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.08 -46.78 65.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.219 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.541 ' CD2' HD23 ' A' ' 98' ' ' LEU . 28.1 t80 -70.66 -47.52 59.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.993 -1.067 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.1 mm? -71.7 -3.36 21.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -87.0 -55.9 3.62 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -28.58 61.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.59 50.28 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.389 -0.82 . . . . 0.0 109.68 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 102' ' ' THR . 3.1 t -124.38 41.41 3.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.855 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 99' ' ' LYS . 2.9 t-20 179.78 50.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.388 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.599 ' CHC' ' HB3' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.43 179.76 6.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -1.165 . . . . 0.0 109.346 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.24 -57.81 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.47 -27.68 69.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.663 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HB3' ' OD2' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -58.25 -62.16 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.64 -37.17 94.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.6 ttmm -58.47 -26.45 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -1.176 . . . . 0.0 109.811 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -82.2 -40.5 21.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 109.994 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HB ' HD22 ' A' ' 94' ' ' LEU . 12.9 mm -61.48 -58.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 0.0 110.123 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.435 ' CE1' HG12 ' A' ' 20' ' ' VAL . 18.8 t80 -62.12 -41.06 97.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.005 -1.06 . . . . 0.0 109.758 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 18.3 mm -68.21 -11.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.7 ttm -133.31 19.47 4.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 110.215 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 5.8 tptt -131.76 -43.25 1.0 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 109.199 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.482 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -134.07 25.33 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.7 t -85.59 10.42 13.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -43.5 6.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 108.748 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.542 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 34.4 m -99.61 -22.02 15.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.136 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.684 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 76.8 m-70 -117.43 79.42 1.34 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -79.53 100.08 7.58 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.827 -1.17 . . . . 0.0 108.781 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG12 ' CE1' ' A' ' 10' ' ' PHE . 3.9 m -83.81 13.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.887 . . . . 0.0 109.742 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -121.94 17.95 10.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.407 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.37 179.44 6.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.7 53.92 4.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.1 7.52 76.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -97.92 159.5 14.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.119 . . . . 0.0 109.356 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.576 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -140.33 109.27 6.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.905 . . . . 0.0 108.706 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.562 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 30.8 m -87.42 -96.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -50.12 158.83 1.55 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 35.5 Cg_endo -69.38 151.92 71.24 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.363 2.042 . . . . 0.0 111.427 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.576 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.0 t-20 -62.41 102.99 0.36 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -82.07 54.86 2.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.121 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -99.51 43.54 1.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 108.888 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA2' ' CG2' ' A' ' 102' ' ' THR . . . 132.01 48.5 0.11 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.621 ' CD2' ' CG ' ' A' ' 59' ' ' TRP . 3.6 tt -65.92 -33.78 76.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -1.027 . . . . 0.0 110.35 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 21.3 m-85 -60.08 140.58 56.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 0.0 109.847 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.04 20.0 74.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 38' ' ' ARG . 16.5 ttp85 -133.36 98.95 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 169.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -70.08 172.95 7.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.658 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 72.15 72.8 0.9 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.449 ' HG3' ' HG2' ' A' ' 38' ' ' ARG . 66.2 mm-40 -135.53 -53.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 109.806 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB2' ' NE2' ' A' ' 26' ' ' HIS . . . -71.11 137.96 84.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.625 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -79.73 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.696 2.264 . . . . 0.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.28 -33.73 1.41 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.62 ' CE1' ' O2D' ' A' ' 105' ' ' HEC . 0.3 OUTLIER -79.91 121.76 25.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -1.089 . . . . 0.0 109.429 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -84.64 65.4 9.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-30 -37.88 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.617 0.723 . . . . 0.0 111.12 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 45.1 p -68.44 88.8 0.34 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 109.466 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.74 -33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -51.28 -65.06 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.528 ' ND2' HG13 ' A' ' 75' ' ' ILE . 2.6 m-20 -39.72 -55.08 1.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.435 -0.791 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -42.31 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.75 -27.33 67.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.278 -0.889 . . . . 0.0 109.852 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 6.1 tptt -73.45 -0.22 14.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.17 -0.956 . . . . 0.0 109.668 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.59 27.26 2.0 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' C ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -81.0 125.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.994 . . . . 0.0 110.085 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -94.05 100.46 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.621 ' CG ' ' CD2' ' A' ' 35' ' ' LEU . 17.2 m95 -37.39 109.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -130.76 -155.09 8.14 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.02 -60.64 2.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -1.191 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.32 -35.24 73.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.493 HG21 ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -65.35 -48.56 72.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.74 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 68' ' ' LEU . 1.3 tt -69.53 -32.59 71.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.103 -0.998 . . . . 0.0 109.533 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.419 ' HG2' ' HD2' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -59.88 -34.15 72.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 108.89 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -77.8 -53.4 7.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.518 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.595 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 38.9 t80 -57.65 -16.34 10.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -92.37 -40.34 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.563 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.95 -22.53 60.23 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 70' ' ' ASN . 22.4 p30 -172.57 95.91 0.37 Allowed Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -73.34 -40.23 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.255 1.97 . . . . 0.0 110.541 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -69.41 -9.36 53.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.995 -1.065 . . . . 0.0 108.948 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -54.41 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.559 ' CE1' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -69.16 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.147 -0.971 . . . . 0.0 108.837 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 67' ' ' TYR . 4.8 mm -98.19 106.82 37.68 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.653 -0.654 . . . . 0.0 109.553 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.5 75.77 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.159 1.906 . . . . 0.0 109.583 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 170.36 -22.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.538 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 13.8 t -36.96 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -1.052 . . . . 0.0 110.329 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.89 13.46 31.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.708 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.3 ptm -114.54 123.07 48.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 110.079 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.41 44.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.574 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 19.9 t80 -59.96 147.27 39.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.653 -0.654 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.37 -24.75 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.79 -171.05 13.79 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 91' ' ' ARG . 2.2 mp -105.41 132.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -1.102 . . . . 0.0 109.493 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 mmtm -81.58 -41.6 21.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.322 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HG2' ' OE2' ' A' ' 89' ' ' GLU . 2.0 tptt -92.65 123.85 36.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -56.7 -55.09 38.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.228 -0.92 . . . . 0.0 109.787 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -48.08 -25.07 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 109.617 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.0 -46.49 43.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' N ' HG23 ' A' ' 85' ' ' ILE . 10.2 ttp85 -58.52 -52.43 65.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 108.918 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.84 73.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -63.75 -30.69 71.76 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.476 HD22 ' HB ' ' A' ' 9' ' ' ILE . 18.3 mt -64.66 -55.75 18.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -63.43 -31.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.27 87.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.73 -49.41 70.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.017 -1.052 . . . . 0.0 109.973 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 3.4 mm? -66.34 -16.33 63.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.727 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -77.64 -51.03 11.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.121 -0.987 . . . . 0.0 109.608 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.8 -22.34 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.76 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.44 -55.73 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 110.222 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.502 ' CG2' ' HA2' ' A' ' 34' ' ' GLY . 3.3 t -110.71 -32.23 6.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.99 -1.069 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.544 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 6.7 t30 -81.4 8.41 9.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 110.017 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.32 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.708 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.04 144.59 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 109.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 14.5 p -93.78 -19.42 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.38 -10.15 59.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -96.3 -49.71 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 9' ' ' ILE . . . -75.11 -33.3 54.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HD2' ' CE1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -69.67 -36.15 75.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 109.605 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -32.03 58.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.524 HG22 ' CD2' ' A' ' 94' ' ' LEU . 53.9 mt -67.92 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.262 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.569 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.7 t80 -54.35 -39.16 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 15' ' ' SER . 5.0 mm -57.09 -37.91 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -107.04 10.54 30.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.065 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -109.79 -60.03 1.84 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.102 -0.999 . . . . 0.0 109.527 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.621 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -132.07 40.81 3.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.313 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.2 t -87.25 -1.15 57.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -100.83 -49.07 4.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 38.3 m -87.75 -13.19 43.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.876 . . . . 0.0 109.357 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.619 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 82.2 m-70 -134.23 81.87 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 110.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.0 p -78.67 90.21 4.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.9 -1.125 . . . . 0.0 108.003 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.1 m -82.85 35.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.625 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 23.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.869 -1.144 . . . . 0.0 110.211 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -95.74 -15.63 22.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.884 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.89 -25.4 4.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 136.53 -6.26 3.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -67.21 141.17 57.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -1.126 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -112.87 115.3 28.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 109.088 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.63 -79.94 0.32 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.761 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.527 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 7.0 m -98.97 -53.54 3.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 175.14 31.99 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -73.52 125.04 9.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.823 2.349 . . . . 0.0 110.94 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 24' ' ' GLY . 15.6 t-20 -49.37 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -78.8 76.54 5.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 -66.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -110.4 27.19 11.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.558 ' HG ' ' CD1' ' A' ' 59' ' ' TRP . 1.9 tt -43.56 -30.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -1.079 . . . . 0.0 109.556 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.1 m-85 -74.91 128.95 36.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.58 66.26 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -120.77 123.6 43.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.406 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -60.09 -177.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' GLY . 2.3 p -80.47 178.43 8.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.51 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 52.83 104.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -155.16 -62.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.279 . . . . 0.0 110.005 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -61.08 139.33 94.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.95 -173.82 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.744 2.296 . . . . 0.0 110.509 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 45.99 25.25 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.623 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -157.16 112.11 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 108.96 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -78.35 77.25 4.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.6 m-85 -46.77 179.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.557 ' CG2' ' CA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.49 88.11 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.105 -0.997 . . . . 0.0 108.871 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.12 -41.75 12.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.77 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -51.03 -66.75 0.33 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.301 -0.875 . . . . 0.0 108.959 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.566 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.25 -42.36 4.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.465 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 5.5 tttt -43.41 -72.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.95 -15.79 60.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -60.42 -13.22 12.2 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.013 -1.055 . . . . 0.0 109.39 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.52 51.51 32.19 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.534 HG23 ' ND2' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -110.82 123.73 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.53 -0.983 . . . . 0.0 110.215 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -87.27 116.39 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.588 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 12.6 m95 -56.55 96.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.299 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -117.68 -176.57 17.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -64.21 -59.69 4.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.108 -1.231 . . . . 0.0 110.073 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.45 -38.35 77.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 109.922 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.59 -35.6 74.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -77.77 -29.81 51.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.071 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.443 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -58.68 -35.0 71.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.33 -0.856 . . . . 0.0 109.105 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.48 -58.61 3.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 52' ' ' ASN . 56.1 t80 -48.69 -28.81 3.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.163 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.52 ' CD2' HMB3 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -87.68 -39.27 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 0.0 109.487 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 65' ' ' MET . 10.8 tt0 -60.54 -21.22 62.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 1.8 m120 -169.21 89.61 0.59 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' CD ' ' CG1' ' A' ' 83' ' ' VAL . 32.3 Cg_endo -76.76 -41.44 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.612 2.208 . . . . 0.0 110.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -31.98 57.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.34 -0.85 . . . . 0.0 109.973 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 1.6 mmpt? -83.19 -26.25 31.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' CD2' HG12 ' A' ' 75' ' ' ILE . 7.1 t80 -83.94 -72.24 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.004 -1.06 . . . . 0.0 109.045 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 22.4 mm -93.73 119.37 67.12 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 109.669 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.8 60.22 7.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.475 2.116 . . . . 0.0 110.134 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 51' ' ' ALA . . . -158.31 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.557 ' CA ' ' CG2' ' A' ' 49' ' ' THR . 9.7 t -59.83 161.96 5.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 109.758 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 11.41 5.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.71 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 7.7 ptm -77.75 114.05 16.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.316 1.055 . . . . 0.0 109.752 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 tt -95.16 33.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.616 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 1.3 t80 -59.69 -32.27 70.34 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.976 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.594 ' CG1' ' CD ' ' A' ' 71' ' ' PRO . 3.3 m -31.65 104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.438 0.637 . . . . 0.0 110.809 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.67 28.89 0.14 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.522 HG22 HD13 ' A' ' 85' ' ' ILE . 14.5 mt -109.63 145.54 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.123 . . . . 0.0 109.346 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 85' ' ' ILE . 12.7 mtpt -144.94 37.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.173 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.52 138.42 41.32 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.241 -0.912 . . . . 0.0 109.502 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -77.89 -37.64 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.05 -22.14 66.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -81.16 -59.4 2.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -53.32 -30.17 37.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.15 -52.67 17.9 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -59.16 -22.03 60.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.61 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD2' HG22 ' A' ' 9' ' ' ILE . 27.4 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 4.9 mm -57.25 -38.58 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.325 -0.859 . . . . 0.0 109.413 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.28 82.46 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.545 -0.722 . . . . 0.0 109.86 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' CE1' ' HD2' ' A' ' 7' ' ' LYS . 23.4 t80 -61.99 -34.95 77.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 109.611 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.3 mm? -83.32 -13.35 55.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -95.05 -9.32 34.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.315 -0.865 . . . . 0.0 109.682 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.98 -52.08 2.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 109.46 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.14 71.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.97 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -128.53 40.41 3.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.826 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 102' ' ' THR . 6.0 t-20 178.85 51.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.71 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.91 110.97 7.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.419 HG23 ' HE2' ' A' ' 100' ' ' LYS . 4.3 p -56.49 -35.91 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.293 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.64 -36.9 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.595 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 9' ' ' ILE . 5.7 mmtt -74.94 -45.26 43.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 93' ' ' ASP . . . -42.27 -52.64 5.07 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 4.1 ttmm -64.16 -36.49 84.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -1.17 . . . . 0.0 109.666 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 11' ' ' ILE . 3.1 tptt -62.56 -23.43 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.073 -1.017 . . . . 0.0 109.915 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 5' ' ' LYS . 17.9 mm -82.65 -67.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.892 -1.13 . . . . 0.0 109.829 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.551 ' CE2' HG23 ' A' ' 20' ' ' VAL . 23.2 t80 -49.99 -31.55 12.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 109.524 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.544 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 3.2 tt -69.73 -40.65 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 ttm -111.77 29.61 7.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.378 -0.826 . . . . 0.0 109.973 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -140.73 -39.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.007 . . . . 0.0 109.951 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.526 ' HB3' ' C4B' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -146.48 16.53 1.3 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.967 -1.083 . . . . 0.0 109.938 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.544 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 28.2 t -85.44 7.94 20.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.893 -1.129 . . . . 0.0 109.594 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -100.1 -43.32 6.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 57.9 m -95.98 -32.83 12.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.67 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 71.4 m-70 -108.18 84.53 1.96 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 109.472 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 91.35 5.28 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.723 -1.235 . . . . 0.0 108.817 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG23 ' CE2' ' A' ' 10' ' ' PHE . 11.8 m -85.12 8.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.433 -0.792 . . . . 0.0 110.133 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 2.6 mt-10 -146.13 24.95 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 110.383 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -96.74 -58.31 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.057 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.8 54.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.38 20.01 3.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -100.81 82.66 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.448 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.85 150.11 30.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 109.373 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -133.77 -85.37 0.44 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.526 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 49.8 m -81.91 -15.6 53.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -132.44 150.26 19.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.67 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.8 Cg_endo -66.36 131.72 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.202 . . . . 0.0 111.108 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.1 t-20 -53.17 102.79 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.486 ' CB ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -81.97 42.69 0.73 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 110.166 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.432 ' ND1' ' CG2' ' A' ' 102' ' ' THR . 22.6 t-80 -89.0 58.43 4.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 108.993 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.85 23.67 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -56.52 -22.19 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.038 -1.272 . . . . 0.0 109.237 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 19.6 m-85 -70.85 134.37 47.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.876 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.77 10.5 61.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -123.64 120.31 32.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -1.202 . . . . 0.0 109.421 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 161.64 16.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.081 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -67.45 176.37 2.37 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 61.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -157.93 -58.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.185 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -53.24 129.79 50.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 0.0 109.862 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.56 145.14 18.23 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.598 2.198 . . . . 0.0 110.386 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.1 -47.02 3.7 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -81.24 113.83 19.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.958 . . . . 0.0 108.766 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -77.35 77.55 3.88 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.665 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-85 -46.6 177.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.647 . . . . 0.0 109.335 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.67 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 109.278 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -47.24 -41.67 19.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.242 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.567 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -47.8 -68.38 0.19 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' ND2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -40.47 -47.12 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.688 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 0.4 OUTLIER -48.15 -60.03 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.858 . . . . 0.0 110.044 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.2 -20.63 66.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 110.065 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -63.84 -8.75 11.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.088 -1.008 . . . . 0.0 109.96 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.08 52.56 34.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.53 HG22 ' ND2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -114.29 135.77 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.51 -0.994 . . . . 0.0 110.436 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -97.98 114.45 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 10.6 m95 -54.59 109.03 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.98 -163.15 10.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.87 -62.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.283 . . . . 0.0 109.839 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.1 93.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.098 -1.001 . . . . 0.0 109.937 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.53 -38.17 80.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.804 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' CD2' HMA2 ' A' ' 105' ' ' HEC . 0.6 OUTLIER -76.32 -32.79 58.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.765 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.6 ttt -55.79 -39.55 71.44 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -75.21 -48.6 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.27 -0.894 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 30.4 t80 -59.55 -18.33 39.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 109.737 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' CD2' HMB2 ' A' ' 105' ' ' HEC . 1.2 mp -92.71 -38.92 11.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -22.2 62.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . 10.3 m-20 -172.25 94.17 0.39 Allowed Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' HG11 ' A' ' 83' ' ' VAL . 31.2 Cg_endo -76.26 -30.78 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 0.0 110.022 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -82.15 -26.94 33.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.381 -0.824 . . . . 0.0 109.711 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -80.9 -44.34 18.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.259 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' CG ' ' A' ' 73' ' ' LYS . 2.4 t80 -72.08 -66.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.567 HG23 ' CB ' ' A' ' 51' ' ' ALA . 31.3 mm -98.43 110.28 55.97 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.479 -0.763 . . . . 0.0 109.62 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -79.35 67.07 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.459 2.106 . . . . 0.0 109.863 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -165.65 -47.65 0.02 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.537 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.0 t -47.57 167.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -1.233 . . . . 0.0 109.692 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -134.72 11.51 3.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.732 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.6 ptm -77.65 118.83 20.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.9 33.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.599 ' CZ ' HBB3 ' A' ' 105' ' ' HEC . 2.4 t80 -59.58 -34.46 72.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' C ' ' O ' ' A' ' 82' ' ' PHE . 2.4 m -30.42 111.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.595 0.712 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.27 40.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 4.4 mp -99.65 168.56 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -1.112 . . . . 0.0 109.868 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 2.5 tttt -166.54 29.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.395 -0.815 . . . . 0.0 108.992 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HE2' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -145.6 117.11 8.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.712 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -62.19 -40.11 94.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.161 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' OE2' ' HE2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -60.56 -23.47 64.66 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -0.841 . . . . 0.0 109.291 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -73.89 -53.61 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 1.4 mpt_? -55.44 -45.88 76.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.126 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.58 89.75 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . 4.3 m-20 -57.87 -29.13 64.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.279 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 91' ' ' ARG . 27.2 mt -66.96 -47.71 70.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.6 mm -65.84 -59.2 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.388 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.2 -42.25 6.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.904 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.01 -52.07 58.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 110.003 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.556 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.2 mm? -75.39 -0.42 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -95.87 -25.1 16.14 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 110.088 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE2' HG23 ' A' ' 3' ' ' VAL . 5.6 mtpp -108.7 -36.41 6.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.68 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.32 67.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.432 ' CG2' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -136.0 49.41 2.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.998 -1.064 . . . . 0.0 110.082 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.9 t30 -178.14 34.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.559 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.479 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.732 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.4 177.66 5.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 0.0 109.122 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG21 ' HD2' ' A' ' 100' ' ' LYS . 2.5 p -75.09 -35.77 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.65 -46.75 44.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.634 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -29.05 70.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.793 -1.192 . . . . 0.0 109.758 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . -72.43 -51.08 13.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 2.7 tttp -43.84 -35.18 1.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.023 -1.281 . . . . 0.0 110.082 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -74.25 -46.05 44.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 109.965 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.1 mt -56.86 -50.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.421 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 13.3 t80 -63.56 -46.41 86.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 110.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -53.21 -37.23 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.968 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.415 ' HE1' ' HA ' ' A' ' 9' ' ' ILE . 11.5 ptt? -107.29 5.72 27.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.831 -1.168 . . . . 0.0 110.448 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.7 tppt? -109.03 -69.47 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.895 -1.128 . . . . 0.0 109.733 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -117.11 40.8 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.146 -0.971 . . . . 0.0 108.599 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 8.2 t -87.99 -53.94 4.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.757 -1.214 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 17' ' ' CYS . 9.5 pt20 -55.95 -38.62 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.831 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.486 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 8.7 m -86.96 -24.52 24.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.128 -0.983 . . . . 0.0 108.978 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.663 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 71.7 m-70 -131.76 76.8 1.73 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.978 -1.076 . . . . 0.0 109.58 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -76.89 92.52 3.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.23 24.44 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 110.531 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 18.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 108.645 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -22.21 51.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.496 -0.753 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.73 -17.18 8.84 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.31 -7.24 3.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.13 155.79 21.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -1.225 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.67 141.71 34.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 0.0 109.568 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 28' ' ' THR . 2.6 ttmt -113.7 -85.07 0.59 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' CG2' ' HAC' ' A' ' 105' ' ' HEC . 19.4 m -79.13 -76.68 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -74.68 155.89 48.88 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.663 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 34.3 Cg_endo -70.14 138.01 35.65 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.236 1.958 . . . . 0.0 110.74 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -48.82 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.897 . . . . 0.0 109.604 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -82.5 53.08 2.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.743 . . . . 0.0 110.181 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -99.81 77.5 2.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 0.0 109.336 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 102' ' ' THR . . . 113.41 11.69 12.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.491 ' CD1' HBA2 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -54.01 -27.99 35.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.601 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 2.8 m-85 -61.96 150.03 38.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 109.908 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.02 17.55 23.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' CZ ' ' O ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -138.66 162.48 34.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -1.161 . . . . 0.0 109.422 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -92.93 -156.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.543 ' O ' ' CZ ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -59.65 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -145.85 -176.04 19.41 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.9 36.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.433 -1.039 . . . . 0.0 109.4 -179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' CB ' ' NE2' ' A' ' 26' ' ' HIS . . . -41.46 160.89 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.94 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.29 154.69 36.71 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.662 2.241 . . . . 0.0 109.962 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.33 20.04 20.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.551 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -153.87 104.48 2.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.932 . . . . 0.0 109.054 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 82.8 p -77.67 81.47 4.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 m-85 -44.65 174.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.662 -0.649 . . . . 0.0 109.309 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.06 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.03 -1.044 . . . . 0.0 109.495 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -55.17 -42.03 72.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.538 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -49.27 -72.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.594 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 1.3 m120 -38.45 -48.63 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.506 -0.746 . . . . 0.0 109.615 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 13.2 tttt -42.81 -69.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 0.0 110.671 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 55' ' ' LYS . 38.7 p30 -63.48 -17.96 63.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -62.44 -12.17 20.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 46.02 81.74 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.486 HG21 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -105.63 134.66 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.386 -1.067 . . . . 0.0 109.804 -179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.46 HD13 ' CD ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -96.32 96.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 0.0 108.597 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 8.0 m95 -42.06 103.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -126.12 -164.01 11.68 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.06 -70.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.0 109.383 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -61.02 -36.63 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.432 -0.792 . . . . 0.0 109.748 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -36.23 75.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.5 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -77.08 -33.73 57.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.335 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 tpt -54.69 -38.75 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.98 -58.15 3.49 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.404 -0.81 . . . . 0.0 109.491 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 53.6 t80 -52.9 -18.92 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.925 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.5 tp -92.33 -38.84 11.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.557 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -59.48 -22.55 61.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 8.3 p30 -178.58 88.98 0.22 Allowed Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HB2' HG22 ' A' ' 78' ' ' THR . 32.8 Cg_endo -75.55 -43.25 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.466 2.111 . . . . 0.0 110.292 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -21.69 65.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.227 -0.921 . . . . 0.0 108.833 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -89.09 -38.91 13.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.389 -0.819 . . . . 0.0 109.227 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.469 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 3.9 t80 -75.76 -68.73 0.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.594 ' CD1' ' ND2' ' A' ' 52' ' ' ASN . 12.1 mm -93.0 109.8 41.79 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.541 -0.724 . . . . 0.0 109.335 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 34.5 Cg_endo -76.23 87.8 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.218 1.945 . . . . 0.0 110.541 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 153.37 -27.14 0.78 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -42.24 145.51 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -1.099 . . . . 0.0 110.023 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HG3' ' O1D' ' A' ' 105' ' ' HEC . 3.2 mttp -107.26 18.9 21.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.442 ' HE2' ' HB2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -61.59 127.28 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 110.016 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.419 ' HB ' HBC3 ' A' ' 105' ' ' HEC . 17.7 mt -95.86 27.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CZ ' HBB3 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -65.38 163.74 15.06 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.546 0.689 . . . . 0.0 110.385 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 p -100.35 -27.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.516 -0.74 . . . . 0.0 109.335 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.01 68.17 0.78 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.497 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 33.9 mm -60.87 119.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 109.587 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -4.2 57.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.945 . . . . 0.0 109.426 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.08 111.83 4.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.21 -37.26 77.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.95 -41.54 97.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.317 -0.865 . . . . 0.0 109.691 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.49 ' CA ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -63.89 -49.47 72.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.594 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.85 -40.04 75.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.2 77.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' CB ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -63.08 -32.91 74.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.829 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt -64.91 -53.15 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 2.3 mm -60.21 -38.64 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.5 83.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.996 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.26 -53.41 57.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.2 -0.938 . . . . 0.0 109.571 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.6 mm? -65.23 -15.8 62.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.389 -0.819 . . . . 0.0 109.809 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -80.56 -28.76 37.16 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.003 -1.061 . . . . 0.0 110.158 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -102.0 -56.05 2.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.866 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.79 65.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -142.85 46.76 1.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.002 -1.061 . . . . 0.0 110.151 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 102' ' ' THR . 7.1 t30 174.12 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.019 . . . . 0.0 110.03 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 3.3 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.324 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.651 ' C3D' ' HD3' ' A' ' 30' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.27 166.13 13.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.54 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 p -92.45 -37.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.893 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.26 -12.61 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -91.26 -54.08 4.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.83 -39.91 79.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 26.6 tttp -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 0.0 109.538 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -74.51 -27.77 60.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.525 HG23 ' CD2' ' A' ' 94' ' ' LEU . 80.5 mt -61.22 -63.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.14 -0.975 . . . . 0.0 109.023 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 14' ' ' CYS . 40.1 t80 -62.69 -42.21 99.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 108.728 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 9.2 mm -61.5 -18.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.747 . . . . 0.0 109.297 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.43 ' O ' ' HG3' ' A' ' 12' ' ' MET . 4.6 tpt -128.52 18.54 6.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 109.618 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -131.64 -50.42 0.98 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -126.51 23.23 6.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.126 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.6 t -87.84 -2.28 58.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.821 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -92.28 -45.79 8.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 108.488 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.4 m -90.94 -35.65 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.67 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 65.1 m-70 -110.63 85.01 2.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.063 -1.023 . . . . 0.0 110.339 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 15' ' ' SER . 2.8 p -79.84 99.39 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.75 -1.219 . . . . 0.0 108.821 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG12 ' CB ' ' A' ' 32' ' ' LEU . 3.4 m -86.95 33.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 21.71 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.28 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -63.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.26 64.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.09 13.23 40.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -100.12 156.92 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.613 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -152.69 119.91 5.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.369 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -93.3 -86.0 0.26 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 22.2 m -87.93 -43.41 11.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.799 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -101.2 153.29 19.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.67 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.1 Cg_endo -66.71 132.81 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.947 2.431 . . . . 0.0 111.692 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -49.58 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.44 0.638 . . . . 0.0 109.909 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.52 HD23 ' CB ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.89 69.93 7.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.509 -0.745 . . . . 0.0 110.677 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.433 ' O ' ' OG1' ' A' ' 102' ' ' THR . 10.0 t-80 -100.5 -59.46 1.7 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.053 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.76 36.72 4.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 59' ' ' TRP . 14.3 tp -48.87 -30.03 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.096 . . . . 0.0 109.768 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 76.5 m-85 -75.56 124.49 27.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.961 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.03 69.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.38 107.8 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.023 -1.281 . . . . 0.0 109.576 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' THR . 4.3 pttt -61.3 150.13 35.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -46.74 176.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 109.886 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 55.99 91.96 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 2.0 tp-100 -151.52 -43.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -1.169 . . . . 0.0 109.644 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB1' ' CE1' ' A' ' 48' ' ' TYR . . . -58.29 146.09 72.33 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.618 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.77 -62.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.794 2.329 . . . . 0.0 110.761 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.33 46.51 3.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -160.79 114.03 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.176 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 48' ' ' TYR . 25.4 m -79.15 77.27 5.66 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.2 m-85 -46.23 -179.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.752 -0.593 . . . . 0.0 109.787 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.555 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.68 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.995 . . . . 0.0 108.971 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.46 -38.94 64.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.54 ' HB1' ' CG2' ' A' ' 75' ' ' ILE . . . -49.72 -64.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.608 ' ND2' ' CH2' ' A' ' 59' ' ' TRP . 2.4 t-20 -53.51 -41.16 66.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.868 -1.145 . . . . 0.0 109.373 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.536 ' N ' HG22 ' A' ' 40' ' ' THR . 24.5 tttm -52.1 -37.0 52.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -82.07 -23.44 35.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 110.33 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 28.9 tttt -76.4 3.07 11.87 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.985 -1.072 . . . . 0.0 109.671 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.2 11.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -103.8 132.01 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -96.67 112.41 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 108.648 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.608 ' CH2' ' ND2' ' A' ' 52' ' ' ASN . 6.1 m95 -59.95 105.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 110.047 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.99 -157.83 8.81 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.78 -63.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -1.118 . . . . 0.0 109.567 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -37.71 85.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.927 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.45 -45.07 92.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.827 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -66.78 -34.27 77.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.993 . . . . 0.0 109.271 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.51 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 2.5 tmm? -54.26 -38.41 65.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.397 -0.815 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.01 -60.81 2.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.526 ' CD1' HG12 ' A' ' 75' ' ' ILE . 39.0 t80 -54.42 -17.71 3.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.781 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.491 ' CD2' HMB3 ' A' ' 105' ' ' HEC . 1.1 tp -90.74 -31.22 16.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.023 -1.048 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.74 -27.34 66.42 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -177.75 100.61 0.22 Allowed Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 32.6 Cg_endo -76.34 -40.71 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.356 2.037 . . . . 0.0 110.262 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 9.5 tptm -70.84 -12.11 61.35 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -102.32 -35.66 8.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.965 . . . . 0.0 109.314 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 11.8 t80 -76.84 -69.35 0.53 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 108.618 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 5.6 mm -95.2 111.09 53.73 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.901 . . . . 0.0 109.214 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.15 70.24 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.289 1.993 . . . . 0.0 110.385 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -177.47 -38.3 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.555 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 13.4 t -44.71 158.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -108.54 -2.8 18.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.17 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.699 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.9 ptm -88.83 121.99 31.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.067 -1.021 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.24 45.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.578 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 48.4 t80 -59.51 147.78 35.57 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 14.0 p -88.04 141.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.585 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.88 120.04 9.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.06 128.51 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -1.159 . . . . 0.0 109.407 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 37.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -143.78 115.73 8.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 1.1 tppt? -64.96 -26.25 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.28 -43.92 54.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.211 -0.93 . . . . 0.0 109.769 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.3 tt0 -59.47 -38.96 82.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.415 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.51 ' NH1' ' HG2' ' A' ' 65' ' ' MET . 1.4 mtp180 -65.62 -47.47 75.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.168 -0.957 . . . . 0.0 109.089 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.58 65.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.888 . . . . 0.0 109.28 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -30.46 66.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.408 -0.807 . . . . 0.0 109.342 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.525 ' CD2' HG23 ' A' ' 9' ' ' ILE . 43.5 mt -65.46 -58.33 6.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 3.3 mm -66.14 -29.09 45.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 109.221 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.57 94.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.603 -0.685 . . . . 0.0 109.929 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.492 ' CD2' HD23 ' A' ' 98' ' ' LEU . 22.6 t80 -73.12 -52.94 12.35 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.109 -0.994 . . . . 0.0 109.245 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.529 ' O ' ' CG2' ' A' ' 102' ' ' THR . 1.4 mm? -60.43 -16.97 41.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.416 -0.803 . . . . 0.0 109.921 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -82.76 -48.04 11.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.883 -1.135 . . . . 0.0 109.463 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.29 77.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.9 -50.03 11.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 98' ' ' LEU . 13.8 t -120.27 40.33 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.948 -1.095 . . . . 0.0 110.368 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 10.9 t-20 -167.97 39.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.481 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.699 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -158.17 102.98 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.466 ' CG2' ' HE2' ' A' ' 100' ' ' LYS . 9.9 p -79.07 -34.87 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 5' ' ' LYS . 15.4 pt-20 -53.47 -36.26 61.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 0.0 109.75 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -97.64 -14.11 21.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.06 -41.21 97.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 20.0 ttmt -61.94 -22.38 65.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.067 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -78.81 -40.41 33.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.086 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' CG2' HD21 ' A' ' 94' ' ' LEU . 42.8 mt -62.36 -50.95 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 108.798 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 34.5 t80 -62.55 -39.22 92.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 6.7 mm -61.48 -22.2 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.42 -0.8 . . . . 0.0 108.872 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.04 13.28 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 4.1 tptt -126.86 -55.74 1.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.188 . . . . 0.0 110.381 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.552 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -130.68 22.36 5.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.821 -1.174 . . . . 0.0 110.216 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 40.0 t -86.41 7.37 26.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.935 -1.103 . . . . 0.0 109.461 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -100.53 -54.58 2.81 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 10.5 m -82.85 -27.41 30.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.6 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 73.6 m-70 -115.2 88.8 2.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.135 -0.978 . . . . 0.0 110.059 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.2 p -78.7 83.37 4.86 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.045 -1.035 . . . . 0.0 108.457 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG13 ' CZ ' ' A' ' 10' ' ' PHE . 2.7 m -84.02 30.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 110.304 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.18 19.57 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.324 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -97.43 -61.1 1.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.23 62.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.54 16.1 54.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -92.0 144.7 25.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -1.155 . . . . 0.0 109.532 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.492 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.79 133.19 19.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 109.683 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 -77.13 0.58 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.511 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 52.5 m -90.53 -40.14 12.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.529 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.509 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -104.99 152.63 17.33 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HA ' ' CE2' ' A' ' 46' ' ' TYR . 31.4 Cg_endo -68.04 133.15 28.12 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.385 2.057 . . . . 0.0 111.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.445 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.4 t-20 -49.1 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.475 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.93 67.69 8.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.545 -0.722 . . . . 0.0 109.49 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 102' ' ' THR . 5.4 t-160 -98.24 -6.93 30.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 109.874 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.82 61.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -78.69 -30.98 46.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.27 -1.136 . . . . 0.0 109.858 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 83.6 m-85 -67.97 124.33 23.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.98 28.62 62.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.03 120.56 9.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.523 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 173.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.962 . . . . 0.0 109.212 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.495 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -85.57 175.44 8.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 60.67 96.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.86 -55.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.853 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -44.32 133.24 4.52 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.21 139.62 15.01 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.578 2.185 . . . . 0.0 110.605 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.07 -49.96 4.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.09 104.51 12.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.462 -1.022 . . . . 0.0 108.84 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.62 80.59 4.09 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 6.6 m-30 -44.35 173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.528 HG23 ' CAD' ' A' ' 105' ' ' HEC . 0.1 OUTLIER -62.89 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.129 -0.982 . . . . 0.0 108.435 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -41.52 -37.83 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -0.763 . . . . 0.0 109.856 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . . . -39.78 -64.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.702 -0.624 . . . . 0.0 109.4 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' ND2' HG13 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -45.83 -51.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.868 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.493 ' CA ' ' OG1' ' A' ' 40' ' ' THR . 25.2 tttt -49.93 -41.45 46.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -71.46 -32.17 67.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.011 -1.055 . . . . 0.0 110.127 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.75 2.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.039 -1.038 . . . . 0.0 109.736 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.27 52.58 46.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.35 132.92 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -1.019 . . . . 0.0 110.371 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -95.29 97.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CD1' HD11 ' A' ' 35' ' ' LEU . 10.1 m95 -37.16 122.77 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.634 0.73 . . . . 0.0 111.127 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -143.04 -164.06 10.03 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -76.08 -73.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 0.0 109.617 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.53 -33.59 72.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.691 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -47.22 86.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 108.835 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -61.69 -35.83 79.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.46 -0.775 . . . . 0.0 109.005 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ttt -55.79 -35.12 65.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.412 -0.805 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' OE2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 tm-20 -71.94 -60.02 2.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.793 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.62 ' CD1' HG12 ' A' ' 75' ' ' ILE . 24.8 t80 -54.79 -21.17 10.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.463 ' CD1' HMB3 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -88.02 -33.21 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.444 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.91 -23.92 66.63 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.497 ' HA ' HG12 ' A' ' 83' ' ' VAL . 9.9 t-20 -177.82 96.54 0.22 Allowed Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 32.2 Cg_endo -74.34 -30.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.446 2.097 . . . . 0.0 110.182 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -13.34 60.54 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 108.646 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -95.58 -46.32 6.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.117 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' OE2' ' A' ' 66' ' ' GLU . 13.2 t80 -71.46 -64.05 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.006 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.62 HG12 ' CD1' ' A' ' 67' ' ' TYR . 4.2 mm -79.31 126.44 81.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.7 Cg_endo -74.98 74.24 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.122 1.882 . . . . 0.0 110.692 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.39 33.37 1.62 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 71' ' ' PRO . 14.0 t -50.48 162.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.342 . . . . 0.0 108.929 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.464 ' CB ' HMD3 ' A' ' 105' ' ' HEC . 2.1 mtpp -103.62 12.35 35.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.949 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.71 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 6.3 ptm -130.57 128.64 41.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 81' ' ' ILE . 9.1 tp -109.41 40.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -59.72 -39.47 84.75 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.451 -178.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -22.77 115.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.585 0.707 . . . . 0.0 111.461 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.04 35.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.1 mp -111.06 174.82 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -1.139 . . . . 0.0 109.636 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -171.13 41.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -139.93 127.82 22.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.955 . . . . 0.0 109.291 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -71.45 -54.8 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.831 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.86 -42.2 68.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.973 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.1 tt0 -59.98 -39.09 84.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.129 -0.982 . . . . 0.0 109.565 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' LYS . 1.3 mmt85 -59.85 -50.67 72.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 -39.99 75.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.429 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -29.55 69.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.587 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.479 HD21 ' CG2' ' A' ' 9' ' ' ILE . 20.6 mt -64.25 -47.4 79.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.877 . . . . 0.0 109.186 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 3.6 mm -71.2 -30.84 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.137 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.03 79.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 101' ' ' ALA . 13.1 t80 -69.61 -33.59 72.89 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 108.951 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -78.63 -9.5 59.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.363 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.11 -16.52 17.81 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HE2' ' CG2' ' A' ' 3' ' ' VAL . 3.3 mtpt -108.9 -20.14 13.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . . . -91.08 -43.45 9.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.384 -0.822 . . . . 0.0 109.935 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.461 ' OG1' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -104.0 -59.27 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.677 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 5.2 t30 -53.2 -26.76 18.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 100' ' ' LYS . 29.5 tp10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.455 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.71 ' C1D' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.09 147.44 24.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.84 -51.3 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.754 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -63.87 -15.83 59.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -82.15 -72.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -53.77 -28.2 38.14 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 35.4 tttt -65.98 -37.77 86.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 109.858 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -75.21 -26.07 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.528 ' CG2' HD22 ' A' ' 94' ' ' LEU . 33.4 mm -64.3 -60.79 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.506 ' CD1' HD22 ' A' ' 98' ' ' LEU . 39.5 t80 -61.28 -38.3 86.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 7' ' ' LYS . 49.4 mt -64.13 -22.49 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 tpp -122.84 16.03 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.126 -0.984 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 6.6 tppt? -127.57 -49.01 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.091 -1.006 . . . . 0.0 109.553 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -131.76 28.69 4.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.982 . . . . 0.0 108.88 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.1 t -86.66 -4.16 59.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -95.23 -43.48 8.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.246 -0.908 . . . . 0.0 108.917 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.489 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 7.0 m -91.26 -44.19 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.963 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.663 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 59.6 m-70 -101.92 81.81 2.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.047 . . . . 0.0 109.772 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 p -79.66 95.51 5.95 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.826 -1.171 . . . . 0.0 108.877 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 32' ' ' LEU . 3.0 m -82.37 13.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.867 . . . . 0.0 109.859 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.32 17.15 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 110.057 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -89.95 -23.94 21.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 109.709 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.35 60.36 0.55 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.71 9.53 52.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 3.5 tttp -91.61 130.76 37.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -1.166 . . . . 0.0 109.536 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.486 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.01 104.85 5.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 -82.03 0.13 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.13 -0.981 . . . . 0.0 110.181 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' O ' HMD2 ' A' ' 105' ' ' HEC . 10.8 m -89.9 -30.86 17.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -108.65 150.4 17.05 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.666 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -67.29 129.05 19.52 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.79 2.327 . . . . 0.0 111.103 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.486 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.0 t-20 -48.68 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.64 -0.663 . . . . 0.0 110.128 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -83.64 62.27 6.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 9.3 p80 -100.26 52.78 0.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.311 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 38' ' ' ARG . . . 118.74 64.49 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -78.3 -26.42 46.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -1.071 . . . . 0.0 110.269 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 7.1 m-30 -71.88 125.63 27.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.076 . . . . 0.0 110.981 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.07 -6.51 69.19 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.203 -0.999 . . . . 0.0 111.281 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.13 134.59 54.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.658 -1.495 . . . . 0.0 110.287 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -70.76 150.42 45.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.501 ' OG1' ' NE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -60.95 163.77 5.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.018 . . . . 0.0 110.212 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.66 99.27 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -160.78 -34.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.258 . . . . 0.0 110.026 179.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.62 128.7 85.14 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.065 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.7 149.73 21.03 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.531 2.154 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.49 -14.2 55.82 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -126.02 111.64 14.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -1.073 . . . . 0.0 108.3 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' TYR . 2.0 p -74.27 78.84 1.82 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.666 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.8 m-85 -48.18 179.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.528 HG22 ' CA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.9 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.16 -40.76 11.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.623 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -53.88 -67.85 0.23 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.449 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.581 ' N ' HG22 ' A' ' 75' ' ' ILE . 2.1 m120 -36.26 -53.8 0.82 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.443 -0.785 . . . . 0.0 111.078 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -55.37 -59.49 4.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.931 -1.106 . . . . 0.0 110.176 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.04 -12.43 11.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.347 -0.846 . . . . 0.0 110.675 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -79.31 5.75 11.68 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.861 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.16 45.88 10.23 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.39 114.06 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -1.125 . . . . 0.0 109.868 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.35 108.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.551 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 4.9 m95 -46.74 113.63 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.52 179.24 17.24 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.1 -60.49 2.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.277 . . . . 0.0 109.535 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.49 -41.72 98.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.676 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.58 -32.44 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.694 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 HD13 HD22 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -78.58 -32.73 47.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.753 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 tpp -60.54 -35.76 76.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -54.07 7.53 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.562 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 45.6 t80 -56.13 -26.5 50.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' CD2' HMB2 ' A' ' 105' ' ' HEC . 1.1 tp -81.97 -39.54 23.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -59.87 -23.18 63.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 9.3 m120 -168.33 96.22 0.58 Allowed Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 32.0 Cg_endo -77.08 -29.91 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.417 2.078 . . . . 0.0 110.44 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -85.29 -31.87 22.83 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.318 -0.863 . . . . 0.0 109.516 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 3.6 mmmt -78.57 -35.29 46.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.001 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.566 ' CE2' HD12 ' A' ' 75' ' ' ILE . 22.1 t80 -75.81 -69.05 0.52 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 52' ' ' ASN . 5.6 mm -101.16 117.73 61.68 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 61.37 8.21 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.428 2.086 . . . . 0.0 110.017 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.45 -48.3 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.528 ' CA ' HG22 ' A' ' 49' ' ' THR . 7.4 t -50.68 167.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.283 . . . . 0.0 109.847 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -135.48 10.19 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.708 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.8 ptm -76.41 123.33 25.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mt -97.87 35.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.599 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 4.4 t80 -59.7 -35.28 74.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.539 . . . . 0.0 109.888 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -38.75 96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.498 -0.751 . . . . 0.0 110.085 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -156.09 20.84 0.5 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.2 163.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -1.138 . . . . 0.0 109.242 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -143.36 16.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.434 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.98 123.08 36.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 0.0 109.639 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -37.56 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 109.419 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -56.85 -39.67 74.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.672 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.5 -49.26 72.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.19 66.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 0.0 109.04 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.61 79.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 109.213 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 89' ' ' GLU . 13.2 m-20 -59.37 -35.9 74.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' A' ' 9' ' ' ILE . 38.1 mt -58.67 -46.42 87.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 3.2 mm -67.85 -49.03 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 0.0 110.039 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.19 -39.19 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.435 -0.79 . . . . 0.0 110.394 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 36.7 t80 -70.51 -50.67 35.4 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.999 -1.063 . . . . 0.0 110.085 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 10' ' ' PHE . 2.3 mm? -72.23 -4.49 29.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -99.49 -20.46 16.41 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.157 -0.964 . . . . 0.0 109.883 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -107.28 -20.08 13.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.647 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.92 -36.34 12.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 110.003 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 47.38 2.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.638 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 6.4 t-20 -171.93 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 109.35 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.708 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -143.64 171.47 14.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -1.13 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 12.7 p -96.02 -46.26 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.538 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 3.8 mt-10 -64.55 -19.9 65.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' HG12 ' A' ' 9' ' ' ILE . 9.9 mttt -91.55 -33.26 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.48 -20.55 75.54 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 25.4 ttpt -70.58 -32.98 70.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -1.118 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' HA ' ' HB ' ' A' ' 11' ' ' ILE . 6.6 mttp -85.46 -31.8 22.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.543 ' CG2' HD23 ' A' ' 94' ' ' LEU . 29.4 mm -57.62 -57.33 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.009 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.524 ' CD2' HD22 ' A' ' 98' ' ' LEU . 20.6 t80 -67.33 -41.65 84.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 108.989 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 8.7 mm -55.85 -18.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 109.108 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 ttt -119.21 -5.89 10.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.94 -62.03 1.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.586 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.593 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -126.49 41.92 3.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.028 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -95.45 -1.1 51.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.828 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.17 -35.26 9.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 108.764 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.7 m -99.96 -21.43 15.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.605 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 76.0 m-70 -126.15 80.42 1.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 0.0 109.742 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -79.0 90.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.514 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.7 8.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 110.394 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -164.94 23.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.927 -1.108 . . . . 0.0 109.9 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 22' ' ' LYS . 2.9 tmtp? -100.62 37.47 1.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.133 -0.979 . . . . 0.0 109.199 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.63 -30.45 8.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.19 8.64 40.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -95.32 117.63 30.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.209 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -90.69 172.05 8.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.052 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -160.01 -91.62 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.372 -0.83 . . . . 0.0 108.912 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' CMD' ' A' ' 105' ' ' HEC . 11.5 m -65.2 -59.76 3.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 108.741 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -95.86 153.9 20.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 33.2 Cg_endo -69.49 134.42 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.176 1.917 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' HIS . 6.9 t-20 -46.55 101.4 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.8 41.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 109.911 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -91.33 70.85 6.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' N ' HG22 ' A' ' 102' ' ' THR . . . 117.36 19.37 5.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.598 ' CD2' ' CD1' ' A' ' 59' ' ' TRP . 17.9 tp -53.77 -29.81 41.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.142 . . . . 0.0 109.508 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' HB3' ' OD1' ' A' ' 103' ' ' ASN . 14.4 m-85 -69.85 135.56 49.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.29 83.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' NH1' HD12 ' A' ' 35' ' ' LEU . 31.2 ttp85 -155.21 123.75 6.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.257 . . . . 0.0 109.599 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -61.7 164.86 5.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.195 -0.94 . . . . 0.0 109.063 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 5.8 t -101.53 169.6 8.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.515 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.496 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 88.93 67.43 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -161.8 -32.07 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.138 -1.213 . . . . 0.0 110.739 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -36.39 141.15 0.37 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.785 . . . . 0.0 110.331 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.58 128.21 9.34 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.626 2.217 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.46 -47.35 3.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -100.5 63.84 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.482 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 m -62.9 95.46 0.08 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 30' ' ' PRO . 1.5 m-30 -50.91 -179.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.756 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.2 p -59.58 90.37 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.001 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -31.4 -35.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.701 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -39.7 -62.93 0.63 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.554 ' CB ' HG22 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -38.78 -69.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 110.665 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 2.3 tmtt? -43.12 -38.97 2.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -66.14 -41.91 89.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 110.488 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HG2' ' CE2' ' A' ' 74' ' ' TYR . 45.4 tptt -50.68 -20.42 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 109.123 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.57 39.47 97.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' C ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -103.88 119.04 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.605 -0.938 . . . . 0.0 110.373 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -82.17 100.78 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 6.3 m95 -38.81 118.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 111.05 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.13 -159.61 9.61 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HA ' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -77.41 -63.02 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.11 -1.229 . . . . 0.0 109.735 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.28 -35.79 71.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.172 -0.955 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -46.27 89.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.095 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -70.22 -36.08 74.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.27 45.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.76 -50.07 59.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.51 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.618 ' CD1' HG12 ' A' ' 75' ' ' ILE . 54.3 t80 -54.87 -21.86 12.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.756 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 HD22 HMB2 ' A' ' 105' ' ' HEC . 1.2 mp -86.73 -38.11 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.369 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.25 -23.51 62.41 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.27 95.04 0.23 Allowed Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.5 Cg_endo -73.7 -36.34 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.354 2.036 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -70.37 -9.06 55.2 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 108.927 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -91.91 -50.21 5.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' CD2' HD12 ' A' ' 75' ' ' ILE . 7.0 t80 -71.89 -64.93 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.618 HG12 ' CD1' ' A' ' 67' ' ' TYR . 4.7 mm -91.35 108.93 32.41 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.6 Cg_endo -77.76 73.15 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.311 2.007 . . . . 0.0 110.291 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.489 ' C ' ' CG2' ' A' ' 49' ' ' THR . . . 171.34 -28.97 0.11 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.924 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 t -50.4 134.1 23.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.849 -1.383 . . . . 0.0 109.45 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.78 12.0 37.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.68 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 5.3 ptm -87.23 123.16 31.94 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.94 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 81' ' ' ILE . 37.4 mm -109.44 36.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 0.8 OUTLIER -58.9 -31.88 69.03 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.976 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.543 ' CG1' ' HD3' ' A' ' 71' ' ' PRO . 3.4 m -34.32 104.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.453 0.644 . . . . 0.0 110.536 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.75 -40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.0 mt -60.94 143.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.89 45.44 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.2 7.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.714 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -52.18 -28.18 17.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.17 -46.63 70.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.945 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.754 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -52.51 -42.54 64.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 109.341 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.61 87.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -30.11 70.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.543 HD23 ' CG2' ' A' ' 9' ' ' ILE . 42.2 mt -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 2.3 mm -75.23 -34.39 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.566 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -47.13 81.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 109.947 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -70.16 -44.21 69.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.524 HD22 ' CD2' ' A' ' 10' ' ' PHE . 1.5 mm? -71.38 -7.7 48.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.1 -1.0 . . . . 0.0 109.434 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.08 -16.93 17.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.776 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -104.11 -26.44 12.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 110.14 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.7 -45.74 9.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.146 -0.971 . . . . 0.0 110.295 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.497 HG22 ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -114.2 38.51 3.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.699 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 99' ' ' LYS . 1.2 t30 -176.41 61.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.68 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER -146.34 145.74 30.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -1.205 . . . . 0.0 109.633 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 6.5 p -66.8 -41.62 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 4.0 tm-20 -59.06 -24.36 62.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.383 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.2 tptm -75.12 -53.44 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 97' ' ' TYR . . . -72.18 -67.66 1.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -39.66 -35.27 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.44 -1.035 . . . . 0.0 110.305 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.55 -44.29 57.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 0.0 109.53 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -72.42 -65.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.705 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 15' ' ' SER . 18.3 t80 -46.05 -40.83 11.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.726 -1.234 . . . . 0.0 109.803 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 15' ' ' SER . 6.9 mm -62.05 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.023 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -107.51 20.12 19.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.129 -0.982 . . . . 0.0 109.842 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -126.96 -61.33 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.772 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 1.9 m -113.3 5.07 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 0.0 110.161 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -88.79 27.23 1.35 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.809 -1.182 . . . . 0.0 109.244 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.32 -61.08 1.46 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.444 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.3 m -80.02 -30.83 39.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.646 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 66.4 m-70 -102.18 173.56 6.32 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.044 0.926 . . . . 0.0 109.46 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 18' ' ' HIS . 20.9 p -161.85 92.77 0.87 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 32' ' ' LEU . 3.5 m -84.14 34.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.78 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.416 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 8.9 tptt -101.23 35.89 2.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.85 -35.28 4.03 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.76 0.18 6.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 137.92 37.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.534 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -120.04 102.53 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.01 . . . . 0.0 110.475 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.72 -74.58 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.59 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 66.4 m -89.77 -99.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 17' ' ' CYS . . . -51.73 150.62 7.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.646 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.4 Cg_endo -69.81 156.67 62.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 111.417 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.534 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -63.26 102.1 0.36 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 30' ' ' PRO . 3.7 mp -79.05 71.17 5.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 109.997 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -100.51 -57.71 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.044 . . . . 0.0 109.013 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -111.24 23.1 19.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' CD1' ' O1A' ' A' ' 105' ' ' HEC . 1.3 tt -44.25 -36.02 2.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -1.082 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 4.4 m-30 -65.81 142.1 58.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.371 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 15.28 61.47 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 5.4 tmm_? -136.76 142.77 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -1.152 . . . . 0.0 109.589 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -82.07 -171.54 3.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -92.92 -176.73 4.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.873 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 51.09 101.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -157.92 -77.1 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.238 . . . . 0.0 110.193 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -40.84 136.51 1.53 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.966 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.59 152.27 29.45 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.707 2.271 . . . . 0.0 110.265 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.63 -53.03 4.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.7 OUTLIER -99.35 69.86 1.7 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.421 -1.046 . . . . 0.0 108.621 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 p -67.8 97.72 0.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 30' ' ' PRO . 1.4 m-30 -53.52 -175.72 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.769 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.509 HG22 ' CGD' ' A' ' 105' ' ' HEC . 3.3 t -60.9 88.02 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -36.84 -32.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.313 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . . . -45.13 -63.03 1.02 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.718 -0.613 . . . . 0.0 109.464 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.526 ' CA ' HG21 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.75 -52.99 6.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.973 . . . . 0.0 109.404 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -50.52 -42.32 54.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 109.664 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.56 -42.83 99.79 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.865 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -49.71 -21.13 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.049 -1.032 . . . . 0.0 109.272 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.3 46.48 78.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 HD12 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -104.05 123.12 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.531 -0.982 . . . . 0.0 110.249 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -87.71 100.9 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 7.4 m95 -40.2 116.72 0.7 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.825 0.822 . . . . 0.0 110.82 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -148.19 -154.09 6.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -77.68 -74.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.262 . . . . 0.0 109.588 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.45 -34.72 78.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 110.301 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -64.42 -56.13 16.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.274 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -64.94 -21.88 66.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.9 ttt -67.14 -32.66 73.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.315 -0.865 . . . . 0.0 109.021 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -54.42 6.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.412 -0.805 . . . . 0.0 109.794 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.667 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 4.9 t80 -54.99 -36.89 65.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.926 -1.109 . . . . 0.0 109.168 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD12 ' C2B' ' A' ' 105' ' ' HEC . 0.8 OUTLIER -77.68 -27.85 50.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.36 -26.66 65.25 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.555 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.28 101.95 0.24 Allowed Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' A' ' 67' ' ' TYR . 30.6 Cg_endo -74.56 -27.09 11.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.372 2.048 . . . . 0.0 109.838 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -78.27 -19.33 53.88 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.598 -0.689 . . . . 0.0 109.371 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -97.53 -29.92 13.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.024 -1.048 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 67' ' ' TYR . 3.7 t80 -80.81 -70.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 67' ' ' TYR . 1.6 mm -85.63 119.2 71.88 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 33.4 Cg_endo -73.25 82.83 1.54 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 110.482 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 113.02 26.24 4.16 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLY . 14.7 t -43.99 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.039 -1.271 . . . . 0.0 109.293 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 10.6 mmtm -93.9 0.75 56.32 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.783 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.747 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 2.5 ptt? -118.1 119.31 34.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.07 -1.019 . . . . 0.0 109.727 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.4 mm -89.51 49.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.286 -0.883 . . . . 0.0 108.919 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.559 ' CZ ' HBB1 ' A' ' 105' ' ' HEC . 35.1 t80 -59.99 152.65 23.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.371 -0.831 . . . . 0.0 109.183 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 84' ' ' GLY . 12.4 p -81.71 10.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 83' ' ' VAL . . . 54.32 169.24 0.04 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 90' ' ' GLU . 1.9 mp -120.65 153.44 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.272 -1.134 . . . . 0.0 109.372 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.1 11.79 5.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -66.15 -32.42 73.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.798 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.71 -52.57 64.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HB3' HG21 ' A' ' 85' ' ' ILE . 2.2 tt0 -59.98 -40.7 90.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.73 -39.04 57.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.584 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.6 75.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.469 ' OD2' ' CG ' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -66.43 -28.89 68.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.0 mt -73.82 -62.04 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 95' ' ' ILE . 4.2 mm -61.06 -30.42 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.85 77.69 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 110.35 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.467 ' HB2' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t80 -63.53 -47.47 81.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.034 -1.042 . . . . 0.0 110.442 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mm? -63.25 -29.2 70.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.596 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HG2' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -66.27 -36.8 83.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.023 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.27 -18.48 36.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.95 47.08 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.907 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.5 HG21 ' N ' ' A' ' 103' ' ' ASN . 6.7 t -132.85 -43.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.067 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.512 ' CB ' ' HG2' ' A' ' 99' ' ' LYS . 7.2 t-20 -63.43 -11.83 26.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 0.0 109.546 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.747 ' C1D' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.28 151.05 25.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -1.128 . . . . 0.0 109.42 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 4' ' ' GLU . 11.4 p -81.17 -31.66 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 3' ' ' VAL . 39.1 mt-10 -76.23 -31.23 58.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.651 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' HD13 ' A' ' 9' ' ' ILE . 3.7 tppt? -73.14 -55.37 6.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.73 97.45 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 3.3 ttpm? -65.06 -18.82 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -40.7 54.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.512 HG22 ' CG ' ' A' ' 94' ' ' LEU . 2.9 mp -67.26 -60.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' SER . 38.9 t80 -52.03 -44.78 64.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.115 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.5 HD12 ' CG ' ' A' ' 7' ' ' LYS . 20.2 mt -56.68 -38.01 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 24.8 12.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.043 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -130.23 -62.31 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.285 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.576 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -120.6 26.43 9.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.206 -0.934 . . . . 0.0 108.81 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 3.0 t -82.81 4.73 24.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 3.6 tp-100 -99.83 -54.52 2.89 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 108.712 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 44.7 m -83.21 -22.26 33.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.653 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 72.8 m-70 -123.31 89.34 3.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.894 . . . . 0.0 109.861 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -93.42 96.28 9.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.96 -1.087 . . . . 0.0 108.806 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.2 m -85.29 31.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.384 -0.823 . . . . 0.0 109.941 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.98 7.19 2.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.017 -1.052 . . . . 0.0 109.708 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -149.47 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.01 36.73 3.92 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.16 80.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.94 159.16 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -141.04 140.77 34.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 -60.88 1.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 HG22 ' SG ' ' A' ' 17' ' ' CYS . 85.0 m -100.17 -61.28 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -93.49 156.29 22.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 29.9 Cg_endo -66.77 135.78 39.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.62 2.213 . . . . 0.0 111.335 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.62 103.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 109.534 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.576 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.35 46.1 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 46.1 t60 -96.06 69.34 2.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 108.822 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 102' ' ' THR . . . 117.98 16.33 5.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.505 HD13 ' NH1' ' A' ' 38' ' ' ARG . 23.0 tp -52.58 -30.69 32.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.507 -0.996 . . . . 0.0 109.872 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 3.3 m-85 -60.9 141.04 57.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.443 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.34 70.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 3.4 tmm_? -135.28 125.63 26.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -1.128 . . . . 0.0 109.382 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 19.1 mttp -72.3 173.39 8.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.463 HG21 ' O1A' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -74.05 170.26 15.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.738 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 67.03 108.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' NE2' ' HD2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -160.95 -63.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.976 -1.308 . . . . 0.0 109.91 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -41.75 150.63 0.35 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.266 -0.896 . . . . 0.0 109.906 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.4 -75.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.836 2.357 . . . . 0.0 110.587 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.72 66.02 3.96 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -160.58 120.97 2.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 108.998 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.52 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 40.4 t -84.07 70.55 10.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.9 m-85 -44.69 179.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.701 -0.625 . . . . 0.0 110.174 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -57.79 88.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 108.886 179.407 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.54 -41.4 66.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.54 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -51.48 -70.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 108.77 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.584 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -40.28 -47.28 2.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 110.062 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.95 -57.25 6.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.28 -33.62 75.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.533 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -14.07 6.3 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.114 -0.992 . . . . 0.0 109.824 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 40.81 97.02 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG21 ' ND2' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -95.29 133.34 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 0.0 110.034 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.54 112.48 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.617 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 10.0 m95 -54.17 101.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 110.245 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.46 -164.88 12.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -73.97 -67.67 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.01 89.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.872 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -36.31 76.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.7 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -80.24 -27.28 38.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttt -57.03 -47.03 81.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 0.0 109.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.32 -51.56 20.12 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.378 -0.827 . . . . 0.0 109.823 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.617 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 51.9 t80 -54.09 -22.7 11.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 109.664 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.511 ' CD2' HMB1 ' A' ' 105' ' ' HEC . 1.6 tp -90.35 -29.77 17.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.0 109.178 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.75 -24.75 65.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.552 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -175.75 102.27 0.25 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.7 Cg_endo -76.61 -37.47 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.35 2.033 . . . . 0.0 110.258 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -75.13 -17.82 60.34 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.334 -0.853 . . . . 0.0 110.266 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.552 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -94.39 -37.65 11.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.856 -1.152 . . . . 0.0 109.581 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CE2' HD13 ' A' ' 75' ' ' ILE . 1.9 t80 -76.6 -66.06 0.86 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.869 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' CD1' ' ND2' ' A' ' 52' ' ' ASN . 8.1 mm -101.06 106.47 44.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.362 -0.836 . . . . 0.0 109.532 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.86 71.18 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.391 2.06 . . . . 0.0 110.024 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -173.42 -42.12 0.04 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.546 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 14.6 t -43.49 158.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 3.69 21.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.489 -0.757 . . . . 0.0 109.411 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.689 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 9.8 ptm -92.87 118.14 30.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.992 . . . . 0.0 109.934 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mm -92.66 48.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CE2' HBB1 ' A' ' 105' ' ' HEC . 15.3 t80 -59.31 146.43 39.6 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.514 0.673 . . . . 0.0 110.173 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.53 -5.12 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 109.501 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.565 ' HA2' ' CE2' ' A' ' 82' ' ' PHE . . . 67.41 175.15 7.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' LYS . 3.8 mp -107.06 139.38 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -1.201 . . . . 0.0 109.517 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -90.81 -22.03 21.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' O ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -97.62 121.18 39.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -62.6 -13.63 33.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.35 -56.12 11.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 109.723 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HB2' HG23 ' A' ' 85' ' ' ILE . 35.8 mt-10 -68.38 -40.59 81.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.462 ' HA ' HD11 ' A' ' 94' ' ' LEU . 7.8 ttp180 -56.6 -45.43 81.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.96 -49.38 70.54 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.235 -0.916 . . . . 0.0 109.596 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -21.43 60.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.767 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.512 ' CG ' HG22 ' A' ' 9' ' ' ILE . 22.2 mt -72.68 -59.64 2.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.404 ' N ' HD11 ' A' ' 95' ' ' ILE . 5.3 mm -56.57 -49.79 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.403 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.94 70.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.611 -0.68 . . . . 0.0 109.633 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 4.5 t80 -53.07 -49.82 65.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.255 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 1.1 mt -82.65 -12.97 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.3 ttmt -79.34 -10.94 59.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.169 -0.957 . . . . 0.0 108.906 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -110.55 -40.06 4.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.91 -55.6 4.86 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.263 -0.898 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.569 ' CG2' ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -99.56 30.48 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 9.3 t-20 -165.01 64.85 0.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.389 179.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.689 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.34 -173.72 4.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -1.123 . . . . 0.0 109.593 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 4' ' ' GLU . 9.7 p -97.8 -33.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.65 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' N ' HG12 ' A' ' 3' ' ' VAL . 4.1 mm-40 -67.15 -40.34 86.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.669 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -49.67 -34.77 21.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -57.83 -45.11 86.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -1.138 . . . . 0.0 109.737 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.62 -27.58 60.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.636 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 93' ' ' ASP . 51.1 mt -60.25 -53.8 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 6.9 t80 -73.76 -46.6 44.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.257 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 11' ' ' ILE . 22.7 mm -56.42 -16.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -120.73 -6.66 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 15.8 tppt? -101.98 -65.81 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 109.858 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.571 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -112.04 29.4 7.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.8 t -89.9 -1.15 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.733 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -94.78 -35.6 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.241 -0.912 . . . . 0.0 108.724 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 16.9 m -103.43 -26.28 12.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.654 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 75.4 m-70 -117.51 78.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.035 -1.041 . . . . 0.0 109.649 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.1 p -78.66 94.8 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.178 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -82.16 22.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 0.0 110.519 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -151.21 20.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.902 -1.124 . . . . 0.0 109.467 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.48 -17.97 27.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.65 -27.1 3.11 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.56 -0.94 3.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -88.34 164.68 15.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.076 -1.25 . . . . 0.0 109.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.539 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.994 -1.066 . . . . 0.0 110.234 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -71.02 -75.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 108.867 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.459 HG21 ' SG ' ' A' ' 17' ' ' CYS . 93.7 m -99.81 -58.89 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 108.713 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -83.2 155.53 32.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.8 Cg_endo -67.88 143.36 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.498 2.132 . . . . 0.0 111.048 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.4 t-20 -56.25 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 110.075 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -85.02 55.44 3.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.403 -0.81 . . . . 0.0 109.826 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -96.99 48.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.269 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.43 62.26 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.469 ' CD1' ' O2A' ' A' ' 105' ' ' HEC . 5.4 tp -79.91 -31.22 40.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.395 -1.062 . . . . 0.0 109.872 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -60.32 137.21 58.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.047 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.4 27.98 73.08 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 58.1 ttp85 -139.96 123.59 17.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.983 -1.304 . . . . 0.0 109.742 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.524 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -64.45 175.59 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.156 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 53' ' ' LYS . 7.5 t -94.81 -173.92 3.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.11 -0.994 . . . . 0.0 109.82 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 91.61 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.637 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 2.2 pm0 -159.44 -36.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.182 -1.187 . . . . 0.0 109.807 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -70.17 137.4 86.88 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 109.566 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.35 173.98 12.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.45 2.1 . . . . 0.0 110.359 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.37 5.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -145.61 121.19 10.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.11 . . . . 0.0 109.12 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -85.04 66.16 9.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.637 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.9 m-85 -43.97 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.722 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -67.28 86.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -44.22 -34.97 2.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . . . -51.17 -59.99 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.62 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 19.4 t-20 -52.85 -52.97 55.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.45 ' N ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.85 -33.44 7.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.318 -0.864 . . . . 0.0 109.297 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -77.87 -35.71 50.62 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.383 -0.823 . . . . 0.0 109.772 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -61.11 -11.96 10.59 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.072 -1.018 . . . . 0.0 109.574 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.98 35.93 78.53 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -87.51 125.45 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.667 -0.902 . . . . 0.0 110.324 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -87.15 95.33 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 5.3 m95 -34.87 121.79 0.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -142.87 -166.51 11.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -65.26 0.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -1.201 . . . . 0.0 109.779 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -60.45 -38.83 85.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.946 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -36.46 75.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 109.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' CD2' HMA2 ' A' ' 105' ' ' HEC . 0.9 OUTLIER -76.24 -24.09 54.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.172 -0.955 . . . . 0.0 109.347 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -42.02 78.49 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.19 -50.94 13.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 75' ' ' ILE . 23.6 t80 -49.72 -44.99 48.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.379 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' CD2' HMB1 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -73.59 -32.15 63.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -25.8 63.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.58 84.11 0.34 Allowed Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 33.0 Cg_endo -76.4 -22.13 12.72 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.645 2.23 . . . . 0.0 109.354 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -75.59 -16.56 60.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -101.45 -38.69 7.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.457 -0.777 . . . . 0.0 109.239 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 11.4 t80 -73.47 -66.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.644 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 4.3 mm -97.53 106.72 34.77 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.75 83.46 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.259 1.973 . . . . 0.0 110.595 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 149.91 -14.37 1.02 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 8.1 t -43.68 132.38 4.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.239 . . . . 0.0 109.908 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 23.8 4.37 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.3 mmm -59.17 125.4 23.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.753 -0.592 . . . . 0.0 109.81 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.519 ' HB ' ' CBC' ' A' ' 105' ' ' HEC . 38.5 mm -89.09 17.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.502 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -59.45 160.73 6.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.611 -0.681 . . . . 0.0 109.929 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' A' ' 84' ' ' GLY . 22.0 m -99.96 -42.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.372 -0.83 . . . . 0.0 109.299 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 83' ' ' VAL . . . 130.24 88.03 0.48 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.27 161.26 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -1.173 . . . . 0.0 109.172 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -147.44 50.93 1.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.062 -1.023 . . . . 0.0 109.917 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 116.46 15.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.121 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.39 -18.85 65.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.817 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -35.31 60.56 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -81.57 -40.85 22.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -67.86 -51.84 43.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 88' ' ' LYS . . . -56.51 -45.89 80.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 109.237 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 9' ' ' ILE . 96.1 m-20 -60.48 -28.96 68.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.384 -0.823 . . . . 0.0 109.592 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 18.0 mt -65.05 -51.92 58.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.6 mm -59.59 -37.59 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.58 99.63 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.582 -0.699 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.1 -46.63 76.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.086 -1.009 . . . . 0.0 109.673 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 98' ' ' LEU . 2.0 mm? -72.89 -15.21 61.59 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 2.0 ttpt -76.81 -32.95 57.97 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -38.83 13.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.891 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.43 -56.77 6.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.64 35.85 4.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.25 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -160.77 47.43 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.698 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.344 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.592 ' C3D' ' HD3' ' A' ' 30' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER -122.66 149.84 43.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.32 -17.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.77 -41.47 37.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -40.65 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 9' ' ' ILE . . . -67.11 -50.86 42.91 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.573 ' HA ' ' CG ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -56.39 -27.2 55.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -79.25 -33.84 43.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 0.0 109.216 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 12.7 mt -60.98 -57.1 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.3 t80 -59.59 -46.24 89.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.093 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 15.1 mm -57.81 -22.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.807 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 ttt -122.31 10.75 9.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 22.4 tptt -122.94 -56.52 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.072 . . . . 0.0 109.591 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.549 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -118.47 22.0 12.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -84.96 2.86 41.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.986 . . . . 0.0 109.597 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -100.11 -41.66 7.05 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.871 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 13.1 m -95.18 -26.36 16.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.621 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 73.9 m-70 -115.09 81.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -0.891 . . . . 0.0 109.808 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 p -78.69 83.27 4.86 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.083 -1.01 . . . . 0.0 108.553 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 4.5 m -82.78 45.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.169 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -165.96 24.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.003 -1.06 . . . . 0.0 109.785 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 25' ' ' LYS . 42.7 tttp -100.22 -73.22 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.48 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.95 52.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 4.98 51.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 9.3 tppt? -91.21 144.86 25.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 109.213 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -133.04 114.88 14.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.901 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.92 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.328 -0.857 . . . . 0.0 109.28 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -99.9 -47.65 4.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.229 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -84.27 153.4 29.08 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 30.6 Cg_endo -68.74 133.53 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.672 2.248 . . . . 0.0 111.256 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.4 t-20 -50.92 99.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.47 0.652 . . . . 0.0 109.59 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.487 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -80.93 70.87 7.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 109.78 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 28.1 p-80 -100.59 -48.99 4.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 109.901 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 33' ' ' HIS . . . -120.96 30.78 5.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.58 -40.09 8.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -1.193 . . . . 0.0 109.043 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 65.0 m-85 -68.61 147.44 51.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.29 17.59 11.95 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' NH1' ' HB3' ' A' ' 42' ' ' GLN . 7.3 ttp85 -147.2 116.08 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -1.211 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -59.39 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 108.94 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.457 HG23 ' O2A' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -79.53 -164.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.614 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA3' ' CD ' ' A' ' 53' ' ' LYS . . . 53.99 101.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -154.45 -30.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.24 . . . . 0.0 110.558 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.479 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -95.38 135.93 22.9 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.719 -1.238 . . . . 0.0 109.552 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.89 136.96 13.62 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.607 2.204 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.29 -24.45 13.8 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -99.2 108.63 21.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -1.053 . . . . 0.0 108.673 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -76.18 80.17 2.98 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 1.8 m-85 -47.96 -179.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.655 -0.653 . . . . 0.0 109.242 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.527 ' CB ' HBD1 ' A' ' 105' ' ' HEC . 0.1 OUTLIER -58.19 88.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.13 -37.31 61.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.459 -0.776 . . . . 0.0 109.707 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.508 ' HB3' HG23 ' A' ' 75' ' ' ILE . . . -59.15 -46.29 88.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.586 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.642 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 21.9 t-20 -64.37 -54.55 31.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.041 . . . . 0.0 110.008 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.421 ' CD ' ' HA3' ' A' ' 41' ' ' GLY . 6.2 tttt -50.81 -38.24 47.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.104 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -81.32 -24.1 37.38 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.621 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -65.31 -10.42 32.49 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.141 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.24 63.99 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.545 HD12 HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.07 121.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -1.117 . . . . 0.0 110.256 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -84.66 99.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 m95 -37.82 110.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.606 0.717 . . . . 0.0 110.839 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -129.76 -168.16 12.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.91 -57.22 4.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -1.183 . . . . 0.0 109.877 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.14 -42.18 80.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.291 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -38.39 77.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.999 -1.063 . . . . 0.0 109.286 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -71.59 -33.34 68.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 108.82 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.0 ttp -54.04 -38.22 64.96 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.408 -0.807 . . . . 0.0 109.317 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.95 -57.02 4.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 39.1 t80 -49.16 -31.27 8.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.546 ' CD2' HMB3 ' A' ' 105' ' ' HEC . 1.1 mp -81.83 -38.14 25.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.052 -1.03 . . . . 0.0 109.266 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -59.08 -22.69 61.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.8 p30 -179.6 99.0 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -74.22 -33.72 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.403 2.069 . . . . 0.0 110.257 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -13.99 60.26 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.896 . . . . 0.0 108.933 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 2.8 tptm -92.71 -45.11 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.5 t80 -72.2 -67.59 0.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 18.3 mm -95.74 107.48 34.08 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.6 Cg_endo -77.57 78.12 3.63 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.244 1.963 . . . . 0.0 110.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 164.8 -23.09 0.15 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.477 ' HA ' HG22 ' A' ' 49' ' ' THR . 13.7 t -43.63 155.49 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.008 -1.289 . . . . 0.0 109.768 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -111.04 8.49 21.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.012 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.714 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 5.7 ptm -96.4 118.05 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.94 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.1 mm -84.03 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.484 -0.76 . . . . 0.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CE2' HBB3 ' A' ' 105' ' ' HEC . 9.6 t80 -99.33 150.47 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -88.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.268 -0.895 . . . . 0.0 109.266 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.67 121.57 1.17 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.454 HG22 ' CG ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -64.5 157.27 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -1.132 . . . . 0.0 109.179 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -10.34 19.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.153 -0.967 . . . . 0.0 109.915 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 122.94 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -33.77 72.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -0.844 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 6.5 tt0 -65.53 -27.92 68.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.283 -0.886 . . . . 0.0 109.632 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -73.3 -42.72 62.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -56.66 8.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 109.635 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.51 30.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 5.5 t0 -63.25 -42.31 99.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -0.809 . . . . 0.0 110.126 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 90' ' ' GLU . 6.5 mt -56.25 -44.92 80.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.553 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -65.83 -42.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.67 16.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.687 . . . . 0.0 110.004 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.573 ' CG ' ' HA ' ' A' ' 7' ' ' LYS . 20.8 t80 -73.85 -46.28 45.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.07 -1.019 . . . . 0.0 109.425 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -71.4 -4.38 26.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.321 -0.862 . . . . 0.0 109.812 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.9 -46.61 8.08 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -79.45 -33.64 42.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.472 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 97' ' ' TYR . . . -68.8 -53.81 19.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 19.3 p -104.03 -37.85 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.959 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 16.0 t30 -85.05 19.43 2.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 10.0 tt0 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.07 . . . . 0.0 109.477 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.714 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.64 171.8 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -1.197 . . . . 0.0 109.666 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t -78.89 -50.52 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -62.28 -44.07 97.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.612 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -71.52 -32.77 68.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.775 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -56.57 19.17 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 7.5 ttmt -54.8 -26.58 35.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.302 -1.117 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.78 -36.19 65.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.296 -0.878 . . . . 0.0 108.909 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 43.4 mm -58.21 -59.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 108.718 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 15' ' ' SER . 30.6 t80 -58.66 -41.3 85.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 109.099 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.557 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -54.26 -30.97 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.112 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.458 ' N ' HG23 ' A' ' 11' ' ' ILE . 3.4 ttt -114.88 7.32 15.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.245 -0.909 . . . . 0.0 110.954 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.21 -61.33 1.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.214 . . . . 0.0 110.275 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -127.44 24.71 6.2 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.065 . . . . 0.0 109.78 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.557 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 38.7 t -88.2 2.65 51.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.139 . . . . 0.0 109.824 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -100.59 -55.11 2.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 34.0 m -81.0 -25.52 37.19 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.644 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 72.8 m-70 -119.39 89.49 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.106 -0.996 . . . . 0.0 109.766 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.7 p -78.43 83.64 4.64 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.5 m -80.9 36.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.457 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -161.6 21.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.072 -1.017 . . . . 0.0 109.244 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -73.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.88 55.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.5 18.52 67.88 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.63 132.28 45.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -1.21 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.533 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -127.09 101.04 6.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 110.069 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -70.0 -63.71 1.03 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.522 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 20.4 m -104.69 -76.76 0.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -71.26 159.34 53.85 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.644 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.9 Cg_endo -68.99 142.89 52.66 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.447 2.098 . . . . 0.0 110.901 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -58.86 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.833 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.587 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -81.68 73.65 8.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.459 -0.776 . . . . 0.0 109.825 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.74 -62.94 1.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.26 28.03 11.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.468 HD11 HBA2 ' A' ' 105' ' ' HEC . 47.9 tp -49.66 -26.37 3.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -1.059 . . . . 0.0 109.835 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 102' ' ' THR . 13.1 m-85 -72.78 130.92 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.24 79.64 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' ARG . 7.1 ttp85 -133.97 126.99 31.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.136 -1.214 . . . . 0.0 109.667 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -61.82 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.515 HG21 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -97.55 -179.31 4.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -0.928 . . . . 0.0 109.769 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.44 97.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' OE1' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -160.74 -33.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.986 -1.302 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.21 138.49 96.04 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.973 -1.079 . . . . 0.0 109.601 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.45 -34.4 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.63 2.22 . . . . 0.0 110.676 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.93 49.08 1.04 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -160.21 128.37 4.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.027 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -86.29 54.24 3.08 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.1 m-85 -31.59 149.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.29 0.567 . . . . 0.0 110.19 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.509 ' CG2' HBD2 ' A' ' 105' ' ' HEC . 0.9 OUTLIER -58.76 90.76 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.6 -34.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.275 0.559 . . . . 0.0 109.556 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . . . -56.03 -64.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.476 -0.765 . . . . 0.0 109.495 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.553 ' OD1' ' CG2' ' A' ' 75' ' ' ILE . 3.6 m120 -36.52 -40.29 0.24 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -47.12 63.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.63 -17.13 63.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -66.45 -7.09 17.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.47 49.29 33.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 ' O ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -116.53 145.15 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -100.93 96.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.703 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 8.1 m95 -40.91 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.419 -0.8 . . . . 0.0 110.492 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -123.22 -153.88 8.87 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG2' HG22 ' A' ' 95' ' ' ILE . 2.0 mt-10 -76.13 -70.83 0.42 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -1.129 . . . . 0.0 109.724 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -37.36 86.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -49.17 78.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.091 -1.006 . . . . 0.0 109.511 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CD2' HD12 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -67.51 -31.96 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.181 -0.949 . . . . 0.0 109.382 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -31.87 66.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -77.91 -54.95 5.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.703 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 5.4 t80 -57.98 -19.7 32.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' CD1' HMB3 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -93.25 -34.47 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.912 -1.117 . . . . 0.0 109.842 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -58.84 -24.86 62.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 20.4 t-20 -170.6 95.67 0.45 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -74.59 -40.58 1.02 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.352 2.034 . . . . 0.0 110.257 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -8.11 41.1 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.274 -0.892 . . . . 0.0 108.922 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -104.05 -34.53 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.429 -0.794 . . . . 0.0 109.251 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.569 ' CD2' ' HB2' ' A' ' 67' ' ' TYR . 7.0 t80 -76.52 -70.0 0.48 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.543 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 67' ' ' TYR . 2.7 mm -86.05 117.11 68.13 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.76 81.36 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.264 1.976 . . . . 0.0 110.742 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.7 -4.26 2.71 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.452 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 15.2 t -54.21 163.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.784 -1.421 . . . . 0.0 109.546 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HD2' HMD1 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -126.11 21.18 7.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.472 ' HE2' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -58.77 109.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.04 43.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' O ' ' C ' ' A' ' 83' ' ' VAL . 11.2 t80 -107.63 -45.99 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.724 -0.61 . . . . 0.0 110.542 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -24.72 106.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.434 0.635 . . . . 0.0 111.25 -179.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 85' ' ' ILE . . . -172.26 29.87 0.11 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 84' ' ' GLY . 4.5 mt -152.85 163.06 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.14 . . . . 0.0 109.627 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.22 36.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 109.335 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -106.54 148.87 27.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -75.88 -35.13 59.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.335 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.72 -29.57 70.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -57.59 3.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.883 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -54.33 -40.8 68.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.703 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.2 96.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.914 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -34.34 75.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.028 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.447 HD22 HG22 ' A' ' 9' ' ' ILE . 92.7 mt -60.83 -51.5 69.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 4.6 mm -67.38 -36.78 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.38 57.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.607 -0.683 . . . . 0.0 110.129 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -73.47 -43.32 60.46 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.998 -1.064 . . . . 0.0 109.948 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -67.15 -7.22 21.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.953 . . . . 0.0 109.977 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 1.8 ttpt -96.01 -36.17 11.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.646 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 9.3 tttm -81.14 -31.63 34.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.11 2.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.21 -0.932 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.52 ' CG2' ' CD1' ' A' ' 36' ' ' PHE . 6.4 t -102.41 25.27 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.054 -1.029 . . . . 0.0 110.422 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -160.94 61.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.959 -1.088 . . . . 0.0 109.533 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' A' ' 100' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.57 ' C3D' ' HD3' ' A' ' 30' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -146.42 155.16 42.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -1.115 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.01 -26.98 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.282 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' HD11 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -93.43 -48.3 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.315 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -57.09 -35.6 70.34 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -66.42 -44.37 83.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -1.068 . . . . 0.0 109.387 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -26.23 68.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' CG2' HD23 ' A' ' 94' ' ' LEU . 7.1 mt -73.53 -66.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 20' ' ' VAL . 45.3 t80 -55.68 -25.26 38.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 108.988 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.505 ' CD1' ' HG3' ' A' ' 7' ' ' LYS . 7.4 mt -70.9 -40.38 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.847 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.5 ptm -107.34 18.1 22.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.593 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -120.58 -62.54 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.967 . . . . 0.0 109.536 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.431 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -123.76 30.01 6.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.122 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 1.3 t -86.1 7.34 25.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -100.98 -54.31 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 3.2 m -84.41 -32.52 24.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.661 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 63.2 m-70 -114.15 93.34 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.11 -0.994 . . . . 0.0 109.992 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.6 p -91.3 97.25 10.99 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.872 -1.142 . . . . 0.0 108.559 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 20' ' ' VAL . 3.0 m -83.97 47.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 110.061 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 3.0 mt-10 -173.34 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.921 -1.112 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 0.56 39.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.549 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.13 -10.46 40.03 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.1 10.86 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -89.82 160.46 16.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -1.18 . . . . 0.0 109.365 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -138.44 167.9 20.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -141.37 -87.04 0.17 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.523 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 38.1 m -94.47 -25.03 17.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 108.98 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -115.6 150.49 18.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.682 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.7 Cg_endo -65.98 131.76 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.444 2.096 . . . . 0.0 111.031 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -49.98 101.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.49 -0.756 . . . . 0.0 110.198 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.01 63.41 6.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 109.717 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.489 ' O ' ' CG2' ' A' ' 102' ' ' THR . 2.2 t60 -94.25 -21.46 19.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.997 . . . . 0.0 109.993 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 38' ' ' ARG . . . -156.19 22.73 0.51 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 5.8 tt -41.61 -35.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -1.053 . . . . 0.0 110.288 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -70.36 131.7 44.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.129 -0.982 . . . . 0.0 110.545 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.02 -13.03 64.28 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -126.71 151.87 47.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.897 -1.355 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 177.83 6.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.818 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 2.6 p -64.5 -164.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.29 94.0 0.01 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.25 -47.27 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -1.148 . . . . 0.0 109.5 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.31 142.75 55.01 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -78.64 -90.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.691 2.26 . . . . 0.0 110.941 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.42 -33.02 0.83 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.61 111.44 18.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -1.109 . . . . 0.0 109.067 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 1.6 p -77.37 78.32 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-85 -46.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 109.668 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -58.66 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 109.208 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.61 -42.93 68.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.53 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -54.16 -73.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.549 ' HB3' ' CG2' ' A' ' 40' ' ' THR . 1.9 m-20 -35.45 -40.97 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.137 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -55.36 -59.17 5.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.883 . . . . 0.0 110.049 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -64.08 -20.66 66.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.79 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -65.36 -8.16 17.13 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.64 45.47 59.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.37 117.48 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -1.014 . . . . 0.0 109.979 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -84.46 111.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.636 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 8.1 m95 -50.26 101.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.944 -1.097 . . . . 0.0 110.271 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -122.41 -167.63 13.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' OE2' ' CG2' ' A' ' 95' ' ' ILE . 19.7 mm-40 -65.47 -74.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -62.95 -35.11 79.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 110.268 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -42.87 93.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.671 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -73.42 -33.79 65.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.446 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 35.7 tpp -59.11 -27.32 65.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.171 -0.956 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.41 -64.48 1.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.881 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 28.5 t80 -49.08 -28.26 4.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.956 . . . . 0.0 109.996 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 HD22 HMB2 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -85.84 -32.79 21.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 65' ' ' MET . 4.0 tt0 -59.42 -24.7 63.71 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -177.25 88.69 0.25 Allowed Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -73.82 -36.53 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.32 -17.21 64.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.061 -1.024 . . . . 0.0 108.363 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 2.4 ttmt -99.57 -25.76 14.32 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 75' ' ' ILE . 11.8 t80 -88.0 -70.26 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.249 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.531 ' CD1' ' OD1' ' A' ' 52' ' ' ASN . 2.6 mm -99.52 106.66 41.09 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.366 -0.834 . . . . 0.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.98 83.76 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.374 2.049 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 158.42 -30.31 0.46 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.472 ' HA ' HG22 ' A' ' 49' ' ' THR . 10.0 t -44.39 160.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.955 -1.32 . . . . 0.0 109.785 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 15.98 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.6 mmm -59.2 118.31 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.799 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.449 HG21 HBC2 ' A' ' 105' ' ' HEC . 1.6 tp -92.32 18.83 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 1.0 OUTLIER -60.07 161.97 6.25 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.411 0.624 . . . . 0.0 110.133 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 84' ' ' GLY . 33.7 m -99.77 -41.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.343 -0.848 . . . . 0.0 109.366 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 118.56 81.18 0.75 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.6 mm -67.17 136.15 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -1.202 . . . . 0.0 109.231 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.89 50.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -127.84 106.8 9.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.255 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -34.73 74.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.872 . . . . 0.0 110.1 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.15 -43.78 94.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.876 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.79 -42.22 81.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.905 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -62.15 -38.16 87.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.812 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.6 71.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.31 -25.58 67.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD23 ' CG2' ' A' ' 9' ' ' ILE . 29.2 mt -69.75 -52.5 24.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.722 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.501 HD11 ' N ' ' A' ' 95' ' ' ILE . 3.3 mm -62.26 -47.76 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.928 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.76 71.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.79 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' CD2' HD22 ' A' ' 98' ' ' LEU . 33.3 t80 -61.74 -44.63 96.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 97' ' ' TYR . 4.0 mm? -81.95 -2.7 52.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 1.6 tmmt? -97.0 -13.83 22.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.162 -0.961 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -119.97 -39.9 2.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.56 -32.78 60.52 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.28 -0.888 . . . . 0.0 110.387 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -127.87 23.19 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.05 -1.031 . . . . 0.0 110.321 -179.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 4.1 t-20 -149.34 14.45 0.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.023 -1.048 . . . . 0.0 109.818 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.601 ' CBB' ' CZ ' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.81 170.1 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -1.115 . . . . 0.0 109.325 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -100.36 -44.45 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.5 -12.81 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.853 . . . . 0.0 109.942 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.424 ' O ' HG12 ' A' ' 9' ' ' ILE . 23.7 mttt -91.88 -54.31 3.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.091 -1.006 . . . . 0.0 109.848 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.59 -30.18 55.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -70.32 -46.7 63.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -1.109 . . . . 0.0 109.728 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -70.48 -18.98 62.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.7 mm -73.18 -64.6 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 108.792 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 98' ' ' LEU . 11.5 t80 -49.23 -42.34 40.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 108.621 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 55.3 mt -56.23 -42.41 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.01 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' A' ' 12' ' ' MET . 3.3 ppp? -107.12 20.06 19.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.49 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.49 -54.59 1.77 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.738 -1.226 . . . . 0.0 109.866 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -133.89 25.65 3.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.136 -0.977 . . . . 0.0 109.468 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.6 t -80.12 3.39 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -56.87 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.345 -0.847 . . . . 0.0 108.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 23.1 m -82.14 -17.9 44.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.415 -0.803 . . . . 0.0 109.13 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.645 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 75.3 m-70 -125.15 84.03 2.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.795 -1.191 . . . . 0.0 110.239 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 15.7 p -79.29 81.53 5.54 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.52 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 4.1 m -79.84 12.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -137.0 24.33 3.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 0.0 109.867 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.7 tmtt? -98.96 -46.98 5.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.567 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.49 67.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.4 22.53 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' CB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 tptt -98.8 140.64 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 0.0 109.588 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.17 128.61 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.436 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -72.5 0.72 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 96.7 m -93.84 -53.94 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.407 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -91.4 160.22 26.69 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 35.1 Cg_endo -70.53 134.36 26.2 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.367 2.045 . . . . 0.0 110.54 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 11.7 t-20 -48.27 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.32 43.59 0.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.421 -0.799 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' VAL . 2.0 t-160 -98.62 77.82 2.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -0.975 . . . . 0.0 108.827 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.03 15.86 7.61 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.464 HD12 HBA2 ' A' ' 105' ' ' HEC . 0.5 OUTLIER -54.2 -30.53 50.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.422 -1.046 . . . . 0.0 109.727 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CE2' HG22 ' A' ' 95' ' ' ILE . 4.4 m-85 -65.3 143.15 57.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.905 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.54 13.62 61.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 40.4 ttp85 -138.52 129.91 27.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -1.131 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -74.39 174.43 8.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 ' CGA' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -71.94 175.7 5.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.715 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 76.51 94.94 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -150.14 -73.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.32 141.25 2.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.7 Cg_endo -79.72 -92.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.691 2.261 . . . . 0.0 111.425 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.38 -29.99 0.76 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -79.78 113.01 17.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -1.057 . . . . 0.0 108.991 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -77.98 77.93 4.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-30 -46.09 178.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.608 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.71 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -43.66 -42.72 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -54.39 -70.54 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.884 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.584 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 0.7 OUTLIER -38.92 -40.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 110.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -57.41 -70.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.197 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.45 -10.56 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.333 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -66.03 -7.64 18.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.83 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.14 50.66 33.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -118.83 118.79 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -1.059 . . . . 0.0 109.727 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG23 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -78.33 121.35 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.023 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 9.0 m95 -64.99 95.08 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.272 -0.892 . . . . 0.0 110.007 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -115.5 -170.7 16.22 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.61 -68.39 0.4 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.089 -1.242 . . . . 0.0 109.69 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.03 -37.22 86.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.882 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -49.03 79.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.074 -1.016 . . . . 0.0 109.315 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 1.2 tt -63.47 -32.61 74.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 109.311 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.1 ttp -56.27 -40.87 74.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.379 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.58 -54.91 13.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.318 -0.864 . . . . 0.0 109.78 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CE1' ' OD1' ' A' ' 52' ' ' ASN . 86.4 t80 -49.18 -34.08 13.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.549 ' CD2' HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -76.3 -37.01 58.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 109.472 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.37 -23.31 62.45 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -170.41 93.0 0.48 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.501 ' CD ' ' CG1' ' A' ' 83' ' ' VAL . 35.8 Cg_endo -79.68 -43.36 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.373 2.049 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -79.27 -22.26 44.95 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -92.26 -36.19 13.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.4 t80 -73.62 -66.6 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' CG2' ' N ' ' A' ' 52' ' ' ASN . 13.6 mm -96.38 113.2 62.05 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.43 -0.793 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.76 70.24 7.04 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.255 1.97 . . . . 0.0 109.747 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.42 -46.69 0.03 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.544 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.7 t -58.09 163.75 2.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.281 . . . . 0.0 109.651 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.32 9.03 5.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.694 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.1 ptm -74.48 115.82 14.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.879 -1.129 . . . . 0.0 109.513 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 81' ' ' ILE . 41.8 mm -94.13 35.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.632 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 4.9 t80 -59.33 -34.62 72.57 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.807 -0.558 . . . . 0.0 110.167 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' C ' ' O ' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -29.51 104.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.44 0.638 . . . . 0.0 111.209 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.86 25.43 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 85' ' ' ILE . 6.9 mt -103.43 160.16 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.93 43.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.372 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -162.12 115.27 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -52.63 -37.03 57.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.6 -38.32 84.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.64 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -62.9 -49.24 75.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -53.51 -43.77 68.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 109.263 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.73 -34.31 71.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.381 -0.824 . . . . 0.0 109.701 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.1 -28.82 66.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.117 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 9' ' ' ILE . 55.7 mt -71.13 -63.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 109.418 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 1.1 mp -59.66 -32.01 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 108.996 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.71 91.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 109.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.2 -48.42 62.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.352 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 10' ' ' PHE . 2.0 mm? -67.13 -16.29 64.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -72.49 -49.26 34.3 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.312 -0.867 . . . . 0.0 109.862 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 6.8 tttt -79.88 -27.4 40.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.31 -59.15 3.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 110.376 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -29.89 7.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.46 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.503 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t30 -81.61 10.96 5.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.508 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.694 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' A' ' 5' ' ' LYS . 1.8 m-20 -85.51 166.8 16.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -1.105 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -95.81 -60.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -13.03 26.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 2' ' ' ASP . 6.9 ttmt -77.44 -63.07 1.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.28 -32.78 60.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 34.9 tttt -64.67 -33.7 76.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -77.08 -24.13 51.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 5' ' ' LYS . 17.9 mt -69.62 -55.94 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 108.838 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 9.7 t80 -62.84 -40.15 96.53 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.324 -0.86 . . . . 0.0 108.921 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 14.5 mt -58.06 -28.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.38 -0.825 . . . . 0.0 109.001 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -114.92 6.89 15.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 110.015 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HG2' HBB3 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -113.68 -66.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.551 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.07 31.18 6.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.965 -1.084 . . . . 0.0 109.459 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.8 t -90.16 8.74 31.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.2 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -101.44 -48.2 4.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 0.0 108.956 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 96.9 m -93.57 -25.52 17.52 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.419 -0.8 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.639 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 79.1 m-70 -113.87 82.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 110.249 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 19' ' ' THR . 5.1 p -78.86 88.4 4.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 108.448 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.5 m -79.88 9.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -137.75 18.01 2.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.046 . . . . 0.0 109.433 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 4.8 tptt -88.9 -57.27 2.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.36 63.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.43 17.63 33.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.93 73.47 1.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -1.192 . . . . 0.0 109.368 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.513 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -78.47 128.9 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 109.964 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' NZ ' HG22 ' A' ' 19' ' ' THR . 0.0 OUTLIER -101.69 -80.39 0.5 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 96.3 m -91.8 -33.33 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.363 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -108.56 156.91 15.51 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.9 Cg_endo -68.68 136.33 35.68 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.543 2.162 . . . . 0.0 110.849 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 6.2 t-20 -51.38 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.812 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.6 ' CD2' ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.64 70.25 7.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.494 -0.754 . . . . 0.0 109.456 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.463 ' O ' ' HB ' ' A' ' 102' ' ' THR . 31.3 t-80 -100.2 -49.58 4.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 109.098 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -122.81 37.67 2.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 ' C ' ' CD2' ' A' ' 35' ' ' LEU . 3.1 tt -49.52 -50.52 41.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.992 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -60.37 137.94 58.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.855 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.92 24.21 76.55 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD2' ' HG2' ' A' ' 42' ' ' GLN . 24.2 ttp85 -145.78 118.11 8.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -1.231 . . . . 0.0 109.797 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -70.68 164.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.91 169.07 4.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.866 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 73.13 83.39 0.29 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -148.61 -39.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -1.148 . . . . 0.0 109.882 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . . . -79.84 136.35 54.87 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 109.693 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.5 Cg_endo -79.15 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.59 2.193 . . . . 0.0 110.972 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -40.13 -37.91 1.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.473 ' OH ' HMD3 ' A' ' 105' ' ' HEC . 0.3 OUTLIER -80.13 125.07 29.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -1.061 . . . . 0.0 108.979 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 48' ' ' TYR . 93.9 p -86.34 57.35 4.44 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m-30 -31.8 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.113 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 31.0 p -63.19 93.4 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.642 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -36.93 -37.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.568 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -41.15 -69.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.576 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 28.6 m-20 -45.1 -45.26 11.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 109.852 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.7 -74.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.93 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.57 -14.03 2.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.885 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HG2' ' CG1' ' A' ' 75' ' ' ILE . 1.8 tptp -59.17 -13.83 8.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.0 109.926 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.94 58.78 12.39 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.73 120.33 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.491 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.07 102.15 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.047 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.465 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 6.7 m95 -41.16 106.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.42 -159.87 10.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.9 -59.45 2.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.11 -1.229 . . . . 0.0 109.868 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.96 -38.12 64.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.846 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.98 -52.1 66.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 1.4 tt -62.94 -37.32 86.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -53.36 -37.9 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE1' ' CD1' ' A' ' 74' ' ' TYR . 7.5 tm-20 -69.87 -57.11 5.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.6 t80 -60.87 -13.41 15.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 109.526 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.456 HD23 HMB3 ' A' ' 105' ' ' HEC . 4.9 tp -85.09 -49.79 7.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.058 . . . . 0.0 109.073 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 6.9 tt0 -59.21 -22.08 60.49 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 69' ' ' GLU . 1.2 m-80 -161.27 92.34 1.48 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 32.8 Cg_endo -76.0 -52.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.0 110.878 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.128 -0.982 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 15.5 mtpt -77.09 -39.91 47.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' A' ' 75' ' ' ILE . 22.8 t80 -68.05 -63.23 1.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -114.21 125.3 29.48 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 71.19 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.239 1.959 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . -160.57 -58.47 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.55 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.4 t -41.81 152.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -1.132 . . . . 0.0 110.164 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.11 5.18 13.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.72 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.5 ptm -77.58 119.29 20.93 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.071 -1.018 . . . . 0.0 109.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.4 mt -90.11 55.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CZ ' ' CBB' ' A' ' 105' ' ' HEC . 48.7 t80 -79.46 148.56 31.84 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.579 -0.7 . . . . 0.0 109.964 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.08 -158.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 109.262 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.04 122.82 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 94' ' ' LEU . 13.4 mt -75.17 134.38 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -1.173 . . . . 0.0 109.157 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.76 -34.14 22.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.693 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' CB ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -70.12 105.94 3.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.144 -0.972 . . . . 0.0 109.701 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.25 68.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.03 -53.84 53.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.421 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' OE1' ' CB ' ' A' ' 87' ' ' LYS . 29.4 mt-10 -62.83 -32.7 73.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.234 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -44.07 92.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.43 96.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.348 -0.845 . . . . 0.0 109.388 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.4 -37.45 62.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 85' ' ' ILE . 41.5 mt -66.09 -53.23 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 96' ' ' ALA . 19.9 mm -61.99 -79.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -33.76 -38.35 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.285 0.564 . . . . 0.0 110.698 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 1.2 t80 -56.62 -57.04 14.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 0.0 109.177 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.68 -13.69 60.65 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.461 -0.774 . . . . 0.0 109.48 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -75.78 -15.81 60.21 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -112.36 -24.36 9.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.609 -0.682 . . . . 0.0 109.215 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.06 -48.78 6.07 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.133 -0.979 . . . . 0.0 110.058 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -109.59 32.03 5.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.923 . . . . 0.0 109.928 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t-20 -154.73 -46.14 0.09 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.171 -0.956 . . . . 0.0 109.376 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HEC . . . . . 0.72 ' CHD' ' HB3' ' A' ' 80' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.231 0.538 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.72 -11.82 60.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.37 -52.47 5.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.893 . . . . 0.0 109.693 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.03 -34.71 62.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 2.5 ttpt -51.08 -42.11 60.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -1.156 . . . . 0.0 109.612 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -77.08 -25.47 52.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.654 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.702 HG22 HD21 ' A' ' 94' ' ' LEU . 12.2 mt -66.58 -62.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE1' HG13 ' A' ' 20' ' ' VAL . 54.6 t80 -62.76 -40.25 96.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.09 -1.006 . . . . 0.0 108.951 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 84.3 mt -66.52 -14.63 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.464 -0.773 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 5.0 ttt -119.07 5.17 11.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.007 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -120.79 -64.25 1.26 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.044 -1.035 . . . . 0.0 109.805 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 37.83 3.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 108.895 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.2 t -91.73 4.34 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.447 -0.783 . . . . 0.0 109.904 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.43 -46.67 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 108.973 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 11.0 m -90.64 -29.53 17.71 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.319 -0.863 . . . . 0.0 108.936 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.86 ' ND1' HD22 ' A' ' 32' ' ' LEU . 69.1 m-70 -114.72 84.51 2.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -84.93 97.98 10.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.931 -1.106 . . . . 0.0 109.12 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 10' ' ' PHE . 2.5 m -85.71 17.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -149.15 31.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -97.59 -77.04 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.53 52.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.23 16.62 35.04 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.85 124.01 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -1.153 . . . . 0.0 109.348 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.434 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -124.71 95.48 4.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -82.11 -73.85 0.37 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.097 -1.002 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.2 m -84.79 -63.08 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.04 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -88.48 152.18 23.14 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.68 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.3 Cg_endo -66.78 134.32 34.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.577 2.185 . . . . 0.0 110.969 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 17.2 t-20 -53.03 103.02 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 109.692 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.06 51.5 1.96 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.665 -0.647 . . . . 0.0 109.826 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.504 ' O ' HG22 ' A' ' 102' ' ' THR . 4.1 t60 -93.46 -8.54 41.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 102' ' ' THR . . . -162.01 31.07 0.31 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -55.48 -28.13 52.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.044 . . . . 0.0 109.85 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 29.9 m-85 -72.28 113.83 9.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.197 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.85 51.03 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -101.61 136.54 41.28 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.056 -1.261 . . . . 0.0 110.075 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' CG ' ' N ' ' A' ' 40' ' ' THR . 30.5 ttmt -82.45 167.52 18.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.024 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.543 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -61.72 165.18 5.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.918 . . . . 0.0 109.946 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' A' ' 53' ' ' LYS . . . 65.4 94.47 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -149.05 -48.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -1.216 . . . . 0.0 109.645 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -61.55 146.4 89.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 109.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.72 -60.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.776 2.317 . . . . 0.0 110.758 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.24 52.77 4.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.01 118.5 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -1.098 . . . . 0.0 108.888 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.538 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 3.9 t -83.33 70.99 10.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 30' ' ' PRO . 2.3 m-85 -44.26 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.684 -0.635 . . . . 0.0 109.747 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.56 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -50.85 -40.62 56.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.435 -0.791 . . . . 0.0 109.219 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -52.45 -72.51 0.05 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.664 ' ND2' HG13 ' A' ' 75' ' ' ILE . 2.1 m-20 -37.2 -49.35 0.91 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -53.79 -48.32 69.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -0.928 . . . . 0.0 110.678 -178.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -65.04 -45.18 86.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.103 -0.998 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -21.03 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.161 -0.962 . . . . 0.0 109.68 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.84 43.94 48.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.961 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -99.34 137.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.993 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.961 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -98.54 115.62 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.635 ' N ' HD12 ' A' ' 58' ' ' ILE . 11.8 m95 -59.02 111.11 1.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -136.42 -158.74 8.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 95' ' ' ILE . 2.9 tt0 -75.78 -74.12 0.23 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.197 -1.178 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -36.91 78.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 110.13 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -59.33 -44.97 92.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.367 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -68.97 -24.97 64.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.242 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.8 tpp -59.75 -44.84 93.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -56.91 5.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 34.3 t80 -51.34 -28.65 12.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.987 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 64' ' ' LEU . 2.7 tp -84.02 -31.48 25.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -58.76 -26.09 63.68 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 7.7 m120 -171.84 102.46 0.37 Allowed Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -75.42 -32.72 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.075 1.85 . . . . 0.0 110.045 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -27.97 31.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.456 -0.777 . . . . 0.0 109.734 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -83.75 -33.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -79.51 -68.41 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.914 . . . . 0.0 108.817 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.724 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.4 mm -102.96 111.18 64.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 70.43 7.23 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.292 1.994 . . . . 0.0 109.711 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -172.98 -40.29 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.803 ' HA ' HG23 ' A' ' 49' ' ' THR . 11.2 t -42.58 151.55 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 109.843 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -111.78 7.12 20.1 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.557 -0.715 . . . . 0.0 109.103 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.57 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 5.7 ptm -86.0 117.79 25.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.931 -1.105 . . . . 0.0 109.695 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -88.89 50.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 27.4 t80 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 121.52 0.676 . . . . 0.0 110.197 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.127 0.489 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.738 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.4 mmt180 -62.06 -44.86 95.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.399 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.68 79.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.979 -1.076 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB2' ' CD1' ' A' ' 9' ' ' ILE . 8.2 m-20 -65.61 -26.41 67.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 91' ' ' ARG . 28.6 mt -66.58 -59.92 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 108.856 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' HG3' ' A' ' 61' ' ' GLU . 4.8 mm -50.52 -32.53 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.428 -0.795 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.3 78.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.404 ' CD2' HD22 ' A' ' 98' ' ' LEU . 23.3 t80 -64.28 -50.33 68.33 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.092 -1.005 . . . . 0.0 109.724 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.1 mm? -64.67 -18.49 65.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.805 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 4.8 mttt -80.86 -25.68 37.48 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.001 -1.062 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 5.5 tptp -78.02 -37.66 46.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.94 -54.8 3.81 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 33' ' ' HIS . 19.3 p -92.69 16.23 12.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.055 -1.028 . . . . 0.0 111.149 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.0 t-20 -156.82 29.03 0.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.923 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.483 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 4' ' ' GLU . 11.2 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.423 ' N ' HG13 ' A' ' 3' ' ' VAL . 14.1 mm-40 -72.21 -7.41 49.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.695 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -55.24 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.796 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.81 -49.31 59.91 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.8 tttt -62.49 -13.63 32.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.9 mmtt -85.46 -54.14 4.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.048 -1.033 . . . . 0.0 109.355 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 70.8 mt -57.22 -53.7 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 15' ' ' SER . 10.1 t80 -60.26 -42.3 95.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 5.2 mt -58.34 -24.42 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.325 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ptm -123.35 18.25 9.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.163 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.64 -48.09 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.05 -1.031 . . . . 0.0 109.725 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -133.72 20.6 3.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.937 -1.102 . . . . 0.0 109.517 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.525 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.7 t -85.3 8.4 18.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.497 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -100.31 -43.87 6.12 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 28' ' ' THR . 35.5 m -93.39 -27.93 16.45 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.031 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.2 m-70 -112.94 84.28 1.96 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 109.798 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -78.53 84.05 4.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 108.364 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.3 m -83.93 31.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 110.692 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 22.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 109.818 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -99.85 6.04 45.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.431 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.16 -22.14 12.56 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.16 7.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 142.1 39.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.16 . . . . 0.0 109.279 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.488 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -127.22 172.77 10.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 109.659 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 -72.63 0.17 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 109.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 17' ' ' CYS . 16.8 m -85.28 -55.41 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.302 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -95.7 153.23 20.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 32.3 Cg_endo -69.1 128.25 16.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.032 1.822 . . . . 0.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 30' ' ' PRO . 14.8 t-20 -44.22 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.031 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.25 41.21 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.88 ' HA ' HG21 ' A' ' 102' ' ' THR . 55.0 t-80 -87.12 -16.64 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.336 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.96 37.93 0.81 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.834 HD11 ' CD1' ' A' ' 59' ' ' TRP . 6.6 tp -67.49 -33.98 76.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.557 -0.966 . . . . 0.0 110.167 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.2 m-85 -64.07 130.26 43.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.981 . . . . 0.0 110.09 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 20.81 76.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -148.0 121.1 8.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.019 -1.283 . . . . 0.0 109.783 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.06 160.02 29.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.223 -0.923 . . . . 0.0 109.148 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.731 HG21 ' HB3' ' A' ' 52' ' ' ASN . 11.3 t -65.05 -174.84 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.906 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 42' ' ' GLN . . . 57.23 79.58 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.1 tp60 -156.39 -56.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -43.2 135.37 3.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.686 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.65 134.01 11.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.505 2.136 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 -11.55 60.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -133.71 76.22 1.65 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 109.718 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -68.56 92.24 0.45 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.768 ' OH ' ' HB2' ' A' ' 43' ' ' ALA . 5.7 m-30 -46.17 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.873 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 78' ' ' THR . 7.4 m -59.67 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.401 -0.812 . . . . 0.0 109.358 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -35.71 -31.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.883 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -32.3 -59.71 0.3 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.373 0.606 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.731 ' HB3' HG21 ' A' ' 40' ' ' THR . 51.2 t30 -62.23 -54.17 44.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 109.328 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HB2' HG23 ' A' ' 40' ' ' THR . 5.3 ttpp -41.94 -27.94 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 110.295 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 51' ' ' ALA . 7.3 p30 -94.94 -33.55 12.73 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.002 -1.061 . . . . 0.0 109.991 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 19.8 tptp -53.11 -20.02 3.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.033 -1.042 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.91 75.07 0.79 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.838 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.41 127.35 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 110.472 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -90.04 101.78 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.834 ' CD1' HD11 ' A' ' 35' ' ' LEU . 5.4 m95 -42.41 107.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.352 -0.843 . . . . 0.0 110.216 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.16 -154.8 7.97 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HG3' HG21 ' A' ' 95' ' ' ILE . 12.7 tt0 -76.58 -75.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -1.213 . . . . 0.0 109.703 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 65' ' ' MET . 21.2 t70 -62.32 -37.46 85.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.817 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.99 -55.2 35.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.873 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.3 tt -63.49 -19.73 65.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.328 -0.858 . . . . 0.0 109.298 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.503 ' HG2' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -64.78 -46.36 82.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -49.93 66.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.187 -0.945 . . . . 0.0 109.758 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.651 ' CG ' ' CH2' ' A' ' 59' ' ' TRP . 7.9 t80 -53.35 -41.02 65.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.105 -0.997 . . . . 0.0 109.352 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -69.98 -33.81 72.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.781 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.7 -24.13 63.72 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 21.1 t-20 -170.98 97.27 0.42 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 29.7 Cg_endo -74.75 -37.52 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.219 1.946 . . . . 0.0 110.769 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -72.84 -9.09 58.29 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.086 -1.009 . . . . 0.0 109.209 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 14.4 tptt -94.17 -57.69 2.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.572 ' CD1' ' HG2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -62.91 -62.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.883 HG22 ' CB ' ' A' ' 51' ' ' ALA . 3.2 mm -80.45 117.23 66.78 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.9 Cg_endo -75.61 74.87 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.165 1.91 . . . . 0.0 110.685 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.42 26.84 1.74 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.632 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 t -49.94 160.7 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.414 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 0.95 37.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 108.813 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.574 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 8.8 ptm -113.46 122.25 46.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' ILE . 16.0 tt -91.04 58.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.574 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 55.3 t80 . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.566 -0.709 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG3' HD13 ' A' ' 9' ' ' ILE . 1.2 tp10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.503 ' CD ' ' HG2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -50.0 -36.1 27.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.223 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.86 89.22 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.253 -0.905 . . . . 0.0 109.174 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.68 -35.44 42.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.0 -55.88 16.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.409 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.448 HG21 ' HG3' ' A' ' 61' ' ' GLU . 16.7 mm -53.51 -69.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.543 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -39.98 -39.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.81 -0.556 . . . . 0.0 110.244 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.03 -50.36 72.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 2.7 mm? -75.22 -3.48 33.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 -12.18 20.64 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.216 -0.927 . . . . 0.0 109.748 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -113.96 -43.55 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 110.123 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.96 -33.4 61.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.88 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -128.54 46.15 2.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.061 -1.024 . . . . 0.0 109.957 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -177.5 45.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.303 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.4 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.217 0.532 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 3' ' ' VAL . 16.6 mt-10 -62.62 -22.62 66.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -84.39 -49.75 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.877 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -52.12 -45.56 57.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -59.9 -37.36 79.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.912 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -21.69 61.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.867 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' LYS . 32.1 mm -75.09 -63.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 20' ' ' VAL . 30.6 t80 -56.22 -45.61 79.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.213 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 18.6 mt -58.93 -30.66 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.6 ttp -116.77 21.9 13.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -134.14 -65.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -115.58 30.83 7.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.106 -0.996 . . . . 0.0 109.564 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 4.3 t -89.68 -14.95 33.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.114 . . . . 0.0 109.466 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -82.43 -44.18 16.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 108.911 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.3 m -90.08 -35.08 15.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 108.869 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.842 ' ND1' HD22 ' A' ' 32' ' ' LEU . 68.6 m-70 -114.02 80.36 1.38 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.039 -1.038 . . . . 0.0 109.934 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 p -79.69 94.55 5.74 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.663 -1.273 . . . . 0.0 108.781 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 10' ' ' PHE . 2.9 m -84.57 -5.56 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.19 26.5 9.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.3 -51.39 3.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.4 60.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.76 24.99 72.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -96.34 115.55 27.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -1.106 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -131.57 89.88 2.77 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.46 -68.5 0.71 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 0.0 109.773 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 99.8 m -90.19 -59.81 2.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.722 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -90.41 149.0 19.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.7 Cg_endo -65.84 136.03 43.68 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.51 2.14 . . . . 0.0 111.232 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 9.5 t-20 -52.4 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.774 -0.579 . . . . 0.0 110.286 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.15 70.07 9.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.729 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.457 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 14.8 t60 -88.86 -45.65 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.599 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.52 38.93 1.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 ' CD1' ' A' ' 59' ' ' TRP . 5.5 tp -54.03 -28.28 37.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -1.131 . . . . 0.0 109.601 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.6 m-85 -66.29 136.75 56.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.81 17.23 57.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 1.8 ttt-85 -133.87 135.68 43.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -1.203 . . . . 0.0 109.326 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -64.68 -174.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.877 . . . . 0.0 109.925 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' N ' ' A' ' 53' ' ' LYS . 4.6 p -53.5 -169.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.582 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -133.3 175.11 20.33 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.879 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -161.82 54.3 0.25 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.954 . . . . 0.0 108.666 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -44.34 169.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 109.666 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.844 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 35.0 Cg_endo -75.12 -66.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.64 2.226 . . . . 0.0 110.585 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.96 6.86 61.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.95 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -131.04 103.89 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -1.135 . . . . 0.0 109.403 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' TYR . 34.7 t -75.14 83.89 2.34 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-30 -44.19 176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.731 -0.606 . . . . 0.0 110.186 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -59.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.906 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -52.61 -38.75 60.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.604 -0.685 . . . . 0.0 109.227 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.26 -70.57 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.394 -0.817 . . . . 0.0 108.847 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -43.97 -54.18 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.603 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' N ' HG21 ' A' ' 40' ' ' THR . 10.1 tptp -40.03 -46.56 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.213 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.67 -34.47 60.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 9.6 tptt -53.65 -17.85 2.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.996 -1.065 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.43 54.34 32.75 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -108.24 138.42 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.997 . . . . 0.0 110.251 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.895 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -98.13 104.21 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.89 ' CD1' HD11 ' A' ' 35' ' ' LEU . 6.6 m95 -49.04 103.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.068 -1.02 . . . . 0.0 110.263 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.86 -164.11 11.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.92 -55.79 5.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.022 -1.281 . . . . 0.0 109.712 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -73.77 -38.93 64.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.157 -0.964 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.44 -37.86 79.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.058 -1.026 . . . . 0.0 109.521 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -77.38 -35.96 53.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.182 -0.949 . . . . 0.0 109.125 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 46.1 ttm -56.77 -28.53 61.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 108.831 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -53.22 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 75' ' ' ILE . 19.9 t80 -58.78 -17.72 25.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.473 HD13 HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -96.08 -36.19 11.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 108.919 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' MET . 21.6 tt0 -59.31 -23.65 62.63 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 23.1 t-20 -176.0 88.52 0.28 Allowed Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.4 Cg_endo -74.59 -37.54 2.28 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.378 2.052 . . . . 0.0 110.274 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -67.63 -14.07 62.63 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.17 -0.956 . . . . 0.0 108.654 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 1.3 tppp? -98.74 -31.66 11.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.227 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.442 ' CD2' HD11 ' A' ' 75' ' ' ILE . 13.1 t80 -83.37 -72.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 108.629 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.5 mm -83.87 115.4 59.65 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 84.26 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.286 1.991 . . . . 0.0 110.396 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 140.18 -7.37 2.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.465 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 12.0 t -44.43 144.67 0.99 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.245 . . . . 0.0 109.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 17.18 24.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.44 124.47 20.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.871 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 81' ' ' ILE . 6.6 mt -92.05 21.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HB2' ' HE3' ' A' ' 80' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.419 0.628 . . . . 0.0 110.193 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.244 0.545 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.644 ' HA ' HD12 ' A' ' 94' ' ' LEU . 4.8 mtp180 -53.04 -36.13 60.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.91 -49.16 60.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.461 ' HB3' HG13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -62.92 -24.58 67.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 110.028 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 91' ' ' ARG . 75.8 mt -68.29 -59.52 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.564 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -61.74 -32.47 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.85 46.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.436 ' HB2' ' C ' ' A' ' 6' ' ' GLY . 32.7 t80 -66.84 -44.27 81.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.963 -1.086 . . . . 0.0 109.814 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.5 mm? -75.91 -4.01 38.54 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.56 -15.13 17.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.197 -0.939 . . . . 0.0 109.14 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 9.0 tttp -103.71 -31.1 10.02 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.23 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.59 -0.694 . . . . 0.0 110.983 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' N ' ' A' ' 103' ' ' ASN . 4.6 t -91.06 -48.62 6.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 0.0 110.855 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.585 ' N ' HG23 ' A' ' 102' ' ' THR . 7.8 t-20 -69.66 -4.26 18.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.871 -1.143 . . . . 0.0 110.029 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 8.4 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.599 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -74.8 -45.93 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 9' ' ' ILE . 2.0 tppm? -76.97 -41.39 43.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.18 94.15 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HD3' ' CE1' ' A' ' 97' ' ' TYR . 3.2 ttpt -61.03 -32.85 72.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -1.158 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -67.44 -25.33 65.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 5.2 mm -76.98 -68.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.523 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 48.8 t80 -53.35 -46.66 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 12' ' ' MET . 12.9 tt -56.01 -43.54 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 110.054 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.515 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.21 14.52 31.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.44 -68.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.072 -1.017 . . . . 0.0 109.592 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -113.59 37.16 3.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 2.9 t -93.51 -48.16 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.881 -1.137 . . . . 0.0 109.835 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.4 -33.79 45.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 36.4 m -98.24 -37.72 9.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.109 -0.994 . . . . 0.0 109.159 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.911 ' ND1' HD22 ' A' ' 32' ' ' LEU . 67.6 m-70 -115.51 74.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.85 -1.156 . . . . 0.0 108.992 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.4 96.83 5.45 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.696 -1.253 . . . . 0.0 109.168 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -87.53 25.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.475 -0.766 . . . . 0.0 109.879 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -140.08 9.29 2.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -85.23 -86.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.8 38.04 0.61 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.52 13.84 63.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -98.66 169.59 9.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -1.13 . . . . 0.0 109.269 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.31 117.51 9.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -91.41 -73.15 0.55 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.283 -0.886 . . . . 0.0 109.158 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m -93.24 -59.88 1.92 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -92.31 153.36 21.72 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.2 Cg_endo -66.57 147.57 82.19 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.403 2.069 . . . . 0.0 111.254 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 16.2 t-20 -64.61 100.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 110.328 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.911 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.88 38.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -90.91 36.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 109.093 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 102' ' ' THR . . . 161.56 37.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.763 HD11 ' CD1' ' A' ' 59' ' ' TRP . 4.2 tp -79.04 -24.39 43.64 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.356 -1.084 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 27.5 m-85 -74.4 127.28 32.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 109.549 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 14.12 82.92 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 11.7 ttt-85 -134.18 134.55 42.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.154 . . . . 0.0 109.516 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 4.0 mttt -73.78 -177.36 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.898 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -92.61 -175.5 3.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.48 89.05 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -147.98 -43.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 109.72 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -73.53 136.35 78.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.327 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 45' ' ' GLY . 35.2 Cg_endo -77.28 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.08 -30.02 0.37 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.526 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -80.59 125.53 30.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.433 -1.039 . . . . 0.0 109.109 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -86.49 57.3 4.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-85 -36.42 158.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.286 0.565 . . . . 0.0 110.066 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -61.0 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.84 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -46.03 -35.89 5.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -49.0 -61.2 2.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HG21 ' A' ' 75' ' ' ILE . 5.6 t-20 -55.94 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 109.592 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 52' ' ' ASN . 6.7 ttpm? -39.99 -30.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.53 0.681 . . . . 0.0 109.338 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLY . 86.1 m-20 -92.23 -39.67 11.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.448 -0.783 . . . . 0.0 109.687 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -56.9 92.72 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.934 -1.104 . . . . 0.0 108.252 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' ASN . . . -38.19 91.52 0.01 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -143.65 145.75 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 110.015 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.081 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -118.61 100.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.898 ' NE1' HG22 ' A' ' 40' ' ' THR . 6.9 m95 -37.56 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.793 0.806 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -122.38 -164.45 12.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -67.9 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -1.146 . . . . 0.0 109.705 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.05 -27.21 66.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.88 -40.69 93.97 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.77 HD22 HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -76.26 -32.49 58.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -37.09 67.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.67 -56.81 4.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.679 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 9.5 t80 -56.07 -19.11 11.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 109.992 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.77 HD13 HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -92.33 -36.31 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.033 -1.042 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.99 -25.16 63.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 5.1 t-20 -168.8 85.46 0.67 Allowed Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -75.01 -26.39 10.95 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.462 2.108 . . . . 0.0 109.766 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 2.2 tttt -74.3 -19.18 60.57 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 43.2 tptt -88.79 -45.06 10.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.501 -0.749 . . . . 0.0 109.438 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.866 ' CD2' HD11 ' A' ' 75' ' ' ILE . 8.1 t80 -71.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.116 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.866 HD11 ' CD2' ' A' ' 74' ' ' TYR . 2.6 mm -96.2 107.81 37.5 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.703 -0.623 . . . . 0.0 109.654 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.749 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -79.13 81.68 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.375 2.05 . . . . 0.0 110.347 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.23 -18.25 0.71 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.5 t -44.97 132.21 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 109.938 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 23.76 5.01 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -59.2 120.0 8.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.607 -0.683 . . . . 0.0 109.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 81' ' ' ILE . 10.9 mt -93.29 26.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 121.625 0.726 . . . . 0.0 110.663 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -55.04 -44.75 74.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.958 . . . . 0.0 109.125 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.52 66.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 0.0 109.23 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.46 -36.63 84.81 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.264 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 66.7 mt -61.97 -29.78 70.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -0.864 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mm -79.15 -46.91 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.351 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.08 -46.78 65.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.219 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' CD2' HD22 ' A' ' 98' ' ' LEU . 28.1 t80 -70.66 -47.52 59.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.993 -1.067 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 102' ' ' THR . 1.1 mm? -71.7 -3.36 21.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -87.0 -55.9 3.62 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -28.58 61.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.59 50.28 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.389 -0.82 . . . . 0.0 109.68 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 102' ' ' THR . 3.1 t -124.38 41.41 3.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.855 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 2.9 t-20 179.78 50.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.388 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.571 HG22 ' HE2' ' A' ' 100' ' ' LYS . 2.1 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.185 0.517 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HG2' ' HE3' ' A' ' 8' ' ' LYS . 5.8 tt0 -62.47 -27.68 69.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.663 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -58.25 -62.16 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.64 -37.17 94.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.6 ttmm -58.47 -26.45 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -1.176 . . . . 0.0 109.811 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HE3' ' HG2' ' A' ' 4' ' ' GLU . 32.2 mttt -82.2 -40.5 21.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 109.994 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.812 HG22 HD21 ' A' ' 94' ' ' LEU . 12.9 mm -61.48 -58.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 0.0 110.123 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HE2' HD23 ' A' ' 32' ' ' LEU . 18.8 t80 -62.12 -41.06 97.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.005 -1.06 . . . . 0.0 109.758 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 18.3 mm -68.21 -11.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.7 ttm -133.31 19.47 4.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 110.215 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 5.8 tptt -131.76 -43.25 1.0 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 109.199 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.07 25.33 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.7 t -85.59 10.42 13.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -43.5 6.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 108.748 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.4 m -99.61 -22.02 15.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.136 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.81 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.8 m-70 -117.43 79.42 1.34 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -79.53 100.08 7.58 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.827 -1.17 . . . . 0.0 108.781 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.9 m -83.81 13.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.887 . . . . 0.0 109.742 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -121.94 17.95 10.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.407 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 1.2 tptp -89.37 179.44 6.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.7 53.92 4.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.1 7.52 76.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 1.4 ttpt -97.92 159.5 14.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.119 . . . . 0.0 109.356 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.604 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -140.33 109.27 6.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.905 . . . . 0.0 108.706 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.695 HG21 ' SG ' ' A' ' 17' ' ' CYS . 30.8 m -87.42 -96.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 28' ' ' THR . . . -50.12 158.83 1.55 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 35.5 Cg_endo -69.38 151.92 71.24 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.363 2.042 . . . . 0.0 111.427 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.0 t-20 -62.41 102.99 0.36 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -82.07 54.86 2.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.121 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -99.51 43.54 1.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 108.888 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA2' HG21 ' A' ' 102' ' ' THR . . . 132.01 48.5 0.11 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.943 HD21 ' CD1' ' A' ' 59' ' ' TRP . 3.6 tt -65.92 -33.78 76.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -1.027 . . . . 0.0 110.35 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 21.3 m-85 -60.08 140.58 56.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 0.0 109.847 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.04 20.0 74.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 38' ' ' ARG . 16.5 ttp85 -133.36 98.95 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 169.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -70.08 172.95 7.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.658 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 72.15 72.8 0.9 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.473 ' HG3' ' HG2' ' A' ' 38' ' ' ARG . 66.2 mm-40 -135.53 -53.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 109.806 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -71.11 137.96 84.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.625 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -79.73 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.696 2.264 . . . . 0.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.28 -33.73 1.41 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.91 121.76 25.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -1.089 . . . . 0.0 109.429 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -84.64 65.4 9.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-30 -37.88 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.617 0.723 . . . . 0.0 111.12 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 78' ' ' THR . 45.1 p -68.44 88.8 0.34 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 109.466 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.74 -33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.28 -65.06 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.719 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-20 -39.72 -55.08 1.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.435 -0.791 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -42.31 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.75 -27.33 67.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.278 -0.889 . . . . 0.0 109.852 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 6.1 tptt -73.45 -0.22 14.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.17 -0.956 . . . . 0.0 109.668 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.59 27.26 2.0 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -81.0 125.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.994 . . . . 0.0 110.085 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -94.05 100.46 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.943 ' CD1' HD21 ' A' ' 35' ' ' LEU . 17.2 m95 -37.39 109.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -130.76 -155.09 8.14 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.02 -60.64 2.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -1.191 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.32 -35.24 73.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.731 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -65.35 -48.56 72.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.74 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.3 tt -69.53 -32.59 71.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.103 -0.998 . . . . 0.0 109.533 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.45 ' HG2' ' HD2' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -59.88 -34.15 72.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 108.89 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -77.8 -53.4 7.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.518 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 38.9 t80 -57.65 -16.34 10.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -92.37 -40.34 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.563 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.95 -22.53 60.23 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 70' ' ' ASN . 22.4 p30 -172.57 95.91 0.37 Allowed Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -73.34 -40.23 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.255 1.97 . . . . 0.0 110.541 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -69.41 -9.36 53.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.995 -1.065 . . . . 0.0 108.948 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -88.15 -54.41 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -69.16 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.147 -0.971 . . . . 0.0 108.837 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.8 mm -98.19 106.82 37.68 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.653 -0.654 . . . . 0.0 109.553 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.5 75.77 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.159 1.906 . . . . 0.0 109.583 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 170.36 -22.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.89 ' HA ' HG21 ' A' ' 49' ' ' THR . 13.8 t -36.96 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -1.052 . . . . 0.0 110.329 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.89 13.46 31.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.582 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 6.3 ptm -114.54 123.07 48.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 110.079 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 81' ' ' ILE . 52.0 mt -94.41 44.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 19.9 t80 . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.653 -0.654 . . . . 0.0 109.766 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 65' ' ' MET . 10.2 ttp85 -58.52 -52.43 65.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 108.918 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.84 73.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -63.75 -30.69 71.76 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.812 HD21 HG22 ' A' ' 9' ' ' ILE . 18.3 mt -64.66 -55.75 18.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -63.43 -31.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.27 87.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' CD2' HD22 ' A' ' 98' ' ' LEU . 34.3 t80 -64.73 -49.41 70.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.017 -1.052 . . . . 0.0 109.973 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' THR . 3.4 mm? -66.34 -16.33 63.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.727 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -77.64 -51.03 11.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.121 -0.987 . . . . 0.0 109.608 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -74.8 -22.34 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.76 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.44 -55.73 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 110.222 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.736 HG21 ' HA2' ' A' ' 34' ' ' GLY . 3.3 t -110.71 -32.23 6.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.99 -1.069 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.559 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 6.7 t30 -81.4 8.41 9.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 110.017 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.32 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 14.5 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.38 -10.15 59.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -96.3 -49.71 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -75.11 -33.3 54.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -69.67 -36.15 75.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 109.605 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -32.03 58.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 HD21 ' A' ' 94' ' ' LEU . 53.9 mt -67.92 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.262 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.549 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.7 t80 -54.35 -39.16 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 15' ' ' SER . 5.0 mm -57.09 -37.91 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -107.04 10.54 30.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.065 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -109.79 -60.03 1.84 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.102 -0.999 . . . . 0.0 109.527 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -132.07 40.81 3.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.313 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.2 t -87.25 -1.15 57.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -100.83 -49.07 4.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' SG ' HG21 ' A' ' 28' ' ' THR . 38.3 m -87.75 -13.19 43.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.876 . . . . 0.0 109.357 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.623 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 82.2 m-70 -134.23 81.87 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 110.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.0 p -78.67 90.21 4.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.9 -1.125 . . . . 0.0 108.003 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.1 m -82.85 35.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.625 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 23.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.869 -1.144 . . . . 0.0 110.211 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -95.74 -15.63 22.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.884 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.89 -25.4 4.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 136.53 -6.26 3.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -67.21 141.17 57.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -1.126 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.482 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -112.87 115.3 28.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 109.088 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.63 -79.94 0.32 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.761 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.605 HG21 ' SG ' ' A' ' 17' ' ' CYS . 7.0 m -98.97 -53.54 3.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 175.14 31.99 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -73.52 125.04 9.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.823 2.349 . . . . 0.0 110.94 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 24' ' ' GLY . 15.6 t-20 -49.37 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -78.8 76.54 5.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 -66.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -110.4 27.19 11.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 59' ' ' TRP . 1.9 tt -43.56 -30.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -1.079 . . . . 0.0 109.556 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.1 m-85 -74.91 128.95 36.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.58 66.26 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -120.77 123.6 43.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.406 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -60.09 -177.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.727 HG22 ' NE1' ' A' ' 59' ' ' TRP . 2.3 p -80.47 178.43 8.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' THR . . . 52.83 104.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.16 -62.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.279 . . . . 0.0 110.005 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -61.08 139.33 94.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.95 -173.82 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.744 2.296 . . . . 0.0 110.509 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 45.99 25.25 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -157.16 112.11 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 108.96 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -78.35 77.25 4.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.6 m-85 -46.77 179.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.81 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.49 88.11 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.105 -0.997 . . . . 0.0 108.871 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.12 -41.75 12.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.77 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.03 -66.75 0.33 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.301 -0.875 . . . . 0.0 108.959 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HB3' HG21 ' A' ' 40' ' ' THR . 1.6 m-20 -43.25 -42.36 4.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.465 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 5.5 tttt -43.41 -72.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.95 -15.79 60.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -60.42 -13.22 12.2 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.013 -1.055 . . . . 0.0 109.39 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.52 51.51 32.19 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -110.82 123.73 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.53 -0.983 . . . . 0.0 110.215 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -87.27 116.39 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.727 ' NE1' HG22 ' A' ' 40' ' ' THR . 12.6 m95 -56.55 96.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.299 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -117.68 -176.57 17.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -64.21 -59.69 4.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.108 -1.231 . . . . 0.0 110.073 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.45 -38.35 77.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 109.922 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.627 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.59 -35.6 74.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.658 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.77 -29.81 51.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.071 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -58.68 -35.0 71.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.33 -0.856 . . . . 0.0 109.105 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.48 -58.61 3.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 52' ' ' ASN . 56.1 t80 -48.69 -28.81 3.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.163 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD13 HD22 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -87.68 -39.27 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 0.0 109.487 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 65' ' ' MET . 10.8 tt0 -60.54 -21.22 62.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 13.7 m-20 -169.21 89.61 0.59 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.3 Cg_endo -76.76 -41.44 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.612 2.208 . . . . 0.0 110.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -31.98 57.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.34 -0.85 . . . . 0.0 109.973 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 1.6 mmpt? -83.19 -26.25 31.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 75' ' ' ILE . 7.1 t80 -83.94 -72.24 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.004 -1.06 . . . . 0.0 109.045 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.855 HG22 ' HB3' ' A' ' 51' ' ' ALA . 22.4 mm -93.73 119.37 67.12 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 109.669 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.6 Cg_endo -80.8 60.22 7.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.475 2.116 . . . . 0.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.31 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.81 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -59.83 161.96 5.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 109.758 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 11.41 5.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.595 ' O ' ' HG3' ' A' ' 80' ' ' MET . 7.7 ptm -77.75 114.05 16.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.316 1.055 . . . . 0.0 109.752 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -95.16 33.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 13' ' ' LYS . 1.3 t80 . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.976 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.231 0.539 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.429 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -53.32 -30.17 37.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.15 -52.67 17.9 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -59.16 -22.03 60.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.61 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HG22 ' A' ' 9' ' ' ILE . 27.4 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.9 mm -57.25 -38.58 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.325 -0.859 . . . . 0.0 109.413 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.28 82.46 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.545 -0.722 . . . . 0.0 109.86 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 7' ' ' LYS . 23.4 t80 -61.99 -34.95 77.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 109.611 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.3 mm? -83.32 -13.35 55.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -95.05 -9.32 34.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.315 -0.865 . . . . 0.0 109.682 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.98 -52.08 2.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 109.46 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.14 71.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.97 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -128.53 40.41 3.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.826 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 102' ' ' THR . 2.5 t30 178.85 51.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 1.5 pt-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.64 -36.9 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.595 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 9' ' ' ILE . 5.7 mmtt -74.94 -45.26 43.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 93' ' ' ASP . . . -42.27 -52.64 5.07 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 4.1 ttmm -64.16 -36.49 84.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -1.17 . . . . 0.0 109.666 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.1 tptt -62.56 -23.43 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.073 -1.017 . . . . 0.0 109.915 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.72 HG22 HD21 ' A' ' 94' ' ' LEU . 17.9 mm -82.65 -67.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.892 -1.13 . . . . 0.0 109.829 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 20' ' ' VAL . 23.2 t80 -49.99 -31.55 12.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 109.524 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.548 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 3.2 tt -69.73 -40.65 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 ttm -111.77 29.61 7.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.378 -0.826 . . . . 0.0 109.973 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -140.73 -39.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.007 . . . . 0.0 109.951 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -146.48 16.53 1.3 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.967 -1.083 . . . . 0.0 109.938 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 28.2 t -85.44 7.94 20.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.893 -1.129 . . . . 0.0 109.594 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -100.1 -43.32 6.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 57.9 m -95.98 -32.83 12.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.841 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.4 m-70 -108.18 84.53 1.96 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 109.472 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -79.73 91.35 5.28 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.723 -1.235 . . . . 0.0 108.817 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 10' ' ' PHE . 11.8 m -85.12 8.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.433 -0.792 . . . . 0.0 110.133 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 2.6 mt-10 -146.13 24.95 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 110.383 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 15.1 tttt -96.74 -58.31 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.057 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.8 54.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.38 20.01 3.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -100.81 82.66 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -79.85 150.11 30.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 109.373 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -133.77 -85.37 0.44 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.526 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 49.8 m -81.91 -15.6 53.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -132.44 150.26 19.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.8 Cg_endo -66.36 131.72 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.202 . . . . 0.0 111.108 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.1 t-20 -53.17 102.79 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.841 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.97 42.69 0.73 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 110.166 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.444 ' HA ' HG21 ' A' ' 102' ' ' THR . 22.6 t-80 -89.0 58.43 4.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 108.993 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.85 23.67 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -56.52 -22.19 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.038 -1.272 . . . . 0.0 109.237 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 19.6 m-85 -70.85 134.37 47.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.876 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.77 10.5 61.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -123.64 120.31 32.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -1.202 . . . . 0.0 109.421 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 161.64 16.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.081 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -67.45 176.37 2.37 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 53' ' ' LYS . . . 61.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.447 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -157.93 -58.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.185 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.409 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -53.24 129.79 50.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 0.0 109.862 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.7 Cg_endo -79.56 145.14 18.23 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.598 2.198 . . . . 0.0 110.386 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.1 -47.02 3.7 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -81.24 113.83 19.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.958 . . . . 0.0 108.766 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -77.35 77.55 3.88 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.665 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-85 -46.6 177.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.647 . . . . 0.0 109.335 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.761 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.67 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 109.278 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -47.24 -41.67 19.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.242 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -47.8 -68.38 0.19 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -40.47 -47.12 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.688 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HA ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -48.15 -60.03 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.858 . . . . 0.0 110.044 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.2 -20.63 66.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 110.065 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -63.84 -8.75 11.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.088 -1.008 . . . . 0.0 109.96 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.08 52.56 34.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -114.29 135.77 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.51 -0.994 . . . . 0.0 110.436 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.981 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -97.98 114.45 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.617 ' N ' HD13 ' A' ' 58' ' ' ILE . 10.6 m95 -54.59 109.03 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.98 -163.15 10.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.87 -62.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.283 . . . . 0.0 109.839 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.1 93.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.098 -1.001 . . . . 0.0 109.937 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.848 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.53 -38.17 80.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.804 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.701 HD22 HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -76.32 -32.79 58.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.765 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.6 ttt -55.79 -39.55 71.44 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -75.21 -48.6 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.27 -0.894 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 30.4 t80 -59.55 -18.33 39.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 109.737 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.701 HD13 HD22 ' A' ' 64' ' ' LEU . 1.2 mp -92.71 -38.92 11.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -22.2 62.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.52 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . 10.3 m-20 -172.25 94.17 0.39 Allowed Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.776 ' HB2' HG21 ' A' ' 78' ' ' THR . 31.2 Cg_endo -76.26 -30.78 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 0.0 110.022 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -82.15 -26.94 33.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.381 -0.824 . . . . 0.0 109.711 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -80.9 -44.34 18.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.259 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 t80 -72.08 -66.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 52' ' ' ASN . 31.3 mm -98.43 110.28 55.97 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.479 -0.763 . . . . 0.0 109.62 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -79.35 67.07 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.459 2.106 . . . . 0.0 109.863 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -165.65 -47.65 0.02 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.776 HG21 ' HB2' ' A' ' 71' ' ' PRO . 9.0 t -47.57 167.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -1.233 . . . . 0.0 109.692 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -134.72 11.51 3.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 80' ' ' MET . 6.6 ptm -77.65 118.83 20.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -93.9 33.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 2.4 t80 . . . . . 0 C--N 1.302 -1.499 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.985 ' HA ' HD12 ' A' ' 94' ' ' LEU . 1.4 mpt_? -55.44 -45.88 76.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.126 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.58 89.75 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' HB3' HG13 ' A' ' 9' ' ' ILE . 4.3 m-20 -57.87 -29.13 64.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.279 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.985 HD12 ' HA ' ' A' ' 91' ' ' ARG . 27.2 mt -66.96 -47.71 70.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.6 mm -65.84 -59.2 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.388 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.2 -42.25 6.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.904 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.01 -52.07 58.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 110.003 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.2 mm? -75.39 -0.42 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -95.87 -25.1 16.14 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 110.088 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -108.7 -36.41 6.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.32 67.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -136.0 49.41 2.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.998 -1.064 . . . . 0.0 110.082 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.9 t30 -178.14 34.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.559 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.444 HG21 ' HD2' ' A' ' 100' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.055 0.455 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.65 -46.75 44.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.634 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -29.05 70.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.793 -1.192 . . . . 0.0 109.758 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . -72.43 -51.08 13.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 2.7 tttp -43.84 -35.18 1.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.023 -1.281 . . . . 0.0 110.082 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -74.25 -46.05 44.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 109.965 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.802 HD12 ' CB ' ' A' ' 93' ' ' ASP . 21.1 mt -56.86 -50.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.421 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 13.3 t80 -63.56 -46.41 86.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 110.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -53.21 -37.23 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.968 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -107.29 5.72 27.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.831 -1.168 . . . . 0.0 110.448 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.7 tppt? -109.03 -69.47 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.895 -1.128 . . . . 0.0 109.733 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -117.11 40.8 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.146 -0.971 . . . . 0.0 108.599 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 8.2 t -87.99 -53.94 4.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.757 -1.214 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 17' ' ' CYS . 9.5 pt20 -55.95 -38.62 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.831 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 28' ' ' THR . 8.7 m -86.96 -24.52 24.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.128 -0.983 . . . . 0.0 108.978 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.829 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.7 m-70 -131.76 76.8 1.73 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.978 -1.076 . . . . 0.0 109.58 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -76.89 92.52 3.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.23 24.44 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 110.531 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 18.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 108.645 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -22.21 51.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.496 -0.753 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.73 -17.18 8.84 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.31 -7.24 3.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.13 155.79 21.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -1.225 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.67 141.71 34.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 0.0 109.568 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 28' ' ' THR . 2.6 ttmt -113.7 -85.07 0.59 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.687 HG21 ' SG ' ' A' ' 17' ' ' CYS . 19.4 m -79.13 -76.68 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -74.68 155.89 48.88 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.668 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 34.3 Cg_endo -70.14 138.01 35.65 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.236 1.958 . . . . 0.0 110.74 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -48.82 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.897 . . . . 0.0 109.604 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.829 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.5 53.08 2.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.743 . . . . 0.0 110.181 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -99.81 77.5 2.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 0.0 109.336 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' ' 102' ' ' THR . . . 113.41 11.69 12.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -54.01 -27.99 35.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.601 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 2.8 m-85 -61.96 150.03 38.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 109.908 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.02 17.55 23.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' CZ ' ' O ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -138.66 162.48 34.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -1.161 . . . . 0.0 109.422 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -92.93 -156.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.543 ' O ' ' CZ ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -59.65 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -145.85 -176.04 19.41 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.9 36.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.433 -1.039 . . . . 0.0 109.4 -179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -41.46 160.89 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.94 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 34.2 Cg_endo -76.29 154.69 36.71 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.662 2.241 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.33 20.04 20.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -153.87 104.48 2.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.932 . . . . 0.0 109.054 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 82.8 p -77.67 81.47 4.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 m-85 -44.65 174.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.662 -0.649 . . . . 0.0 109.309 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -59.06 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.03 -1.044 . . . . 0.0 109.495 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -55.17 -42.03 72.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.7 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.27 -72.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.626 ' ND2' HG13 ' A' ' 75' ' ' ILE . 6.3 m-20 -38.45 -48.63 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.506 -0.746 . . . . 0.0 109.615 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 13.2 tttt -42.81 -69.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 0.0 110.671 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 55' ' ' LYS . 38.7 p30 -63.48 -17.96 63.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -62.44 -12.17 20.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 46.02 81.74 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -105.63 134.66 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.386 -1.067 . . . . 0.0 109.804 -179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.32 96.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 0.0 108.597 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD1' HD11 ' A' ' 35' ' ' LEU . 8.0 m95 -42.06 103.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -126.12 -164.01 11.68 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.06 -70.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.0 109.383 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -61.02 -36.63 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.432 -0.792 . . . . 0.0 109.748 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.438 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.62 -36.23 75.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.5 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.08 -33.73 57.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.335 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 tpt -54.69 -38.75 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.98 -58.15 3.49 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.404 -0.81 . . . . 0.0 109.491 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 53.6 t80 -52.9 -18.92 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.925 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.757 HD23 ' HD2' ' A' ' 91' ' ' ARG . 1.5 tp -92.33 -38.84 11.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.557 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -59.48 -22.55 61.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 8.3 p30 -178.58 88.98 0.22 Allowed Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -75.55 -43.25 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.466 2.111 . . . . 0.0 110.292 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -21.69 65.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.227 -0.921 . . . . 0.0 108.833 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -89.09 -38.91 13.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.389 -0.819 . . . . 0.0 109.227 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 3.9 t80 -75.76 -68.73 0.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.7 HG22 ' CB ' ' A' ' 51' ' ' ALA . 12.1 mm -93.0 109.8 41.79 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.541 -0.724 . . . . 0.0 109.335 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 34.5 Cg_endo -76.23 87.8 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.218 1.945 . . . . 0.0 110.541 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 153.37 -27.14 0.78 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.482 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -42.24 145.51 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -1.099 . . . . 0.0 110.023 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -107.26 18.9 21.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.487 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -61.59 127.28 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 110.016 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 81' ' ' ILE . 17.7 mt -95.86 27.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' HB2' ' HE3' ' A' ' 80' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.546 0.689 . . . . 0.0 110.385 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.49 ' OE1' ' CA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.301 0.572 . . . . 0.0 109.594 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.998 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.85 -40.04 75.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.2 77.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.802 ' CB ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -63.08 -32.91 74.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.829 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt -64.91 -53.15 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.702 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -60.21 -38.64 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.5 83.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.996 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.26 -53.41 57.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.2 -0.938 . . . . 0.0 109.571 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 98' ' ' LEU . 3.6 mm? -65.23 -15.8 62.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.389 -0.819 . . . . 0.0 109.809 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -80.56 -28.76 37.16 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.003 -1.061 . . . . 0.0 110.158 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -102.0 -56.05 2.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.866 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.79 65.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -142.85 46.76 1.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.002 -1.061 . . . . 0.0 110.151 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 7.1 t30 174.12 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.019 . . . . 0.0 110.03 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 3.3 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.324 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 4' ' ' GLU . 13.1 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.4 mt-10 -65.26 -12.61 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.529 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -91.26 -54.08 4.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -55.83 -39.91 79.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 26.6 tttp -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 0.0 109.538 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -74.51 -27.77 60.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG2' HD21 ' A' ' 94' ' ' LEU . 80.5 mt -61.22 -63.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.14 -0.975 . . . . 0.0 109.023 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CE1' HG13 ' A' ' 20' ' ' VAL . 40.1 t80 -62.69 -42.21 99.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 108.728 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 9.2 mm -61.5 -18.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.747 . . . . 0.0 109.297 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' A' ' 12' ' ' MET . 4.6 tpt -128.52 18.54 6.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 109.618 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -131.64 -50.42 0.98 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -126.51 23.23 6.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.126 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.6 t -87.84 -2.28 58.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.821 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -92.28 -45.79 8.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 108.488 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.4 m -90.94 -35.65 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.882 ' CG ' HD22 ' A' ' 32' ' ' LEU . 65.1 m-70 -110.63 85.01 2.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.063 -1.023 . . . . 0.0 110.339 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -79.84 99.39 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.75 -1.219 . . . . 0.0 108.821 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.4 m -86.95 33.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 21.71 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.28 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -63.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.26 64.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.09 13.23 40.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -100.12 156.92 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.613 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -152.69 119.91 5.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.369 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -93.3 -86.0 0.26 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 22.2 m -87.93 -43.41 11.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.799 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -101.2 153.29 19.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.672 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.1 Cg_endo -66.71 132.81 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.947 2.431 . . . . 0.0 111.692 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -49.58 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.44 0.638 . . . . 0.0 109.909 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.882 HD22 ' CG ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.89 69.93 7.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.509 -0.745 . . . . 0.0 110.677 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -100.5 -59.46 1.7 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.053 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.76 36.72 4.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 59' ' ' TRP . 14.3 tp -48.87 -30.03 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.096 . . . . 0.0 109.768 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 76.5 m-85 -75.56 124.49 27.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.961 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.03 69.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.38 107.8 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.023 -1.281 . . . . 0.0 109.576 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' THR . 4.3 pttt -61.3 150.13 35.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.864 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -46.74 176.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 109.886 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . . . 55.99 91.96 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -151.52 -43.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -1.169 . . . . 0.0 109.644 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -58.29 146.09 72.33 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.618 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.77 -62.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.794 2.329 . . . . 0.0 110.761 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.33 46.51 3.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -160.79 114.03 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.176 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.523 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 25.4 m -79.15 77.27 5.66 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.2 m-85 -46.23 -179.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.752 -0.593 . . . . 0.0 109.787 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.68 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.995 . . . . 0.0 108.971 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.46 -38.94 64.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -49.72 -64.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.864 ' HB3' HG21 ' A' ' 40' ' ' THR . 2.4 t-20 -53.51 -41.16 66.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.868 -1.145 . . . . 0.0 109.373 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HA ' HG23 ' A' ' 40' ' ' THR . 24.5 tttm -52.1 -37.0 52.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -82.07 -23.44 35.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 110.33 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 28.9 tttt -76.4 3.07 11.87 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.985 -1.072 . . . . 0.0 109.671 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.2 11.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.739 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -103.8 132.01 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.739 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -96.67 112.41 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 108.648 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.608 ' CH2' ' ND2' ' A' ' 52' ' ' ASN . 6.1 m95 -59.95 105.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 110.047 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.99 -157.83 8.81 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 95' ' ' ILE . 45.6 tt0 -77.78 -63.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -1.118 . . . . 0.0 109.567 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -37.71 85.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.927 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -45.07 92.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.827 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -66.78 -34.27 77.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.993 . . . . 0.0 109.271 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.514 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 2.5 tmm? -54.26 -38.41 65.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.397 -0.815 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.01 -60.81 2.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CD1' HG12 ' A' ' 75' ' ' ILE . 39.0 t80 -54.42 -17.71 3.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.781 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD13 HD22 ' A' ' 64' ' ' LEU . 1.1 tp -90.74 -31.22 16.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.023 -1.048 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.74 -27.34 66.42 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -177.75 100.61 0.22 Allowed Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.6 Cg_endo -76.34 -40.71 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.356 2.037 . . . . 0.0 110.262 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 9.5 tptm -70.84 -12.11 61.35 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -102.32 -35.66 8.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.965 . . . . 0.0 109.314 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CE2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -76.84 -69.35 0.53 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 108.618 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.772 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -95.2 111.09 53.73 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.901 . . . . 0.0 109.214 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.15 70.24 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.289 1.993 . . . . 0.0 110.385 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -177.47 -38.3 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.576 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -44.71 158.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -108.54 -2.8 18.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.17 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.62 ' HE2' ' CB ' ' A' ' 82' ' ' PHE . 8.9 ptm -88.83 121.99 31.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.067 -1.021 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 81' ' ' ILE . 4.2 mp -99.24 45.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.62 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 48.4 t80 . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.514 ' NH1' ' HG2' ' A' ' 65' ' ' MET . 1.4 mtp180 -65.62 -47.47 75.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.168 -0.957 . . . . 0.0 109.089 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -55.15 -36.58 65.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.888 . . . . 0.0 109.28 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -30.46 66.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.408 -0.807 . . . . 0.0 109.342 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.71 HD21 ' CG2' ' A' ' 9' ' ' ILE . 43.5 mt -65.46 -58.33 6.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 61' ' ' GLU . 3.3 mm -66.14 -29.09 45.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 109.221 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -61.39 -40.57 94.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.603 -0.685 . . . . 0.0 109.929 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -73.12 -52.94 12.35 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.109 -0.994 . . . . 0.0 109.245 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.852 ' O ' HG22 ' A' ' 102' ' ' THR . 1.4 mm? -60.43 -16.97 41.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.416 -0.803 . . . . 0.0 109.921 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HD2' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.76 -48.04 11.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.883 -1.135 . . . . 0.0 109.463 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.29 77.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.9 -50.03 11.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 98' ' ' LEU . 13.8 t -120.27 40.33 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.948 -1.095 . . . . 0.0 110.368 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' CA ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -167.97 39.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.481 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.889 HG21 ' HE2' ' A' ' 100' ' ' LYS . 9.9 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.304 0.574 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 5' ' ' LYS . 15.4 pt-20 -53.47 -36.26 61.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 0.0 109.75 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -97.64 -14.11 21.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.06 -41.21 97.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 20.0 ttmt -61.94 -22.38 65.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.067 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -78.81 -40.41 33.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.086 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 HD21 ' A' ' 94' ' ' LEU . 42.8 mt -62.36 -50.95 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 108.798 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 98' ' ' LEU . 34.5 t80 -62.55 -39.22 92.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 6.7 mm -61.48 -22.2 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.42 -0.8 . . . . 0.0 108.872 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.04 13.28 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 4.1 tptt -126.86 -55.74 1.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.188 . . . . 0.0 110.381 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -130.68 22.36 5.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.821 -1.174 . . . . 0.0 110.216 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 40.0 t -86.41 7.37 26.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.935 -1.103 . . . . 0.0 109.461 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -100.53 -54.58 2.81 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 10.5 m -82.85 -27.41 30.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.975 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.6 m-70 -115.2 88.8 2.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.135 -0.978 . . . . 0.0 110.059 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.2 p -78.7 83.37 4.86 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.045 -1.035 . . . . 0.0 108.457 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' VAL . 2.7 m -84.02 30.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 110.304 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.18 19.57 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.324 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -97.43 -61.1 1.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.23 62.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.54 16.1 54.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -92.0 144.7 25.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -1.155 . . . . 0.0 109.532 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.489 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.79 133.19 19.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 109.683 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 -77.13 0.58 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.511 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 52.5 m -90.53 -40.14 12.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.529 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.509 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -104.99 152.63 17.33 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -68.04 133.15 28.12 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.385 2.057 . . . . 0.0 111.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.459 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.4 t-20 -49.1 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.475 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.975 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.93 67.69 8.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.545 -0.722 . . . . 0.0 109.49 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 102' ' ' THR . 5.4 t-160 -98.24 -6.93 30.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 109.874 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.82 61.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -78.69 -30.98 46.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.27 -1.136 . . . . 0.0 109.858 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 83.6 m-85 -67.97 124.33 23.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.98 28.62 62.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.03 120.56 9.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.523 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 173.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.962 . . . . 0.0 109.212 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.986 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -85.57 175.44 8.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 42' ' ' GLN . . . 60.67 96.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tp60 -159.86 -55.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.853 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -44.32 133.24 4.52 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.21 139.62 15.01 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.578 2.185 . . . . 0.0 110.605 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.07 -49.96 4.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.09 104.51 12.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.462 -1.022 . . . . 0.0 108.84 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.62 80.59 4.09 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 6.6 m-30 -44.35 173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -62.89 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.129 -0.982 . . . . 0.0 108.435 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -41.52 -37.83 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -0.763 . . . . 0.0 109.856 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.669 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -39.78 -64.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.702 -0.624 . . . . 0.0 109.4 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.619 ' N ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -45.83 -51.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.868 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.493 ' CA ' ' OG1' ' A' ' 40' ' ' THR . 25.2 tttt -49.93 -41.45 46.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -71.46 -32.17 67.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.011 -1.055 . . . . 0.0 110.127 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.75 2.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.039 -1.038 . . . . 0.0 109.736 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.27 52.58 46.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.997 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.35 132.92 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -1.019 . . . . 0.0 110.371 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.997 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -95.29 97.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.986 ' NE1' HG22 ' A' ' 40' ' ' THR . 10.1 m95 -37.16 122.77 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.634 0.73 . . . . 0.0 111.127 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -143.04 -164.06 10.03 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -76.08 -73.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 0.0 109.617 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.53 -33.59 72.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.691 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -47.22 86.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 108.835 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.635 HD22 HD13 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -61.69 -35.83 79.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.46 -0.775 . . . . 0.0 109.005 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ttt -55.79 -35.12 65.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.412 -0.805 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' OE2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 tm-20 -71.94 -60.02 2.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.793 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 24.8 t80 -54.79 -21.17 10.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -88.02 -33.21 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.444 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.91 -23.92 66.63 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 9.9 t-20 -177.82 96.54 0.22 Allowed Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 32.2 Cg_endo -74.34 -30.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.446 2.097 . . . . 0.0 110.182 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -13.34 60.54 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 108.646 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -95.58 -46.32 6.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.117 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' OE2' ' A' ' 66' ' ' GLU . 13.2 t80 -71.46 -64.05 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.006 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.2 mm -79.31 126.44 81.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.7 Cg_endo -74.98 74.24 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.122 1.882 . . . . 0.0 110.692 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.39 33.37 1.62 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.0 t -50.48 162.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.342 . . . . 0.0 108.929 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.62 12.35 35.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.949 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 80' ' ' MET . 6.3 ptm -130.57 128.64 41.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 81' ' ' ILE . 9.1 tp -109.41 40.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.507 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.302 -1.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.451 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -59.85 -50.67 72.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.161 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 -39.99 75.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.429 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -29.55 69.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.587 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.618 HD21 HG22 ' A' ' 9' ' ' ILE . 20.6 mt -64.25 -47.4 79.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.877 . . . . 0.0 109.186 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.648 HG21 ' HG2' ' A' ' 61' ' ' GLU . 3.6 mm -71.2 -30.84 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.137 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.03 79.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 101' ' ' ALA . 13.1 t80 -69.61 -33.59 72.89 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 108.951 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -78.63 -9.5 59.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.363 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.11 -16.52 17.81 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.889 ' HE2' HG21 ' A' ' 3' ' ' VAL . 3.3 mtpt -108.9 -20.14 13.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.564 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . . . -91.08 -43.45 9.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.384 -0.822 . . . . 0.0 109.935 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -104.0 -59.27 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.677 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 18.8 t-20 -53.2 -26.76 18.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 100' ' ' LYS . 29.5 tp10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.455 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.323 0.582 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -63.87 -15.83 59.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -82.15 -72.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.424 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -53.77 -28.2 38.14 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 35.4 tttt -65.98 -37.77 86.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 109.858 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -75.21 -26.07 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' CD2' ' A' ' 94' ' ' LEU . 33.4 mm -64.3 -60.79 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.636 ' CE2' HG13 ' A' ' 20' ' ' VAL . 39.5 t80 -61.28 -38.3 86.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 49.4 mt -64.13 -22.49 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 tpp -122.84 16.03 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.126 -0.984 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 6.6 tppt? -127.57 -49.01 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.091 -1.006 . . . . 0.0 109.553 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 28.69 4.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.982 . . . . 0.0 108.88 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.1 t -86.66 -4.16 59.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -95.23 -43.48 8.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.246 -0.908 . . . . 0.0 108.917 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 7.0 m -91.26 -44.19 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.963 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.871 ' ND1' HD22 ' A' ' 32' ' ' LEU . 59.6 m-70 -101.92 81.81 2.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.047 . . . . 0.0 109.772 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 p -79.66 95.51 5.95 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.826 -1.171 . . . . 0.0 108.877 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.636 HG13 ' CE2' ' A' ' 10' ' ' PHE . 3.0 m -82.37 13.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.867 . . . . 0.0 109.859 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.32 17.15 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 110.057 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -89.95 -23.94 21.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 109.709 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.35 60.36 0.55 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.71 9.53 52.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 3.5 tttp -91.61 130.76 37.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -1.166 . . . . 0.0 109.536 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.506 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.01 104.85 5.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 -82.03 0.13 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.13 -0.981 . . . . 0.0 110.181 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.404 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 10.8 m -89.9 -30.86 17.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -108.65 150.4 17.05 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.666 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -67.29 129.05 19.52 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.79 2.327 . . . . 0.0 111.103 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.0 t-20 -48.68 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.64 -0.663 . . . . 0.0 110.128 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.871 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -83.64 62.27 6.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.576 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 46.3 p-80 -100.26 52.78 0.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.311 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 38' ' ' ARG . . . 118.74 64.49 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -78.3 -26.42 46.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -1.071 . . . . 0.0 110.269 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 7.1 m-30 -71.88 125.63 27.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.076 . . . . 0.0 110.981 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.07 -6.51 69.19 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.203 -0.999 . . . . 0.0 111.281 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.601 ' HD2' ' NE2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -122.13 134.59 54.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.658 -1.495 . . . . 0.0 110.287 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -70.76 150.42 45.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -60.95 163.77 5.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.018 . . . . 0.0 110.212 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.66 99.27 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.601 ' NE2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -160.78 -34.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.258 . . . . 0.0 110.026 179.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.62 128.7 85.14 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.065 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.7 149.73 21.03 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.531 2.154 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.49 -14.2 55.82 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -126.02 111.64 14.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -1.073 . . . . 0.0 108.3 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.49 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 2.0 p -74.27 78.84 1.82 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.666 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.8 m-85 -48.18 179.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.833 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.9 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.16 -40.76 11.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.623 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -53.88 -67.85 0.23 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.449 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.623 ' ND2' HG13 ' A' ' 75' ' ' ILE . 7.2 m-80 -36.26 -53.8 0.82 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.443 -0.785 . . . . 0.0 111.078 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -55.37 -59.49 4.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.931 -1.106 . . . . 0.0 110.176 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.04 -12.43 11.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.347 -0.846 . . . . 0.0 110.675 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -79.31 5.75 11.68 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.861 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.16 45.88 10.23 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.39 114.06 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -1.125 . . . . 0.0 109.868 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.62 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -77.35 108.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.57 ' CD1' HD11 ' A' ' 35' ' ' LEU . 4.9 m95 -46.74 113.63 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.52 179.24 17.24 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.1 -60.49 2.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.277 . . . . 0.0 109.535 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.49 -41.72 98.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.676 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.58 -32.44 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.694 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -78.58 -32.73 47.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.753 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 tpp -60.54 -35.76 76.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -54.07 7.53 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 45.6 t80 -56.13 -26.5 50.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 64' ' ' LEU . 1.1 tp -81.97 -39.54 23.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -59.87 -23.18 63.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 9.3 m120 -168.33 96.22 0.58 Allowed Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.748 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.0 Cg_endo -77.08 -29.91 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.417 2.078 . . . . 0.0 110.44 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -85.29 -31.87 22.83 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.318 -0.863 . . . . 0.0 109.516 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 3.6 mmmt -78.57 -35.29 46.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.001 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 75' ' ' ILE . 22.1 t80 -75.81 -69.05 0.52 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -101.16 117.73 61.68 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 61.37 8.21 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.428 2.086 . . . . 0.0 110.017 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.45 -48.3 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 49' ' ' THR . 7.4 t -50.68 167.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.283 . . . . 0.0 109.847 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -135.48 10.19 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.564 ' HE2' ' HB3' ' A' ' 82' ' ' PHE . 6.8 ptm -76.41 123.33 25.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 mt -97.87 35.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HB3' ' HE2' ' A' ' 80' ' ' MET . 4.4 t80 . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.539 . . . . 0.0 109.888 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.129 0.49 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -52.62 -45.19 66.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 0.0 109.04 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.61 79.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 109.213 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -59.37 -35.9 74.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 91' ' ' ARG . 38.1 mt -58.67 -46.42 87.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.612 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.2 mm -67.85 -49.03 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 0.0 110.039 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.19 -39.19 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.435 -0.79 . . . . 0.0 110.394 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 36.7 t80 -70.51 -50.67 35.4 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.999 -1.063 . . . . 0.0 110.085 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 98' ' ' LEU . 2.3 mm? -72.23 -4.49 29.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -99.49 -20.46 16.41 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.157 -0.964 . . . . 0.0 109.883 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -107.28 -20.08 13.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.647 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.92 -36.34 12.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 110.003 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.414 ' HB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -130.96 47.38 2.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.638 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 10.0 t30 -171.93 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 109.35 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 4' ' ' GLU . 12.7 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.24 0.543 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 3' ' ' VAL . 3.8 mt-10 -64.55 -19.9 65.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 9' ' ' ILE . 9.9 mttt -91.55 -33.26 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.48 -20.55 75.54 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 25.4 ttpt -70.58 -32.98 70.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -1.118 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 11' ' ' ILE . 6.6 mttp -85.46 -31.8 22.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 29.4 mm -57.62 -57.33 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.009 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.784 ' CD2' HD21 ' A' ' 98' ' ' LEU . 20.6 t80 -67.33 -41.65 84.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 108.989 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 8.7 mm -55.85 -18.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 109.108 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 ttt -119.21 -5.89 10.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.94 -62.03 1.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.586 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -126.49 41.92 3.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.028 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -95.45 -1.1 51.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.828 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.17 -35.26 9.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 108.764 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.7 m -99.96 -21.43 15.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.0 m-70 -126.15 80.42 1.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 0.0 109.742 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -79.0 90.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.514 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.7 8.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 110.394 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -164.94 23.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.927 -1.108 . . . . 0.0 109.9 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 22' ' ' LYS . 2.9 tmtp? -100.62 37.47 1.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.133 -0.979 . . . . 0.0 109.199 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.63 -30.45 8.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.19 8.64 40.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -95.32 117.63 30.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.209 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -90.69 172.05 8.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.052 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -160.01 -91.62 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.372 -0.83 . . . . 0.0 108.912 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.457 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 11.5 m -65.2 -59.76 3.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 108.741 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -95.86 153.9 20.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 33.2 Cg_endo -69.49 134.42 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.176 1.917 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 26' ' ' HIS . 6.9 t-20 -46.55 101.4 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.8 41.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 109.911 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -91.33 70.85 6.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.36 19.37 5.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.927 HD21 ' CD1' ' A' ' 59' ' ' TRP . 17.9 tp -53.77 -29.81 41.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.142 . . . . 0.0 109.508 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HB3' ' OD1' ' A' ' 103' ' ' ASN . 14.4 m-85 -69.85 135.56 49.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.29 83.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NH1' HD12 ' A' ' 35' ' ' LEU . 31.2 ttp85 -155.21 123.75 6.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.257 . . . . 0.0 109.599 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -61.7 164.86 5.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.195 -0.94 . . . . 0.0 109.063 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.505 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 5.8 t -101.53 169.6 8.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.515 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.496 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 88.93 67.43 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -161.8 -32.07 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.138 -1.213 . . . . 0.0 110.739 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -36.39 141.15 0.37 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.785 . . . . 0.0 110.331 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 35.5 Cg_endo -77.58 128.21 9.34 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.626 2.217 . . . . 0.0 110.487 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.46 -47.35 3.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -100.5 63.84 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.482 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 m -62.9 95.46 0.08 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 30' ' ' PRO . 1.5 m-30 -50.91 -179.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.756 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.941 HG21 ' C ' ' A' ' 77' ' ' GLY . 3.2 p -59.58 90.37 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.001 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -31.4 -35.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.701 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -39.7 -62.93 0.63 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.713 ' CA ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -38.78 -69.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 110.665 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.461 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 2.3 tmtt? -43.12 -38.97 2.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -66.14 -41.91 89.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 110.488 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HG2' ' CE2' ' A' ' 74' ' ' TYR . 45.4 tptt -50.68 -20.42 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 109.123 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.57 39.47 97.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.758 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -103.88 119.04 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.605 -0.938 . . . . 0.0 110.373 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -82.17 100.78 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.148 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.927 ' CD1' HD21 ' A' ' 35' ' ' LEU . 6.3 m95 -38.81 118.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 111.05 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.13 -159.61 9.61 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -77.41 -63.02 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.11 -1.229 . . . . 0.0 109.735 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.28 -35.79 71.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.172 -0.955 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.51 -46.27 89.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.095 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -70.22 -36.08 74.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.27 45.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.76 -50.07 59.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.51 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 54.3 t80 -54.87 -21.86 12.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.756 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.2 mp -86.73 -38.11 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.369 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.25 -23.51 62.41 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.27 95.04 0.23 Allowed Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.872 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -73.7 -36.34 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.354 2.036 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -70.37 -9.06 55.2 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 108.927 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -91.91 -50.21 5.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -71.89 -64.93 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 52' ' ' ASN . 4.7 mm -91.35 108.93 32.41 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.76 73.15 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.311 2.007 . . . . 0.0 110.291 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.941 ' C ' HG21 ' A' ' 49' ' ' THR . . . 171.34 -28.97 0.11 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.924 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 71' ' ' PRO . 11.1 t -50.4 134.1 23.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.849 -1.383 . . . . 0.0 109.45 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.78 12.0 37.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.582 ' O ' ' HG3' ' A' ' 80' ' ' MET . 5.3 ptm -87.23 123.16 31.94 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.94 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 81' ' ' ILE . 37.4 mm -109.44 36.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.976 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.199 0.523 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -52.51 -42.54 64.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 109.341 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.61 87.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -30.11 70.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.683 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -75.23 -34.39 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.566 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -47.13 81.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 109.947 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -70.16 -44.21 69.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.784 HD21 ' CD2' ' A' ' 10' ' ' PHE . 1.5 mm? -71.38 -7.7 48.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.1 -1.0 . . . . 0.0 109.434 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.08 -16.93 17.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.776 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -104.11 -26.44 12.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 110.14 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.7 -45.74 9.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.146 -0.971 . . . . 0.0 110.295 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.2 38.51 3.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.699 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 36' ' ' PHE . 1.2 t30 -176.41 61.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.616 HG22 ' HD2' ' A' ' 7' ' ' LYS . 6.5 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.0 tm-20 -59.06 -24.36 62.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.383 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.2 tptm -75.12 -53.44 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 97' ' ' TYR . . . -72.18 -67.66 1.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.616 ' HD2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -39.66 -35.27 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.44 -1.035 . . . . 0.0 110.305 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.55 -44.29 57.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 0.0 109.53 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -72.42 -65.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.705 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 98' ' ' LEU . 18.3 t80 -46.05 -40.83 11.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.726 -1.234 . . . . 0.0 109.803 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' SER . 6.9 mm -62.05 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.023 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -107.51 20.12 19.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.129 -0.982 . . . . 0.0 109.842 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -126.96 -61.33 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.772 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 1.9 m -113.3 5.07 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 0.0 110.161 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -88.79 27.23 1.35 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.809 -1.182 . . . . 0.0 109.244 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.32 -61.08 1.46 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 28' ' ' THR . 5.3 m -80.02 -30.83 39.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.653 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 66.4 m-70 -102.18 173.56 6.32 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.044 0.926 . . . . 0.0 109.46 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 18' ' ' HIS . 20.9 p -161.85 92.77 0.87 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.5 m -84.14 34.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.78 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.416 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 tptt -101.23 35.89 2.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.85 -35.28 4.03 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.76 0.18 6.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 137.92 37.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.554 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -120.04 102.53 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.01 . . . . 0.0 110.475 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.72 -74.58 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.759 HG21 ' SG ' ' A' ' 17' ' ' CYS . 66.4 m -89.77 -99.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 28' ' ' THR . . . -51.73 150.62 7.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.4 Cg_endo -69.81 156.67 62.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 111.417 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.554 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -63.26 102.1 0.36 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.538 HD13 ' ND1' ' A' ' 18' ' ' HIS . 3.7 mp -79.05 71.17 5.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 109.997 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t60 -100.51 -57.71 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.044 . . . . 0.0 109.013 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -111.24 23.1 19.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.3 tt -44.25 -36.02 2.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -1.082 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 4.4 m-30 -65.81 142.1 58.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.371 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 15.28 61.47 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 5.4 tmm_? -136.76 142.77 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -1.152 . . . . 0.0 109.589 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -82.07 -171.54 3.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -92.92 -176.73 4.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.873 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' H ' HG22 ' A' ' 40' ' ' THR . . . 51.09 101.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 43' ' ' ALA . 2.2 tp60 -157.92 -77.1 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.238 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -40.84 136.51 1.53 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.966 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.59 152.27 29.45 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.707 2.271 . . . . 0.0 110.265 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.63 -53.03 4.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.7 OUTLIER -99.35 69.86 1.7 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.421 -1.046 . . . . 0.0 108.621 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 p -67.8 97.72 0.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 30' ' ' PRO . 1.4 m-30 -53.52 -175.72 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.769 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 49' ' ' THR . 3.3 t -60.9 88.02 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -36.84 -32.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.313 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.637 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -45.13 -63.03 1.02 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.718 -0.613 . . . . 0.0 109.464 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.75 -52.99 6.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.973 . . . . 0.0 109.404 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -50.52 -42.32 54.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 109.664 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.56 -42.83 99.79 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.865 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -49.71 -21.13 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.049 -1.032 . . . . 0.0 109.272 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.3 46.48 78.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -104.05 123.12 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.531 -0.982 . . . . 0.0 110.249 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -87.71 100.9 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 7.4 m95 -40.2 116.72 0.7 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.825 0.822 . . . . 0.0 110.82 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -148.19 -154.09 6.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -77.68 -74.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.262 . . . . 0.0 109.588 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.45 -34.72 78.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 110.301 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.992 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -64.42 -56.13 16.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.274 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -64.94 -21.88 66.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 19.9 ttt -67.14 -32.66 73.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.315 -0.865 . . . . 0.0 109.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -54.42 6.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.412 -0.805 . . . . 0.0 109.794 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.667 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 4.9 t80 -54.99 -36.89 65.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.926 -1.109 . . . . 0.0 109.168 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.679 ' CD2' HD13 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -77.68 -27.85 50.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.36 -26.66 65.25 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.28 101.95 0.24 Allowed Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.586 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.6 Cg_endo -74.56 -27.09 11.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.372 2.048 . . . . 0.0 109.838 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -78.27 -19.33 53.88 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.598 -0.689 . . . . 0.0 109.371 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.578 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -97.53 -29.92 13.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.024 -1.048 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' HD2' HD11 ' A' ' 75' ' ' ILE . 3.7 t80 -80.81 -70.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 51' ' ' ALA . 1.6 mm -85.63 119.2 71.88 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.4 Cg_endo -73.25 82.83 1.54 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 110.482 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 113.02 26.24 4.16 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.7 t -43.99 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.039 -1.271 . . . . 0.0 109.293 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 10.6 mmtm -93.9 0.75 56.32 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.783 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.563 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 2.5 ptt? -118.1 119.31 34.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.07 -1.019 . . . . 0.0 109.727 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.4 mm -89.51 49.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.286 -0.883 . . . . 0.0 108.919 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.563 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 35.1 t80 . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.371 -0.831 . . . . 0.0 109.183 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.206 0.526 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.73 -39.04 57.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.584 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -70.29 -38.6 75.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -66.43 -28.89 68.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 68' ' ' LEU . 89.0 mt -73.82 -62.04 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.159 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.564 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.2 mm -61.06 -30.42 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -62.56 -48.85 77.69 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 110.35 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.65 ' HD2' HD22 ' A' ' 98' ' ' LEU . 61.3 t80 -63.53 -47.47 81.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.034 -1.042 . . . . 0.0 110.442 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 10' ' ' PHE . 2.5 mm? -63.25 -29.2 70.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.596 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -66.27 -36.8 83.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.023 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.27 -18.48 36.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.95 47.08 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.907 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 103' ' ' ASN . 6.7 t -132.85 -43.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.067 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' N ' HG23 ' A' ' 102' ' ' THR . 7.2 t-20 -63.43 -11.83 26.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 0.0 109.546 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.266 0.555 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -76.23 -31.23 58.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.651 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.7 tppt? -73.14 -55.37 6.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.73 97.45 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 3.3 ttpm? -65.06 -18.82 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -40.7 54.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.017 HG22 HD21 ' A' ' 94' ' ' LEU . 2.9 mp -67.26 -60.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' SER . 38.9 t80 -52.03 -44.78 64.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.115 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 20.2 mt -56.68 -38.01 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 24.8 12.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.043 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -130.23 -62.31 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.285 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -120.6 26.43 9.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.206 -0.934 . . . . 0.0 108.81 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 3.0 t -82.81 4.73 24.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 3.6 tp-100 -99.83 -54.52 2.89 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 108.712 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 44.7 m -83.21 -22.26 33.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -123.31 89.34 3.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.894 . . . . 0.0 109.861 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -93.42 96.28 9.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.96 -1.087 . . . . 0.0 108.806 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.2 m -85.29 31.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.384 -0.823 . . . . 0.0 109.941 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.98 7.19 2.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.017 -1.052 . . . . 0.0 109.708 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -149.47 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.01 36.73 3.92 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.16 80.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.94 159.16 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -141.04 140.77 34.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 -60.88 1.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 HG21 ' SG ' ' A' ' 17' ' ' CYS . 85.0 m -100.17 -61.28 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -93.49 156.29 22.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 29.9 Cg_endo -66.77 135.78 39.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.62 2.213 . . . . 0.0 111.335 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.62 103.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 109.534 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.35 46.1 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.436 ' HA ' HG21 ' A' ' 102' ' ' THR . 54.5 t-80 -96.06 69.34 2.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 108.822 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.661 ' N ' HG21 ' A' ' 102' ' ' THR . . . 117.98 16.33 5.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.547 HD12 ' NH1' ' A' ' 38' ' ' ARG . 23.0 tp -52.58 -30.69 32.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.507 -0.996 . . . . 0.0 109.872 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 3.3 m-85 -60.9 141.04 57.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.443 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.34 70.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.547 ' NH1' HD12 ' A' ' 35' ' ' LEU . 3.4 tmm_? -135.28 125.63 26.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -1.128 . . . . 0.0 109.382 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 19.1 mttp -72.3 173.39 8.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -74.05 170.26 15.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.738 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.03 108.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.456 ' HG2' ' HD3' ' A' ' 38' ' ' ARG . 1.8 tp60 -160.95 -63.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.976 -1.308 . . . . 0.0 109.91 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -41.75 150.63 0.35 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.266 -0.896 . . . . 0.0 109.906 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.4 -75.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.836 2.357 . . . . 0.0 110.587 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.72 66.02 3.96 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.639 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.58 120.97 2.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 108.998 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.545 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 40.4 t -84.07 70.55 10.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.9 m-85 -44.69 179.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.701 -0.625 . . . . 0.0 110.174 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.852 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -57.79 88.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 108.886 179.407 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.54 -41.4 66.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -51.48 -70.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 108.77 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 75' ' ' ILE . 2.7 m-20 -40.28 -47.28 2.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 110.062 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.95 -57.25 6.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.28 -33.62 75.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.533 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -14.07 6.3 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.114 -0.992 . . . . 0.0 109.824 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 40.81 97.02 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -95.29 133.34 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 0.0 110.034 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.942 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -94.54 112.48 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.617 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 10.0 m95 -54.17 101.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 110.245 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.46 -164.88 12.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -73.97 -67.67 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.01 89.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.872 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.67 -36.31 76.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.7 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -80.24 -27.28 38.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttt -57.03 -47.03 81.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 0.0 109.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.32 -51.56 20.12 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.378 -0.827 . . . . 0.0 109.823 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.617 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 51.9 t80 -54.09 -22.7 11.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 109.664 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.6 tp -90.35 -29.77 17.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.0 109.178 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.75 -24.75 65.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -175.75 102.27 0.25 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.563 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.7 Cg_endo -76.61 -37.47 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.35 2.033 . . . . 0.0 110.258 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -75.13 -17.82 60.34 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.334 -0.853 . . . . 0.0 110.266 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -94.39 -37.65 11.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.856 -1.152 . . . . 0.0 109.581 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.675 ' CE2' HD11 ' A' ' 75' ' ' ILE . 1.9 t80 -76.6 -66.06 0.86 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.869 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.768 HG22 ' CB ' ' A' ' 51' ' ' ALA . 8.1 mm -101.06 106.47 44.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.362 -0.836 . . . . 0.0 109.532 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.86 71.18 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.391 2.06 . . . . 0.0 110.024 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.687 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -173.42 -42.12 0.04 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' HG23 ' A' ' 49' ' ' THR . 14.6 t -43.49 158.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 3.69 21.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.489 -0.757 . . . . 0.0 109.411 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.58 ' O ' ' HG3' ' A' ' 80' ' ' MET . 9.8 ptm -92.87 118.14 30.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.992 . . . . 0.0 109.934 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mm -92.66 48.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 15.3 t80 . . . . . 0 C--N 1.301 -1.5 0 CA-C-O 121.514 0.673 . . . . 0.0 110.173 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.245 0.545 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.8 ttp180 -56.6 -45.43 81.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.96 -49.38 70.54 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.235 -0.916 . . . . 0.0 109.596 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' HB3' HD13 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -59.72 -21.43 60.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.767 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.017 HD21 HG22 ' A' ' 9' ' ' ILE . 22.2 mt -72.68 -59.64 2.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -56.57 -49.79 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.403 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.94 70.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.611 -0.68 . . . . 0.0 109.633 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 4.5 t80 -53.07 -49.82 65.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.255 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 102' ' ' THR . 1.1 mt -82.65 -12.97 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 1.3 ttmt -79.34 -10.94 59.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.169 -0.957 . . . . 0.0 108.906 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -110.55 -40.06 4.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.91 -55.6 4.86 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.263 -0.898 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.661 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -99.56 30.48 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 9.3 t-20 -165.01 64.85 0.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.389 179.784 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.214 0.53 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -67.15 -40.34 86.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -49.67 -34.77 21.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -57.83 -45.11 86.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -1.138 . . . . 0.0 109.737 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.62 -27.58 60.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.636 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' A' ' 6' ' ' GLY . 51.1 mt -60.25 -53.8 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 6.9 t80 -73.76 -46.6 44.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.257 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.474 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 22.7 mm -56.42 -16.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -120.73 -6.66 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 15.8 tppt? -101.98 -65.81 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 109.858 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -112.04 29.4 7.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.8 t -89.9 -1.15 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.733 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -94.78 -35.6 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.241 -0.912 . . . . 0.0 108.724 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 16.9 m -103.43 -26.28 12.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.045 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.4 m-70 -117.51 78.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.035 -1.041 . . . . 0.0 109.649 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.1 p -78.66 94.8 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.178 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 20' ' ' VAL . 1.6 m -82.16 22.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 0.0 110.519 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -151.21 20.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.902 -1.124 . . . . 0.0 109.467 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.48 -17.97 27.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.65 -27.1 3.11 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.56 -0.94 3.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -88.34 164.68 15.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.076 -1.25 . . . . 0.0 109.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.573 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.994 -1.066 . . . . 0.0 110.234 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -71.02 -75.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 108.867 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 93.7 m -99.81 -58.89 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 108.713 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -83.2 155.53 32.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -67.88 143.36 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.498 2.132 . . . . 0.0 111.048 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.4 t-20 -56.25 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 110.075 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.045 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -85.02 55.44 3.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.403 -0.81 . . . . 0.0 109.826 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -96.99 48.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.269 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.43 62.26 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.4 tp -79.91 -31.22 40.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.395 -1.062 . . . . 0.0 109.872 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -60.32 137.21 58.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.047 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.4 27.98 73.08 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 58.1 ttp85 -139.96 123.59 17.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.983 -1.304 . . . . 0.0 109.742 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.524 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -64.45 175.59 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.156 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.466 HG21 ' N ' ' A' ' 53' ' ' LYS . 7.5 t -94.81 -173.92 3.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.11 -0.994 . . . . 0.0 109.82 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 91.61 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.637 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 2.2 pm0 -159.44 -36.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.182 -1.187 . . . . 0.0 109.807 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -70.17 137.4 86.88 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 109.566 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.35 173.98 12.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.45 2.1 . . . . 0.0 110.359 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.37 5.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -145.61 121.19 10.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.11 . . . . 0.0 109.12 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -85.04 66.16 9.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.9 m-85 -43.97 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.722 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -67.28 86.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -44.22 -34.97 2.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.17 -59.99 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.62 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 19.4 t-20 -52.85 -52.97 55.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.466 ' N ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.85 -33.44 7.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.318 -0.864 . . . . 0.0 109.297 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -77.87 -35.71 50.62 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.383 -0.823 . . . . 0.0 109.772 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -61.11 -11.96 10.59 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.072 -1.018 . . . . 0.0 109.574 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.98 35.93 78.53 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.51 125.45 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.667 -0.902 . . . . 0.0 110.324 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.834 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -87.15 95.33 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 5.3 m95 -34.87 121.79 0.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -142.87 -166.51 11.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -73.91 -65.26 0.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -1.201 . . . . 0.0 109.779 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -60.45 -38.83 85.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.946 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.33 -36.46 75.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 109.303 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -76.24 -24.09 54.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.172 -0.955 . . . . 0.0 109.347 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -42.02 78.49 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.19 -50.94 13.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 75' ' ' ILE . 23.6 t80 -49.72 -44.99 48.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.379 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -73.59 -32.15 63.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -25.8 63.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -174.58 84.11 0.34 Allowed Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 33.0 Cg_endo -76.4 -22.13 12.72 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.645 2.23 . . . . 0.0 109.354 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -75.59 -16.56 60.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -101.45 -38.69 7.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.457 -0.777 . . . . 0.0 109.239 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.57 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.4 t80 -73.47 -66.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.912 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.3 mm -97.53 106.72 34.77 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -77.75 83.46 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.259 1.973 . . . . 0.0 110.595 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 149.91 -14.37 1.02 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.695 ' HA ' HG23 ' A' ' 49' ' ' THR . 8.1 t -43.68 132.38 4.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.239 . . . . 0.0 109.908 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 23.8 4.37 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.3 mmm -59.17 125.4 23.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.753 -0.592 . . . . 0.0 109.81 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 81' ' ' ILE . 38.5 mm -89.09 17.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.611 -0.681 . . . . 0.0 109.929 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.341 0.591 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -67.86 -51.84 43.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.89 80.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 109.237 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 9' ' ' ILE . 96.1 m-20 -60.48 -28.96 68.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.384 -0.823 . . . . 0.0 109.592 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 18.0 mt -65.05 -51.92 58.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.566 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -59.59 -37.59 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.58 99.63 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.582 -0.699 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -66.1 -46.63 76.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.086 -1.009 . . . . 0.0 109.673 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' A' ' 97' ' ' TYR . 2.0 mm? -72.89 -15.21 61.59 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 2.0 ttpt -76.81 -32.95 57.97 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -38.83 13.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.891 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.43 -56.77 6.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.64 35.85 4.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.25 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -160.77 47.43 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.698 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.344 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.77 -41.47 37.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -40.65 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.928 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -67.11 -50.86 42.91 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -56.39 -27.2 55.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -79.25 -33.84 43.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 0.0 109.216 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.928 HD12 ' HA2' ' A' ' 6' ' ' GLY . 12.7 mt -60.98 -57.1 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 15' ' ' SER . 8.3 t80 -59.59 -46.24 89.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.093 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 15.1 mm -57.81 -22.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.807 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 ttt -122.31 10.75 9.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 22.4 tptt -122.94 -56.52 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.072 . . . . 0.0 109.591 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -118.47 22.0 12.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -84.96 2.86 41.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.986 . . . . 0.0 109.597 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -100.11 -41.66 7.05 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.871 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.468 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 13.1 m -95.18 -26.36 16.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.973 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.9 m-70 -115.09 81.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -0.891 . . . . 0.0 109.808 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 p -78.69 83.27 4.86 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.083 -1.01 . . . . 0.0 108.553 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -82.78 45.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.169 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -165.96 24.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.003 -1.06 . . . . 0.0 109.785 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 25' ' ' LYS . 42.7 tttp -100.22 -73.22 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.48 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.95 52.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 4.98 51.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 9.3 tppt? -91.21 144.86 25.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 109.213 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.435 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -133.04 114.88 14.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.901 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.92 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.328 -0.857 . . . . 0.0 109.28 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -99.9 -47.65 4.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.229 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -84.27 153.4 29.08 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 30.6 Cg_endo -68.74 133.53 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.672 2.248 . . . . 0.0 111.256 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.4 t-20 -50.92 99.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.47 0.652 . . . . 0.0 109.59 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.973 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -80.93 70.87 7.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 109.78 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 28.1 p-80 -100.59 -48.99 4.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 109.901 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 33' ' ' HIS . . . -120.96 30.78 5.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.58 -40.09 8.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -1.193 . . . . 0.0 109.043 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 65.0 m-85 -68.61 147.44 51.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.29 17.59 11.95 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NH1' ' HB3' ' A' ' 42' ' ' GLN . 7.3 ttp85 -147.2 116.08 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -1.211 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -59.39 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 108.94 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.615 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -79.53 -164.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.614 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 53' ' ' LYS . . . 53.99 101.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -154.45 -30.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.24 . . . . 0.0 110.558 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -95.38 135.93 22.9 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.719 -1.238 . . . . 0.0 109.552 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.0 Cg_endo -78.89 136.96 13.62 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.607 2.204 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.29 -24.45 13.8 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.525 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -99.2 108.63 21.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -1.053 . . . . 0.0 108.673 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -76.18 80.17 2.98 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 1.8 m-85 -47.96 -179.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.655 -0.653 . . . . 0.0 109.242 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.1 OUTLIER -58.19 88.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.13 -37.31 61.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.459 -0.776 . . . . 0.0 109.707 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.022 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -59.15 -46.29 88.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.586 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.849 ' HA ' HD12 ' A' ' 75' ' ' ILE . 21.9 t-20 -64.37 -54.55 31.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.041 . . . . 0.0 110.008 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CD ' ' HA3' ' A' ' 41' ' ' GLY . 6.2 tttt -50.81 -38.24 47.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.104 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -81.32 -24.1 37.38 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.621 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -65.31 -10.42 32.49 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.141 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.24 63.99 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.07 121.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -1.117 . . . . 0.0 110.256 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -84.66 99.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 m95 -37.82 110.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.606 0.717 . . . . 0.0 110.839 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -129.76 -168.16 12.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.91 -57.22 4.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -1.183 . . . . 0.0 109.877 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.14 -42.18 80.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.291 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.606 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -58.6 -38.39 77.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.999 -1.063 . . . . 0.0 109.286 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -71.59 -33.34 68.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 108.82 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.0 ttp -54.04 -38.22 64.96 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.408 -0.807 . . . . 0.0 109.317 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.95 -57.02 4.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 39.1 t80 -49.16 -31.27 8.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.1 mp -81.83 -38.14 25.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.052 -1.03 . . . . 0.0 109.266 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -59.08 -22.69 61.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.8 p30 -179.6 99.0 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.653 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.7 Cg_endo -74.22 -33.72 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.403 2.069 . . . . 0.0 110.257 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -13.99 60.26 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.896 . . . . 0.0 108.933 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 2.8 tptm -92.71 -45.11 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.536 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.5 t80 -72.2 -67.59 0.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.022 HG22 ' HB3' ' A' ' 51' ' ' ALA . 18.3 mm -95.74 107.48 34.08 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.57 78.12 3.63 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.244 1.963 . . . . 0.0 110.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 164.8 -23.09 0.15 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.7 t -43.63 155.49 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.008 -1.289 . . . . 0.0 109.768 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -111.04 8.49 21.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.012 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 80' ' ' MET . 5.7 ptm -96.4 118.05 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.94 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.1 mm -84.03 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.484 -0.76 . . . . 0.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.497 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 9.6 t80 . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 108.984 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -56.66 8.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 109.635 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.51 30.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.25 -42.31 99.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -0.809 . . . . 0.0 110.126 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' GLU . 6.5 mt -56.25 -44.92 80.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.553 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -65.83 -42.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.67 16.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.687 . . . . 0.0 110.004 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 20.8 t80 -73.85 -46.28 45.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.07 -1.019 . . . . 0.0 109.425 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -71.4 -4.38 26.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.321 -0.862 . . . . 0.0 109.812 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.9 -46.61 8.08 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -79.45 -33.64 42.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.472 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.81 19.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 19.3 p -104.03 -37.85 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.959 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 16.0 t30 -85.05 19.43 2.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 10.0 tt0 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.07 . . . . 0.0 109.477 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.173 0.511 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -62.28 -44.07 97.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.612 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -71.52 -32.77 68.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.775 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -56.57 19.17 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 7.5 ttmt -54.8 -26.58 35.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.302 -1.117 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.7 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.78 -36.19 65.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.296 -0.878 . . . . 0.0 108.909 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 43.4 mm -58.21 -59.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 108.718 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.653 ' CE2' HD21 ' A' ' 98' ' ' LEU . 30.6 t80 -58.66 -41.3 85.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 109.099 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -54.26 -30.97 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.112 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 ttt -114.88 7.32 15.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.245 -0.909 . . . . 0.0 110.954 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.21 -61.33 1.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.214 . . . . 0.0 110.275 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -127.44 24.71 6.2 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.065 . . . . 0.0 109.78 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 38.7 t -88.2 2.65 51.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.139 . . . . 0.0 109.824 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -100.59 -55.11 2.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.0 m -81.0 -25.52 37.19 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.038 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -119.39 89.49 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.106 -0.996 . . . . 0.0 109.766 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.7 p -78.43 83.64 4.64 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -80.9 36.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.457 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -161.6 21.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.072 -1.017 . . . . 0.0 109.244 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -73.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.88 55.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.5 18.52 67.88 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.63 132.28 45.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -1.21 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.545 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -127.09 101.04 6.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 110.069 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -70.0 -63.71 1.03 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.604 HG21 ' SG ' ' A' ' 17' ' ' CYS . 20.4 m -104.69 -76.76 0.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -71.26 159.34 53.85 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.9 Cg_endo -68.99 142.89 52.66 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.447 2.098 . . . . 0.0 110.901 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -58.86 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.833 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -81.68 73.65 8.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.459 -0.776 . . . . 0.0 109.825 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.74 -62.94 1.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.26 28.03 11.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD11 ' CD1' ' A' ' 59' ' ' TRP . 47.9 tp -49.66 -26.37 3.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -1.059 . . . . 0.0 109.835 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.622 ' CD1' HG21 ' A' ' 102' ' ' THR . 13.1 m-85 -72.78 130.92 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.24 79.64 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' NH2' HD12 ' A' ' 35' ' ' LEU . 7.1 ttp85 -133.97 126.99 31.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.136 -1.214 . . . . 0.0 109.667 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -61.82 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.722 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -97.55 -179.31 4.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -0.928 . . . . 0.0 109.769 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.44 97.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.724 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 4.1 pm0 -160.74 -33.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.986 -1.302 . . . . 0.0 110.455 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.21 138.49 96.04 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.973 -1.079 . . . . 0.0 109.601 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.45 -34.4 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.63 2.22 . . . . 0.0 110.676 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.93 49.08 1.04 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CG ' ' CD1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -160.21 128.37 4.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.027 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -86.29 54.24 3.08 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.724 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.1 m-85 -31.59 149.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.29 0.567 . . . . 0.0 110.19 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -58.76 90.76 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.6 -34.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.275 0.559 . . . . 0.0 109.556 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -56.03 -64.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.476 -0.765 . . . . 0.0 109.495 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 1.091 ' OD1' HG21 ' A' ' 75' ' ' ILE . 3.6 m120 -36.52 -40.29 0.24 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -47.12 63.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.63 -17.13 63.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -66.45 -7.09 17.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.47 49.29 33.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.791 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -116.53 145.15 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.775 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -100.93 96.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.722 ' NE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -40.91 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.419 -0.8 . . . . 0.0 110.492 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -123.22 -153.88 8.87 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.852 ' HG2' HG21 ' A' ' 95' ' ' ILE . 2.0 mt-10 -76.13 -70.83 0.42 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -1.129 . . . . 0.0 109.724 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -37.36 86.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.791 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.37 -49.17 78.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.091 -1.006 . . . . 0.0 109.511 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -67.51 -31.96 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.181 -0.949 . . . . 0.0 109.382 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -31.87 66.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -77.91 -54.95 5.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.703 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 5.4 t80 -57.98 -19.7 32.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -93.25 -34.47 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.912 -1.117 . . . . 0.0 109.842 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -58.84 -24.86 62.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 20.4 t-20 -170.6 95.67 0.45 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -74.59 -40.58 1.02 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.352 2.034 . . . . 0.0 110.257 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -8.11 41.1 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.274 -0.892 . . . . 0.0 108.922 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -104.05 -34.53 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.429 -0.794 . . . . 0.0 109.251 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -76.52 -70.0 0.48 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.543 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.091 HG21 ' OD1' ' A' ' 52' ' ' ASN . 2.7 mm -86.05 117.11 68.13 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.76 81.36 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.264 1.976 . . . . 0.0 110.742 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.7 -4.26 2.71 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.452 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.617 ' HA ' HG21 ' A' ' 49' ' ' THR . 15.2 t -54.21 163.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.784 -1.421 . . . . 0.0 109.546 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.11 21.18 7.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -58.77 109.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.04 43.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.58 ' HB3' ' HE3' ' A' ' 80' ' ' MET . 11.2 t80 . . . . . 0 N--CA 1.488 1.429 0 O-C-N 121.724 -0.61 . . . . 0.0 110.542 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.288 0.566 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -54.33 -40.8 68.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.703 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.2 96.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.914 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -34.34 75.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.028 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 91' ' ' ARG . 92.7 mt -60.83 -51.5 69.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.852 HG21 ' HG2' ' A' ' 61' ' ' GLU . 4.6 mm -67.38 -36.78 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.38 57.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.607 -0.683 . . . . 0.0 110.129 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -73.47 -43.32 60.46 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.998 -1.064 . . . . 0.0 109.948 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.653 HD21 ' CE2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -67.15 -7.22 21.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.953 . . . . 0.0 109.977 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 1.8 ttpt -96.01 -36.17 11.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.646 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 9.3 tttm -81.14 -31.63 34.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.11 2.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.21 -0.932 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 36' ' ' PHE . 6.4 t -102.41 25.27 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.054 -1.029 . . . . 0.0 110.422 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -160.94 61.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.959 -1.088 . . . . 0.0 109.533 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HG3' ' HG3' ' A' ' 100' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.282 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -48.3 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.315 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.659 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -57.09 -35.6 70.34 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.529 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -66.42 -44.37 83.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -1.068 . . . . 0.0 109.387 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -26.23 68.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.659 HD12 ' HA2' ' A' ' 6' ' ' GLY . 7.1 mt -73.53 -66.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 20' ' ' VAL . 45.3 t80 -55.68 -25.26 38.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 108.988 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 7' ' ' LYS . 7.4 mt -70.9 -40.38 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.847 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.5 ptm -107.34 18.1 22.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.593 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -120.58 -62.54 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.967 . . . . 0.0 109.536 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 30.01 6.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.122 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 1.3 t -86.1 7.34 25.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -100.98 -54.31 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 3.2 m -84.41 -32.52 24.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.875 ' ND1' HD22 ' A' ' 32' ' ' LEU . 63.2 m-70 -114.15 93.34 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.11 -0.994 . . . . 0.0 109.992 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.6 p -91.3 97.25 10.99 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.872 -1.142 . . . . 0.0 108.559 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -83.97 47.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 110.061 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 3.0 mt-10 -173.34 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.921 -1.112 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 0.56 39.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.549 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.13 -10.46 40.03 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.1 10.86 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -89.82 160.46 16.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -1.18 . . . . 0.0 109.365 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -138.44 167.9 20.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -141.37 -87.04 0.17 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.523 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 38.1 m -94.47 -25.03 17.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 108.98 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -115.6 150.49 18.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.682 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.7 Cg_endo -65.98 131.76 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.444 2.096 . . . . 0.0 111.031 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -49.98 101.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.49 -0.756 . . . . 0.0 110.198 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.875 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.01 63.41 6.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 109.717 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.731 ' O ' HG22 ' A' ' 102' ' ' THR . 2.2 t60 -94.25 -21.46 19.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.997 . . . . 0.0 109.993 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 38' ' ' ARG . . . -156.19 22.73 0.51 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 59' ' ' TRP . 5.8 tt -41.61 -35.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -1.053 . . . . 0.0 110.288 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' HD1' HD23 ' A' ' 35' ' ' LEU . 4.3 m-30 -70.36 131.7 44.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.129 -0.982 . . . . 0.0 110.545 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.02 -13.03 64.28 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -126.71 151.87 47.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.897 -1.355 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 177.83 6.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.818 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 1.019 HG21 ' HB3' ' A' ' 52' ' ' ASN . 2.6 p -64.5 -164.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.29 94.0 0.01 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -152.25 -47.27 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -1.148 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -80.31 142.75 55.01 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -78.64 -90.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.691 2.26 . . . . 0.0 110.941 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.42 -33.02 0.83 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.61 111.44 18.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -1.109 . . . . 0.0 109.067 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 1.6 p -77.37 78.32 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-85 -46.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 109.668 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.66 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 109.208 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.61 -42.93 68.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -54.16 -73.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' THR . 1.9 m-20 -35.45 -40.97 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.137 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 50' ' ' ALA . 6.0 ttpp -55.36 -59.17 5.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.883 . . . . 0.0 110.049 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -64.08 -20.66 66.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.79 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -65.36 -8.16 17.13 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.64 45.47 59.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.37 117.48 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -1.014 . . . . 0.0 109.979 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -84.46 111.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.852 ' HE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -50.26 101.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.944 -1.097 . . . . 0.0 110.271 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -122.41 -167.63 13.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' OE2' ' CG2' ' A' ' 95' ' ' ILE . 19.7 mm-40 -65.47 -74.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -62.95 -35.11 79.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 110.268 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.47 -42.87 93.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.671 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.689 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -73.42 -33.79 65.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 35.7 tpp -59.11 -27.32 65.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.171 -0.956 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.41 -64.48 1.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.881 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.636 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 28.5 t80 -49.08 -28.26 4.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.956 . . . . 0.0 109.996 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -85.84 -32.79 21.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' MET . 4.0 tt0 -59.42 -24.7 63.71 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 6.8 t-20 -177.25 88.69 0.25 Allowed Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -73.82 -36.53 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.32 -17.21 64.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.061 -1.024 . . . . 0.0 108.363 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 2.4 ttmt -99.57 -25.76 14.32 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -88.0 -70.26 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.249 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.746 HG21 ' N ' ' A' ' 52' ' ' ASN . 2.6 mm -99.52 106.66 41.09 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.366 -0.834 . . . . 0.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.98 83.76 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.374 2.049 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 158.42 -30.31 0.46 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.552 ' HA ' HG23 ' A' ' 49' ' ' THR . 10.0 t -44.39 160.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.955 -1.32 . . . . 0.0 109.785 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 15.98 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.401 ' HG3' ' OH ' ' A' ' 67' ' ' TYR . 7.6 mmm -59.2 118.31 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 tp -92.32 18.83 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.411 0.624 . . . . 0.0 110.133 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.209 0.528 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -62.15 -38.16 87.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.812 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.6 71.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.31 -25.58 67.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 9' ' ' ILE . 29.2 mt -69.75 -52.5 24.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.722 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.3 mm -62.26 -47.76 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.928 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.76 71.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.79 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.51 ' CD2' HD22 ' A' ' 98' ' ' LEU . 33.3 t80 -61.74 -44.63 96.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 ' OG1' ' A' ' 102' ' ' THR . 4.0 mm? -81.95 -2.7 52.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 1.6 tmmt? -97.0 -13.83 22.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.162 -0.961 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -119.97 -39.9 2.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.56 -32.78 60.52 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.28 -0.888 . . . . 0.0 110.387 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -127.87 23.19 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.05 -1.031 . . . . 0.0 110.321 -179.357 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' C ' ' A' ' 99' ' ' LYS . 4.1 t-20 -149.34 14.45 0.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.023 -1.048 . . . . 0.0 109.818 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.268 0.556 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.5 -12.81 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.853 . . . . 0.0 109.942 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' O ' HG12 ' A' ' 9' ' ' ILE . 23.7 mttt -91.88 -54.31 3.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.091 -1.006 . . . . 0.0 109.848 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.59 -30.18 55.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -70.32 -46.7 63.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -1.109 . . . . 0.0 109.728 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -70.48 -18.98 62.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.7 mm -73.18 -64.6 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 108.792 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 98' ' ' LEU . 11.5 t80 -49.23 -42.34 40.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 108.621 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 55.3 mt -56.23 -42.41 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.01 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' A' ' 12' ' ' MET . 3.3 ppp? -107.12 20.06 19.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.49 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.49 -54.59 1.77 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.738 -1.226 . . . . 0.0 109.866 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -133.89 25.65 3.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.136 -0.977 . . . . 0.0 109.468 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.6 t -80.12 3.39 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -56.87 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.345 -0.847 . . . . 0.0 108.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.486 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 23.1 m -82.14 -17.9 44.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.415 -0.803 . . . . 0.0 109.13 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.033 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.3 m-70 -125.15 84.03 2.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.795 -1.191 . . . . 0.0 110.239 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 15.7 p -79.29 81.53 5.54 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.52 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 4.1 m -79.84 12.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -137.0 24.33 3.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 0.0 109.867 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.7 tmtt? -98.96 -46.98 5.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.567 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.49 67.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.4 22.53 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' CB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 tptt -98.8 140.64 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 0.0 109.588 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -140.17 128.61 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.436 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -72.5 0.72 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -53.94 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.407 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -91.4 160.22 26.69 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 35.1 Cg_endo -70.53 134.36 26.2 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.367 2.045 . . . . 0.0 110.54 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 11.7 t-20 -48.27 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.033 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.32 43.59 0.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.421 -0.799 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' VAL . 2.0 t-160 -98.62 77.82 2.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -0.975 . . . . 0.0 108.827 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' HG21 ' A' ' 102' ' ' THR . . . 115.03 15.86 7.61 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -54.2 -30.53 50.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.422 -1.046 . . . . 0.0 109.727 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.4 m-85 -65.3 143.15 57.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.905 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.54 13.62 61.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 40.4 ttp85 -138.52 129.91 27.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -1.131 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -74.39 174.43 8.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -71.94 175.7 5.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.715 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.51 94.94 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' HD2' ' A' ' 38' ' ' ARG . 1.4 tp60 -150.14 -73.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.32 141.25 2.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.7 Cg_endo -79.72 -92.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.691 2.261 . . . . 0.0 111.425 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.38 -29.99 0.76 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -79.78 113.01 17.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -1.057 . . . . 0.0 108.991 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -77.98 77.93 4.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-30 -46.09 178.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.608 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.846 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.71 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -43.66 -42.72 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -54.39 -70.54 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.884 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.725 ' HB3' HG21 ' A' ' 40' ' ' THR . 3.2 m-80 -38.92 -40.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 110.408 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -57.41 -70.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.197 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.45 -10.56 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.333 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -66.03 -7.64 18.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.83 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.14 50.66 33.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.83 118.79 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -1.059 . . . . 0.0 109.727 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.77 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -78.33 121.35 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.023 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.77 ' N ' HD13 ' A' ' 58' ' ' ILE . 9.0 m95 -64.99 95.08 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.272 -0.892 . . . . 0.0 110.007 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -115.5 -170.7 16.22 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 6.3 mt-10 -68.61 -68.39 0.4 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.089 -1.242 . . . . 0.0 109.69 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.03 -37.22 86.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.882 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.46 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.63 -49.03 79.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.074 -1.016 . . . . 0.0 109.315 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.682 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.2 tt -63.47 -32.61 74.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 109.311 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.1 ttp -56.27 -40.87 74.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.379 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.58 -54.91 13.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.318 -0.864 . . . . 0.0 109.78 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.688 ' CE1' ' ND2' ' A' ' 52' ' ' ASN . 86.4 t80 -49.18 -34.08 13.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.682 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -76.3 -37.01 58.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 109.472 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.37 -23.31 62.45 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -170.41 93.0 0.48 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HB2' HG21 ' A' ' 78' ' ' THR . 35.8 Cg_endo -79.68 -43.36 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.373 2.049 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -79.27 -22.26 44.95 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -92.26 -36.19 13.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.4 t80 -73.62 -66.6 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 51' ' ' ALA . 13.6 mm -96.38 113.2 62.05 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.43 -0.793 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.76 70.24 7.04 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.255 1.97 . . . . 0.0 109.747 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.42 -46.69 0.03 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.846 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -58.09 163.75 2.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.281 . . . . 0.0 109.651 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.32 9.03 5.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.586 ' O ' ' HG3' ' A' ' 80' ' ' MET . 8.1 ptm -74.48 115.82 14.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.879 -1.129 . . . . 0.0 109.513 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 41.8 mm -94.13 35.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 4.9 t80 . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.807 -0.558 . . . . 0.0 110.167 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.307 0.575 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -53.51 -43.77 68.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 109.263 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -58.73 -34.31 71.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.381 -0.824 . . . . 0.0 109.701 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.1 -28.82 66.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.117 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.452 ' CD2' HG21 ' A' ' 9' ' ' ILE . 55.7 mt -71.13 -63.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 109.418 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -59.66 -32.01 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 108.996 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -60.39 -40.71 91.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 109.873 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.2 -48.42 62.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.352 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.0 mm? -67.13 -16.29 64.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -72.49 -49.26 34.3 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.312 -0.867 . . . . 0.0 109.862 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 6.8 tttt -79.88 -27.4 40.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.31 -59.15 3.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 110.376 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -111.54 -29.89 7.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.46 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t30 -81.61 10.96 5.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.541 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.508 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.268 0.556 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -13.03 26.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' ILE . 6.9 ttmt -77.44 -63.07 1.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.28 -32.78 60.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 34.9 tttt -64.67 -33.7 76.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -77.08 -24.13 51.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 5' ' ' LYS . 17.9 mt -69.62 -55.94 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 108.838 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' SER . 9.7 t80 -62.84 -40.15 96.53 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.324 -0.86 . . . . 0.0 108.921 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 14.5 mt -58.06 -28.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.38 -0.825 . . . . 0.0 109.001 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -114.92 6.89 15.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 110.015 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -113.68 -66.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -115.07 31.18 6.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.965 -1.084 . . . . 0.0 109.459 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.8 t -90.16 8.74 31.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.2 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -101.44 -48.2 4.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 0.0 108.956 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 96.9 m -93.57 -25.52 17.52 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.419 -0.8 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.042 ' ND1' HD22 ' A' ' 32' ' ' LEU . 79.1 m-70 -113.87 82.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 110.249 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.536 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 5.1 p -78.86 88.4 4.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 108.448 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 32' ' ' LEU . 5.5 m -79.88 9.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -137.75 18.01 2.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.046 . . . . 0.0 109.433 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 4.8 tptt -88.9 -57.27 2.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.36 63.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.43 17.63 33.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.93 73.47 1.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -1.192 . . . . 0.0 109.368 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.527 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -78.47 128.9 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 109.964 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' NZ ' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -101.69 -80.39 0.5 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 96.3 m -91.8 -33.33 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.363 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -108.56 156.91 15.51 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 32.9 Cg_endo -68.68 136.33 35.68 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.543 2.162 . . . . 0.0 110.849 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 6.2 t-20 -51.38 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.812 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.042 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.64 70.25 7.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.494 -0.754 . . . . 0.0 109.456 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 102' ' ' THR . 31.3 t-80 -100.2 -49.58 4.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 109.098 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -122.81 37.67 2.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.73 ' O ' HD23 ' A' ' 35' ' ' LEU . 3.1 tt -49.52 -50.52 41.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.992 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -60.37 137.94 58.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.855 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.92 24.21 76.55 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD2' ' HG2' ' A' ' 42' ' ' GLN . 24.2 ttp85 -145.78 118.11 8.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -1.231 . . . . 0.0 109.797 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -70.68 164.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.91 169.07 4.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.866 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 73.13 83.39 0.29 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -148.61 -39.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -1.148 . . . . 0.0 109.882 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -79.84 136.35 54.87 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 109.693 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.5 Cg_endo -79.15 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.59 2.193 . . . . 0.0 110.972 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -40.13 -37.91 1.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -80.13 125.07 29.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -1.061 . . . . 0.0 108.979 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 48' ' ' TYR . 93.9 p -86.34 57.35 4.44 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m-30 -31.8 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.113 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.994 HG21 ' HA ' ' A' ' 78' ' ' THR . 31.0 p -63.19 93.4 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.642 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -36.93 -37.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -41.15 -69.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.92 ' OD1' HD13 ' A' ' 75' ' ' ILE . 28.6 m-20 -45.1 -45.26 11.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 109.852 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.7 -74.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.93 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.57 -14.03 2.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.885 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HB2' HG12 ' A' ' 75' ' ' ILE . 1.8 tptp -59.17 -13.83 8.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.0 109.926 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.94 58.78 12.39 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -133.73 120.33 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.731 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.07 102.15 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.047 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CG ' HD21 ' A' ' 35' ' ' LEU . 6.7 m95 -41.16 106.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.42 -159.87 10.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.9 -59.45 2.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.11 -1.229 . . . . 0.0 109.868 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.96 -38.12 64.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.846 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.98 -52.1 66.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.4 tt -62.94 -37.32 86.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -53.36 -37.9 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE1' ' CD1' ' A' ' 74' ' ' TYR . 7.5 tm-20 -69.87 -57.11 5.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.576 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.6 t80 -60.87 -13.41 15.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 109.526 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.674 HD13 ' CD2' ' A' ' 64' ' ' LEU . 4.9 tp -85.09 -49.79 7.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.058 . . . . 0.0 109.073 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 6.9 tt0 -59.21 -22.08 60.49 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 69' ' ' GLU . 1.2 m-80 -161.27 92.34 1.48 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.736 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -76.0 -52.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.0 110.878 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.128 -0.982 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . 15.5 mtpt -77.09 -39.91 47.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.884 ' CD2' HD12 ' A' ' 75' ' ' ILE . 22.8 t80 -68.05 -63.23 1.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.92 HD13 ' OD1' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -114.21 125.3 29.48 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 71.19 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.239 1.959 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 51' ' ' ALA . . . -160.57 -58.47 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.994 ' HA ' HG21 ' A' ' 49' ' ' THR . 9.4 t -41.81 152.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -1.132 . . . . 0.0 110.164 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.11 5.18 13.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.662 ' HE2' ' CB ' ' A' ' 82' ' ' PHE . 8.5 ptm -77.58 119.29 20.93 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.071 -1.018 . . . . 0.0 109.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.4 mt -90.11 55.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.662 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 48.7 t80 . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.579 -0.7 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -44.07 92.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.43 96.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.348 -0.845 . . . . 0.0 109.388 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.4 -37.45 62.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.09 -53.23 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 95' ' ' ILE . 19.9 mm -61.99 -79.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -33.76 -38.35 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.285 0.564 . . . . 0.0 110.698 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 1.2 t80 -56.62 -57.04 14.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 0.0 109.177 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 102' ' ' THR . 4.8 mt -74.68 -13.69 60.65 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.461 -0.774 . . . . 0.0 109.48 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -75.78 -15.81 60.21 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -112.36 -24.36 9.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.609 -0.682 . . . . 0.0 109.215 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.06 -48.78 6.07 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.133 -0.979 . . . . 0.0 110.058 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -109.59 32.03 5.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.923 . . . . 0.0 109.928 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t-20 -154.73 -46.14 0.09 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.171 -0.956 . . . . 0.0 109.376 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.65 173.75 16.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.168 -1.195 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.5 t -98.93 -49.15 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.575 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.72 -11.82 60.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.37 -52.47 5.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.893 . . . . 0.0 109.693 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.03 -34.71 62.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 2.5 ttpt -51.08 -42.11 60.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -1.156 . . . . 0.0 109.612 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -77.08 -25.47 52.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.654 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.702 HG22 HD21 ' A' ' 94' ' ' LEU . 12.2 mt -66.58 -62.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE1' HG13 ' A' ' 20' ' ' VAL . 54.6 t80 -62.76 -40.25 96.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.09 -1.006 . . . . 0.0 108.951 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 84.3 mt -66.52 -14.63 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.464 -0.773 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 5.0 ttt -119.07 5.17 11.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.007 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -120.79 -64.25 1.26 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.044 -1.035 . . . . 0.0 109.805 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.64 37.83 3.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 108.895 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.2 t -91.73 4.34 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.447 -0.783 . . . . 0.0 109.904 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.43 -46.67 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 108.973 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 11.0 m -90.64 -29.53 17.71 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.319 -0.863 . . . . 0.0 108.936 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.86 ' ND1' HD22 ' A' ' 32' ' ' LEU . 69.1 m-70 -114.72 84.51 2.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -84.93 97.98 10.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.931 -1.106 . . . . 0.0 109.12 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 10' ' ' PHE . 2.5 m -85.71 17.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -149.15 31.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -97.59 -77.04 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.53 52.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.23 16.62 35.04 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.85 124.01 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -1.153 . . . . 0.0 109.348 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.434 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -124.71 95.48 4.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -82.11 -73.85 0.37 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.097 -1.002 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.2 m -84.79 -63.08 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.04 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -88.48 152.18 23.14 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.68 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.3 Cg_endo -66.78 134.32 34.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.577 2.185 . . . . 0.0 110.969 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 17.2 t-20 -53.03 103.02 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 109.692 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.06 51.5 1.96 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.665 -0.647 . . . . 0.0 109.826 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.504 ' O ' HG22 ' A' ' 102' ' ' THR . 4.1 t60 -93.46 -8.54 41.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 102' ' ' THR . . . -162.01 31.07 0.31 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -55.48 -28.13 52.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.044 . . . . 0.0 109.85 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 29.9 m-85 -72.28 113.83 9.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.197 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.85 51.03 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -101.61 136.54 41.28 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.056 -1.261 . . . . 0.0 110.075 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' CG ' ' N ' ' A' ' 40' ' ' THR . 30.5 ttmt -82.45 167.52 18.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.024 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.889 HG23 ' CGA' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -61.72 165.18 5.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.918 . . . . 0.0 109.946 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' A' ' 53' ' ' LYS . . . 65.4 94.47 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -149.05 -48.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -1.216 . . . . 0.0 109.645 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -61.55 146.4 89.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 109.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.72 -60.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.776 2.317 . . . . 0.0 110.758 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.24 52.77 4.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.01 118.5 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -1.098 . . . . 0.0 108.888 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.538 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 3.9 t -83.33 70.99 10.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 30' ' ' PRO . 2.3 m-85 -44.26 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.684 -0.635 . . . . 0.0 109.747 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.56 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -50.85 -40.62 56.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.435 -0.791 . . . . 0.0 109.219 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -52.45 -72.51 0.05 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.664 ' ND2' HG13 ' A' ' 75' ' ' ILE . 2.1 m-20 -37.2 -49.35 0.91 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -53.79 -48.32 69.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -0.928 . . . . 0.0 110.678 -178.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -65.04 -45.18 86.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.103 -0.998 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -21.03 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.161 -0.962 . . . . 0.0 109.68 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.84 43.94 48.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.961 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -99.34 137.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.993 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.961 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -98.54 115.62 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.643 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 11.8 m95 -59.02 111.11 1.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -136.42 -158.74 8.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 95' ' ' ILE . 2.9 tt0 -75.78 -74.12 0.23 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.197 -1.178 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -36.91 78.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 110.13 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -59.33 -44.97 92.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.367 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -68.97 -24.97 64.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.242 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.8 tpp -59.75 -44.84 93.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -56.91 5.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 34.3 t80 -51.34 -28.65 12.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.987 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.032 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 2.7 tp -84.02 -31.48 25.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -58.76 -26.09 63.68 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 7.7 m120 -171.84 102.46 0.37 Allowed Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -75.42 -32.72 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.075 1.85 . . . . 0.0 110.045 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -27.97 31.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.456 -0.777 . . . . 0.0 109.734 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -83.75 -33.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -79.51 -68.41 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.914 . . . . 0.0 108.817 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.724 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.4 mm -102.96 111.18 64.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 70.43 7.23 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.292 1.994 . . . . 0.0 109.711 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -172.98 -40.29 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.803 ' HA ' HG23 ' A' ' 49' ' ' THR . 11.2 t -42.58 151.55 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 109.843 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' HG2' ' O2D' ' A' ' 105' ' ' HEC . 6.2 mmmt -111.78 7.12 20.1 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.557 -0.715 . . . . 0.0 109.103 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.772 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 5.7 ptm -86.0 117.79 25.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.931 -1.105 . . . . 0.0 109.695 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -88.89 50.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.628 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 27.4 t80 -59.53 149.83 28.79 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.52 0.676 . . . . 0.0 110.197 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 83' ' ' VAL . 0.6 OUTLIER -76.21 149.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.213 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.86 143.13 48.54 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 2.2 mp -70.32 142.56 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -1.143 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -131.93 16.82 4.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 109.411 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.29 86.9 0.82 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.593 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -29.29 58.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -55.41 -52.84 62.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.322 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.39 -32.98 72.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.301 -0.874 . . . . 0.0 109.8 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.738 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.4 mmt180 -62.06 -44.86 95.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.399 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.68 79.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.979 -1.076 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB2' ' CD1' ' A' ' 9' ' ' ILE . 8.2 m-20 -65.61 -26.41 67.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 91' ' ' ARG . 28.6 mt -66.58 -59.92 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 108.856 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' HG3' ' A' ' 61' ' ' GLU . 4.8 mm -50.52 -32.53 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.428 -0.795 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.3 78.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.404 ' CD2' HD22 ' A' ' 98' ' ' LEU . 23.3 t80 -64.28 -50.33 68.33 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.092 -1.005 . . . . 0.0 109.724 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.1 mm? -64.67 -18.49 65.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.805 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 4.8 mttt -80.86 -25.68 37.48 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.001 -1.062 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 5.5 tptp -78.02 -37.66 46.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.94 -54.8 3.81 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 33' ' ' HIS . 19.3 p -92.69 16.23 12.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.055 -1.028 . . . . 0.0 111.149 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.0 t-20 -156.82 29.03 0.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.923 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.483 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.063 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 11.1 m-20 -114.77 162.93 16.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -1.152 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 4' ' ' GLU . 11.2 p -94.59 -36.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.943 . . . . 0.0 109.51 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.423 ' N ' HG13 ' A' ' 3' ' ' VAL . 14.1 mm-40 -72.21 -7.41 49.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.695 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -93.11 -55.24 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.796 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.81 -49.31 59.91 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.8 tttt -62.49 -13.63 32.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.9 mmtt -85.46 -54.14 4.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.048 -1.033 . . . . 0.0 109.355 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 70.8 mt -57.22 -53.7 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 15' ' ' SER . 10.1 t80 -60.26 -42.3 95.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 5.2 mt -58.34 -24.42 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.325 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ptm -123.35 18.25 9.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.163 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.64 -48.09 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.05 -1.031 . . . . 0.0 109.725 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.572 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -133.72 20.6 3.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.937 -1.102 . . . . 0.0 109.517 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.525 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.7 t -85.3 8.4 18.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.497 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -100.31 -43.87 6.12 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 28' ' ' THR . 35.5 m -93.39 -27.93 16.45 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.031 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.2 m-70 -112.94 84.28 1.96 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 109.798 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -78.53 84.05 4.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 108.364 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.3 m -83.93 31.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 110.692 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 22.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 109.818 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -99.85 6.04 45.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.431 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.16 -22.14 12.56 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.16 7.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 142.1 39.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.16 . . . . 0.0 109.279 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.488 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -127.22 172.77 10.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 109.659 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 -72.63 0.17 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 109.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 17' ' ' CYS . 16.8 m -85.28 -55.41 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.302 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -95.7 153.23 20.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 32.3 Cg_endo -69.1 128.25 16.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.032 1.822 . . . . 0.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 30' ' ' PRO . 14.8 t-20 -44.22 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.031 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.25 41.21 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.88 ' HA ' HG21 ' A' ' 102' ' ' THR . 55.0 t-80 -87.12 -16.64 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.336 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.96 37.93 0.81 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.834 HD11 ' CD1' ' A' ' 59' ' ' TRP . 6.6 tp -67.49 -33.98 76.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.557 -0.966 . . . . 0.0 110.167 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.2 m-85 -64.07 130.26 43.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.981 . . . . 0.0 110.09 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 20.81 76.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -148.0 121.1 8.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.019 -1.283 . . . . 0.0 109.783 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.06 160.02 29.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.223 -0.923 . . . . 0.0 109.148 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.731 HG21 ' HB3' ' A' ' 52' ' ' ASN . 11.3 t -65.05 -174.84 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.906 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 42' ' ' GLN . . . 57.23 79.58 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 43' ' ' ALA . 1.1 tp60 -156.39 -56.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -43.2 135.37 3.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.686 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.65 134.01 11.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.505 2.136 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 -11.55 60.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -133.71 76.22 1.65 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 109.718 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -68.56 92.24 0.45 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.768 ' OH ' ' HB2' ' A' ' 43' ' ' ALA . 5.7 m-30 -46.17 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.873 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 78' ' ' THR . 7.4 m -59.67 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.401 -0.812 . . . . 0.0 109.358 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -35.71 -31.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.883 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -32.3 -59.71 0.3 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.373 0.606 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.731 ' HB3' HG21 ' A' ' 40' ' ' THR . 51.2 t30 -62.23 -54.17 44.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 109.328 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HB2' HG23 ' A' ' 40' ' ' THR . 5.3 ttpp -41.94 -27.94 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 110.295 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 51' ' ' ALA . 7.3 p30 -94.94 -33.55 12.73 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.002 -1.061 . . . . 0.0 109.991 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 19.8 tptp -53.11 -20.02 3.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.033 -1.042 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.91 75.07 0.79 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.838 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.41 127.35 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 110.472 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -90.04 101.78 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.834 ' CD1' HD11 ' A' ' 35' ' ' LEU . 5.4 m95 -42.41 107.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.352 -0.843 . . . . 0.0 110.216 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.16 -154.8 7.97 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HG3' HG21 ' A' ' 95' ' ' ILE . 12.7 tt0 -76.58 -75.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -1.213 . . . . 0.0 109.703 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 65' ' ' MET . 21.2 t70 -62.32 -37.46 85.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.817 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.99 -55.2 35.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.873 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.3 tt -63.49 -19.73 65.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.328 -0.858 . . . . 0.0 109.298 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.503 ' HG2' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -64.78 -46.36 82.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -49.93 66.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.187 -0.945 . . . . 0.0 109.758 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.651 ' CG ' ' CH2' ' A' ' 59' ' ' TRP . 7.9 t80 -53.35 -41.02 65.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.105 -0.997 . . . . 0.0 109.352 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -69.98 -33.81 72.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.781 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.7 -24.13 63.72 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 21.1 t-20 -170.98 97.27 0.42 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 29.7 Cg_endo -74.75 -37.52 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.219 1.946 . . . . 0.0 110.769 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -72.84 -9.09 58.29 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.086 -1.009 . . . . 0.0 109.209 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 14.4 tptt -94.17 -57.69 2.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.572 ' CD1' ' HG2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -62.91 -62.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.883 HG22 ' CB ' ' A' ' 51' ' ' ALA . 3.2 mm -80.45 117.23 66.78 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.9 Cg_endo -75.61 74.87 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.165 1.91 . . . . 0.0 110.685 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.42 26.84 1.74 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.632 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 t -49.94 160.7 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.414 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.746 ' HB3' HMD2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -101.57 0.95 37.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 108.813 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.791 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.8 ptm -113.46 122.25 46.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' ILE . 16.0 tt -91.04 58.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.734 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 55.3 t80 -75.57 154.67 36.61 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.566 -0.709 . . . . 0.0 109.907 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 p -99.12 149.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.486 -0.759 . . . . 0.0 109.246 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.48 120.07 5.16 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.4 mt -74.51 131.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -1.158 . . . . 0.0 109.183 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -74.49 -48.09 29.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 109.383 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 96.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -33.12 69.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.688 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.7 -53.47 18.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG3' HD13 ' A' ' 9' ' ' ILE . 1.2 tp10 -60.31 -45.27 93.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.256 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.503 ' CD ' ' HG2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -50.0 -36.1 27.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.223 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.86 89.22 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.253 -0.905 . . . . 0.0 109.174 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.68 -35.44 42.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.0 -55.88 16.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.409 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.448 HG21 ' HG3' ' A' ' 61' ' ' GLU . 16.7 mm -53.51 -69.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.543 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -39.98 -39.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.81 -0.556 . . . . 0.0 110.244 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.03 -50.36 72.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 2.7 mm? -75.22 -3.48 33.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 -12.18 20.64 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.216 -0.927 . . . . 0.0 109.748 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -113.96 -43.55 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 110.123 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.96 -33.4 61.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.88 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -128.54 46.15 2.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.061 -1.024 . . . . 0.0 109.957 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -177.5 45.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.303 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 0.903 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -108.48 152.69 24.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -1.097 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.4 p -73.32 -37.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.76 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 3' ' ' VAL . 16.6 mt-10 -62.62 -22.62 66.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -84.39 -49.75 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.877 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -52.12 -45.56 57.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -59.9 -37.36 79.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.912 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -21.69 61.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.867 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' LYS . 32.1 mm -75.09 -63.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 20' ' ' VAL . 30.6 t80 -56.22 -45.61 79.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.213 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 18.6 mt -58.93 -30.66 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.6 ttp -116.77 21.9 13.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -134.14 -65.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.58 30.83 7.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.106 -0.996 . . . . 0.0 109.564 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 4.3 t -89.68 -14.95 33.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.114 . . . . 0.0 109.466 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -82.43 -44.18 16.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 108.911 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.3 m -90.08 -35.08 15.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 108.869 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.842 ' ND1' HD22 ' A' ' 32' ' ' LEU . 68.6 m-70 -114.02 80.36 1.38 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.039 -1.038 . . . . 0.0 109.934 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 p -79.69 94.55 5.74 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.663 -1.273 . . . . 0.0 108.781 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 10' ' ' PHE . 2.9 m -84.57 -5.56 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.19 26.5 9.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.3 -51.39 3.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.4 60.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.76 24.99 72.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -96.34 115.55 27.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -1.106 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -131.57 89.88 2.77 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.46 -68.5 0.71 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 0.0 109.773 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 99.8 m -90.19 -59.81 2.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.722 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -90.41 149.0 19.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.7 Cg_endo -65.84 136.03 43.68 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.51 2.14 . . . . 0.0 111.232 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 9.5 t-20 -52.4 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.774 -0.579 . . . . 0.0 110.286 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.15 70.07 9.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.729 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.457 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 14.8 t60 -88.86 -45.65 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.599 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.52 38.93 1.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 ' CD1' ' A' ' 59' ' ' TRP . 5.5 tp -54.03 -28.28 37.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -1.131 . . . . 0.0 109.601 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.6 m-85 -66.29 136.75 56.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.81 17.23 57.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 1.8 ttt-85 -133.87 135.68 43.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -1.203 . . . . 0.0 109.326 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -64.68 -174.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.877 . . . . 0.0 109.925 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' N ' ' A' ' 53' ' ' LYS . 4.6 p -53.5 -169.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.582 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -133.3 175.11 20.33 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.879 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -161.82 54.3 0.25 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.954 . . . . 0.0 108.666 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -44.34 169.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 109.666 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.844 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 35.0 Cg_endo -75.12 -66.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.64 2.226 . . . . 0.0 110.585 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.96 6.86 61.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.95 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -131.04 103.89 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -1.135 . . . . 0.0 109.403 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' TYR . 34.7 t -75.14 83.89 2.34 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-30 -44.19 176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.731 -0.606 . . . . 0.0 110.186 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.5 ' OG1' HAD1 ' A' ' 105' ' ' HEC . 0.3 OUTLIER -59.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.906 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -52.61 -38.75 60.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.604 -0.685 . . . . 0.0 109.227 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.26 -70.57 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.394 -0.817 . . . . 0.0 108.847 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -43.97 -54.18 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.603 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' N ' HG21 ' A' ' 40' ' ' THR . 10.1 tptp -40.03 -46.56 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.213 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.67 -34.47 60.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 9.6 tptt -53.65 -17.85 2.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.996 -1.065 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.43 54.34 32.75 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -108.24 138.42 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.997 . . . . 0.0 110.251 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.895 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -98.13 104.21 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.89 ' CD1' HD11 ' A' ' 35' ' ' LEU . 6.6 m95 -49.04 103.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.068 -1.02 . . . . 0.0 110.263 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.86 -164.11 11.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.92 -55.79 5.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.022 -1.281 . . . . 0.0 109.712 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -73.77 -38.93 64.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.157 -0.964 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.44 -37.86 79.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.058 -1.026 . . . . 0.0 109.521 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -77.38 -35.96 53.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.182 -0.949 . . . . 0.0 109.125 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 46.1 ttm -56.77 -28.53 61.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 108.831 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -53.22 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 75' ' ' ILE . 19.9 t80 -58.78 -17.72 25.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -96.08 -36.19 11.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 108.919 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' MET . 21.6 tt0 -59.31 -23.65 62.63 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 23.1 t-20 -176.0 88.52 0.28 Allowed Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.4 Cg_endo -74.59 -37.54 2.28 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.378 2.052 . . . . 0.0 110.274 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -67.63 -14.07 62.63 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.17 -0.956 . . . . 0.0 108.654 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 1.3 tppp? -98.74 -31.66 11.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.227 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.442 ' CD2' HD11 ' A' ' 75' ' ' ILE . 13.1 t80 -83.37 -72.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 108.629 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.5 mm -83.87 115.4 59.65 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 84.26 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.286 1.991 . . . . 0.0 110.396 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 140.18 -7.37 2.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.465 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 12.0 t -44.43 144.67 0.99 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.245 . . . . 0.0 109.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' CGD' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -104.77 17.18 24.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.44 124.47 20.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.871 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.638 ' HB ' HBC2 ' A' ' 105' ' ' HEC . 6.6 mt -92.05 21.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HD1' HMC2 ' A' ' 105' ' ' HEC . 0.5 OUTLIER -59.72 160.28 7.62 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.419 0.628 . . . . 0.0 110.193 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 84' ' ' GLY . 17.3 m -86.93 -37.75 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.238 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 121.84 101.85 1.71 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 85' ' ' ILE . 28.7 mm -101.85 142.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 108.854 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.24 10.43 3.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.055 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 122.81 42.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.048 -1.032 . . . . 0.0 109.245 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -17.7 9.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.61 -61.34 2.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.68 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 -49.05 79.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.644 ' HA ' HD12 ' A' ' 94' ' ' LEU . 4.8 mtp180 -53.04 -36.13 60.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.91 -49.16 60.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.461 ' HB3' HG13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -62.92 -24.58 67.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 110.028 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 91' ' ' ARG . 75.8 mt -68.29 -59.52 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.564 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -61.74 -32.47 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.85 46.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.436 ' HB2' ' C ' ' A' ' 6' ' ' GLY . 32.7 t80 -66.84 -44.27 81.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.963 -1.086 . . . . 0.0 109.814 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.5 mm? -75.91 -4.01 38.54 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.56 -15.13 17.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.197 -0.939 . . . . 0.0 109.14 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 9.0 tttp -103.71 -31.1 10.02 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.23 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.59 -0.694 . . . . 0.0 110.983 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' N ' ' A' ' 103' ' ' ASN . 4.6 t -91.06 -48.62 6.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 0.0 110.855 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.585 ' N ' HG23 ' A' ' 102' ' ' THR . 7.8 t-20 -69.66 -4.26 18.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.871 -1.143 . . . . 0.0 110.029 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 8.4 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.599 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.04 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -79.86 121.5 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -1.123 . . . . 0.0 109.497 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.82 -29.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -74.8 -45.93 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 9' ' ' ILE . 2.0 tppm? -76.97 -41.39 43.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.18 94.15 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HD3' ' CE1' ' A' ' 97' ' ' TYR . 3.2 ttpt -61.03 -32.85 72.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -1.158 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -67.44 -25.33 65.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 5.2 mm -76.98 -68.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.523 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 48.8 t80 -53.35 -46.66 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 12' ' ' MET . 12.9 tt -56.01 -43.54 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 110.054 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.515 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.21 14.52 31.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.44 -68.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.072 -1.017 . . . . 0.0 109.592 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.603 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -113.59 37.16 3.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 2.9 t -93.51 -48.16 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.881 -1.137 . . . . 0.0 109.835 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.4 -33.79 45.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 36.4 m -98.24 -37.72 9.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.109 -0.994 . . . . 0.0 109.159 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.911 ' ND1' HD22 ' A' ' 32' ' ' LEU . 67.6 m-70 -115.51 74.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.85 -1.156 . . . . 0.0 108.992 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.4 96.83 5.45 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.696 -1.253 . . . . 0.0 109.168 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -87.53 25.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.475 -0.766 . . . . 0.0 109.879 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -140.08 9.29 2.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -85.23 -86.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.8 38.04 0.61 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.52 13.84 63.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -98.66 169.59 9.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -1.13 . . . . 0.0 109.269 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.31 117.51 9.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -91.41 -73.15 0.55 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.283 -0.886 . . . . 0.0 109.158 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m -93.24 -59.88 1.92 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -92.31 153.36 21.72 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.2 Cg_endo -66.57 147.57 82.19 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.403 2.069 . . . . 0.0 111.254 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 16.2 t-20 -64.61 100.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 110.328 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.911 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.88 38.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -90.91 36.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 109.093 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 102' ' ' THR . . . 161.56 37.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.763 HD11 ' CD1' ' A' ' 59' ' ' TRP . 4.2 tp -79.04 -24.39 43.64 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.356 -1.084 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 27.5 m-85 -74.4 127.28 32.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 109.549 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 14.12 82.92 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 11.7 ttt-85 -134.18 134.55 42.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.154 . . . . 0.0 109.516 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 4.0 mttt -73.78 -177.36 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.898 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -92.61 -175.5 3.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.48 89.05 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -147.98 -43.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 109.72 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -73.53 136.35 78.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.327 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 45' ' ' GLY . 35.2 Cg_endo -77.28 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.08 -30.02 0.37 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.526 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -80.59 125.53 30.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.433 -1.039 . . . . 0.0 109.109 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -86.49 57.3 4.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-85 -36.42 158.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.286 0.565 . . . . 0.0 110.066 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -61.0 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.84 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -46.03 -35.89 5.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -49.0 -61.2 2.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HG21 ' A' ' 75' ' ' ILE . 5.6 t-20 -55.94 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 109.592 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 52' ' ' ASN . 6.7 ttpm? -39.99 -30.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.53 0.681 . . . . 0.0 109.338 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLY . 86.1 m-20 -92.23 -39.67 11.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.448 -0.783 . . . . 0.0 109.687 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -56.9 92.72 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.934 -1.104 . . . . 0.0 108.252 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' ASN . . . -38.19 91.52 0.01 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -143.65 145.75 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 110.015 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.081 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -118.61 100.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.898 ' NE1' HG22 ' A' ' 40' ' ' THR . 6.9 m95 -37.56 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.793 0.806 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -122.38 -164.45 12.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -67.9 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -1.146 . . . . 0.0 109.705 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.05 -27.21 66.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.88 -40.69 93.97 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.9 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.6 OUTLIER -76.26 -32.49 58.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -37.09 67.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.67 -56.81 4.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.679 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 9.5 t80 -56.07 -19.11 11.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 109.992 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.77 HD13 HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -92.33 -36.31 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.033 -1.042 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.99 -25.16 63.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 5.1 t-20 -168.8 85.46 0.67 Allowed Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -75.01 -26.39 10.95 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.462 2.108 . . . . 0.0 109.766 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 2.2 tttt -74.3 -19.18 60.57 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 43.2 tptt -88.79 -45.06 10.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.501 -0.749 . . . . 0.0 109.438 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.866 ' CD2' HD11 ' A' ' 75' ' ' ILE . 8.1 t80 -71.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.116 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.866 HD11 ' CD2' ' A' ' 74' ' ' TYR . 2.6 mm -96.2 107.81 37.5 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.703 -0.623 . . . . 0.0 109.654 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.749 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -79.13 81.68 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.375 2.05 . . . . 0.0 110.347 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.23 -18.25 0.71 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.5 t -44.97 132.21 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 109.938 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 23.76 5.01 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -59.2 120.0 8.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.607 -0.683 . . . . 0.0 109.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.507 ' HB ' HBC2 ' A' ' 105' ' ' HEC . 10.9 mt -93.29 26.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 0.3 OUTLIER -60.04 162.3 5.85 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.625 0.726 . . . . 0.0 110.663 -179.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 p -100.63 -33.11 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.35 93.82 2.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.827 HG22 ' H ' ' A' ' 87' ' ' LYS . 30.5 mt -62.15 125.9 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.156 . . . . 0.0 109.502 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -97.87 25.48 5.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.239 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.827 ' H ' HG22 ' A' ' 85' ' ' ILE . 2.5 mttt -135.55 107.13 6.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.575 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -61.03 -25.88 67.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.425 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.8 -39.38 76.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.772 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.81 -51.15 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -55.04 -44.75 74.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.958 . . . . 0.0 109.125 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.52 66.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 0.0 109.23 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.46 -36.63 84.81 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.264 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 66.7 mt -61.97 -29.78 70.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -0.864 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mm -79.15 -46.91 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.351 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.08 -46.78 65.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.219 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' CD2' HD22 ' A' ' 98' ' ' LEU . 28.1 t80 -70.66 -47.52 59.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.993 -1.067 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 102' ' ' THR . 1.1 mm? -71.7 -3.36 21.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -87.0 -55.9 3.62 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -28.58 61.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.59 50.28 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.389 -0.82 . . . . 0.0 109.68 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 102' ' ' THR . 3.1 t -124.38 41.41 3.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.855 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 2.9 t-20 179.78 50.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.388 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 0.955 HMB1 HBB3 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.43 179.76 6.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -1.165 . . . . 0.0 109.346 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.571 HG22 ' HE2' ' A' ' 100' ' ' LYS . 2.1 t -81.24 -57.81 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HG2' ' HE3' ' A' ' 8' ' ' LYS . 5.8 tt0 -62.47 -27.68 69.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.663 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -58.25 -62.16 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.64 -37.17 94.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.6 ttmm -58.47 -26.45 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -1.176 . . . . 0.0 109.811 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HE3' ' HG2' ' A' ' 4' ' ' GLU . 32.2 mttt -82.2 -40.5 21.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 109.994 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.812 HG22 HD21 ' A' ' 94' ' ' LEU . 12.9 mm -61.48 -58.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 0.0 110.123 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HE2' HD23 ' A' ' 32' ' ' LEU . 18.8 t80 -62.12 -41.06 97.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.005 -1.06 . . . . 0.0 109.758 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 18.3 mm -68.21 -11.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.7 ttm -133.31 19.47 4.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 110.215 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 5.8 tptt -131.76 -43.25 1.0 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 109.199 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -134.07 25.33 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.7 t -85.59 10.42 13.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -43.5 6.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 108.748 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.4 m -99.61 -22.02 15.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.136 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.81 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.8 m-70 -117.43 79.42 1.34 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -79.53 100.08 7.58 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.827 -1.17 . . . . 0.0 108.781 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.9 m -83.81 13.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.887 . . . . 0.0 109.742 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -121.94 17.95 10.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.407 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 1.2 tptp -89.37 179.44 6.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.7 53.92 4.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.1 7.52 76.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 1.4 ttpt -97.92 159.5 14.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.119 . . . . 0.0 109.356 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.604 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -140.33 109.27 6.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.905 . . . . 0.0 108.706 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.695 HG21 ' SG ' ' A' ' 17' ' ' CYS . 30.8 m -87.42 -96.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 28' ' ' THR . . . -50.12 158.83 1.55 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 35.5 Cg_endo -69.38 151.92 71.24 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.363 2.042 . . . . 0.0 111.427 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.0 t-20 -62.41 102.99 0.36 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -82.07 54.86 2.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.121 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -99.51 43.54 1.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 108.888 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA2' HG21 ' A' ' 102' ' ' THR . . . 132.01 48.5 0.11 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.943 HD21 ' CD1' ' A' ' 59' ' ' TRP . 3.6 tt -65.92 -33.78 76.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -1.027 . . . . 0.0 110.35 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 21.3 m-85 -60.08 140.58 56.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 0.0 109.847 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.04 20.0 74.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 38' ' ' ARG . 16.5 ttp85 -133.36 98.95 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 169.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -70.08 172.95 7.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.658 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 72.15 72.8 0.9 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.473 ' HG3' ' HG2' ' A' ' 38' ' ' ARG . 66.2 mm-40 -135.53 -53.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 109.806 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -71.11 137.96 84.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.625 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -79.73 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.696 2.264 . . . . 0.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.28 -33.73 1.41 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.62 ' CE1' ' O2D' ' A' ' 105' ' ' HEC . 0.3 OUTLIER -79.91 121.76 25.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -1.089 . . . . 0.0 109.429 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -84.64 65.4 9.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-30 -37.88 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.617 0.723 . . . . 0.0 111.12 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 78' ' ' THR . 45.1 p -68.44 88.8 0.34 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 109.466 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.74 -33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.28 -65.06 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.719 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-20 -39.72 -55.08 1.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.435 -0.791 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -42.31 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.75 -27.33 67.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.278 -0.889 . . . . 0.0 109.852 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 6.1 tptt -73.45 -0.22 14.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.17 -0.956 . . . . 0.0 109.668 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.59 27.26 2.0 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -81.0 125.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.994 . . . . 0.0 110.085 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -94.05 100.46 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.943 ' CD1' HD21 ' A' ' 35' ' ' LEU . 17.2 m95 -37.39 109.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -130.76 -155.09 8.14 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.02 -60.64 2.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -1.191 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.32 -35.24 73.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.731 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -65.35 -48.56 72.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.74 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.3 tt -69.53 -32.59 71.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.103 -0.998 . . . . 0.0 109.533 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.45 ' HG2' ' HD2' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -59.88 -34.15 72.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 108.89 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -77.8 -53.4 7.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.518 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 38.9 t80 -57.65 -16.34 10.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -92.37 -40.34 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.563 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.95 -22.53 60.23 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 70' ' ' ASN . 22.4 p30 -172.57 95.91 0.37 Allowed Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -73.34 -40.23 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.255 1.97 . . . . 0.0 110.541 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -69.41 -9.36 53.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.995 -1.065 . . . . 0.0 108.948 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -88.15 -54.41 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -69.16 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.147 -0.971 . . . . 0.0 108.837 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.8 mm -98.19 106.82 37.68 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.653 -0.654 . . . . 0.0 109.553 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.5 75.77 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.159 1.906 . . . . 0.0 109.583 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 170.36 -22.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.89 ' HA ' HG21 ' A' ' 49' ' ' THR . 13.8 t -36.96 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -1.052 . . . . 0.0 110.329 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.631 ' HB3' HMD2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -104.89 13.46 31.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.759 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.3 ptm -114.54 123.07 48.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 110.079 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 81' ' ' ILE . 52.0 mt -94.41 44.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.824 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 19.9 t80 -59.96 147.27 39.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.653 -0.654 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.37 -24.75 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.79 -171.05 13.79 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.825 HD13 ' HG3' ' A' ' 91' ' ' ARG . 2.2 mp -105.41 132.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -1.102 . . . . 0.0 109.493 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 mmtm -81.58 -41.6 21.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.322 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HG2' ' OE2' ' A' ' 89' ' ' GLU . 2.0 tptt -92.65 123.85 36.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -56.7 -55.09 38.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.228 -0.92 . . . . 0.0 109.787 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' OE2' ' HG2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -48.08 -25.07 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 109.617 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.0 -46.49 43.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.825 ' HG3' HD13 ' A' ' 85' ' ' ILE . 10.2 ttp85 -58.52 -52.43 65.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 108.918 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.84 73.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -63.75 -30.69 71.76 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.812 HD21 HG22 ' A' ' 9' ' ' ILE . 18.3 mt -64.66 -55.75 18.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -63.43 -31.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.27 87.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' CD2' HD22 ' A' ' 98' ' ' LEU . 34.3 t80 -64.73 -49.41 70.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.017 -1.052 . . . . 0.0 109.973 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' THR . 3.4 mm? -66.34 -16.33 63.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.727 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -77.64 -51.03 11.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.121 -0.987 . . . . 0.0 109.608 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -74.8 -22.34 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.76 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.44 -55.73 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 110.222 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.736 HG21 ' HA2' ' A' ' 34' ' ' GLY . 3.3 t -110.71 -32.23 6.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.99 -1.069 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.559 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 6.7 t30 -81.4 8.41 9.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 110.017 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.32 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.072 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.04 144.59 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 109.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 14.5 p -93.78 -19.42 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.38 -10.15 59.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -96.3 -49.71 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -75.11 -33.3 54.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -69.67 -36.15 75.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 109.605 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -32.03 58.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 HD21 ' A' ' 94' ' ' LEU . 53.9 mt -67.92 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.262 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.549 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.7 t80 -54.35 -39.16 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 15' ' ' SER . 5.0 mm -57.09 -37.91 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -107.04 10.54 30.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.065 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -109.79 -60.03 1.84 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.102 -0.999 . . . . 0.0 109.527 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -132.07 40.81 3.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.313 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.2 t -87.25 -1.15 57.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -100.83 -49.07 4.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' SG ' HG21 ' A' ' 28' ' ' THR . 38.3 m -87.75 -13.19 43.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.876 . . . . 0.0 109.357 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.623 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 82.2 m-70 -134.23 81.87 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 110.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.0 p -78.67 90.21 4.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.9 -1.125 . . . . 0.0 108.003 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.1 m -82.85 35.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.625 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 23.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.869 -1.144 . . . . 0.0 110.211 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -95.74 -15.63 22.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.884 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.89 -25.4 4.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 136.53 -6.26 3.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -67.21 141.17 57.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -1.126 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.482 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -112.87 115.3 28.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 109.088 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.63 -79.94 0.32 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.761 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.605 HG21 ' SG ' ' A' ' 17' ' ' CYS . 7.0 m -98.97 -53.54 3.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 175.14 31.99 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -73.52 125.04 9.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.823 2.349 . . . . 0.0 110.94 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 24' ' ' GLY . 15.6 t-20 -49.37 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -78.8 76.54 5.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 -66.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -110.4 27.19 11.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 59' ' ' TRP . 1.9 tt -43.56 -30.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -1.079 . . . . 0.0 109.556 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.1 m-85 -74.91 128.95 36.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.58 66.26 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -120.77 123.6 43.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.406 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -60.09 -177.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.727 HG22 ' NE1' ' A' ' 59' ' ' TRP . 2.3 p -80.47 178.43 8.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' THR . . . 52.83 104.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.16 -62.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.279 . . . . 0.0 110.005 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -61.08 139.33 94.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.95 -173.82 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.744 2.296 . . . . 0.0 110.509 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 45.99 25.25 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -157.16 112.11 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 108.96 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -78.35 77.25 4.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.6 m-85 -46.77 179.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.81 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.49 88.11 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.105 -0.997 . . . . 0.0 108.871 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.12 -41.75 12.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.77 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.03 -66.75 0.33 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.301 -0.875 . . . . 0.0 108.959 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HB3' HG21 ' A' ' 40' ' ' THR . 1.6 m-20 -43.25 -42.36 4.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.465 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 5.5 tttt -43.41 -72.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.95 -15.79 60.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -60.42 -13.22 12.2 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.013 -1.055 . . . . 0.0 109.39 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.52 51.51 32.19 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -110.82 123.73 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.53 -0.983 . . . . 0.0 110.215 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -87.27 116.39 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.727 ' NE1' HG22 ' A' ' 40' ' ' THR . 12.6 m95 -56.55 96.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.299 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -117.68 -176.57 17.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -64.21 -59.69 4.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.108 -1.231 . . . . 0.0 110.073 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.45 -38.35 77.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 109.922 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.627 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.59 -35.6 74.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.658 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.77 -29.81 51.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.071 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -58.68 -35.0 71.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.33 -0.856 . . . . 0.0 109.105 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.48 -58.61 3.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.623 ' CE2' ' ND2' ' A' ' 52' ' ' ASN . 56.1 t80 -48.69 -28.81 3.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.163 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.944 HD21 HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -87.68 -39.27 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 0.0 109.487 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 65' ' ' MET . 10.8 tt0 -60.54 -21.22 62.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 13.7 m-20 -169.21 89.61 0.59 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' CD ' ' CG1' ' A' ' 83' ' ' VAL . 32.3 Cg_endo -76.76 -41.44 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.612 2.208 . . . . 0.0 110.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -31.98 57.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.34 -0.85 . . . . 0.0 109.973 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 1.6 mmpt? -83.19 -26.25 31.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 75' ' ' ILE . 7.1 t80 -83.94 -72.24 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.004 -1.06 . . . . 0.0 109.045 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.855 HG22 ' HB3' ' A' ' 51' ' ' ALA . 22.4 mm -93.73 119.37 67.12 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 109.669 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.6 Cg_endo -80.8 60.22 7.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.475 2.116 . . . . 0.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.31 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.81 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -59.83 161.96 5.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 109.758 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 11.41 5.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.756 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 7.7 ptm -77.75 114.05 16.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.316 1.055 . . . . 0.0 109.752 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -95.16 33.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.835 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 1.3 t80 -59.69 -32.27 70.34 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.976 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.594 ' CG1' ' CD ' ' A' ' 71' ' ' PRO . 3.3 m -31.65 104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.438 0.637 . . . . 0.0 110.809 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.67 28.89 0.14 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -109.63 145.54 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.123 . . . . 0.0 109.346 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -144.94 37.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.173 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.52 138.42 41.32 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.241 -0.912 . . . . 0.0 109.502 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -77.89 -37.64 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.05 -22.14 66.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -81.16 -59.4 2.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -53.32 -30.17 37.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.15 -52.67 17.9 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -59.16 -22.03 60.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.61 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HG22 ' A' ' 9' ' ' ILE . 27.4 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.9 mm -57.25 -38.58 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.325 -0.859 . . . . 0.0 109.413 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.28 82.46 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.545 -0.722 . . . . 0.0 109.86 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 7' ' ' LYS . 23.4 t80 -61.99 -34.95 77.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 109.611 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.3 mm? -83.32 -13.35 55.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -95.05 -9.32 34.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.315 -0.865 . . . . 0.0 109.682 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.98 -52.08 2.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 109.46 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.14 71.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.97 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -128.53 40.41 3.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.826 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 102' ' ' THR . 2.5 t30 178.85 51.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 1.5 pt-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.038 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.91 110.97 7.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.49 -35.91 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.293 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.64 -36.9 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.595 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 9' ' ' ILE . 5.7 mmtt -74.94 -45.26 43.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 93' ' ' ASP . . . -42.27 -52.64 5.07 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 4.1 ttmm -64.16 -36.49 84.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -1.17 . . . . 0.0 109.666 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.1 tptt -62.56 -23.43 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.073 -1.017 . . . . 0.0 109.915 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.72 HG22 HD21 ' A' ' 94' ' ' LEU . 17.9 mm -82.65 -67.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.892 -1.13 . . . . 0.0 109.829 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 20' ' ' VAL . 23.2 t80 -49.99 -31.55 12.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 109.524 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.548 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 3.2 tt -69.73 -40.65 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 ttm -111.77 29.61 7.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.378 -0.826 . . . . 0.0 109.973 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -140.73 -39.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.007 . . . . 0.0 109.951 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' HB3' ' C4B' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -146.48 16.53 1.3 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.967 -1.083 . . . . 0.0 109.938 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 28.2 t -85.44 7.94 20.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.893 -1.129 . . . . 0.0 109.594 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -100.1 -43.32 6.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 57.9 m -95.98 -32.83 12.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.841 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.4 m-70 -108.18 84.53 1.96 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 109.472 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -79.73 91.35 5.28 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.723 -1.235 . . . . 0.0 108.817 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 10' ' ' PHE . 11.8 m -85.12 8.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.433 -0.792 . . . . 0.0 110.133 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 2.6 mt-10 -146.13 24.95 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 110.383 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 15.1 tttt -96.74 -58.31 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.057 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.8 54.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.38 20.01 3.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -100.81 82.66 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -79.85 150.11 30.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 109.373 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -133.77 -85.37 0.44 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.927 ' O ' HMD3 ' A' ' 105' ' ' HEC . 49.8 m -81.91 -15.6 53.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -132.44 150.26 19.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.8 Cg_endo -66.36 131.72 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.202 . . . . 0.0 111.108 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.1 t-20 -53.17 102.79 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.841 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.97 42.69 0.73 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 110.166 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.444 ' HA ' HG21 ' A' ' 102' ' ' THR . 22.6 t-80 -89.0 58.43 4.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 108.993 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.85 23.67 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.494 HD11 HBA2 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -56.52 -22.19 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.038 -1.272 . . . . 0.0 109.237 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 19.6 m-85 -70.85 134.37 47.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.876 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.77 10.5 61.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -123.64 120.31 32.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -1.202 . . . . 0.0 109.421 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 161.64 16.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.081 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -67.45 176.37 2.37 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 53' ' ' LYS . . . 61.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -157.93 -58.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.185 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -53.24 129.79 50.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 0.0 109.862 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.7 Cg_endo -79.56 145.14 18.23 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.598 2.198 . . . . 0.0 110.386 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.1 -47.02 3.7 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -81.24 113.83 19.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.958 . . . . 0.0 108.766 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -77.35 77.55 3.88 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.665 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-85 -46.6 177.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.647 . . . . 0.0 109.335 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.761 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.67 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 109.278 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -47.24 -41.67 19.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.242 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -47.8 -68.38 0.19 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -40.47 -47.12 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.688 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HA ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -48.15 -60.03 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.858 . . . . 0.0 110.044 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.2 -20.63 66.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 110.065 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -63.84 -8.75 11.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.088 -1.008 . . . . 0.0 109.96 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.08 52.56 34.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -114.29 135.77 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.51 -0.994 . . . . 0.0 110.436 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.981 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -97.98 114.45 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.617 ' N ' HD13 ' A' ' 58' ' ' ILE . 10.6 m95 -54.59 109.03 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.98 -163.15 10.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.87 -62.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.283 . . . . 0.0 109.839 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.1 93.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.098 -1.001 . . . . 0.0 109.937 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.848 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.53 -38.17 80.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.804 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.95 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.6 OUTLIER -76.32 -32.79 58.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.765 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.6 ttt -55.79 -39.55 71.44 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -75.21 -48.6 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.27 -0.894 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 30.4 t80 -59.55 -18.33 39.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 109.737 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.877 HD21 HMB2 ' A' ' 105' ' ' HEC . 1.2 mp -92.71 -38.92 11.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -22.2 62.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.52 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . 10.3 m-20 -172.25 94.17 0.39 Allowed Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.776 ' HB2' HG21 ' A' ' 78' ' ' THR . 31.2 Cg_endo -76.26 -30.78 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 0.0 110.022 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -82.15 -26.94 33.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.381 -0.824 . . . . 0.0 109.711 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -80.9 -44.34 18.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.259 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 t80 -72.08 -66.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 52' ' ' ASN . 31.3 mm -98.43 110.28 55.97 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.479 -0.763 . . . . 0.0 109.62 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -79.35 67.07 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.459 2.106 . . . . 0.0 109.863 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -165.65 -47.65 0.02 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.776 HG21 ' HB2' ' A' ' 71' ' ' PRO . 9.0 t -47.57 167.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -1.233 . . . . 0.0 109.692 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -134.72 11.51 3.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.78 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.6 ptm -77.65 118.83 20.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -93.9 33.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.985 ' CE2' HD11 ' A' ' 85' ' ' ILE . 2.4 t80 -59.58 -34.46 72.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' C ' ' O ' ' A' ' 82' ' ' PHE . 2.4 m -30.42 111.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.595 0.712 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.545 ' H ' HD12 ' A' ' 85' ' ' ILE . . . 168.27 40.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.985 HD11 ' CE2' ' A' ' 82' ' ' PHE . 4.4 mp -99.65 168.56 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -1.112 . . . . 0.0 109.868 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.605 ' N ' HG22 ' A' ' 85' ' ' ILE . 2.5 tttt -166.54 29.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.395 -0.815 . . . . 0.0 108.992 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' H ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -145.6 117.11 8.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.712 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -62.19 -40.11 94.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.161 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' OE2' ' HE2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -60.56 -23.47 64.66 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -0.841 . . . . 0.0 109.291 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -73.89 -53.61 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.985 ' HA ' HD12 ' A' ' 94' ' ' LEU . 1.4 mpt_? -55.44 -45.88 76.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.126 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.58 89.75 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' HB3' HG13 ' A' ' 9' ' ' ILE . 4.3 m-20 -57.87 -29.13 64.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.279 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.985 HD12 ' HA ' ' A' ' 91' ' ' ARG . 27.2 mt -66.96 -47.71 70.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.6 mm -65.84 -59.2 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.388 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.2 -42.25 6.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.904 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.01 -52.07 58.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 110.003 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.2 mm? -75.39 -0.42 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -95.87 -25.1 16.14 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 110.088 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -108.7 -36.41 6.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.32 67.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -136.0 49.41 2.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.998 -1.064 . . . . 0.0 110.082 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.9 t30 -178.14 34.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.559 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.479 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.01 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.4 177.66 5.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 0.0 109.122 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.444 HG21 ' HD2' ' A' ' 100' ' ' LYS . 2.5 p -75.09 -35.77 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.65 -46.75 44.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.634 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -29.05 70.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.793 -1.192 . . . . 0.0 109.758 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . -72.43 -51.08 13.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 2.7 tttp -43.84 -35.18 1.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.023 -1.281 . . . . 0.0 110.082 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -74.25 -46.05 44.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 109.965 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.802 HD12 ' CB ' ' A' ' 93' ' ' ASP . 21.1 mt -56.86 -50.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.421 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 13.3 t80 -63.56 -46.41 86.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 110.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -53.21 -37.23 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.968 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -107.29 5.72 27.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.831 -1.168 . . . . 0.0 110.448 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.7 tppt? -109.03 -69.47 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.895 -1.128 . . . . 0.0 109.733 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -117.11 40.8 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.146 -0.971 . . . . 0.0 108.599 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 8.2 t -87.99 -53.94 4.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.757 -1.214 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 17' ' ' CYS . 9.5 pt20 -55.95 -38.62 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.831 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 28' ' ' THR . 8.7 m -86.96 -24.52 24.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.128 -0.983 . . . . 0.0 108.978 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.829 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.7 m-70 -131.76 76.8 1.73 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.978 -1.076 . . . . 0.0 109.58 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -76.89 92.52 3.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.23 24.44 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 110.531 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 18.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 108.645 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -22.21 51.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.496 -0.753 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.73 -17.18 8.84 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.31 -7.24 3.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.13 155.79 21.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -1.225 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.67 141.71 34.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 0.0 109.568 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 28' ' ' THR . 2.6 ttmt -113.7 -85.07 0.59 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.687 HG21 ' SG ' ' A' ' 17' ' ' CYS . 19.4 m -79.13 -76.68 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -74.68 155.89 48.88 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.694 ' HD3' ' C3D' ' A' ' 105' ' ' HEC . 34.3 Cg_endo -70.14 138.01 35.65 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.236 1.958 . . . . 0.0 110.74 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -48.82 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.897 . . . . 0.0 109.604 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.829 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.5 53.08 2.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.743 . . . . 0.0 110.181 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -99.81 77.5 2.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 0.0 109.336 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' ' 102' ' ' THR . . . 113.41 11.69 12.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -54.01 -27.99 35.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.601 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 2.8 m-85 -61.96 150.03 38.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 109.908 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.02 17.55 23.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' CZ ' ' O ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -138.66 162.48 34.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -1.161 . . . . 0.0 109.422 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -92.93 -156.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.543 ' O ' ' CZ ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -59.65 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -145.85 -176.04 19.41 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.9 36.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.433 -1.039 . . . . 0.0 109.4 -179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -41.46 160.89 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.94 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 34.2 Cg_endo -76.29 154.69 36.71 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.662 2.241 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.33 20.04 20.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' HBD1 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -153.87 104.48 2.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.932 . . . . 0.0 109.054 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 82.8 p -77.67 81.47 4.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 m-85 -44.65 174.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.662 -0.649 . . . . 0.0 109.309 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -59.06 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.03 -1.044 . . . . 0.0 109.495 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -55.17 -42.03 72.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.7 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.27 -72.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.626 ' ND2' HG13 ' A' ' 75' ' ' ILE . 6.3 m-20 -38.45 -48.63 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.506 -0.746 . . . . 0.0 109.615 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 13.2 tttt -42.81 -69.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 0.0 110.671 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 55' ' ' LYS . 38.7 p30 -63.48 -17.96 63.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -62.44 -12.17 20.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 46.02 81.74 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -105.63 134.66 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.386 -1.067 . . . . 0.0 109.804 -179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.32 96.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 0.0 108.597 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD1' HD11 ' A' ' 35' ' ' LEU . 8.0 m95 -42.06 103.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -126.12 -164.01 11.68 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.06 -70.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.0 109.383 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -61.02 -36.63 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.432 -0.792 . . . . 0.0 109.748 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.438 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.62 -36.23 75.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.5 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.08 -33.73 57.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.335 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 tpt -54.69 -38.75 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.98 -58.15 3.49 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.404 -0.81 . . . . 0.0 109.491 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 53.6 t80 -52.9 -18.92 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.925 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.757 HD23 ' HD2' ' A' ' 91' ' ' ARG . 1.5 tp -92.33 -38.84 11.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.557 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -59.48 -22.55 61.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 8.3 p30 -178.58 88.98 0.22 Allowed Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -75.55 -43.25 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.466 2.111 . . . . 0.0 110.292 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -21.69 65.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.227 -0.921 . . . . 0.0 108.833 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -89.09 -38.91 13.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.389 -0.819 . . . . 0.0 109.227 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 3.9 t80 -75.76 -68.73 0.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.7 HG22 ' CB ' ' A' ' 51' ' ' ALA . 12.1 mm -93.0 109.8 41.79 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.541 -0.724 . . . . 0.0 109.335 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 34.5 Cg_endo -76.23 87.8 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.218 1.945 . . . . 0.0 110.541 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 153.37 -27.14 0.78 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.482 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -42.24 145.51 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -1.099 . . . . 0.0 110.023 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG3' ' O1D' ' A' ' 105' ' ' HEC . 3.2 mttp -107.26 18.9 21.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.487 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -61.59 127.28 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 110.016 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 81' ' ' ILE . 17.7 mt -95.86 27.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' HB2' ' HE3' ' A' ' 80' ' ' MET . 0.4 OUTLIER -65.38 163.74 15.06 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.546 0.689 . . . . 0.0 110.385 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 p -100.35 -27.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.516 -0.74 . . . . 0.0 109.335 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.01 68.17 0.78 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.497 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 33.9 mm -60.87 119.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 109.587 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -4.2 57.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.945 . . . . 0.0 109.426 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.08 111.83 4.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.21 -37.26 77.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.95 -41.54 97.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.317 -0.865 . . . . 0.0 109.691 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.49 ' OE1' ' CA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -63.89 -49.47 72.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.594 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.998 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.85 -40.04 75.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.2 77.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.802 ' CB ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -63.08 -32.91 74.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.829 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt -64.91 -53.15 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.702 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -60.21 -38.64 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.5 83.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.996 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.26 -53.41 57.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.2 -0.938 . . . . 0.0 109.571 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 98' ' ' LEU . 3.6 mm? -65.23 -15.8 62.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.389 -0.819 . . . . 0.0 109.809 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -80.56 -28.76 37.16 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.003 -1.061 . . . . 0.0 110.158 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -102.0 -56.05 2.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.866 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.79 65.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -142.85 46.76 1.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.002 -1.061 . . . . 0.0 110.151 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 7.1 t30 174.12 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.019 . . . . 0.0 110.03 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 3.3 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.324 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 0.88 HMB1 HBB3 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.27 166.13 13.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.54 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 4' ' ' GLU . 13.1 p -92.45 -37.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.893 . . . . 0.0 109.45 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.4 mt-10 -65.26 -12.61 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.529 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -91.26 -54.08 4.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -55.83 -39.91 79.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 26.6 tttp -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 0.0 109.538 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -74.51 -27.77 60.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG2' HD21 ' A' ' 94' ' ' LEU . 80.5 mt -61.22 -63.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.14 -0.975 . . . . 0.0 109.023 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CE1' HG13 ' A' ' 20' ' ' VAL . 40.1 t80 -62.69 -42.21 99.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 108.728 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 9.2 mm -61.5 -18.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.747 . . . . 0.0 109.297 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' A' ' 12' ' ' MET . 4.6 tpt -128.52 18.54 6.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 109.618 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HG2' HBB1 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -131.64 -50.42 0.98 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -126.51 23.23 6.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.126 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.6 t -87.84 -2.28 58.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.821 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -92.28 -45.79 8.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 108.488 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.4 m -90.94 -35.65 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.882 ' CG ' HD22 ' A' ' 32' ' ' LEU . 65.1 m-70 -110.63 85.01 2.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.063 -1.023 . . . . 0.0 110.339 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -79.84 99.39 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.75 -1.219 . . . . 0.0 108.821 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.4 m -86.95 33.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 21.71 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.28 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -63.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.26 64.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.09 13.23 40.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -100.12 156.92 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.613 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -152.69 119.91 5.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.369 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -93.3 -86.0 0.26 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 22.2 m -87.93 -43.41 11.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.799 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -101.2 153.29 19.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.672 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.1 Cg_endo -66.71 132.81 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.947 2.431 . . . . 0.0 111.692 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -49.58 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.44 0.638 . . . . 0.0 109.909 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.882 HD22 ' CG ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.89 69.93 7.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.509 -0.745 . . . . 0.0 110.677 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -100.5 -59.46 1.7 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.053 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.76 36.72 4.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 59' ' ' TRP . 14.3 tp -48.87 -30.03 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.096 . . . . 0.0 109.768 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 76.5 m-85 -75.56 124.49 27.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.961 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.03 69.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.38 107.8 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.023 -1.281 . . . . 0.0 109.576 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' THR . 4.3 pttt -61.3 150.13 35.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.864 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -46.74 176.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 109.886 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . . . 55.99 91.96 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -151.52 -43.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -1.169 . . . . 0.0 109.644 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -58.29 146.09 72.33 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.618 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.77 -62.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.794 2.329 . . . . 0.0 110.761 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.33 46.51 3.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -160.79 114.03 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.176 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.523 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 25.4 m -79.15 77.27 5.66 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.2 m-85 -46.23 -179.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.752 -0.593 . . . . 0.0 109.787 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.68 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.995 . . . . 0.0 108.971 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.46 -38.94 64.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -49.72 -64.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.864 ' HB3' HG21 ' A' ' 40' ' ' THR . 2.4 t-20 -53.51 -41.16 66.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.868 -1.145 . . . . 0.0 109.373 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HA ' HG23 ' A' ' 40' ' ' THR . 24.5 tttm -52.1 -37.0 52.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -82.07 -23.44 35.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 110.33 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 28.9 tttt -76.4 3.07 11.87 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.985 -1.072 . . . . 0.0 109.671 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.2 11.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.739 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -103.8 132.01 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.739 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -96.67 112.41 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 108.648 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.638 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 6.1 m95 -59.95 105.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 110.047 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.99 -157.83 8.81 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 95' ' ' ILE . 45.6 tt0 -77.78 -63.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -1.118 . . . . 0.0 109.567 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -37.71 85.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.927 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -45.07 92.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.827 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.891 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.7 OUTLIER -66.78 -34.27 77.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.993 . . . . 0.0 109.271 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.514 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 2.5 tmm? -54.26 -38.41 65.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.397 -0.815 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.01 -60.81 2.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CD1' HG12 ' A' ' 75' ' ' ILE . 39.0 t80 -54.42 -17.71 3.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.781 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.826 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.1 tp -90.74 -31.22 16.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.023 -1.048 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.74 -27.34 66.42 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -177.75 100.61 0.22 Allowed Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.6 Cg_endo -76.34 -40.71 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.356 2.037 . . . . 0.0 110.262 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 9.5 tptm -70.84 -12.11 61.35 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -102.32 -35.66 8.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.965 . . . . 0.0 109.314 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CE2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -76.84 -69.35 0.53 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 108.618 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.772 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -95.2 111.09 53.73 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.901 . . . . 0.0 109.214 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.15 70.24 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.289 1.993 . . . . 0.0 110.385 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -177.47 -38.3 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.576 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -44.71 158.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -108.54 -2.8 18.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.17 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.734 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.9 ptm -88.83 121.99 31.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.067 -1.021 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 81' ' ' ILE . 4.2 mp -99.24 45.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.62 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 48.4 t80 -59.51 147.78 35.57 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 14.0 p -88.04 141.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.585 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.88 120.04 9.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.697 HG21 ' HB3' ' A' ' 90' ' ' GLU . 2.3 mp -62.06 128.51 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -1.159 . . . . 0.0 109.407 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 37.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -143.78 115.73 8.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 1.1 tppt? -64.96 -26.25 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.28 -43.92 54.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.211 -0.93 . . . . 0.0 109.769 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.697 ' HB3' HG21 ' A' ' 85' ' ' ILE . 1.3 tt0 -59.47 -38.96 82.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.415 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.514 ' NH1' ' HG2' ' A' ' 65' ' ' MET . 1.4 mtp180 -65.62 -47.47 75.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.168 -0.957 . . . . 0.0 109.089 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -55.15 -36.58 65.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.888 . . . . 0.0 109.28 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -30.46 66.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.408 -0.807 . . . . 0.0 109.342 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.71 HD21 ' CG2' ' A' ' 9' ' ' ILE . 43.5 mt -65.46 -58.33 6.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 61' ' ' GLU . 3.3 mm -66.14 -29.09 45.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 109.221 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -61.39 -40.57 94.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.603 -0.685 . . . . 0.0 109.929 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -73.12 -52.94 12.35 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.109 -0.994 . . . . 0.0 109.245 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.852 ' O ' HG22 ' A' ' 102' ' ' THR . 1.4 mm? -60.43 -16.97 41.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.416 -0.803 . . . . 0.0 109.921 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HD2' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.76 -48.04 11.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.883 -1.135 . . . . 0.0 109.463 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.29 77.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.9 -50.03 11.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 98' ' ' LEU . 13.8 t -120.27 40.33 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.948 -1.095 . . . . 0.0 110.368 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' CA ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -167.97 39.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.481 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.014 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -158.17 102.98 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.889 HG21 ' HE2' ' A' ' 100' ' ' LYS . 9.9 p -79.07 -34.87 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 5' ' ' LYS . 15.4 pt-20 -53.47 -36.26 61.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 0.0 109.75 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -97.64 -14.11 21.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.06 -41.21 97.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 20.0 ttmt -61.94 -22.38 65.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.067 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -78.81 -40.41 33.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.086 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 HD21 ' A' ' 94' ' ' LEU . 42.8 mt -62.36 -50.95 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 108.798 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 98' ' ' LEU . 34.5 t80 -62.55 -39.22 92.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 6.7 mm -61.48 -22.2 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.42 -0.8 . . . . 0.0 108.872 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.04 13.28 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 4.1 tptt -126.86 -55.74 1.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.188 . . . . 0.0 110.381 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.552 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -130.68 22.36 5.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.821 -1.174 . . . . 0.0 110.216 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 40.0 t -86.41 7.37 26.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.935 -1.103 . . . . 0.0 109.461 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -100.53 -54.58 2.81 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 10.5 m -82.85 -27.41 30.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.975 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.6 m-70 -115.2 88.8 2.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.135 -0.978 . . . . 0.0 110.059 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.2 p -78.7 83.37 4.86 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.045 -1.035 . . . . 0.0 108.457 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' VAL . 2.7 m -84.02 30.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 110.304 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.18 19.57 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.324 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -97.43 -61.1 1.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.23 62.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.54 16.1 54.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -92.0 144.7 25.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -1.155 . . . . 0.0 109.532 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.489 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.79 133.19 19.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 109.683 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 -77.13 0.58 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.692 ' O ' HMD3 ' A' ' 105' ' ' HEC . 52.5 m -90.53 -40.14 12.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.529 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.509 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -104.99 152.63 17.33 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -68.04 133.15 28.12 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.385 2.057 . . . . 0.0 111.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.4 t-20 -49.1 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.475 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.975 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.93 67.69 8.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.545 -0.722 . . . . 0.0 109.49 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 102' ' ' THR . 5.4 t-160 -98.24 -6.93 30.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 109.874 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.82 61.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -78.69 -30.98 46.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.27 -1.136 . . . . 0.0 109.858 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 83.6 m-85 -67.97 124.33 23.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.98 28.62 62.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.03 120.56 9.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.523 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 173.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.962 . . . . 0.0 109.212 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.986 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -85.57 175.44 8.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 42' ' ' GLN . . . 60.67 96.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tp60 -159.86 -55.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.853 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -44.32 133.24 4.52 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.21 139.62 15.01 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.578 2.185 . . . . 0.0 110.605 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.07 -49.96 4.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.09 104.51 12.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.462 -1.022 . . . . 0.0 108.84 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.62 80.59 4.09 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 6.6 m-30 -44.35 173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.695 HG22 HAD1 ' A' ' 105' ' ' HEC . 0.1 OUTLIER -62.89 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.129 -0.982 . . . . 0.0 108.435 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -41.52 -37.83 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -0.763 . . . . 0.0 109.856 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.669 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -39.78 -64.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.702 -0.624 . . . . 0.0 109.4 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.619 ' N ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -45.83 -51.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.868 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.493 ' CA ' ' OG1' ' A' ' 40' ' ' THR . 25.2 tttt -49.93 -41.45 46.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -71.46 -32.17 67.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.011 -1.055 . . . . 0.0 110.127 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.75 2.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.039 -1.038 . . . . 0.0 109.736 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.27 52.58 46.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.997 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.35 132.92 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -1.019 . . . . 0.0 110.371 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.997 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -95.29 97.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.986 ' NE1' HG22 ' A' ' 40' ' ' THR . 10.1 m95 -37.16 122.77 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.634 0.73 . . . . 0.0 111.127 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -143.04 -164.06 10.03 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -76.08 -73.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 0.0 109.617 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.53 -33.59 72.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.691 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -47.22 86.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 108.835 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.667 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -61.69 -35.83 79.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.46 -0.775 . . . . 0.0 109.005 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ttt -55.79 -35.12 65.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.412 -0.805 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' OE2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 tm-20 -71.94 -60.02 2.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.793 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 24.8 t80 -54.79 -21.17 10.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.938 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -88.02 -33.21 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.444 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.91 -23.92 66.63 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.519 ' HA ' HG11 ' A' ' 83' ' ' VAL . 9.9 t-20 -177.82 96.54 0.22 Allowed Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 32.2 Cg_endo -74.34 -30.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.446 2.097 . . . . 0.0 110.182 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -13.34 60.54 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 108.646 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -95.58 -46.32 6.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.117 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' OE2' ' A' ' 66' ' ' GLU . 13.2 t80 -71.46 -64.05 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.006 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.2 mm -79.31 126.44 81.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.7 Cg_endo -74.98 74.24 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.122 1.882 . . . . 0.0 110.692 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.39 33.37 1.62 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.0 t -50.48 162.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.342 . . . . 0.0 108.929 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.62 12.35 35.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.949 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.755 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 6.3 ptm -130.57 128.64 41.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 81' ' ' ILE . 9.1 tp -109.41 40.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 1.042 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -59.72 -39.47 84.75 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.451 -178.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -22.77 115.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.585 0.707 . . . . 0.0 111.461 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.04 35.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.741 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 1.1 mp -111.06 174.82 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -1.139 . . . . 0.0 109.636 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 85' ' ' ILE . 4.5 mmtt -171.13 41.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -139.93 127.82 22.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.955 . . . . 0.0 109.291 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -71.45 -54.8 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.831 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.86 -42.2 68.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.973 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.1 tt0 -59.98 -39.09 84.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.129 -0.982 . . . . 0.0 109.565 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 87' ' ' LYS . 1.3 mmt85 -59.85 -50.67 72.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 -39.99 75.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.429 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -29.55 69.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.587 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.618 HD21 HG22 ' A' ' 9' ' ' ILE . 20.6 mt -64.25 -47.4 79.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.877 . . . . 0.0 109.186 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.648 HG21 ' HG2' ' A' ' 61' ' ' GLU . 3.6 mm -71.2 -30.84 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.137 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.03 79.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 101' ' ' ALA . 13.1 t80 -69.61 -33.59 72.89 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 108.951 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -78.63 -9.5 59.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.363 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.11 -16.52 17.81 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.889 ' HE2' HG21 ' A' ' 3' ' ' VAL . 3.3 mtpt -108.9 -20.14 13.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.564 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . . . -91.08 -43.45 9.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.384 -0.822 . . . . 0.0 109.935 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -104.0 -59.27 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.677 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 18.8 t-20 -53.2 -26.76 18.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 100' ' ' LYS . 29.5 tp10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.455 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.042 HBB2 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -154.09 147.44 24.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.84 -51.3 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.754 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -63.87 -15.83 59.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 2' ' ' ASP . 7.0 tttm -82.15 -72.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.873 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -53.77 -28.2 38.14 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 35.4 tttt -65.98 -37.77 86.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 109.858 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -75.21 -26.07 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' CD2' ' A' ' 94' ' ' LEU . 33.4 mm -64.3 -60.79 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.636 ' CE2' HG13 ' A' ' 20' ' ' VAL . 39.5 t80 -61.28 -38.3 86.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 49.4 mt -64.13 -22.49 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 tpp -122.84 16.03 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.126 -0.984 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 6.6 tppt? -127.57 -49.01 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.091 -1.006 . . . . 0.0 109.553 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -131.76 28.69 4.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.982 . . . . 0.0 108.88 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.1 t -86.66 -4.16 59.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -95.23 -43.48 8.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.246 -0.908 . . . . 0.0 108.917 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 7.0 m -91.26 -44.19 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.963 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.871 ' ND1' HD22 ' A' ' 32' ' ' LEU . 59.6 m-70 -101.92 81.81 2.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.047 . . . . 0.0 109.772 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 p -79.66 95.51 5.95 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.826 -1.171 . . . . 0.0 108.877 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.636 HG13 ' CE2' ' A' ' 10' ' ' PHE . 3.0 m -82.37 13.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.867 . . . . 0.0 109.859 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.32 17.15 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 110.057 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -89.95 -23.94 21.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 109.709 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.35 60.36 0.55 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.71 9.53 52.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 3.5 tttp -91.61 130.76 37.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -1.166 . . . . 0.0 109.536 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.506 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.01 104.85 5.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 -82.03 0.13 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.13 -0.981 . . . . 0.0 110.181 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' HMD3 ' A' ' 105' ' ' HEC . 10.8 m -89.9 -30.86 17.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -108.65 150.4 17.05 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.666 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -67.29 129.05 19.52 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.79 2.327 . . . . 0.0 111.103 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.0 t-20 -48.68 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.64 -0.663 . . . . 0.0 110.128 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.871 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -83.64 62.27 6.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.576 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 46.3 p-80 -100.26 52.78 0.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.311 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 38' ' ' ARG . . . 118.74 64.49 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -78.3 -26.42 46.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -1.071 . . . . 0.0 110.269 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 7.1 m-30 -71.88 125.63 27.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.076 . . . . 0.0 110.981 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.07 -6.51 69.19 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.203 -0.999 . . . . 0.0 111.281 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.601 ' HD2' ' NE2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -122.13 134.59 54.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.658 -1.495 . . . . 0.0 110.287 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -70.76 150.42 45.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -60.95 163.77 5.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.018 . . . . 0.0 110.212 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.66 99.27 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.601 ' NE2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -160.78 -34.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.258 . . . . 0.0 110.026 179.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.62 128.7 85.14 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.065 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.7 149.73 21.03 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.531 2.154 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.49 -14.2 55.82 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -126.02 111.64 14.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -1.073 . . . . 0.0 108.3 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.49 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 2.0 p -74.27 78.84 1.82 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.666 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.8 m-85 -48.18 179.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.833 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.9 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.16 -40.76 11.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.623 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -53.88 -67.85 0.23 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.449 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.623 ' ND2' HG13 ' A' ' 75' ' ' ILE . 7.2 m-80 -36.26 -53.8 0.82 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.443 -0.785 . . . . 0.0 111.078 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -55.37 -59.49 4.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.931 -1.106 . . . . 0.0 110.176 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.04 -12.43 11.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.347 -0.846 . . . . 0.0 110.675 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -79.31 5.75 11.68 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.861 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.16 45.88 10.23 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.39 114.06 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -1.125 . . . . 0.0 109.868 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.62 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -77.35 108.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.57 ' CD1' HD11 ' A' ' 35' ' ' LEU . 4.9 m95 -46.74 113.63 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.52 179.24 17.24 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.1 -60.49 2.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.277 . . . . 0.0 109.535 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.49 -41.72 98.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.676 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.58 -32.44 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.694 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -78.58 -32.73 47.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.753 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 tpp -60.54 -35.76 76.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -54.07 7.53 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 45.6 t80 -56.13 -26.5 50.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.869 HD21 HMB2 ' A' ' 105' ' ' HEC . 1.1 tp -81.97 -39.54 23.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -59.87 -23.18 63.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 9.3 m120 -168.33 96.22 0.58 Allowed Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.748 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.0 Cg_endo -77.08 -29.91 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.417 2.078 . . . . 0.0 110.44 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -85.29 -31.87 22.83 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.318 -0.863 . . . . 0.0 109.516 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 3.6 mmmt -78.57 -35.29 46.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.001 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 75' ' ' ILE . 22.1 t80 -75.81 -69.05 0.52 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -101.16 117.73 61.68 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 61.37 8.21 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.428 2.086 . . . . 0.0 110.017 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.45 -48.3 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 49' ' ' THR . 7.4 t -50.68 167.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.283 . . . . 0.0 109.847 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -135.48 10.19 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.749 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.8 ptm -76.41 123.33 25.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 mt -97.87 35.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.87 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 4.4 t80 -59.7 -35.28 74.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.539 . . . . 0.0 109.888 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG13 ' HD3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -38.75 96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.498 -0.751 . . . . 0.0 110.085 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -156.09 20.84 0.5 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.615 HD13 ' HD2' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -105.2 163.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -1.138 . . . . 0.0 109.242 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -143.36 16.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.434 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.98 123.08 36.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 0.0 109.639 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -37.56 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 109.419 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -56.85 -39.67 74.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.672 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.5 -49.26 72.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -52.62 -45.19 66.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 0.0 109.04 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.61 79.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 109.213 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 89' ' ' GLU . 13.2 m-20 -59.37 -35.9 74.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 91' ' ' ARG . 38.1 mt -58.67 -46.42 87.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.612 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.2 mm -67.85 -49.03 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 0.0 110.039 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.19 -39.19 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.435 -0.79 . . . . 0.0 110.394 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 36.7 t80 -70.51 -50.67 35.4 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.999 -1.063 . . . . 0.0 110.085 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 98' ' ' LEU . 2.3 mm? -72.23 -4.49 29.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -99.49 -20.46 16.41 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.157 -0.964 . . . . 0.0 109.883 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -107.28 -20.08 13.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.647 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.92 -36.34 12.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 110.003 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.414 ' HB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -130.96 47.38 2.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.638 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 10.0 t30 -171.93 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 109.35 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.01 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -143.64 171.47 14.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -1.13 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 4' ' ' GLU . 12.7 p -96.02 -46.26 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.538 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 3' ' ' VAL . 3.8 mt-10 -64.55 -19.9 65.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 9' ' ' ILE . 9.9 mttt -91.55 -33.26 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.48 -20.55 75.54 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 25.4 ttpt -70.58 -32.98 70.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -1.118 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 11' ' ' ILE . 6.6 mttp -85.46 -31.8 22.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 29.4 mm -57.62 -57.33 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.009 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.784 ' CD2' HD21 ' A' ' 98' ' ' LEU . 20.6 t80 -67.33 -41.65 84.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 108.989 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 8.7 mm -55.85 -18.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 109.108 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 ttt -119.21 -5.89 10.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.94 -62.03 1.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.586 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -126.49 41.92 3.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.028 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -95.45 -1.1 51.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.828 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.17 -35.26 9.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 108.764 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.7 m -99.96 -21.43 15.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.0 m-70 -126.15 80.42 1.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 0.0 109.742 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -79.0 90.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.514 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.7 8.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 110.394 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -164.94 23.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.927 -1.108 . . . . 0.0 109.9 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 22' ' ' LYS . 2.9 tmtp? -100.62 37.47 1.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.133 -0.979 . . . . 0.0 109.199 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.63 -30.45 8.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.19 8.64 40.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -95.32 117.63 30.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.209 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -90.69 172.05 8.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.052 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -160.01 -91.62 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.372 -0.83 . . . . 0.0 108.912 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.845 ' O ' HMD3 ' A' ' 105' ' ' HEC . 11.5 m -65.2 -59.76 3.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 108.741 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -95.86 153.9 20.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' HD3' ' C3D' ' A' ' 105' ' ' HEC . 33.2 Cg_endo -69.49 134.42 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.176 1.917 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 26' ' ' HIS . 6.9 t-20 -46.55 101.4 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.8 41.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 109.911 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -91.33 70.85 6.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.36 19.37 5.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.927 HD21 ' CD1' ' A' ' 59' ' ' TRP . 17.9 tp -53.77 -29.81 41.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.142 . . . . 0.0 109.508 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HB3' ' OD1' ' A' ' 103' ' ' ASN . 14.4 m-85 -69.85 135.56 49.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.29 83.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NH1' HD12 ' A' ' 35' ' ' LEU . 31.2 ttp85 -155.21 123.75 6.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.257 . . . . 0.0 109.599 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -61.7 164.86 5.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.195 -0.94 . . . . 0.0 109.063 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.505 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 5.8 t -101.53 169.6 8.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.515 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.496 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 88.93 67.43 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -161.8 -32.07 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.138 -1.213 . . . . 0.0 110.739 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -36.39 141.15 0.37 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.785 . . . . 0.0 110.331 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 35.5 Cg_endo -77.58 128.21 9.34 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.626 2.217 . . . . 0.0 110.487 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.46 -47.35 3.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -100.5 63.84 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.482 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 m -62.9 95.46 0.08 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 30' ' ' PRO . 1.5 m-30 -50.91 -179.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.756 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.941 HG21 ' C ' ' A' ' 77' ' ' GLY . 3.2 p -59.58 90.37 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.001 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -31.4 -35.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.701 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -39.7 -62.93 0.63 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.713 ' CA ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -38.78 -69.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 110.665 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.461 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 2.3 tmtt? -43.12 -38.97 2.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -66.14 -41.91 89.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 110.488 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HG2' ' CE2' ' A' ' 74' ' ' TYR . 45.4 tptt -50.68 -20.42 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 109.123 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.57 39.47 97.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.758 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -103.88 119.04 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.605 -0.938 . . . . 0.0 110.373 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -82.17 100.78 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.148 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.927 ' CD1' HD21 ' A' ' 35' ' ' LEU . 6.3 m95 -38.81 118.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 111.05 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.13 -159.61 9.61 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -77.41 -63.02 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.11 -1.229 . . . . 0.0 109.735 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.28 -35.79 71.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.172 -0.955 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.51 -46.27 89.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.095 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -70.22 -36.08 74.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.27 45.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.76 -50.07 59.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.51 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 54.3 t80 -54.87 -21.86 12.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.756 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.669 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.2 mp -86.73 -38.11 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.369 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.25 -23.51 62.41 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.27 95.04 0.23 Allowed Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.872 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -73.7 -36.34 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.354 2.036 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -70.37 -9.06 55.2 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 108.927 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -91.91 -50.21 5.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -71.89 -64.93 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 52' ' ' ASN . 4.7 mm -91.35 108.93 32.41 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.76 73.15 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.311 2.007 . . . . 0.0 110.291 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.941 ' C ' HG21 ' A' ' 49' ' ' THR . . . 171.34 -28.97 0.11 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.924 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 71' ' ' PRO . 11.1 t -50.4 134.1 23.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.849 -1.383 . . . . 0.0 109.45 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.78 12.0 37.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.726 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 5.3 ptm -87.23 123.16 31.94 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.94 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 81' ' ' ILE . 37.4 mm -109.44 36.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -58.9 -31.88 69.03 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.976 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.583 ' CG1' ' HD3' ' A' ' 71' ' ' PRO . 3.4 m -34.32 104.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.453 0.644 . . . . 0.0 110.536 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.75 -40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD11 ' CD ' ' A' ' 13' ' ' LYS . 49.0 mt -60.94 143.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.89 45.44 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.2 7.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.714 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -52.18 -28.18 17.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.17 -46.63 70.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.945 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.754 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -52.51 -42.54 64.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 109.341 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.61 87.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -30.11 70.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.683 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -75.23 -34.39 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.566 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -47.13 81.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 109.947 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -70.16 -44.21 69.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.784 HD21 ' CD2' ' A' ' 10' ' ' PHE . 1.5 mm? -71.38 -7.7 48.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.1 -1.0 . . . . 0.0 109.434 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.08 -16.93 17.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.776 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -104.11 -26.44 12.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 110.14 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.7 -45.74 9.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.146 -0.971 . . . . 0.0 110.295 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.2 38.51 3.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.699 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 36' ' ' PHE . 1.2 t30 -176.41 61.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.031 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER -146.34 145.74 30.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -1.205 . . . . 0.0 109.633 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.616 HG22 ' HD2' ' A' ' 7' ' ' LYS . 6.5 p -66.8 -41.62 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.0 tm-20 -59.06 -24.36 62.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.383 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.2 tptm -75.12 -53.44 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 97' ' ' TYR . . . -72.18 -67.66 1.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.616 ' HD2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -39.66 -35.27 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.44 -1.035 . . . . 0.0 110.305 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.55 -44.29 57.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 0.0 109.53 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -72.42 -65.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.705 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 98' ' ' LEU . 18.3 t80 -46.05 -40.83 11.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.726 -1.234 . . . . 0.0 109.803 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' SER . 6.9 mm -62.05 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.023 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -107.51 20.12 19.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.129 -0.982 . . . . 0.0 109.842 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -126.96 -61.33 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.772 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 1.9 m -113.3 5.07 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 0.0 110.161 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -88.79 27.23 1.35 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.809 -1.182 . . . . 0.0 109.244 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.32 -61.08 1.46 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 28' ' ' THR . 5.3 m -80.02 -30.83 39.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.845 ' HD1' HD13 ' A' ' 32' ' ' LEU . 66.4 m-70 -102.18 173.56 6.32 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.044 0.926 . . . . 0.0 109.46 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 18' ' ' HIS . 20.9 p -161.85 92.77 0.87 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.5 m -84.14 34.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.78 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.416 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 tptt -101.23 35.89 2.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.85 -35.28 4.03 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.76 0.18 6.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 137.92 37.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.554 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -120.04 102.53 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.01 . . . . 0.0 110.475 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.72 -74.58 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.759 HG21 ' SG ' ' A' ' 17' ' ' CYS . 66.4 m -89.77 -99.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 28' ' ' THR . . . -51.73 150.62 7.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.4 Cg_endo -69.81 156.67 62.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 111.417 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.554 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -63.26 102.1 0.36 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.845 HD13 ' HD1' ' A' ' 18' ' ' HIS . 3.7 mp -79.05 71.17 5.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 109.997 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t60 -100.51 -57.71 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.044 . . . . 0.0 109.013 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -111.24 23.1 19.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.758 HD11 HMA3 ' A' ' 105' ' ' HEC . 1.3 tt -44.25 -36.02 2.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -1.082 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 4.4 m-30 -65.81 142.1 58.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.371 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 15.28 61.47 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 5.4 tmm_? -136.76 142.77 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -1.152 . . . . 0.0 109.589 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -82.07 -171.54 3.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -92.92 -176.73 4.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.873 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' H ' HG22 ' A' ' 40' ' ' THR . . . 51.09 101.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 43' ' ' ALA . 2.2 tp60 -157.92 -77.1 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.238 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -40.84 136.51 1.53 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.966 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.59 152.27 29.45 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.707 2.271 . . . . 0.0 110.265 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.63 -53.03 4.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.7 OUTLIER -99.35 69.86 1.7 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.421 -1.046 . . . . 0.0 108.621 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 p -67.8 97.72 0.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 30' ' ' PRO . 1.4 m-30 -53.52 -175.72 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.769 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 49' ' ' THR . 3.3 t -60.9 88.02 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -36.84 -32.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.313 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.637 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -45.13 -63.03 1.02 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.718 -0.613 . . . . 0.0 109.464 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.75 -52.99 6.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.973 . . . . 0.0 109.404 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -50.52 -42.32 54.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 109.664 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.56 -42.83 99.79 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.865 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -49.71 -21.13 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.049 -1.032 . . . . 0.0 109.272 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.3 46.48 78.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -104.05 123.12 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.531 -0.982 . . . . 0.0 110.249 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -87.71 100.9 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 7.4 m95 -40.2 116.72 0.7 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.825 0.822 . . . . 0.0 110.82 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -148.19 -154.09 6.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -77.68 -74.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.262 . . . . 0.0 109.588 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.45 -34.72 78.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 110.301 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.992 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -64.42 -56.13 16.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.274 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -64.94 -21.88 66.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 19.9 ttt -67.14 -32.66 73.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.315 -0.865 . . . . 0.0 109.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -54.42 6.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.412 -0.805 . . . . 0.0 109.794 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.667 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 4.9 t80 -54.99 -36.89 65.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.926 -1.109 . . . . 0.0 109.168 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.883 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -77.68 -27.85 50.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.36 -26.66 65.25 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.28 101.95 0.24 Allowed Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.586 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.6 Cg_endo -74.56 -27.09 11.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.372 2.048 . . . . 0.0 109.838 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -78.27 -19.33 53.88 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.598 -0.689 . . . . 0.0 109.371 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.578 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -97.53 -29.92 13.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.024 -1.048 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' HD2' HD11 ' A' ' 75' ' ' ILE . 3.7 t80 -80.81 -70.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 51' ' ' ALA . 1.6 mm -85.63 119.2 71.88 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.4 Cg_endo -73.25 82.83 1.54 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 110.482 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 113.02 26.24 4.16 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.7 t -43.99 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.039 -1.271 . . . . 0.0 109.293 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 10.6 mmtm -93.9 0.75 56.32 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.783 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.786 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 2.5 ptt? -118.1 119.31 34.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.07 -1.019 . . . . 0.0 109.727 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.4 mm -89.51 49.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.286 -0.883 . . . . 0.0 108.919 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.698 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 35.1 t80 -59.99 152.65 23.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.371 -0.831 . . . . 0.0 109.183 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 83' ' ' VAL . 12.4 p -81.71 10.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 83' ' ' VAL . . . 54.32 169.24 0.04 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.574 HG21 ' HB3' ' A' ' 90' ' ' GLU . 1.9 mp -120.65 153.44 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.272 -1.134 . . . . 0.0 109.372 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.1 11.79 5.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.463 ' H ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -66.15 -32.42 73.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.798 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.71 -52.57 64.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 85' ' ' ILE . 2.2 tt0 -59.98 -40.7 90.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.73 -39.04 57.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.584 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -70.29 -38.6 75.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -66.43 -28.89 68.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 68' ' ' LEU . 89.0 mt -73.82 -62.04 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.159 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.564 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.2 mm -61.06 -30.42 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -62.56 -48.85 77.69 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 110.35 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.65 ' HD2' HD22 ' A' ' 98' ' ' LEU . 61.3 t80 -63.53 -47.47 81.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.034 -1.042 . . . . 0.0 110.442 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 10' ' ' PHE . 2.5 mm? -63.25 -29.2 70.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.596 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -66.27 -36.8 83.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.023 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.27 -18.48 36.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.95 47.08 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.907 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 103' ' ' ASN . 6.7 t -132.85 -43.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.067 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' N ' HG23 ' A' ' 102' ' ' THR . 7.2 t-20 -63.43 -11.83 26.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 0.0 109.546 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.045 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.28 151.05 25.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -1.128 . . . . 0.0 109.42 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.17 -31.66 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -76.23 -31.23 58.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.651 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.7 tppt? -73.14 -55.37 6.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.73 97.45 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 3.3 ttpm? -65.06 -18.82 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -40.7 54.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.017 HG22 HD21 ' A' ' 94' ' ' LEU . 2.9 mp -67.26 -60.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' SER . 38.9 t80 -52.03 -44.78 64.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.115 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 20.2 mt -56.68 -38.01 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 24.8 12.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.043 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -130.23 -62.31 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.285 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -120.6 26.43 9.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.206 -0.934 . . . . 0.0 108.81 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 3.0 t -82.81 4.73 24.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 3.6 tp-100 -99.83 -54.52 2.89 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 108.712 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 44.7 m -83.21 -22.26 33.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -123.31 89.34 3.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.894 . . . . 0.0 109.861 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -93.42 96.28 9.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.96 -1.087 . . . . 0.0 108.806 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.2 m -85.29 31.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.384 -0.823 . . . . 0.0 109.941 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.98 7.19 2.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.017 -1.052 . . . . 0.0 109.708 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -149.47 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.01 36.73 3.92 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.16 80.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.94 159.16 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -141.04 140.77 34.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 -60.88 1.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.554 ' O ' HMD3 ' A' ' 105' ' ' HEC . 85.0 m -100.17 -61.28 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -93.49 156.29 22.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 29.9 Cg_endo -66.77 135.78 39.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.62 2.213 . . . . 0.0 111.335 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.62 103.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 109.534 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.35 46.1 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.436 ' HA ' HG21 ' A' ' 102' ' ' THR . 54.5 t-80 -96.06 69.34 2.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 108.822 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.661 ' N ' HG21 ' A' ' 102' ' ' THR . . . 117.98 16.33 5.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.937 HD21 HMA3 ' A' ' 105' ' ' HEC . 23.0 tp -52.58 -30.69 32.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.507 -0.996 . . . . 0.0 109.872 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 3.3 m-85 -60.9 141.04 57.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.443 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.34 70.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.547 ' NH1' HD12 ' A' ' 35' ' ' LEU . 3.4 tmm_? -135.28 125.63 26.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -1.128 . . . . 0.0 109.382 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 19.1 mttp -72.3 173.39 8.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -74.05 170.26 15.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.738 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.03 108.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.456 ' HG2' ' HD3' ' A' ' 38' ' ' ARG . 1.8 tp60 -160.95 -63.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.976 -1.308 . . . . 0.0 109.91 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -41.75 150.63 0.35 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.266 -0.896 . . . . 0.0 109.906 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.4 -75.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.836 2.357 . . . . 0.0 110.587 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.72 66.02 3.96 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.639 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.58 120.97 2.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 108.998 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.545 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 40.4 t -84.07 70.55 10.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.9 m-85 -44.69 179.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.701 -0.625 . . . . 0.0 110.174 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.852 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -57.79 88.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 108.886 179.407 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.54 -41.4 66.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -51.48 -70.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 108.77 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 75' ' ' ILE . 2.7 m-20 -40.28 -47.28 2.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 110.062 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.95 -57.25 6.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.28 -33.62 75.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.533 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -14.07 6.3 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.114 -0.992 . . . . 0.0 109.824 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 40.81 97.02 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -95.29 133.34 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 0.0 110.034 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.942 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -94.54 112.48 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.617 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 10.0 m95 -54.17 101.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 110.245 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.46 -164.88 12.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -73.97 -67.67 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.01 89.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.872 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.67 -36.31 76.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.7 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -80.24 -27.28 38.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttt -57.03 -47.03 81.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 0.0 109.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.32 -51.56 20.12 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.378 -0.827 . . . . 0.0 109.823 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.617 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 51.9 t80 -54.09 -22.7 11.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 109.664 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.6 tp -90.35 -29.77 17.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.0 109.178 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.75 -24.75 65.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -175.75 102.27 0.25 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.563 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.7 Cg_endo -76.61 -37.47 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.35 2.033 . . . . 0.0 110.258 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -75.13 -17.82 60.34 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.334 -0.853 . . . . 0.0 110.266 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -94.39 -37.65 11.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.856 -1.152 . . . . 0.0 109.581 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.675 ' CE2' HD11 ' A' ' 75' ' ' ILE . 1.9 t80 -76.6 -66.06 0.86 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.869 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.768 HG22 ' CB ' ' A' ' 51' ' ' ALA . 8.1 mm -101.06 106.47 44.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.362 -0.836 . . . . 0.0 109.532 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.86 71.18 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.391 2.06 . . . . 0.0 110.024 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.687 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -173.42 -42.12 0.04 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' HG23 ' A' ' 49' ' ' THR . 14.6 t -43.49 158.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 3.69 21.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.489 -0.757 . . . . 0.0 109.411 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.737 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 9.8 ptm -92.87 118.14 30.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.992 . . . . 0.0 109.934 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mm -92.66 48.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.951 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 15.3 t80 -59.31 146.43 39.6 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.514 0.673 . . . . 0.0 110.173 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 84' ' ' GLY . 8.2 p -88.53 -5.12 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 82' ' ' PHE . . . 67.41 175.15 7.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 85' ' ' ILE . 3.8 mp -107.06 139.38 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -1.201 . . . . 0.0 109.517 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -90.81 -22.03 21.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 121.18 39.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -62.6 -13.63 33.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.35 -56.12 11.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 109.723 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.38 -40.59 81.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.8 ttp180 -56.6 -45.43 81.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.96 -49.38 70.54 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.235 -0.916 . . . . 0.0 109.596 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' HB3' HD13 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -59.72 -21.43 60.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.767 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.017 HD21 HG22 ' A' ' 9' ' ' ILE . 22.2 mt -72.68 -59.64 2.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -56.57 -49.79 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.403 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.94 70.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.611 -0.68 . . . . 0.0 109.633 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 4.5 t80 -53.07 -49.82 65.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.255 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 102' ' ' THR . 1.1 mt -82.65 -12.97 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 1.3 ttmt -79.34 -10.94 59.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.169 -0.957 . . . . 0.0 108.906 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -110.55 -40.06 4.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.91 -55.6 4.86 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.263 -0.898 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.661 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -99.56 30.48 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 9.3 t-20 -165.01 64.85 0.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.389 179.784 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.068 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.34 -173.72 4.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -1.123 . . . . 0.0 109.593 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -97.8 -33.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.65 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -67.15 -40.34 86.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -49.67 -34.77 21.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -57.83 -45.11 86.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -1.138 . . . . 0.0 109.737 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.62 -27.58 60.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.636 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' A' ' 6' ' ' GLY . 51.1 mt -60.25 -53.8 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 6.9 t80 -73.76 -46.6 44.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.257 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 22.7 mm -56.42 -16.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -120.73 -6.66 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 15.8 tppt? -101.98 -65.81 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 109.858 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.569 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -112.04 29.4 7.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.8 t -89.9 -1.15 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.733 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -94.78 -35.6 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.241 -0.912 . . . . 0.0 108.724 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 16.9 m -103.43 -26.28 12.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.045 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.4 m-70 -117.51 78.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.035 -1.041 . . . . 0.0 109.649 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.1 p -78.66 94.8 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.178 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 20' ' ' VAL . 1.6 m -82.16 22.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 0.0 110.519 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -151.21 20.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.902 -1.124 . . . . 0.0 109.467 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.48 -17.97 27.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.65 -27.1 3.11 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.56 -0.94 3.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -88.34 164.68 15.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.076 -1.25 . . . . 0.0 109.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.573 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.994 -1.066 . . . . 0.0 110.234 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -71.02 -75.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 108.867 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 93.7 m -99.81 -58.89 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 108.713 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -83.2 155.53 32.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -67.88 143.36 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.498 2.132 . . . . 0.0 111.048 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.4 t-20 -56.25 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 110.075 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.045 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -85.02 55.44 3.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.403 -0.81 . . . . 0.0 109.826 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -96.99 48.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.269 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.43 62.26 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.469 ' CD1' ' O2A' ' A' ' 105' ' ' HEC . 5.4 tp -79.91 -31.22 40.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.395 -1.062 . . . . 0.0 109.872 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -60.32 137.21 58.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.047 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.4 27.98 73.08 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 58.1 ttp85 -139.96 123.59 17.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.983 -1.304 . . . . 0.0 109.742 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.524 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -64.45 175.59 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.156 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.466 HG21 ' N ' ' A' ' 53' ' ' LYS . 7.5 t -94.81 -173.92 3.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.11 -0.994 . . . . 0.0 109.82 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 91.61 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.637 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 2.2 pm0 -159.44 -36.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.182 -1.187 . . . . 0.0 109.807 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -70.17 137.4 86.88 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 109.566 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.35 173.98 12.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.45 2.1 . . . . 0.0 110.359 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.37 5.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -145.61 121.19 10.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.11 . . . . 0.0 109.12 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -85.04 66.16 9.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.9 m-85 -43.97 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.722 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -67.28 86.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -44.22 -34.97 2.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.17 -59.99 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.62 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 19.4 t-20 -52.85 -52.97 55.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' N ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.85 -33.44 7.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.318 -0.864 . . . . 0.0 109.297 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -77.87 -35.71 50.62 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.383 -0.823 . . . . 0.0 109.772 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -61.11 -11.96 10.59 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.072 -1.018 . . . . 0.0 109.574 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.98 35.93 78.53 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.51 125.45 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.667 -0.902 . . . . 0.0 110.324 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.834 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -87.15 95.33 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 5.3 m95 -34.87 121.79 0.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -142.87 -166.51 11.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -73.91 -65.26 0.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -1.201 . . . . 0.0 109.779 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -60.45 -38.83 85.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.946 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.33 -36.46 75.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 109.303 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.022 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.9 OUTLIER -76.24 -24.09 54.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.172 -0.955 . . . . 0.0 109.347 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -42.02 78.49 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.19 -50.94 13.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 75' ' ' ILE . 23.6 t80 -49.72 -44.99 48.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.379 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.542 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -73.59 -32.15 63.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -25.8 63.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -174.58 84.11 0.34 Allowed Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 33.0 Cg_endo -76.4 -22.13 12.72 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.645 2.23 . . . . 0.0 109.354 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -75.59 -16.56 60.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -101.45 -38.69 7.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.457 -0.777 . . . . 0.0 109.239 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.57 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.4 t80 -73.47 -66.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.912 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.3 mm -97.53 106.72 34.77 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -77.75 83.46 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.259 1.973 . . . . 0.0 110.595 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 149.91 -14.37 1.02 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.695 ' HA ' HG23 ' A' ' 49' ' ' THR . 8.1 t -43.68 132.38 4.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.239 . . . . 0.0 109.908 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 23.8 4.37 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.3 mmm -59.17 125.4 23.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.753 -0.592 . . . . 0.0 109.81 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.589 ' HB ' HBC2 ' A' ' 105' ' ' HEC . 38.5 mm -89.09 17.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -59.45 160.73 6.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.611 -0.681 . . . . 0.0 109.929 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 84' ' ' GLY . 22.0 m -99.96 -42.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.372 -0.83 . . . . 0.0 109.299 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 130.24 88.03 0.48 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.27 161.26 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -1.173 . . . . 0.0 109.172 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -147.44 50.93 1.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.062 -1.023 . . . . 0.0 109.917 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 116.46 15.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.121 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -18.85 65.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.817 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -35.31 60.56 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -81.57 -40.85 22.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -67.86 -51.84 43.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.89 80.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 109.237 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 9' ' ' ILE . 96.1 m-20 -60.48 -28.96 68.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.384 -0.823 . . . . 0.0 109.592 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 18.0 mt -65.05 -51.92 58.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.566 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -59.59 -37.59 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.58 99.63 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.582 -0.699 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -66.1 -46.63 76.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.086 -1.009 . . . . 0.0 109.673 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' A' ' 97' ' ' TYR . 2.0 mm? -72.89 -15.21 61.59 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 2.0 ttpt -76.81 -32.95 57.97 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -38.83 13.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.891 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.43 -56.77 6.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.64 35.85 4.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.25 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -160.77 47.43 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.698 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.344 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.08 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER -122.66 149.84 43.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.32 -17.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.77 -41.47 37.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -40.65 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.928 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -67.11 -50.86 42.91 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -56.39 -27.2 55.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -79.25 -33.84 43.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 0.0 109.216 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.928 HD12 ' HA2' ' A' ' 6' ' ' GLY . 12.7 mt -60.98 -57.1 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 15' ' ' SER . 8.3 t80 -59.59 -46.24 89.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.093 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 15.1 mm -57.81 -22.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.807 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 ttt -122.31 10.75 9.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 22.4 tptt -122.94 -56.52 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.072 . . . . 0.0 109.591 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -118.47 22.0 12.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -84.96 2.86 41.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.986 . . . . 0.0 109.597 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -100.11 -41.66 7.05 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.871 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.468 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 13.1 m -95.18 -26.36 16.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.973 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.9 m-70 -115.09 81.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -0.891 . . . . 0.0 109.808 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 p -78.69 83.27 4.86 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.083 -1.01 . . . . 0.0 108.553 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -82.78 45.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.169 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -165.96 24.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.003 -1.06 . . . . 0.0 109.785 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 25' ' ' LYS . 42.7 tttp -100.22 -73.22 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.48 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.95 52.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 4.98 51.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 9.3 tppt? -91.21 144.86 25.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 109.213 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.435 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -133.04 114.88 14.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.901 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.92 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.328 -0.857 . . . . 0.0 109.28 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -99.9 -47.65 4.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.229 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -84.27 153.4 29.08 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 30.6 Cg_endo -68.74 133.53 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.672 2.248 . . . . 0.0 111.256 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.4 t-20 -50.92 99.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.47 0.652 . . . . 0.0 109.59 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.973 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -80.93 70.87 7.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 109.78 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 28.1 p-80 -100.59 -48.99 4.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 109.901 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 33' ' ' HIS . . . -120.96 30.78 5.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.58 -40.09 8.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -1.193 . . . . 0.0 109.043 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 65.0 m-85 -68.61 147.44 51.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.29 17.59 11.95 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NH1' ' HB3' ' A' ' 42' ' ' GLN . 7.3 ttp85 -147.2 116.08 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -1.211 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -59.39 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 108.94 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.615 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -79.53 -164.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.614 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 53' ' ' LYS . . . 53.99 101.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -154.45 -30.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.24 . . . . 0.0 110.558 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -95.38 135.93 22.9 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.719 -1.238 . . . . 0.0 109.552 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.0 Cg_endo -78.89 136.96 13.62 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.607 2.204 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.29 -24.45 13.8 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.525 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -99.2 108.63 21.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -1.053 . . . . 0.0 108.673 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -76.18 80.17 2.98 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 1.8 m-85 -47.96 -179.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.655 -0.653 . . . . 0.0 109.242 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.845 HG23 ' CBD' ' A' ' 105' ' ' HEC . 0.1 OUTLIER -58.19 88.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.13 -37.31 61.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.459 -0.776 . . . . 0.0 109.707 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.022 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -59.15 -46.29 88.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.586 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.849 ' HA ' HD12 ' A' ' 75' ' ' ILE . 21.9 t-20 -64.37 -54.55 31.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.041 . . . . 0.0 110.008 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CD ' ' HA3' ' A' ' 41' ' ' GLY . 6.2 tttt -50.81 -38.24 47.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.104 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -81.32 -24.1 37.38 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.621 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -65.31 -10.42 32.49 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.141 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.24 63.99 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.07 121.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -1.117 . . . . 0.0 110.256 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -84.66 99.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 m95 -37.82 110.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.606 0.717 . . . . 0.0 110.839 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -129.76 -168.16 12.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.91 -57.22 4.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -1.183 . . . . 0.0 109.877 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.14 -42.18 80.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.291 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.606 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -58.6 -38.39 77.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.999 -1.063 . . . . 0.0 109.286 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -71.59 -33.34 68.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 108.82 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.0 ttp -54.04 -38.22 64.96 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.408 -0.807 . . . . 0.0 109.317 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.95 -57.02 4.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 39.1 t80 -49.16 -31.27 8.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.869 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.1 mp -81.83 -38.14 25.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.052 -1.03 . . . . 0.0 109.266 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -59.08 -22.69 61.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.8 p30 -179.6 99.0 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.653 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.7 Cg_endo -74.22 -33.72 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.403 2.069 . . . . 0.0 110.257 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -13.99 60.26 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.896 . . . . 0.0 108.933 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 2.8 tptm -92.71 -45.11 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.5 t80 -72.2 -67.59 0.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.022 HG22 ' HB3' ' A' ' 51' ' ' ALA . 18.3 mm -95.74 107.48 34.08 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.57 78.12 3.63 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.244 1.963 . . . . 0.0 110.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 164.8 -23.09 0.15 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.7 t -43.63 155.49 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.008 -1.289 . . . . 0.0 109.768 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -111.04 8.49 21.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.012 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.768 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 5.7 ptm -96.4 118.05 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.94 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.1 mm -84.03 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.484 -0.76 . . . . 0.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.74 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 9.6 t80 -99.33 150.47 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -88.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.268 -0.895 . . . . 0.0 109.266 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.67 121.57 1.17 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.561 HG21 ' CG ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -64.5 157.27 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -1.132 . . . . 0.0 109.179 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -10.34 19.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.153 -0.967 . . . . 0.0 109.915 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -91.28 122.94 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.694 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -33.77 72.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -0.844 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 6.5 tt0 -65.53 -27.92 68.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.283 -0.886 . . . . 0.0 109.632 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' CG ' HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -73.3 -42.72 62.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -67.23 -56.66 8.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 109.635 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.51 30.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 5.5 t0 -63.25 -42.31 99.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -0.809 . . . . 0.0 110.126 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' GLU . 6.5 mt -56.25 -44.92 80.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.553 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -65.83 -42.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.67 16.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.687 . . . . 0.0 110.004 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 20.8 t80 -73.85 -46.28 45.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.07 -1.019 . . . . 0.0 109.425 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -71.4 -4.38 26.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.321 -0.862 . . . . 0.0 109.812 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.9 -46.61 8.08 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -79.45 -33.64 42.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.472 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.81 19.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 19.3 p -104.03 -37.85 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.959 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 16.0 t30 -85.05 19.43 2.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 10.0 tt0 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.07 . . . . 0.0 109.477 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.025 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.64 171.8 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -1.197 . . . . 0.0 109.666 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t -78.89 -50.52 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -62.28 -44.07 97.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.612 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -71.52 -32.77 68.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.775 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -56.57 19.17 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 7.5 ttmt -54.8 -26.58 35.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.302 -1.117 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.7 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.78 -36.19 65.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.296 -0.878 . . . . 0.0 108.909 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 43.4 mm -58.21 -59.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 108.718 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.653 ' CE2' HD21 ' A' ' 98' ' ' LEU . 30.6 t80 -58.66 -41.3 85.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 109.099 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -54.26 -30.97 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.112 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 ttt -114.88 7.32 15.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.245 -0.909 . . . . 0.0 110.954 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.21 -61.33 1.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.214 . . . . 0.0 110.275 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -127.44 24.71 6.2 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.065 . . . . 0.0 109.78 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 38.7 t -88.2 2.65 51.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.139 . . . . 0.0 109.824 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -100.59 -55.11 2.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.0 m -81.0 -25.52 37.19 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.038 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -119.39 89.49 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.106 -0.996 . . . . 0.0 109.766 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.7 p -78.43 83.64 4.64 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -80.9 36.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.457 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -161.6 21.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.072 -1.017 . . . . 0.0 109.244 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -73.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.88 55.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.5 18.52 67.88 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.63 132.28 45.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -1.21 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.545 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -127.09 101.04 6.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 110.069 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -70.0 -63.71 1.03 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.604 HG21 ' SG ' ' A' ' 17' ' ' CYS . 20.4 m -104.69 -76.76 0.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -71.26 159.34 53.85 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.9 Cg_endo -68.99 142.89 52.66 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.447 2.098 . . . . 0.0 110.901 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -58.86 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.833 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -81.68 73.65 8.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.459 -0.776 . . . . 0.0 109.825 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.74 -62.94 1.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.26 28.03 11.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.985 HD21 HMA3 ' A' ' 105' ' ' HEC . 47.9 tp -49.66 -26.37 3.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -1.059 . . . . 0.0 109.835 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.622 ' CD1' HG21 ' A' ' 102' ' ' THR . 13.1 m-85 -72.78 130.92 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.24 79.64 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' NH2' HD12 ' A' ' 35' ' ' LEU . 7.1 ttp85 -133.97 126.99 31.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.136 -1.214 . . . . 0.0 109.667 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -61.82 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.722 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -97.55 -179.31 4.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -0.928 . . . . 0.0 109.769 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.44 97.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.724 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 4.1 pm0 -160.74 -33.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.986 -1.302 . . . . 0.0 110.455 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.21 138.49 96.04 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.973 -1.079 . . . . 0.0 109.601 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.45 -34.4 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.63 2.22 . . . . 0.0 110.676 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.93 49.08 1.04 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CG ' ' CD1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -160.21 128.37 4.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.027 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -86.29 54.24 3.08 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.724 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.1 m-85 -31.59 149.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.29 0.567 . . . . 0.0 110.19 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -58.76 90.76 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.6 -34.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.275 0.559 . . . . 0.0 109.556 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -56.03 -64.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.476 -0.765 . . . . 0.0 109.495 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 1.091 ' OD1' HG21 ' A' ' 75' ' ' ILE . 3.6 m120 -36.52 -40.29 0.24 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -47.12 63.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.63 -17.13 63.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -66.45 -7.09 17.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.47 49.29 33.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.791 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -116.53 145.15 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.775 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -100.93 96.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.722 ' NE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -40.91 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.419 -0.8 . . . . 0.0 110.492 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -123.22 -153.88 8.87 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.852 ' HG2' HG21 ' A' ' 95' ' ' ILE . 2.0 mt-10 -76.13 -70.83 0.42 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -1.129 . . . . 0.0 109.724 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -37.36 86.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.791 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.37 -49.17 78.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.091 -1.006 . . . . 0.0 109.511 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -67.51 -31.96 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.181 -0.949 . . . . 0.0 109.382 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -31.87 66.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -77.91 -54.95 5.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.703 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 5.4 t80 -57.98 -19.7 32.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -93.25 -34.47 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.912 -1.117 . . . . 0.0 109.842 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -58.84 -24.86 62.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 20.4 t-20 -170.6 95.67 0.45 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' CG ' HG13 ' A' ' 83' ' ' VAL . 30.7 Cg_endo -74.59 -40.58 1.02 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.352 2.034 . . . . 0.0 110.257 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -8.11 41.1 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.274 -0.892 . . . . 0.0 108.922 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -104.05 -34.53 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.429 -0.794 . . . . 0.0 109.251 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -76.52 -70.0 0.48 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.543 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.091 HG21 ' OD1' ' A' ' 52' ' ' ASN . 2.7 mm -86.05 117.11 68.13 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.76 81.36 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.264 1.976 . . . . 0.0 110.742 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.7 -4.26 2.71 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.452 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.617 ' HA ' HG21 ' A' ' 49' ' ' THR . 15.2 t -54.21 163.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.784 -1.421 . . . . 0.0 109.546 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' HD2' HMD2 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -126.11 21.18 7.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -58.77 109.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.04 43.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.74 ' HB2' HMC2 ' A' ' 105' ' ' HEC . 11.2 t80 -107.63 -45.99 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.724 -0.61 . . . . 0.0 110.542 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.603 HG13 ' CG ' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -24.72 106.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.434 0.635 . . . . 0.0 111.25 -179.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 85' ' ' ILE . . . -172.26 29.87 0.11 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 84' ' ' GLY . 4.5 mt -152.85 163.06 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.14 . . . . 0.0 109.627 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.22 36.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 109.335 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -106.54 148.87 27.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -75.88 -35.13 59.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.335 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.72 -29.57 70.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -57.59 3.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.883 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -54.33 -40.8 68.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.703 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.2 96.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.914 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -34.34 75.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.028 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 91' ' ' ARG . 92.7 mt -60.83 -51.5 69.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.852 HG21 ' HG2' ' A' ' 61' ' ' GLU . 4.6 mm -67.38 -36.78 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.38 57.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.607 -0.683 . . . . 0.0 110.129 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -73.47 -43.32 60.46 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.998 -1.064 . . . . 0.0 109.948 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.653 HD21 ' CE2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -67.15 -7.22 21.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.953 . . . . 0.0 109.977 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 1.8 ttpt -96.01 -36.17 11.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.646 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 9.3 tttm -81.14 -31.63 34.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.11 2.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.21 -0.932 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 36' ' ' PHE . 6.4 t -102.41 25.27 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.054 -1.029 . . . . 0.0 110.422 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -160.94 61.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.959 -1.088 . . . . 0.0 109.533 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HG3' ' HG3' ' A' ' 100' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.024 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -146.42 155.16 42.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -1.115 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.01 -26.98 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.282 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -48.3 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.315 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.659 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -57.09 -35.6 70.34 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -66.42 -44.37 83.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -1.068 . . . . 0.0 109.387 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -26.23 68.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.659 HD12 ' HA2' ' A' ' 6' ' ' GLY . 7.1 mt -73.53 -66.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 20' ' ' VAL . 45.3 t80 -55.68 -25.26 38.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 108.988 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 7' ' ' LYS . 7.4 mt -70.9 -40.38 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.847 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.5 ptm -107.34 18.1 22.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.593 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -120.58 -62.54 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.967 . . . . 0.0 109.536 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.433 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -123.76 30.01 6.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.122 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 1.3 t -86.1 7.34 25.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -100.98 -54.31 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 3.2 m -84.41 -32.52 24.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.875 ' ND1' HD22 ' A' ' 32' ' ' LEU . 63.2 m-70 -114.15 93.34 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.11 -0.994 . . . . 0.0 109.992 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.6 p -91.3 97.25 10.99 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.872 -1.142 . . . . 0.0 108.559 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -83.97 47.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 110.061 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 3.0 mt-10 -173.34 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.921 -1.112 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 0.56 39.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.549 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.13 -10.46 40.03 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.1 10.86 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -89.82 160.46 16.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -1.18 . . . . 0.0 109.365 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -138.44 167.9 20.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -141.37 -87.04 0.17 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.78 ' O ' HMD3 ' A' ' 105' ' ' HEC . 38.1 m -94.47 -25.03 17.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 108.98 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -115.6 150.49 18.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.682 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.7 Cg_endo -65.98 131.76 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.444 2.096 . . . . 0.0 111.031 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -49.98 101.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.49 -0.756 . . . . 0.0 110.198 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.875 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.01 63.41 6.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 109.717 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.731 ' O ' HG22 ' A' ' 102' ' ' THR . 2.2 t60 -94.25 -21.46 19.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.997 . . . . 0.0 109.993 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 38' ' ' ARG . . . -156.19 22.73 0.51 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 59' ' ' TRP . 5.8 tt -41.61 -35.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -1.053 . . . . 0.0 110.288 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' HD1' HD23 ' A' ' 35' ' ' LEU . 4.3 m-30 -70.36 131.7 44.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.129 -0.982 . . . . 0.0 110.545 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.02 -13.03 64.28 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -126.71 151.87 47.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.897 -1.355 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 177.83 6.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.818 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 1.019 HG21 ' HB3' ' A' ' 52' ' ' ASN . 2.6 p -64.5 -164.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.29 94.0 0.01 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -152.25 -47.27 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -1.148 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -80.31 142.75 55.01 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -78.64 -90.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.691 2.26 . . . . 0.0 110.941 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.42 -33.02 0.83 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.61 111.44 18.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -1.109 . . . . 0.0 109.067 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 1.6 p -77.37 78.32 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-85 -46.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 109.668 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.66 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 109.208 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.61 -42.93 68.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -54.16 -73.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' THR . 1.9 m-20 -35.45 -40.97 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.137 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 50' ' ' ALA . 6.0 ttpp -55.36 -59.17 5.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.883 . . . . 0.0 110.049 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -64.08 -20.66 66.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.79 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -65.36 -8.16 17.13 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.64 45.47 59.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.37 117.48 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -1.014 . . . . 0.0 109.979 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -84.46 111.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.852 ' HE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -50.26 101.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.944 -1.097 . . . . 0.0 110.271 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -122.41 -167.63 13.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' OE2' ' CG2' ' A' ' 95' ' ' ILE . 19.7 mm-40 -65.47 -74.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -62.95 -35.11 79.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 110.268 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.47 -42.87 93.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.671 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.689 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -73.42 -33.79 65.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 35.7 tpp -59.11 -27.32 65.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.171 -0.956 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.41 -64.48 1.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.881 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 28.5 t80 -49.08 -28.26 4.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.956 . . . . 0.0 109.996 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -85.84 -32.79 21.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' MET . 4.0 tt0 -59.42 -24.7 63.71 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 6.8 t-20 -177.25 88.69 0.25 Allowed Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -73.82 -36.53 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.32 -17.21 64.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.061 -1.024 . . . . 0.0 108.363 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 2.4 ttmt -99.57 -25.76 14.32 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -88.0 -70.26 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.249 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.746 HG21 ' N ' ' A' ' 52' ' ' ASN . 2.6 mm -99.52 106.66 41.09 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.366 -0.834 . . . . 0.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.98 83.76 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.374 2.049 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 158.42 -30.31 0.46 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.552 ' HA ' HG23 ' A' ' 49' ' ' THR . 10.0 t -44.39 160.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.955 -1.32 . . . . 0.0 109.785 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 15.98 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.401 ' HG3' ' OH ' ' A' ' 67' ' ' TYR . 7.6 mmm -59.2 118.31 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.742 HG22 HBC2 ' A' ' 105' ' ' HEC . 1.6 tp -92.32 18.83 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.812 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -60.07 161.97 6.25 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.411 0.624 . . . . 0.0 110.133 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 84' ' ' GLY . 33.7 m -99.77 -41.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.343 -0.848 . . . . 0.0 109.366 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 118.56 81.18 0.75 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.6 mm -67.17 136.15 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -1.202 . . . . 0.0 109.231 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.89 50.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -127.84 106.8 9.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.255 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -34.73 74.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.872 . . . . 0.0 110.1 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.15 -43.78 94.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.876 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.79 -42.22 81.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.905 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -62.15 -38.16 87.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.812 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.6 71.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.31 -25.58 67.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 9' ' ' ILE . 29.2 mt -69.75 -52.5 24.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.722 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.3 mm -62.26 -47.76 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.928 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.76 71.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.79 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.51 ' CD2' HD22 ' A' ' 98' ' ' LEU . 33.3 t80 -61.74 -44.63 96.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 ' OG1' ' A' ' 102' ' ' THR . 4.0 mm? -81.95 -2.7 52.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 1.6 tmmt? -97.0 -13.83 22.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.162 -0.961 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -119.97 -39.9 2.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.56 -32.78 60.52 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.28 -0.888 . . . . 0.0 110.387 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -127.87 23.19 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.05 -1.031 . . . . 0.0 110.321 -179.357 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' C ' ' A' ' 99' ' ' LYS . 4.1 t-20 -149.34 14.45 0.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.023 -1.048 . . . . 0.0 109.818 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.082 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.81 170.1 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -1.115 . . . . 0.0 109.325 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -100.36 -44.45 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.5 -12.81 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.853 . . . . 0.0 109.942 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' O ' HG12 ' A' ' 9' ' ' ILE . 23.7 mttt -91.88 -54.31 3.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.091 -1.006 . . . . 0.0 109.848 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.59 -30.18 55.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -70.32 -46.7 63.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -1.109 . . . . 0.0 109.728 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -70.48 -18.98 62.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.7 mm -73.18 -64.6 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 108.792 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 98' ' ' LEU . 11.5 t80 -49.23 -42.34 40.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 108.621 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 55.3 mt -56.23 -42.41 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.01 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' A' ' 12' ' ' MET . 3.3 ppp? -107.12 20.06 19.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.49 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.49 -54.59 1.77 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.738 -1.226 . . . . 0.0 109.866 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.568 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -133.89 25.65 3.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.136 -0.977 . . . . 0.0 109.468 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.6 t -80.12 3.39 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -56.87 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.345 -0.847 . . . . 0.0 108.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.486 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 23.1 m -82.14 -17.9 44.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.415 -0.803 . . . . 0.0 109.13 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.033 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.3 m-70 -125.15 84.03 2.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.795 -1.191 . . . . 0.0 110.239 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 15.7 p -79.29 81.53 5.54 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.52 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 4.1 m -79.84 12.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -137.0 24.33 3.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 0.0 109.867 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.7 tmtt? -98.96 -46.98 5.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.567 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.49 67.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.4 22.53 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' CB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 tptt -98.8 140.64 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 0.0 109.588 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -140.17 128.61 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.436 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -72.5 0.72 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -53.94 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.407 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -91.4 160.22 26.69 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 35.1 Cg_endo -70.53 134.36 26.2 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.367 2.045 . . . . 0.0 110.54 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 11.7 t-20 -48.27 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.033 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.32 43.59 0.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.421 -0.799 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' VAL . 2.0 t-160 -98.62 77.82 2.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -0.975 . . . . 0.0 108.827 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' HG21 ' A' ' 102' ' ' THR . . . 115.03 15.86 7.61 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -54.2 -30.53 50.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.422 -1.046 . . . . 0.0 109.727 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.4 m-85 -65.3 143.15 57.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.905 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.54 13.62 61.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 40.4 ttp85 -138.52 129.91 27.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -1.131 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -74.39 174.43 8.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -71.94 175.7 5.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.715 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.51 94.94 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' HD2' ' A' ' 38' ' ' ARG . 1.4 tp60 -150.14 -73.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.32 141.25 2.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.7 Cg_endo -79.72 -92.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.691 2.261 . . . . 0.0 111.425 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.38 -29.99 0.76 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -79.78 113.01 17.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -1.057 . . . . 0.0 108.991 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -77.98 77.93 4.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-30 -46.09 178.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.608 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.846 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.71 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -43.66 -42.72 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -54.39 -70.54 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.884 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.725 ' HB3' HG21 ' A' ' 40' ' ' THR . 3.2 m-80 -38.92 -40.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 110.408 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -57.41 -70.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.197 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.45 -10.56 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.333 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -66.03 -7.64 18.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.83 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.14 50.66 33.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.83 118.79 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -1.059 . . . . 0.0 109.727 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.77 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -78.33 121.35 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.023 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.77 ' N ' HD13 ' A' ' 58' ' ' ILE . 9.0 m95 -64.99 95.08 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.272 -0.892 . . . . 0.0 110.007 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -115.5 -170.7 16.22 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 6.3 mt-10 -68.61 -68.39 0.4 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.089 -1.242 . . . . 0.0 109.69 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.03 -37.22 86.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.882 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.46 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.63 -49.03 79.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.074 -1.016 . . . . 0.0 109.315 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.682 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.2 tt -63.47 -32.61 74.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 109.311 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.1 ttp -56.27 -40.87 74.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.379 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.58 -54.91 13.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.318 -0.864 . . . . 0.0 109.78 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.688 ' CE1' ' ND2' ' A' ' 52' ' ' ASN . 86.4 t80 -49.18 -34.08 13.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.803 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -76.3 -37.01 58.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 109.472 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.37 -23.31 62.45 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -170.41 93.0 0.48 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' CD ' HG13 ' A' ' 83' ' ' VAL . 35.8 Cg_endo -79.68 -43.36 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.373 2.049 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -79.27 -22.26 44.95 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -92.26 -36.19 13.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.4 t80 -73.62 -66.6 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 51' ' ' ALA . 13.6 mm -96.38 113.2 62.05 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.43 -0.793 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.76 70.24 7.04 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.255 1.97 . . . . 0.0 109.747 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.42 -46.69 0.03 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.846 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -58.09 163.75 2.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.281 . . . . 0.0 109.651 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.32 9.03 5.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.736 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.1 ptm -74.48 115.82 14.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.879 -1.129 . . . . 0.0 109.513 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 41.8 mm -94.13 35.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.78 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 4.9 t80 -59.33 -34.62 72.57 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.807 -0.558 . . . . 0.0 110.167 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG13 ' CD ' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -29.51 104.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.44 0.638 . . . . 0.0 111.209 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.86 25.43 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD11 ' HZ ' ' A' ' 82' ' ' PHE . 6.9 mt -103.43 160.16 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.93 43.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.372 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 89' ' ' GLU . 9.4 ttmm -162.12 115.27 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -52.63 -37.03 57.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 87' ' ' LYS . 3.0 mm-40 -60.6 -38.32 84.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.64 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -62.9 -49.24 75.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -53.51 -43.77 68.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 109.263 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -58.73 -34.31 71.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.381 -0.824 . . . . 0.0 109.701 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.1 -28.82 66.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.117 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' CD2' HG21 ' A' ' 9' ' ' ILE . 55.7 mt -71.13 -63.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 109.418 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -59.66 -32.01 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 108.996 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -60.39 -40.71 91.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 109.873 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.2 -48.42 62.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.352 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.0 mm? -67.13 -16.29 64.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -72.49 -49.26 34.3 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.312 -0.867 . . . . 0.0 109.862 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 6.8 tttt -79.88 -27.4 40.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.31 -59.15 3.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 110.376 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -111.54 -29.89 7.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.46 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t30 -81.61 10.96 5.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.541 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.508 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 1.068 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.506 ' CB ' ' HB2' ' A' ' 5' ' ' LYS . 1.8 m-20 -85.51 166.8 16.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -1.105 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -95.81 -60.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -13.03 26.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 2' ' ' ASP . 6.9 ttmt -77.44 -63.07 1.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.28 -32.78 60.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 34.9 tttt -64.67 -33.7 76.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -77.08 -24.13 51.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 5' ' ' LYS . 17.9 mt -69.62 -55.94 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 108.838 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' SER . 9.7 t80 -62.84 -40.15 96.53 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.324 -0.86 . . . . 0.0 108.921 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 14.5 mt -58.06 -28.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.38 -0.825 . . . . 0.0 109.001 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -114.92 6.89 15.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 110.015 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' HBB1 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -113.68 -66.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.07 31.18 6.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.965 -1.084 . . . . 0.0 109.459 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.8 t -90.16 8.74 31.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.2 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -101.44 -48.2 4.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 0.0 108.956 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 96.9 m -93.57 -25.52 17.52 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.419 -0.8 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.042 ' ND1' HD22 ' A' ' 32' ' ' LEU . 79.1 m-70 -113.87 82.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 110.249 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.536 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 5.1 p -78.86 88.4 4.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 108.448 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 32' ' ' LEU . 5.5 m -79.88 9.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -137.75 18.01 2.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.046 . . . . 0.0 109.433 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 4.8 tptt -88.9 -57.27 2.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.36 63.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.43 17.63 33.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.93 73.47 1.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -1.192 . . . . 0.0 109.368 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.527 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -78.47 128.9 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 109.964 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' NZ ' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -101.69 -80.39 0.5 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.933 ' O ' HMD3 ' A' ' 105' ' ' HEC . 96.3 m -91.8 -33.33 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.363 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -108.56 156.91 15.51 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 32.9 Cg_endo -68.68 136.33 35.68 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.543 2.162 . . . . 0.0 110.849 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 6.2 t-20 -51.38 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.812 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.042 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.64 70.25 7.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.494 -0.754 . . . . 0.0 109.456 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 102' ' ' THR . 31.3 t-80 -100.2 -49.58 4.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 109.098 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -122.81 37.67 2.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.948 HD11 HMA3 ' A' ' 105' ' ' HEC . 3.1 tt -49.52 -50.52 41.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.992 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -60.37 137.94 58.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.855 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.92 24.21 76.55 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD2' ' HG2' ' A' ' 42' ' ' GLN . 24.2 ttp85 -145.78 118.11 8.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -1.231 . . . . 0.0 109.797 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -70.68 164.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.91 169.07 4.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.866 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 73.13 83.39 0.29 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -148.61 -39.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -1.148 . . . . 0.0 109.882 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -79.84 136.35 54.87 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 109.693 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.5 Cg_endo -79.15 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.59 2.193 . . . . 0.0 110.972 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -40.13 -37.91 1.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.468 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -80.13 125.07 29.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -1.061 . . . . 0.0 108.979 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 48' ' ' TYR . 93.9 p -86.34 57.35 4.44 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m-30 -31.8 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.113 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.994 HG21 ' HA ' ' A' ' 78' ' ' THR . 31.0 p -63.19 93.4 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.642 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -36.93 -37.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -41.15 -69.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.92 ' OD1' HD13 ' A' ' 75' ' ' ILE . 28.6 m-20 -45.1 -45.26 11.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 109.852 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.7 -74.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.93 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.57 -14.03 2.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.885 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HB2' HG12 ' A' ' 75' ' ' ILE . 1.8 tptp -59.17 -13.83 8.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.0 109.926 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.94 58.78 12.39 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -133.73 120.33 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.731 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.07 102.15 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.047 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CG ' HD21 ' A' ' 35' ' ' LEU . 6.7 m95 -41.16 106.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.42 -159.87 10.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.9 -59.45 2.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.11 -1.229 . . . . 0.0 109.868 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.96 -38.12 64.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.846 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.98 -52.1 66.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.4 tt -62.94 -37.32 86.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -53.36 -37.9 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE1' ' CD1' ' A' ' 74' ' ' TYR . 7.5 tm-20 -69.87 -57.11 5.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.6 t80 -60.87 -13.41 15.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 109.526 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.947 HD11 HMB2 ' A' ' 105' ' ' HEC . 4.9 tp -85.09 -49.79 7.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.058 . . . . 0.0 109.073 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 6.9 tt0 -59.21 -22.08 60.49 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 69' ' ' GLU . 1.2 m-80 -161.27 92.34 1.48 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.736 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -76.0 -52.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.0 110.878 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.128 -0.982 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . 15.5 mtpt -77.09 -39.91 47.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.884 ' CD2' HD12 ' A' ' 75' ' ' ILE . 22.8 t80 -68.05 -63.23 1.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.92 HD13 ' OD1' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -114.21 125.3 29.48 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 71.19 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.239 1.959 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 51' ' ' ALA . . . -160.57 -58.47 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.994 ' HA ' HG21 ' A' ' 49' ' ' THR . 9.4 t -41.81 152.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -1.132 . . . . 0.0 110.164 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.11 5.18 13.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.766 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.5 ptm -77.58 119.29 20.93 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.071 -1.018 . . . . 0.0 109.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.4 mt -90.11 55.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.763 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 48.7 t80 -79.46 148.56 31.84 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.579 -0.7 . . . . 0.0 109.964 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.08 -158.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 109.262 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.04 122.82 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.466 ' CD1' HD11 ' A' ' 94' ' ' LEU . 13.4 mt -75.17 134.38 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -1.173 . . . . 0.0 109.157 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.76 -34.14 22.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.693 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' CB ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -70.12 105.94 3.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.144 -0.972 . . . . 0.0 109.701 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.25 68.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.03 -53.84 53.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.421 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' OE1' ' CB ' ' A' ' 87' ' ' LYS . 29.4 mt-10 -62.83 -32.7 73.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.234 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -44.07 92.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.43 96.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.348 -0.845 . . . . 0.0 109.388 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.4 -37.45 62.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 85' ' ' ILE . 41.5 mt -66.09 -53.23 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 95' ' ' ILE . 19.9 mm -61.99 -79.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -33.76 -38.35 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.285 0.564 . . . . 0.0 110.698 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 1.2 t80 -56.62 -57.04 14.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 0.0 109.177 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 102' ' ' THR . 4.8 mt -74.68 -13.69 60.65 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.461 -0.774 . . . . 0.0 109.48 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -75.78 -15.81 60.21 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -112.36 -24.36 9.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.609 -0.682 . . . . 0.0 109.215 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.06 -48.78 6.07 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.133 -0.979 . . . . 0.0 110.058 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -109.59 32.03 5.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.923 . . . . 0.0 109.928 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t-20 -154.73 -46.14 0.09 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.171 -0.956 . . . . 0.0 109.376 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HEC . . . . . 0.948 HMA3 HD11 ' A' ' 35' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.231 0.538 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.72 -11.82 60.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.37 -52.47 5.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.893 . . . . 0.0 109.693 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.03 -34.71 62.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 2.5 ttpt -51.08 -42.11 60.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -1.156 . . . . 0.0 109.612 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -77.08 -25.47 52.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.654 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.702 HG22 HD21 ' A' ' 94' ' ' LEU . 12.2 mt -66.58 -62.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE1' HG13 ' A' ' 20' ' ' VAL . 54.6 t80 -62.76 -40.25 96.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.09 -1.006 . . . . 0.0 108.951 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 84.3 mt -66.52 -14.63 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.464 -0.773 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 5.0 ttt -119.07 5.17 11.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.007 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -120.79 -64.25 1.26 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.044 -1.035 . . . . 0.0 109.805 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 37.83 3.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 108.895 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.2 t -91.73 4.34 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.447 -0.783 . . . . 0.0 109.904 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.43 -46.67 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 108.973 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 11.0 m -90.64 -29.53 17.71 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.319 -0.863 . . . . 0.0 108.936 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.86 ' ND1' HD22 ' A' ' 32' ' ' LEU . 69.1 m-70 -114.72 84.51 2.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -84.93 97.98 10.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.931 -1.106 . . . . 0.0 109.12 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 10' ' ' PHE . 2.5 m -85.71 17.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -149.15 31.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -97.59 -77.04 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.53 52.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.23 16.62 35.04 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.85 124.01 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -1.153 . . . . 0.0 109.348 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.434 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -124.71 95.48 4.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -82.11 -73.85 0.37 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.097 -1.002 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.2 m -84.79 -63.08 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.04 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -88.48 152.18 23.14 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.68 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.3 Cg_endo -66.78 134.32 34.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.577 2.185 . . . . 0.0 110.969 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 17.2 t-20 -53.03 103.02 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 109.692 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.06 51.5 1.96 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.665 -0.647 . . . . 0.0 109.826 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.504 ' O ' HG22 ' A' ' 102' ' ' THR . 4.1 t60 -93.46 -8.54 41.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 102' ' ' THR . . . -162.01 31.07 0.31 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -55.48 -28.13 52.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.044 . . . . 0.0 109.85 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 29.9 m-85 -72.28 113.83 9.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.197 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.85 51.03 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -101.61 136.54 41.28 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.056 -1.261 . . . . 0.0 110.075 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' CG ' ' N ' ' A' ' 40' ' ' THR . 30.5 ttmt -82.45 167.52 18.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.024 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.543 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -61.72 165.18 5.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.918 . . . . 0.0 109.946 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 65.4 94.47 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.6 tp-100 -149.05 -48.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -1.216 . . . . 0.0 109.645 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -61.55 146.4 89.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 109.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.72 -60.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.776 2.317 . . . . 0.0 110.758 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.24 52.77 4.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.01 118.5 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -1.098 . . . . 0.0 108.888 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.538 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 3.9 t -83.33 70.99 10.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 30' ' ' PRO . 2.3 m-85 -44.26 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.684 -0.635 . . . . 0.0 109.747 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.56 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -50.85 -40.62 56.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.435 -0.791 . . . . 0.0 109.219 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -52.45 -72.51 0.05 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.629 ' N ' HG21 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -37.2 -49.35 0.91 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -53.79 -48.32 69.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -0.928 . . . . 0.0 110.678 -178.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -65.04 -45.18 86.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.103 -0.998 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -21.03 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.161 -0.962 . . . . 0.0 109.68 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.84 43.94 48.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.961 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -99.34 137.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.993 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.961 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -98.54 115.62 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.635 ' N ' HD12 ' A' ' 58' ' ' ILE . 11.8 m95 -59.02 111.11 1.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -136.42 -158.74 8.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 95' ' ' ILE . 2.9 tt0 -75.78 -74.12 0.23 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.197 -1.178 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -36.91 78.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 110.13 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -59.33 -44.97 92.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.367 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -68.97 -24.97 64.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.242 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.8 tpp -59.75 -44.84 93.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -56.91 5.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 34.3 t80 -51.34 -28.65 12.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.987 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 64' ' ' LEU . 2.7 tp -84.02 -31.48 25.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -58.76 -26.09 63.68 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 7.7 m120 -171.84 102.46 0.37 Allowed Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -75.42 -32.72 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.075 1.85 . . . . 0.0 110.045 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -27.97 31.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.456 -0.777 . . . . 0.0 109.734 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -83.75 -33.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -79.51 -68.41 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.914 . . . . 0.0 108.817 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.724 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.4 mm -102.96 111.18 64.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 70.43 7.23 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.292 1.994 . . . . 0.0 109.711 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -172.98 -40.29 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.803 ' HA ' HG23 ' A' ' 49' ' ' THR . 11.2 t -42.58 151.55 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 109.843 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -111.78 7.12 20.1 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.557 -0.715 . . . . 0.0 109.103 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.57 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 5.7 ptm -86.0 117.79 25.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.931 -1.105 . . . . 0.0 109.695 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -88.89 50.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 27.4 t80 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 121.52 0.676 . . . . 0.0 110.197 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.127 0.489 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.738 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.4 mmt180 -62.06 -44.86 95.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.399 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.68 79.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.979 -1.076 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB2' ' CD1' ' A' ' 9' ' ' ILE . 8.2 m-20 -65.61 -26.41 67.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 91' ' ' ARG . 28.6 mt -66.58 -59.92 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 108.856 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' HG3' ' A' ' 61' ' ' GLU . 4.8 mm -50.52 -32.53 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.428 -0.795 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.3 78.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.404 ' CD2' HD22 ' A' ' 98' ' ' LEU . 23.3 t80 -64.28 -50.33 68.33 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.092 -1.005 . . . . 0.0 109.724 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.1 mm? -64.67 -18.49 65.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.805 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 4.8 mttt -80.86 -25.68 37.48 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.001 -1.062 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 5.5 tptp -78.02 -37.66 46.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.94 -54.8 3.81 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 33' ' ' HIS . 19.3 p -92.69 16.23 12.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.055 -1.028 . . . . 0.0 111.149 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.0 t-20 -156.82 29.03 0.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.923 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.483 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 4' ' ' GLU . 11.2 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.423 ' N ' HG13 ' A' ' 3' ' ' VAL . 14.1 mm-40 -72.21 -7.41 49.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.695 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -55.24 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.796 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.81 -49.31 59.91 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.8 tttt -62.49 -13.63 32.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.9 mmtt -85.46 -54.14 4.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.048 -1.033 . . . . 0.0 109.355 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 70.8 mt -57.22 -53.7 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 15' ' ' SER . 10.1 t80 -60.26 -42.3 95.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 5.2 mt -58.34 -24.42 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.325 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ptm -123.35 18.25 9.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.163 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.64 -48.09 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.05 -1.031 . . . . 0.0 109.725 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -133.72 20.6 3.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.937 -1.102 . . . . 0.0 109.517 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.525 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.7 t -85.3 8.4 18.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.497 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -100.31 -43.87 6.12 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 28' ' ' THR . 35.5 m -93.39 -27.93 16.45 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.031 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.2 m-70 -112.94 84.28 1.96 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 109.798 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -78.53 84.05 4.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 108.364 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.3 m -83.93 31.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 110.692 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 22.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 109.818 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -99.85 6.04 45.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.431 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.16 -22.14 12.56 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.16 7.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 142.1 39.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.16 . . . . 0.0 109.279 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.488 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -127.22 172.77 10.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 109.659 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 -72.63 0.17 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 109.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 17' ' ' CYS . 16.8 m -85.28 -55.41 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.302 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -95.7 153.23 20.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 32.3 Cg_endo -69.1 128.25 16.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.032 1.822 . . . . 0.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 30' ' ' PRO . 14.8 t-20 -44.22 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.031 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.25 41.21 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.88 ' HA ' HG21 ' A' ' 102' ' ' THR . 55.0 t-80 -87.12 -16.64 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.336 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.96 37.93 0.81 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.834 HD11 ' CD1' ' A' ' 59' ' ' TRP . 6.6 tp -67.49 -33.98 76.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.557 -0.966 . . . . 0.0 110.167 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.2 m-85 -64.07 130.26 43.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.981 . . . . 0.0 110.09 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 20.81 76.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -148.0 121.1 8.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.019 -1.283 . . . . 0.0 109.783 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.06 160.02 29.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.223 -0.923 . . . . 0.0 109.148 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.731 HG21 ' HB3' ' A' ' 52' ' ' ASN . 11.3 t -65.05 -174.84 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.906 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 57.23 79.58 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -156.39 -56.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -43.2 135.37 3.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.686 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.65 134.01 11.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.505 2.136 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 -11.55 60.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -133.71 76.22 1.65 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 109.718 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -68.56 92.24 0.45 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.768 ' OH ' ' HB2' ' A' ' 43' ' ' ALA . 5.7 m-30 -46.17 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.873 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 78' ' ' THR . 7.4 m -59.67 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.401 -0.812 . . . . 0.0 109.358 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -35.71 -31.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.883 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -32.3 -59.71 0.3 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.373 0.606 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.731 ' HB3' HG21 ' A' ' 40' ' ' THR . 51.2 t30 -62.23 -54.17 44.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 109.328 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HB2' HG23 ' A' ' 40' ' ' THR . 5.3 ttpp -41.94 -27.94 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 110.295 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 51' ' ' ALA . 7.3 p30 -94.94 -33.55 12.73 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.002 -1.061 . . . . 0.0 109.991 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 19.8 tptp -53.11 -20.02 3.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.033 -1.042 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.91 75.07 0.79 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.838 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.41 127.35 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 110.472 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -90.04 101.78 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.834 ' CD1' HD11 ' A' ' 35' ' ' LEU . 5.4 m95 -42.41 107.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.352 -0.843 . . . . 0.0 110.216 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.16 -154.8 7.97 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HG3' HG21 ' A' ' 95' ' ' ILE . 12.7 tt0 -76.58 -75.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -1.213 . . . . 0.0 109.703 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 65' ' ' MET . 21.2 t70 -62.32 -37.46 85.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.817 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.99 -55.2 35.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.873 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.3 tt -63.49 -19.73 65.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.328 -0.858 . . . . 0.0 109.298 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.503 ' HG2' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -64.78 -46.36 82.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -49.93 66.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.187 -0.945 . . . . 0.0 109.758 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.651 ' CG ' ' CH2' ' A' ' 59' ' ' TRP . 7.9 t80 -53.35 -41.02 65.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.105 -0.997 . . . . 0.0 109.352 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -69.98 -33.81 72.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.781 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.7 -24.13 63.72 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 21.1 t-20 -170.98 97.27 0.42 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 29.7 Cg_endo -74.75 -37.52 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.219 1.946 . . . . 0.0 110.769 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -72.84 -9.09 58.29 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.086 -1.009 . . . . 0.0 109.209 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 14.4 tptt -94.17 -57.69 2.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.572 ' CD1' ' HG2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -62.91 -62.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.883 HG22 ' CB ' ' A' ' 51' ' ' ALA . 3.2 mm -80.45 117.23 66.78 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.9 Cg_endo -75.61 74.87 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.165 1.91 . . . . 0.0 110.685 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.42 26.84 1.74 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.632 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 t -49.94 160.7 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.414 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.57 0.95 37.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 108.813 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.574 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 8.8 ptm -113.46 122.25 46.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' ILE . 16.0 tt -91.04 58.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.574 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 55.3 t80 . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.566 -0.709 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG3' HD13 ' A' ' 9' ' ' ILE . 1.2 tp10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.503 ' CD ' ' HG2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -50.0 -36.1 27.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.223 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.86 89.22 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.253 -0.905 . . . . 0.0 109.174 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.68 -35.44 42.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.0 -55.88 16.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.409 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.448 HG21 ' HG3' ' A' ' 61' ' ' GLU . 16.7 mm -53.51 -69.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.543 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -39.98 -39.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.81 -0.556 . . . . 0.0 110.244 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.03 -50.36 72.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 2.7 mm? -75.22 -3.48 33.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 -12.18 20.64 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.216 -0.927 . . . . 0.0 109.748 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -113.96 -43.55 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 110.123 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.96 -33.4 61.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.88 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -128.54 46.15 2.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.061 -1.024 . . . . 0.0 109.957 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -177.5 45.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.303 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.4 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.217 0.532 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 3' ' ' VAL . 16.6 mt-10 -62.62 -22.62 66.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -84.39 -49.75 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.877 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -52.12 -45.56 57.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -59.9 -37.36 79.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.912 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -21.69 61.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.867 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' LYS . 32.1 mm -75.09 -63.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 20' ' ' VAL . 30.6 t80 -56.22 -45.61 79.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.213 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 18.6 mt -58.93 -30.66 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.6 ttp -116.77 21.9 13.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -134.14 -65.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -115.58 30.83 7.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.106 -0.996 . . . . 0.0 109.564 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 4.3 t -89.68 -14.95 33.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.114 . . . . 0.0 109.466 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -82.43 -44.18 16.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 108.911 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.3 m -90.08 -35.08 15.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 108.869 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.842 ' ND1' HD22 ' A' ' 32' ' ' LEU . 68.6 m-70 -114.02 80.36 1.38 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.039 -1.038 . . . . 0.0 109.934 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 p -79.69 94.55 5.74 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.663 -1.273 . . . . 0.0 108.781 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 10' ' ' PHE . 2.9 m -84.57 -5.56 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.19 26.5 9.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.3 -51.39 3.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.4 60.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.76 24.99 72.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -96.34 115.55 27.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -1.106 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -131.57 89.88 2.77 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.46 -68.5 0.71 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 0.0 109.773 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 99.8 m -90.19 -59.81 2.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.722 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -90.41 149.0 19.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.7 Cg_endo -65.84 136.03 43.68 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.51 2.14 . . . . 0.0 111.232 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 9.5 t-20 -52.4 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.774 -0.579 . . . . 0.0 110.286 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.15 70.07 9.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.729 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.457 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 14.8 t60 -88.86 -45.65 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.599 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.52 38.93 1.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 ' CD1' ' A' ' 59' ' ' TRP . 5.5 tp -54.03 -28.28 37.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -1.131 . . . . 0.0 109.601 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.6 m-85 -66.29 136.75 56.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.81 17.23 57.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 1.8 ttt-85 -133.87 135.68 43.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -1.203 . . . . 0.0 109.326 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -64.68 -174.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.877 . . . . 0.0 109.925 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' N ' ' A' ' 53' ' ' LYS . 4.6 p -53.5 -169.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.582 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -133.3 175.11 20.33 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.879 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -161.82 54.3 0.25 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.954 . . . . 0.0 108.666 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -44.34 169.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 109.666 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.844 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 35.0 Cg_endo -75.12 -66.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.64 2.226 . . . . 0.0 110.585 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.96 6.86 61.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.95 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -131.04 103.89 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -1.135 . . . . 0.0 109.403 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' TYR . 34.7 t -75.14 83.89 2.34 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-30 -44.19 176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.731 -0.606 . . . . 0.0 110.186 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -59.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.906 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -52.61 -38.75 60.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.604 -0.685 . . . . 0.0 109.227 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.26 -70.57 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.394 -0.817 . . . . 0.0 108.847 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -43.97 -54.18 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.603 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' N ' HG21 ' A' ' 40' ' ' THR . 10.1 tptp -40.03 -46.56 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.213 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.67 -34.47 60.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 9.6 tptt -53.65 -17.85 2.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.996 -1.065 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.43 54.34 32.75 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -108.24 138.42 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.997 . . . . 0.0 110.251 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.895 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -98.13 104.21 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.89 ' CD1' HD11 ' A' ' 35' ' ' LEU . 6.6 m95 -49.04 103.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.068 -1.02 . . . . 0.0 110.263 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.86 -164.11 11.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.92 -55.79 5.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.022 -1.281 . . . . 0.0 109.712 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -73.77 -38.93 64.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.157 -0.964 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.44 -37.86 79.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.058 -1.026 . . . . 0.0 109.521 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -77.38 -35.96 53.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.182 -0.949 . . . . 0.0 109.125 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 46.1 ttm -56.77 -28.53 61.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 108.831 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -53.22 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 75' ' ' ILE . 19.9 t80 -58.78 -17.72 25.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.473 HD13 HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -96.08 -36.19 11.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 108.919 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' MET . 21.6 tt0 -59.31 -23.65 62.63 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 23.1 t-20 -176.0 88.52 0.28 Allowed Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.4 Cg_endo -74.59 -37.54 2.28 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.378 2.052 . . . . 0.0 110.274 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -67.63 -14.07 62.63 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.17 -0.956 . . . . 0.0 108.654 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 1.3 tppp? -98.74 -31.66 11.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.227 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.442 ' CD2' HD11 ' A' ' 75' ' ' ILE . 13.1 t80 -83.37 -72.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 108.629 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.5 mm -83.87 115.4 59.65 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 84.26 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.286 1.991 . . . . 0.0 110.396 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 140.18 -7.37 2.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.465 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 12.0 t -44.43 144.67 0.99 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.245 . . . . 0.0 109.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 17.18 24.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.44 124.47 20.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.871 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 81' ' ' ILE . 6.6 mt -92.05 21.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HB2' ' HE3' ' A' ' 80' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.419 0.628 . . . . 0.0 110.193 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.244 0.545 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.644 ' HA ' HD12 ' A' ' 94' ' ' LEU . 4.8 mtp180 -53.04 -36.13 60.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.91 -49.16 60.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.461 ' HB3' HG13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -62.92 -24.58 67.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 110.028 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 91' ' ' ARG . 75.8 mt -68.29 -59.52 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.564 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -61.74 -32.47 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.85 46.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.436 ' HB2' ' C ' ' A' ' 6' ' ' GLY . 32.7 t80 -66.84 -44.27 81.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.963 -1.086 . . . . 0.0 109.814 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.5 mm? -75.91 -4.01 38.54 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.56 -15.13 17.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.197 -0.939 . . . . 0.0 109.14 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 9.0 tttp -103.71 -31.1 10.02 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.23 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.59 -0.694 . . . . 0.0 110.983 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' N ' ' A' ' 103' ' ' ASN . 4.6 t -91.06 -48.62 6.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 0.0 110.855 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.585 ' N ' HG23 ' A' ' 102' ' ' THR . 7.8 t-20 -69.66 -4.26 18.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.871 -1.143 . . . . 0.0 110.029 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 8.4 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.599 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -74.8 -45.93 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 9' ' ' ILE . 2.0 tppm? -76.97 -41.39 43.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.18 94.15 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HD3' ' CE1' ' A' ' 97' ' ' TYR . 3.2 ttpt -61.03 -32.85 72.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -1.158 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -67.44 -25.33 65.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 5.2 mm -76.98 -68.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.523 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 48.8 t80 -53.35 -46.66 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 12' ' ' MET . 12.9 tt -56.01 -43.54 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 110.054 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.515 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.21 14.52 31.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.44 -68.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.072 -1.017 . . . . 0.0 109.592 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -113.59 37.16 3.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 2.9 t -93.51 -48.16 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.881 -1.137 . . . . 0.0 109.835 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.4 -33.79 45.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 36.4 m -98.24 -37.72 9.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.109 -0.994 . . . . 0.0 109.159 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.911 ' ND1' HD22 ' A' ' 32' ' ' LEU . 67.6 m-70 -115.51 74.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.85 -1.156 . . . . 0.0 108.992 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.4 96.83 5.45 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.696 -1.253 . . . . 0.0 109.168 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -87.53 25.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.475 -0.766 . . . . 0.0 109.879 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -140.08 9.29 2.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -85.23 -86.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.8 38.04 0.61 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.52 13.84 63.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -98.66 169.59 9.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -1.13 . . . . 0.0 109.269 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.31 117.51 9.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -91.41 -73.15 0.55 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.283 -0.886 . . . . 0.0 109.158 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m -93.24 -59.88 1.92 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -92.31 153.36 21.72 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.2 Cg_endo -66.57 147.57 82.19 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.403 2.069 . . . . 0.0 111.254 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 16.2 t-20 -64.61 100.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 110.328 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.911 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.88 38.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -90.91 36.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 109.093 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 102' ' ' THR . . . 161.56 37.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.763 HD11 ' CD1' ' A' ' 59' ' ' TRP . 4.2 tp -79.04 -24.39 43.64 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.356 -1.084 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 27.5 m-85 -74.4 127.28 32.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 109.549 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 14.12 82.92 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 11.7 ttt-85 -134.18 134.55 42.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.154 . . . . 0.0 109.516 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 4.0 mttt -73.78 -177.36 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.898 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -92.61 -175.5 3.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 59.48 89.05 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.5 tp-100 -147.98 -43.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 109.72 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -73.53 136.35 78.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.327 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 45' ' ' GLY . 35.2 Cg_endo -77.28 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.08 -30.02 0.37 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.526 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -80.59 125.53 30.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.433 -1.039 . . . . 0.0 109.109 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -86.49 57.3 4.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-85 -36.42 158.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.286 0.565 . . . . 0.0 110.066 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -61.0 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.84 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -46.03 -35.89 5.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -49.0 -61.2 2.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HG21 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -55.94 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 109.592 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 52' ' ' ASN . 6.7 ttpm? -39.99 -30.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.53 0.681 . . . . 0.0 109.338 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLY . 86.1 m-20 -92.23 -39.67 11.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.448 -0.783 . . . . 0.0 109.687 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -56.9 92.72 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.934 -1.104 . . . . 0.0 108.252 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' ASN . . . -38.19 91.52 0.01 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -143.65 145.75 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 110.015 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.081 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -118.61 100.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.898 ' NE1' HG22 ' A' ' 40' ' ' THR . 6.9 m95 -37.56 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.793 0.806 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -122.38 -164.45 12.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -67.9 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -1.146 . . . . 0.0 109.705 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.05 -27.21 66.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.88 -40.69 93.97 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.77 HD22 HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -76.26 -32.49 58.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -37.09 67.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.67 -56.81 4.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.679 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 9.5 t80 -56.07 -19.11 11.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 109.992 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.77 HD13 HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -92.33 -36.31 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.033 -1.042 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.99 -25.16 63.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 5.1 t-20 -168.8 85.46 0.67 Allowed Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -75.01 -26.39 10.95 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.462 2.108 . . . . 0.0 109.766 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 2.2 tttt -74.3 -19.18 60.57 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 43.2 tptt -88.79 -45.06 10.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.501 -0.749 . . . . 0.0 109.438 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.866 ' CD2' HD11 ' A' ' 75' ' ' ILE . 8.1 t80 -71.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.116 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.866 HD11 ' CD2' ' A' ' 74' ' ' TYR . 2.6 mm -96.2 107.81 37.5 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.703 -0.623 . . . . 0.0 109.654 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.749 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -79.13 81.68 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.375 2.05 . . . . 0.0 110.347 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.23 -18.25 0.71 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.5 t -44.97 132.21 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 109.938 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 23.76 5.01 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -59.2 120.0 8.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.607 -0.683 . . . . 0.0 109.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 81' ' ' ILE . 10.9 mt -93.29 26.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 121.625 0.726 . . . . 0.0 110.663 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -55.04 -44.75 74.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.958 . . . . 0.0 109.125 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.52 66.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 0.0 109.23 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.46 -36.63 84.81 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.264 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 66.7 mt -61.97 -29.78 70.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -0.864 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mm -79.15 -46.91 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.351 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.08 -46.78 65.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.219 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' CD2' HD22 ' A' ' 98' ' ' LEU . 28.1 t80 -70.66 -47.52 59.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.993 -1.067 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 102' ' ' THR . 1.1 mm? -71.7 -3.36 21.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -87.0 -55.9 3.62 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -28.58 61.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.59 50.28 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.389 -0.82 . . . . 0.0 109.68 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 102' ' ' THR . 3.1 t -124.38 41.41 3.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.855 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 2.9 t-20 179.78 50.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.388 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.571 HG22 ' HE2' ' A' ' 100' ' ' LYS . 2.1 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.185 0.517 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HG2' ' HE3' ' A' ' 8' ' ' LYS . 5.8 tt0 -62.47 -27.68 69.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.663 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -58.25 -62.16 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.64 -37.17 94.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.6 ttmm -58.47 -26.45 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -1.176 . . . . 0.0 109.811 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HE3' ' HG2' ' A' ' 4' ' ' GLU . 32.2 mttt -82.2 -40.5 21.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 109.994 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.812 HG22 HD21 ' A' ' 94' ' ' LEU . 12.9 mm -61.48 -58.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 0.0 110.123 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HE2' HD23 ' A' ' 32' ' ' LEU . 18.8 t80 -62.12 -41.06 97.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.005 -1.06 . . . . 0.0 109.758 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 18.3 mm -68.21 -11.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.7 ttm -133.31 19.47 4.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 110.215 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 5.8 tptt -131.76 -43.25 1.0 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 109.199 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.07 25.33 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.7 t -85.59 10.42 13.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -43.5 6.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 108.748 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.4 m -99.61 -22.02 15.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.136 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.81 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.8 m-70 -117.43 79.42 1.34 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -79.53 100.08 7.58 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.827 -1.17 . . . . 0.0 108.781 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.9 m -83.81 13.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.887 . . . . 0.0 109.742 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -121.94 17.95 10.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.407 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 1.2 tptp -89.37 179.44 6.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.7 53.92 4.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.1 7.52 76.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 1.4 ttpt -97.92 159.5 14.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.119 . . . . 0.0 109.356 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.604 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -140.33 109.27 6.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.905 . . . . 0.0 108.706 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.695 HG21 ' SG ' ' A' ' 17' ' ' CYS . 30.8 m -87.42 -96.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 28' ' ' THR . . . -50.12 158.83 1.55 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 35.5 Cg_endo -69.38 151.92 71.24 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.363 2.042 . . . . 0.0 111.427 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.0 t-20 -62.41 102.99 0.36 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -82.07 54.86 2.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.121 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -99.51 43.54 1.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 108.888 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA2' HG21 ' A' ' 102' ' ' THR . . . 132.01 48.5 0.11 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.943 HD21 ' CD1' ' A' ' 59' ' ' TRP . 3.6 tt -65.92 -33.78 76.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -1.027 . . . . 0.0 110.35 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 21.3 m-85 -60.08 140.58 56.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 0.0 109.847 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.04 20.0 74.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 38' ' ' ARG . 16.5 ttp85 -133.36 98.95 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 169.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -70.08 172.95 7.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.658 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 72.15 72.8 0.9 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.473 ' HG3' ' HG2' ' A' ' 38' ' ' ARG . 66.2 mm-40 -135.53 -53.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 109.806 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -71.11 137.96 84.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.625 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -79.73 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.696 2.264 . . . . 0.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.28 -33.73 1.41 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.91 121.76 25.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -1.089 . . . . 0.0 109.429 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -84.64 65.4 9.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-30 -37.88 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.617 0.723 . . . . 0.0 111.12 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 78' ' ' THR . 45.1 p -68.44 88.8 0.34 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 109.466 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.74 -33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.28 -65.06 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.719 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-20 -39.72 -55.08 1.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.435 -0.791 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -42.31 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.75 -27.33 67.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.278 -0.889 . . . . 0.0 109.852 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 6.1 tptt -73.45 -0.22 14.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.17 -0.956 . . . . 0.0 109.668 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.59 27.26 2.0 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -81.0 125.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.994 . . . . 0.0 110.085 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -94.05 100.46 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.943 ' CD1' HD21 ' A' ' 35' ' ' LEU . 17.2 m95 -37.39 109.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -130.76 -155.09 8.14 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.02 -60.64 2.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -1.191 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.32 -35.24 73.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.731 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -65.35 -48.56 72.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.74 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.3 tt -69.53 -32.59 71.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.103 -0.998 . . . . 0.0 109.533 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.45 ' HG2' ' HD2' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -59.88 -34.15 72.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 108.89 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -77.8 -53.4 7.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.518 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 38.9 t80 -57.65 -16.34 10.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -92.37 -40.34 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.563 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.95 -22.53 60.23 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 70' ' ' ASN . 22.4 p30 -172.57 95.91 0.37 Allowed Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -73.34 -40.23 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.255 1.97 . . . . 0.0 110.541 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -69.41 -9.36 53.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.995 -1.065 . . . . 0.0 108.948 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -88.15 -54.41 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -69.16 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.147 -0.971 . . . . 0.0 108.837 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.8 mm -98.19 106.82 37.68 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.653 -0.654 . . . . 0.0 109.553 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.5 75.77 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.159 1.906 . . . . 0.0 109.583 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 170.36 -22.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.89 ' HA ' HG21 ' A' ' 49' ' ' THR . 13.8 t -36.96 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -1.052 . . . . 0.0 110.329 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.89 13.46 31.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.582 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 6.3 ptm -114.54 123.07 48.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 110.079 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 81' ' ' ILE . 52.0 mt -94.41 44.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 19.9 t80 . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.653 -0.654 . . . . 0.0 109.766 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 65' ' ' MET . 10.2 ttp85 -58.52 -52.43 65.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 108.918 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.84 73.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -63.75 -30.69 71.76 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.812 HD21 HG22 ' A' ' 9' ' ' ILE . 18.3 mt -64.66 -55.75 18.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -63.43 -31.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.27 87.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' CD2' HD22 ' A' ' 98' ' ' LEU . 34.3 t80 -64.73 -49.41 70.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.017 -1.052 . . . . 0.0 109.973 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' THR . 3.4 mm? -66.34 -16.33 63.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.727 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -77.64 -51.03 11.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.121 -0.987 . . . . 0.0 109.608 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -74.8 -22.34 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.76 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.44 -55.73 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 110.222 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.736 HG21 ' HA2' ' A' ' 34' ' ' GLY . 3.3 t -110.71 -32.23 6.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.99 -1.069 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.559 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 6.7 t30 -81.4 8.41 9.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 110.017 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.32 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 14.5 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.38 -10.15 59.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -96.3 -49.71 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -75.11 -33.3 54.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -69.67 -36.15 75.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 109.605 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -32.03 58.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 HD21 ' A' ' 94' ' ' LEU . 53.9 mt -67.92 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.262 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.549 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.7 t80 -54.35 -39.16 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 15' ' ' SER . 5.0 mm -57.09 -37.91 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -107.04 10.54 30.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.065 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -109.79 -60.03 1.84 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.102 -0.999 . . . . 0.0 109.527 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -132.07 40.81 3.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.313 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.2 t -87.25 -1.15 57.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -100.83 -49.07 4.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' SG ' HG21 ' A' ' 28' ' ' THR . 38.3 m -87.75 -13.19 43.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.876 . . . . 0.0 109.357 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.623 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 82.2 m-70 -134.23 81.87 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 110.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.0 p -78.67 90.21 4.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.9 -1.125 . . . . 0.0 108.003 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.1 m -82.85 35.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.625 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 23.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.869 -1.144 . . . . 0.0 110.211 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -95.74 -15.63 22.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.884 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.89 -25.4 4.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 136.53 -6.26 3.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -67.21 141.17 57.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -1.126 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.482 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -112.87 115.3 28.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 109.088 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.63 -79.94 0.32 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.761 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.605 HG21 ' SG ' ' A' ' 17' ' ' CYS . 7.0 m -98.97 -53.54 3.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 175.14 31.99 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -73.52 125.04 9.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.823 2.349 . . . . 0.0 110.94 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 24' ' ' GLY . 15.6 t-20 -49.37 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -78.8 76.54 5.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 -66.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -110.4 27.19 11.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 59' ' ' TRP . 1.9 tt -43.56 -30.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -1.079 . . . . 0.0 109.556 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.1 m-85 -74.91 128.95 36.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.58 66.26 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -120.77 123.6 43.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.406 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -60.09 -177.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.727 HG22 ' NE1' ' A' ' 59' ' ' TRP . 2.3 p -80.47 178.43 8.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.51 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 52.83 104.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -155.16 -62.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.279 . . . . 0.0 110.005 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -61.08 139.33 94.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.95 -173.82 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.744 2.296 . . . . 0.0 110.509 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 45.99 25.25 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -157.16 112.11 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 108.96 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -78.35 77.25 4.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.6 m-85 -46.77 179.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.81 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.49 88.11 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.105 -0.997 . . . . 0.0 108.871 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.12 -41.75 12.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.77 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.03 -66.75 0.33 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.301 -0.875 . . . . 0.0 108.959 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HB3' HG21 ' A' ' 40' ' ' THR . 0.1 OUTLIER -43.25 -42.36 4.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.465 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 5.5 tttt -43.41 -72.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.95 -15.79 60.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -60.42 -13.22 12.2 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.013 -1.055 . . . . 0.0 109.39 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.52 51.51 32.19 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -110.82 123.73 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.53 -0.983 . . . . 0.0 110.215 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -87.27 116.39 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.727 ' NE1' HG22 ' A' ' 40' ' ' THR . 12.6 m95 -56.55 96.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.299 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -117.68 -176.57 17.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -64.21 -59.69 4.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.108 -1.231 . . . . 0.0 110.073 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.45 -38.35 77.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 109.922 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.627 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.59 -35.6 74.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.658 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.77 -29.81 51.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.071 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -58.68 -35.0 71.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.33 -0.856 . . . . 0.0 109.105 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.48 -58.61 3.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CD2' HG13 ' A' ' 75' ' ' ILE . 56.1 t80 -48.69 -28.81 3.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.163 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD13 HD22 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -87.68 -39.27 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 0.0 109.487 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 65' ' ' MET . 10.8 tt0 -60.54 -21.22 62.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 1.8 m120 -169.21 89.61 0.59 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.3 Cg_endo -76.76 -41.44 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.612 2.208 . . . . 0.0 110.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -31.98 57.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.34 -0.85 . . . . 0.0 109.973 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 1.6 mmpt? -83.19 -26.25 31.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 75' ' ' ILE . 7.1 t80 -83.94 -72.24 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.004 -1.06 . . . . 0.0 109.045 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.855 HG22 ' HB3' ' A' ' 51' ' ' ALA . 22.4 mm -93.73 119.37 67.12 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 109.669 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.6 Cg_endo -80.8 60.22 7.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.475 2.116 . . . . 0.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.31 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.81 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -59.83 161.96 5.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 109.758 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 11.41 5.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.595 ' O ' ' HG3' ' A' ' 80' ' ' MET . 7.7 ptm -77.75 114.05 16.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.316 1.055 . . . . 0.0 109.752 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -95.16 33.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 13' ' ' LYS . 1.3 t80 . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.976 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.231 0.539 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.429 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -53.32 -30.17 37.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.15 -52.67 17.9 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -59.16 -22.03 60.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.61 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HG22 ' A' ' 9' ' ' ILE . 27.4 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.9 mm -57.25 -38.58 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.325 -0.859 . . . . 0.0 109.413 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.28 82.46 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.545 -0.722 . . . . 0.0 109.86 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 7' ' ' LYS . 23.4 t80 -61.99 -34.95 77.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 109.611 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.3 mm? -83.32 -13.35 55.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -95.05 -9.32 34.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.315 -0.865 . . . . 0.0 109.682 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.98 -52.08 2.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 109.46 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.14 71.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.97 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -128.53 40.41 3.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.826 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 102' ' ' THR . 6.0 t-20 178.85 51.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 1.5 pt-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.64 -36.9 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.595 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 9' ' ' ILE . 5.7 mmtt -74.94 -45.26 43.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 93' ' ' ASP . . . -42.27 -52.64 5.07 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 4.1 ttmm -64.16 -36.49 84.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -1.17 . . . . 0.0 109.666 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.1 tptt -62.56 -23.43 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.073 -1.017 . . . . 0.0 109.915 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.72 HG22 HD21 ' A' ' 94' ' ' LEU . 17.9 mm -82.65 -67.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.892 -1.13 . . . . 0.0 109.829 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 20' ' ' VAL . 23.2 t80 -49.99 -31.55 12.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 109.524 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.548 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 3.2 tt -69.73 -40.65 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 ttm -111.77 29.61 7.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.378 -0.826 . . . . 0.0 109.973 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -140.73 -39.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.007 . . . . 0.0 109.951 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -146.48 16.53 1.3 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.967 -1.083 . . . . 0.0 109.938 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 28.2 t -85.44 7.94 20.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.893 -1.129 . . . . 0.0 109.594 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -100.1 -43.32 6.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 57.9 m -95.98 -32.83 12.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.841 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.4 m-70 -108.18 84.53 1.96 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 109.472 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -79.73 91.35 5.28 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.723 -1.235 . . . . 0.0 108.817 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 10' ' ' PHE . 11.8 m -85.12 8.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.433 -0.792 . . . . 0.0 110.133 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 2.6 mt-10 -146.13 24.95 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 110.383 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 15.1 tttt -96.74 -58.31 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.057 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.8 54.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.38 20.01 3.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -100.81 82.66 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -79.85 150.11 30.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 109.373 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -133.77 -85.37 0.44 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.526 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 49.8 m -81.91 -15.6 53.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -132.44 150.26 19.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.8 Cg_endo -66.36 131.72 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.202 . . . . 0.0 111.108 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.1 t-20 -53.17 102.79 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.841 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.97 42.69 0.73 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 110.166 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.444 ' HA ' HG21 ' A' ' 102' ' ' THR . 22.6 t-80 -89.0 58.43 4.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 108.993 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.85 23.67 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -56.52 -22.19 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.038 -1.272 . . . . 0.0 109.237 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 19.6 m-85 -70.85 134.37 47.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.876 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.77 10.5 61.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -123.64 120.31 32.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -1.202 . . . . 0.0 109.421 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 161.64 16.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.081 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -67.45 176.37 2.37 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 61.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -157.93 -58.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.185 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.409 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -53.24 129.79 50.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 0.0 109.862 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.7 Cg_endo -79.56 145.14 18.23 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.598 2.198 . . . . 0.0 110.386 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.1 -47.02 3.7 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -81.24 113.83 19.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.958 . . . . 0.0 108.766 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -77.35 77.55 3.88 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.665 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-85 -46.6 177.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.647 . . . . 0.0 109.335 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.761 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.67 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 109.278 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -47.24 -41.67 19.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.242 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -47.8 -68.38 0.19 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -40.47 -47.12 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.688 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HA ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -48.15 -60.03 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.858 . . . . 0.0 110.044 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.2 -20.63 66.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 110.065 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -63.84 -8.75 11.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.088 -1.008 . . . . 0.0 109.96 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.08 52.56 34.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -114.29 135.77 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.51 -0.994 . . . . 0.0 110.436 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.981 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -97.98 114.45 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.617 ' N ' HD13 ' A' ' 58' ' ' ILE . 10.6 m95 -54.59 109.03 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.98 -163.15 10.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.87 -62.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.283 . . . . 0.0 109.839 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.1 93.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.098 -1.001 . . . . 0.0 109.937 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.848 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.53 -38.17 80.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.804 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.701 HD22 HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -76.32 -32.79 58.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.765 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.6 ttt -55.79 -39.55 71.44 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -75.21 -48.6 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.27 -0.894 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 30.4 t80 -59.55 -18.33 39.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 109.737 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.701 HD13 HD22 ' A' ' 64' ' ' LEU . 1.2 mp -92.71 -38.92 11.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -22.2 62.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.52 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . 10.3 m-20 -172.25 94.17 0.39 Allowed Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.776 ' HB2' HG21 ' A' ' 78' ' ' THR . 31.2 Cg_endo -76.26 -30.78 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 0.0 110.022 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -82.15 -26.94 33.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.381 -0.824 . . . . 0.0 109.711 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -80.9 -44.34 18.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.259 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 t80 -72.08 -66.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 52' ' ' ASN . 31.3 mm -98.43 110.28 55.97 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.479 -0.763 . . . . 0.0 109.62 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -79.35 67.07 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.459 2.106 . . . . 0.0 109.863 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -165.65 -47.65 0.02 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.776 HG21 ' HB2' ' A' ' 71' ' ' PRO . 9.0 t -47.57 167.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -1.233 . . . . 0.0 109.692 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -134.72 11.51 3.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 80' ' ' MET . 6.6 ptm -77.65 118.83 20.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -93.9 33.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 2.4 t80 . . . . . 0 C--N 1.302 -1.499 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.985 ' HA ' HD12 ' A' ' 94' ' ' LEU . 1.4 mpt_? -55.44 -45.88 76.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.126 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.58 89.75 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' HB3' HG13 ' A' ' 9' ' ' ILE . 4.3 m-20 -57.87 -29.13 64.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.279 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.985 HD12 ' HA ' ' A' ' 91' ' ' ARG . 27.2 mt -66.96 -47.71 70.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.6 mm -65.84 -59.2 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.388 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.2 -42.25 6.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.904 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.01 -52.07 58.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 110.003 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.2 mm? -75.39 -0.42 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -95.87 -25.1 16.14 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 110.088 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -108.7 -36.41 6.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.32 67.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -136.0 49.41 2.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.998 -1.064 . . . . 0.0 110.082 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.9 t30 -178.14 34.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.559 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.444 HG21 ' HD2' ' A' ' 100' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.055 0.455 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.65 -46.75 44.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.634 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -29.05 70.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.793 -1.192 . . . . 0.0 109.758 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . -72.43 -51.08 13.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 2.7 tttp -43.84 -35.18 1.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.023 -1.281 . . . . 0.0 110.082 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -74.25 -46.05 44.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 109.965 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.802 HD12 ' CB ' ' A' ' 93' ' ' ASP . 21.1 mt -56.86 -50.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.421 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 13.3 t80 -63.56 -46.41 86.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 110.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -53.21 -37.23 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.968 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -107.29 5.72 27.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.831 -1.168 . . . . 0.0 110.448 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.7 tppt? -109.03 -69.47 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.895 -1.128 . . . . 0.0 109.733 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -117.11 40.8 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.146 -0.971 . . . . 0.0 108.599 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 8.2 t -87.99 -53.94 4.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.757 -1.214 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 17' ' ' CYS . 9.5 pt20 -55.95 -38.62 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.831 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 28' ' ' THR . 8.7 m -86.96 -24.52 24.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.128 -0.983 . . . . 0.0 108.978 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.829 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.7 m-70 -131.76 76.8 1.73 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.978 -1.076 . . . . 0.0 109.58 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -76.89 92.52 3.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.23 24.44 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 110.531 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 18.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 108.645 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -22.21 51.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.496 -0.753 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.73 -17.18 8.84 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.31 -7.24 3.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.13 155.79 21.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -1.225 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.67 141.71 34.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 0.0 109.568 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 28' ' ' THR . 2.6 ttmt -113.7 -85.07 0.59 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.687 HG21 ' SG ' ' A' ' 17' ' ' CYS . 19.4 m -79.13 -76.68 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -74.68 155.89 48.88 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.668 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 34.3 Cg_endo -70.14 138.01 35.65 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.236 1.958 . . . . 0.0 110.74 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -48.82 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.897 . . . . 0.0 109.604 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.829 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.5 53.08 2.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.743 . . . . 0.0 110.181 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -99.81 77.5 2.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 0.0 109.336 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' ' 102' ' ' THR . . . 113.41 11.69 12.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -54.01 -27.99 35.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.601 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 2.8 m-85 -61.96 150.03 38.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 109.908 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.02 17.55 23.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' CZ ' ' O ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -138.66 162.48 34.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -1.161 . . . . 0.0 109.422 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -92.93 -156.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.543 ' O ' ' CZ ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -59.65 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -145.85 -176.04 19.41 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.9 36.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.433 -1.039 . . . . 0.0 109.4 -179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -41.46 160.89 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.94 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 34.2 Cg_endo -76.29 154.69 36.71 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.662 2.241 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.33 20.04 20.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -153.87 104.48 2.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.932 . . . . 0.0 109.054 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 82.8 p -77.67 81.47 4.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 m-85 -44.65 174.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.662 -0.649 . . . . 0.0 109.309 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -59.06 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.03 -1.044 . . . . 0.0 109.495 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -55.17 -42.03 72.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.7 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.27 -72.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.594 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 1.3 m120 -38.45 -48.63 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.506 -0.746 . . . . 0.0 109.615 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 13.2 tttt -42.81 -69.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 0.0 110.671 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 55' ' ' LYS . 38.7 p30 -63.48 -17.96 63.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -62.44 -12.17 20.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 46.02 81.74 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -105.63 134.66 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.386 -1.067 . . . . 0.0 109.804 -179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.32 96.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 0.0 108.597 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD1' HD11 ' A' ' 35' ' ' LEU . 8.0 m95 -42.06 103.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -126.12 -164.01 11.68 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.06 -70.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.0 109.383 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -61.02 -36.63 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.432 -0.792 . . . . 0.0 109.748 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.438 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.62 -36.23 75.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.5 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.08 -33.73 57.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.335 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 tpt -54.69 -38.75 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.98 -58.15 3.49 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.404 -0.81 . . . . 0.0 109.491 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 53.6 t80 -52.9 -18.92 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.925 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.757 HD23 ' HD2' ' A' ' 91' ' ' ARG . 1.5 tp -92.33 -38.84 11.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.557 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -59.48 -22.55 61.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 8.3 p30 -178.58 88.98 0.22 Allowed Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -75.55 -43.25 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.466 2.111 . . . . 0.0 110.292 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -21.69 65.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.227 -0.921 . . . . 0.0 108.833 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -89.09 -38.91 13.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.389 -0.819 . . . . 0.0 109.227 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 3.9 t80 -75.76 -68.73 0.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.7 HG22 ' CB ' ' A' ' 51' ' ' ALA . 12.1 mm -93.0 109.8 41.79 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.541 -0.724 . . . . 0.0 109.335 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 34.5 Cg_endo -76.23 87.8 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.218 1.945 . . . . 0.0 110.541 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 153.37 -27.14 0.78 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.482 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -42.24 145.51 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -1.099 . . . . 0.0 110.023 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -107.26 18.9 21.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.487 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -61.59 127.28 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 110.016 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 81' ' ' ILE . 17.7 mt -95.86 27.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' HB2' ' HE3' ' A' ' 80' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.546 0.689 . . . . 0.0 110.385 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.49 ' OE1' ' CA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.301 0.572 . . . . 0.0 109.594 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.998 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.85 -40.04 75.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.2 77.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.802 ' CB ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -63.08 -32.91 74.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.829 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt -64.91 -53.15 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.702 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -60.21 -38.64 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.5 83.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.996 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.26 -53.41 57.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.2 -0.938 . . . . 0.0 109.571 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 98' ' ' LEU . 3.6 mm? -65.23 -15.8 62.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.389 -0.819 . . . . 0.0 109.809 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -80.56 -28.76 37.16 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.003 -1.061 . . . . 0.0 110.158 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -102.0 -56.05 2.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.866 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.79 65.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -142.85 46.76 1.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.002 -1.061 . . . . 0.0 110.151 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 7.1 t30 174.12 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.019 . . . . 0.0 110.03 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 3.3 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.324 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 4' ' ' GLU . 13.1 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.4 mt-10 -65.26 -12.61 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.529 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -91.26 -54.08 4.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -55.83 -39.91 79.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 26.6 tttp -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 0.0 109.538 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -74.51 -27.77 60.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG2' HD21 ' A' ' 94' ' ' LEU . 80.5 mt -61.22 -63.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.14 -0.975 . . . . 0.0 109.023 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CE1' HG13 ' A' ' 20' ' ' VAL . 40.1 t80 -62.69 -42.21 99.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 108.728 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 9.2 mm -61.5 -18.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.747 . . . . 0.0 109.297 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' A' ' 12' ' ' MET . 4.6 tpt -128.52 18.54 6.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 109.618 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -131.64 -50.42 0.98 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -126.51 23.23 6.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.126 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.6 t -87.84 -2.28 58.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.821 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -92.28 -45.79 8.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 108.488 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.4 m -90.94 -35.65 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.882 ' CG ' HD22 ' A' ' 32' ' ' LEU . 65.1 m-70 -110.63 85.01 2.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.063 -1.023 . . . . 0.0 110.339 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -79.84 99.39 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.75 -1.219 . . . . 0.0 108.821 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.4 m -86.95 33.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 21.71 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.28 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -63.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.26 64.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.09 13.23 40.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -100.12 156.92 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.613 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -152.69 119.91 5.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.369 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -93.3 -86.0 0.26 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 22.2 m -87.93 -43.41 11.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.799 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -101.2 153.29 19.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.672 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.1 Cg_endo -66.71 132.81 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.947 2.431 . . . . 0.0 111.692 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -49.58 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.44 0.638 . . . . 0.0 109.909 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.882 HD22 ' CG ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.89 69.93 7.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.509 -0.745 . . . . 0.0 110.677 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -100.5 -59.46 1.7 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.053 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.76 36.72 4.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 59' ' ' TRP . 14.3 tp -48.87 -30.03 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.096 . . . . 0.0 109.768 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 76.5 m-85 -75.56 124.49 27.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.961 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.03 69.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.38 107.8 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.023 -1.281 . . . . 0.0 109.576 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' THR . 4.3 pttt -61.3 150.13 35.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.864 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -46.74 176.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 109.886 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 55.99 91.96 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 2.0 tp-100 -151.52 -43.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -1.169 . . . . 0.0 109.644 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -58.29 146.09 72.33 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.618 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.77 -62.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.794 2.329 . . . . 0.0 110.761 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.33 46.51 3.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -160.79 114.03 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.176 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.523 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 25.4 m -79.15 77.27 5.66 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.2 m-85 -46.23 -179.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.752 -0.593 . . . . 0.0 109.787 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.68 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.995 . . . . 0.0 108.971 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.46 -38.94 64.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -49.72 -64.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.864 ' HB3' HG21 ' A' ' 40' ' ' THR . 2.4 t-20 -53.51 -41.16 66.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.868 -1.145 . . . . 0.0 109.373 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HA ' HG23 ' A' ' 40' ' ' THR . 24.5 tttm -52.1 -37.0 52.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -82.07 -23.44 35.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 110.33 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 28.9 tttt -76.4 3.07 11.87 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.985 -1.072 . . . . 0.0 109.671 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.2 11.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.739 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -103.8 132.01 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.739 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -96.67 112.41 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 108.648 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.608 ' CH2' ' ND2' ' A' ' 52' ' ' ASN . 6.1 m95 -59.95 105.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 110.047 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.99 -157.83 8.81 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 95' ' ' ILE . 45.6 tt0 -77.78 -63.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -1.118 . . . . 0.0 109.567 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -37.71 85.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.927 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -45.07 92.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.827 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -66.78 -34.27 77.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.993 . . . . 0.0 109.271 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.514 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 2.5 tmm? -54.26 -38.41 65.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.397 -0.815 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.01 -60.81 2.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CD1' HG12 ' A' ' 75' ' ' ILE . 39.0 t80 -54.42 -17.71 3.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.781 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD13 HD22 ' A' ' 64' ' ' LEU . 1.1 tp -90.74 -31.22 16.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.023 -1.048 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.74 -27.34 66.42 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -177.75 100.61 0.22 Allowed Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.6 Cg_endo -76.34 -40.71 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.356 2.037 . . . . 0.0 110.262 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 9.5 tptm -70.84 -12.11 61.35 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -102.32 -35.66 8.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.965 . . . . 0.0 109.314 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CE2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -76.84 -69.35 0.53 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 108.618 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.772 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -95.2 111.09 53.73 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.901 . . . . 0.0 109.214 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.15 70.24 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.289 1.993 . . . . 0.0 110.385 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -177.47 -38.3 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.576 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -44.71 158.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -108.54 -2.8 18.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.17 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.62 ' HE2' ' CB ' ' A' ' 82' ' ' PHE . 8.9 ptm -88.83 121.99 31.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.067 -1.021 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 81' ' ' ILE . 4.2 mp -99.24 45.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.62 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 48.4 t80 . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.844 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.514 ' NH1' ' HG2' ' A' ' 65' ' ' MET . 1.4 mtp180 -65.62 -47.47 75.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.168 -0.957 . . . . 0.0 109.089 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -55.15 -36.58 65.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.888 . . . . 0.0 109.28 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -30.46 66.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.408 -0.807 . . . . 0.0 109.342 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.71 HD21 ' CG2' ' A' ' 9' ' ' ILE . 43.5 mt -65.46 -58.33 6.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 61' ' ' GLU . 3.3 mm -66.14 -29.09 45.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 109.221 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -61.39 -40.57 94.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.603 -0.685 . . . . 0.0 109.929 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -73.12 -52.94 12.35 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.109 -0.994 . . . . 0.0 109.245 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.852 ' O ' HG22 ' A' ' 102' ' ' THR . 1.4 mm? -60.43 -16.97 41.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.416 -0.803 . . . . 0.0 109.921 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HD2' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.76 -48.04 11.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.883 -1.135 . . . . 0.0 109.463 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.29 77.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.9 -50.03 11.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 98' ' ' LEU . 13.8 t -120.27 40.33 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.948 -1.095 . . . . 0.0 110.368 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' CA ' ' A' ' 99' ' ' LYS . 10.9 t-20 -167.97 39.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.481 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.889 HG21 ' HE2' ' A' ' 100' ' ' LYS . 9.9 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.304 0.574 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 5' ' ' LYS . 15.4 pt-20 -53.47 -36.26 61.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 0.0 109.75 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -97.64 -14.11 21.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.06 -41.21 97.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 20.0 ttmt -61.94 -22.38 65.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.067 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -78.81 -40.41 33.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.086 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 HD21 ' A' ' 94' ' ' LEU . 42.8 mt -62.36 -50.95 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 108.798 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 98' ' ' LEU . 34.5 t80 -62.55 -39.22 92.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 6.7 mm -61.48 -22.2 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.42 -0.8 . . . . 0.0 108.872 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.04 13.28 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 4.1 tptt -126.86 -55.74 1.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.188 . . . . 0.0 110.381 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -130.68 22.36 5.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.821 -1.174 . . . . 0.0 110.216 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 40.0 t -86.41 7.37 26.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.935 -1.103 . . . . 0.0 109.461 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -100.53 -54.58 2.81 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 10.5 m -82.85 -27.41 30.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.975 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.6 m-70 -115.2 88.8 2.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.135 -0.978 . . . . 0.0 110.059 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.2 p -78.7 83.37 4.86 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.045 -1.035 . . . . 0.0 108.457 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' VAL . 2.7 m -84.02 30.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 110.304 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.18 19.57 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.324 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -97.43 -61.1 1.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.23 62.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.54 16.1 54.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -92.0 144.7 25.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -1.155 . . . . 0.0 109.532 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.489 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.79 133.19 19.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 109.683 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 -77.13 0.58 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.511 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 52.5 m -90.53 -40.14 12.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.529 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.509 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -104.99 152.63 17.33 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -68.04 133.15 28.12 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.385 2.057 . . . . 0.0 111.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.459 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.4 t-20 -49.1 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.475 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.975 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.93 67.69 8.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.545 -0.722 . . . . 0.0 109.49 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 102' ' ' THR . 5.4 t-160 -98.24 -6.93 30.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 109.874 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.82 61.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -78.69 -30.98 46.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.27 -1.136 . . . . 0.0 109.858 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 83.6 m-85 -67.97 124.33 23.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.98 28.62 62.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.03 120.56 9.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.523 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 173.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.962 . . . . 0.0 109.212 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.986 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -85.57 175.44 8.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 60.67 96.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.86 -55.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.853 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -44.32 133.24 4.52 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.21 139.62 15.01 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.578 2.185 . . . . 0.0 110.605 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.07 -49.96 4.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.09 104.51 12.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.462 -1.022 . . . . 0.0 108.84 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.62 80.59 4.09 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 6.6 m-30 -44.35 173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -62.89 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.129 -0.982 . . . . 0.0 108.435 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -41.52 -37.83 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -0.763 . . . . 0.0 109.856 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.669 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -39.78 -64.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.702 -0.624 . . . . 0.0 109.4 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.619 ' N ' HG23 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -45.83 -51.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.868 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.493 ' CA ' ' OG1' ' A' ' 40' ' ' THR . 25.2 tttt -49.93 -41.45 46.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -71.46 -32.17 67.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.011 -1.055 . . . . 0.0 110.127 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.75 2.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.039 -1.038 . . . . 0.0 109.736 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.27 52.58 46.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.997 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.35 132.92 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -1.019 . . . . 0.0 110.371 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.997 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -95.29 97.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.986 ' NE1' HG22 ' A' ' 40' ' ' THR . 10.1 m95 -37.16 122.77 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.634 0.73 . . . . 0.0 111.127 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -143.04 -164.06 10.03 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -76.08 -73.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 0.0 109.617 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.53 -33.59 72.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.691 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -47.22 86.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 108.835 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.635 HD22 HD13 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -61.69 -35.83 79.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.46 -0.775 . . . . 0.0 109.005 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ttt -55.79 -35.12 65.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.412 -0.805 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' OE2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 tm-20 -71.94 -60.02 2.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.793 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 24.8 t80 -54.79 -21.17 10.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -88.02 -33.21 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.444 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.91 -23.92 66.63 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 9.9 t-20 -177.82 96.54 0.22 Allowed Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 32.2 Cg_endo -74.34 -30.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.446 2.097 . . . . 0.0 110.182 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -13.34 60.54 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 108.646 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -95.58 -46.32 6.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.117 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' OE2' ' A' ' 66' ' ' GLU . 13.2 t80 -71.46 -64.05 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.006 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.2 mm -79.31 126.44 81.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.7 Cg_endo -74.98 74.24 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.122 1.882 . . . . 0.0 110.692 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.39 33.37 1.62 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.0 t -50.48 162.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.342 . . . . 0.0 108.929 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.62 12.35 35.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.949 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 80' ' ' MET . 6.3 ptm -130.57 128.64 41.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 81' ' ' ILE . 9.1 tp -109.41 40.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.507 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.302 -1.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.451 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -59.85 -50.67 72.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.161 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 -39.99 75.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.429 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -29.55 69.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.587 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.618 HD21 HG22 ' A' ' 9' ' ' ILE . 20.6 mt -64.25 -47.4 79.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.877 . . . . 0.0 109.186 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.648 HG21 ' HG2' ' A' ' 61' ' ' GLU . 3.6 mm -71.2 -30.84 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.137 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.03 79.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 101' ' ' ALA . 13.1 t80 -69.61 -33.59 72.89 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 108.951 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -78.63 -9.5 59.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.363 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.11 -16.52 17.81 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.889 ' HE2' HG21 ' A' ' 3' ' ' VAL . 3.3 mtpt -108.9 -20.14 13.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.564 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . . . -91.08 -43.45 9.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.384 -0.822 . . . . 0.0 109.935 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -104.0 -59.27 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.677 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 5.2 t30 -53.2 -26.76 18.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 100' ' ' LYS . 29.5 tp10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.455 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.323 0.582 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -63.87 -15.83 59.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -82.15 -72.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.424 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -53.77 -28.2 38.14 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 35.4 tttt -65.98 -37.77 86.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 109.858 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -75.21 -26.07 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' CD2' ' A' ' 94' ' ' LEU . 33.4 mm -64.3 -60.79 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.636 ' CE2' HG13 ' A' ' 20' ' ' VAL . 39.5 t80 -61.28 -38.3 86.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 49.4 mt -64.13 -22.49 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 tpp -122.84 16.03 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.126 -0.984 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 6.6 tppt? -127.57 -49.01 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.091 -1.006 . . . . 0.0 109.553 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 28.69 4.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.982 . . . . 0.0 108.88 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.1 t -86.66 -4.16 59.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -95.23 -43.48 8.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.246 -0.908 . . . . 0.0 108.917 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 7.0 m -91.26 -44.19 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.963 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.871 ' ND1' HD22 ' A' ' 32' ' ' LEU . 59.6 m-70 -101.92 81.81 2.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.047 . . . . 0.0 109.772 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 p -79.66 95.51 5.95 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.826 -1.171 . . . . 0.0 108.877 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.636 HG13 ' CE2' ' A' ' 10' ' ' PHE . 3.0 m -82.37 13.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.867 . . . . 0.0 109.859 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.32 17.15 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 110.057 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -89.95 -23.94 21.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 109.709 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.35 60.36 0.55 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.71 9.53 52.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 3.5 tttp -91.61 130.76 37.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -1.166 . . . . 0.0 109.536 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.506 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.01 104.85 5.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 -82.03 0.13 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.13 -0.981 . . . . 0.0 110.181 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.404 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 10.8 m -89.9 -30.86 17.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -108.65 150.4 17.05 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.666 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -67.29 129.05 19.52 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.79 2.327 . . . . 0.0 111.103 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.0 t-20 -48.68 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.64 -0.663 . . . . 0.0 110.128 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.871 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -83.64 62.27 6.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 9.3 p80 -100.26 52.78 0.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.311 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 38' ' ' ARG . . . 118.74 64.49 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -78.3 -26.42 46.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -1.071 . . . . 0.0 110.269 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 7.1 m-30 -71.88 125.63 27.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.076 . . . . 0.0 110.981 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.07 -6.51 69.19 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.203 -0.999 . . . . 0.0 111.281 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.13 134.59 54.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.658 -1.495 . . . . 0.0 110.287 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -70.76 150.42 45.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -60.95 163.77 5.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.018 . . . . 0.0 110.212 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.66 99.27 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -160.78 -34.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.258 . . . . 0.0 110.026 179.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.62 128.7 85.14 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.065 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.7 149.73 21.03 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.531 2.154 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.49 -14.2 55.82 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -126.02 111.64 14.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -1.073 . . . . 0.0 108.3 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.49 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 2.0 p -74.27 78.84 1.82 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.666 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.8 m-85 -48.18 179.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.833 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.9 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.16 -40.76 11.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.623 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -53.88 -67.85 0.23 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.449 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.605 ' N ' HG21 ' A' ' 75' ' ' ILE . 2.1 m120 -36.26 -53.8 0.82 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.443 -0.785 . . . . 0.0 111.078 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -55.37 -59.49 4.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.931 -1.106 . . . . 0.0 110.176 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.04 -12.43 11.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.347 -0.846 . . . . 0.0 110.675 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -79.31 5.75 11.68 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.861 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.16 45.88 10.23 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.39 114.06 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -1.125 . . . . 0.0 109.868 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.62 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -77.35 108.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.57 ' CD1' HD11 ' A' ' 35' ' ' LEU . 4.9 m95 -46.74 113.63 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.52 179.24 17.24 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.1 -60.49 2.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.277 . . . . 0.0 109.535 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.49 -41.72 98.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.676 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.58 -32.44 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.694 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -78.58 -32.73 47.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.753 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 tpp -60.54 -35.76 76.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -54.07 7.53 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 45.6 t80 -56.13 -26.5 50.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 64' ' ' LEU . 1.1 tp -81.97 -39.54 23.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -59.87 -23.18 63.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 9.3 m120 -168.33 96.22 0.58 Allowed Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.748 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.0 Cg_endo -77.08 -29.91 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.417 2.078 . . . . 0.0 110.44 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -85.29 -31.87 22.83 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.318 -0.863 . . . . 0.0 109.516 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 3.6 mmmt -78.57 -35.29 46.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.001 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 75' ' ' ILE . 22.1 t80 -75.81 -69.05 0.52 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -101.16 117.73 61.68 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 61.37 8.21 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.428 2.086 . . . . 0.0 110.017 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.45 -48.3 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 49' ' ' THR . 7.4 t -50.68 167.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.283 . . . . 0.0 109.847 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -135.48 10.19 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.564 ' HE2' ' HB3' ' A' ' 82' ' ' PHE . 6.8 ptm -76.41 123.33 25.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 mt -97.87 35.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HB3' ' HE2' ' A' ' 80' ' ' MET . 4.4 t80 . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.539 . . . . 0.0 109.888 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.129 0.49 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -52.62 -45.19 66.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 0.0 109.04 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.61 79.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 109.213 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -59.37 -35.9 74.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 91' ' ' ARG . 38.1 mt -58.67 -46.42 87.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.612 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.2 mm -67.85 -49.03 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 0.0 110.039 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.19 -39.19 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.435 -0.79 . . . . 0.0 110.394 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 36.7 t80 -70.51 -50.67 35.4 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.999 -1.063 . . . . 0.0 110.085 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 98' ' ' LEU . 2.3 mm? -72.23 -4.49 29.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -99.49 -20.46 16.41 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.157 -0.964 . . . . 0.0 109.883 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -107.28 -20.08 13.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.647 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.92 -36.34 12.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 110.003 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.414 ' HB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -130.96 47.38 2.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.638 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 6.4 t-20 -171.93 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 109.35 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 4' ' ' GLU . 12.7 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.24 0.543 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 3' ' ' VAL . 3.8 mt-10 -64.55 -19.9 65.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 9' ' ' ILE . 9.9 mttt -91.55 -33.26 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.48 -20.55 75.54 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 25.4 ttpt -70.58 -32.98 70.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -1.118 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 11' ' ' ILE . 6.6 mttp -85.46 -31.8 22.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 29.4 mm -57.62 -57.33 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.009 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.784 ' CD2' HD21 ' A' ' 98' ' ' LEU . 20.6 t80 -67.33 -41.65 84.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 108.989 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 8.7 mm -55.85 -18.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 109.108 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 ttt -119.21 -5.89 10.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.94 -62.03 1.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.586 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -126.49 41.92 3.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.028 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -95.45 -1.1 51.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.828 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.17 -35.26 9.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 108.764 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.7 m -99.96 -21.43 15.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.0 m-70 -126.15 80.42 1.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 0.0 109.742 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -79.0 90.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.514 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.7 8.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 110.394 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -164.94 23.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.927 -1.108 . . . . 0.0 109.9 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 22' ' ' LYS . 2.9 tmtp? -100.62 37.47 1.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.133 -0.979 . . . . 0.0 109.199 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.63 -30.45 8.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.19 8.64 40.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -95.32 117.63 30.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.209 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -90.69 172.05 8.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.052 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -160.01 -91.62 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.372 -0.83 . . . . 0.0 108.912 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.457 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 11.5 m -65.2 -59.76 3.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 108.741 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -95.86 153.9 20.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 33.2 Cg_endo -69.49 134.42 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.176 1.917 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 26' ' ' HIS . 6.9 t-20 -46.55 101.4 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.8 41.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 109.911 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -91.33 70.85 6.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.36 19.37 5.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.927 HD21 ' CD1' ' A' ' 59' ' ' TRP . 17.9 tp -53.77 -29.81 41.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.142 . . . . 0.0 109.508 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HB3' ' OD1' ' A' ' 103' ' ' ASN . 14.4 m-85 -69.85 135.56 49.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.29 83.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NH1' HD12 ' A' ' 35' ' ' LEU . 31.2 ttp85 -155.21 123.75 6.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.257 . . . . 0.0 109.599 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -61.7 164.86 5.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.195 -0.94 . . . . 0.0 109.063 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.505 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 5.8 t -101.53 169.6 8.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.515 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.496 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 88.93 67.43 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -161.8 -32.07 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.138 -1.213 . . . . 0.0 110.739 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -36.39 141.15 0.37 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.785 . . . . 0.0 110.331 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 35.5 Cg_endo -77.58 128.21 9.34 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.626 2.217 . . . . 0.0 110.487 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.46 -47.35 3.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -100.5 63.84 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.482 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 m -62.9 95.46 0.08 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 30' ' ' PRO . 1.5 m-30 -50.91 -179.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.756 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.941 HG21 ' C ' ' A' ' 77' ' ' GLY . 3.2 p -59.58 90.37 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.001 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -31.4 -35.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.701 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -39.7 -62.93 0.63 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.713 ' CA ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -38.78 -69.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 110.665 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.461 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 2.3 tmtt? -43.12 -38.97 2.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -66.14 -41.91 89.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 110.488 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HG2' ' CE2' ' A' ' 74' ' ' TYR . 45.4 tptt -50.68 -20.42 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 109.123 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.57 39.47 97.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.758 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -103.88 119.04 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.605 -0.938 . . . . 0.0 110.373 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -82.17 100.78 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.927 ' CD1' HD21 ' A' ' 35' ' ' LEU . 6.3 m95 -38.81 118.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 111.05 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.13 -159.61 9.61 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -77.41 -63.02 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.11 -1.229 . . . . 0.0 109.735 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.28 -35.79 71.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.172 -0.955 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.51 -46.27 89.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.095 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -70.22 -36.08 74.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.27 45.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.76 -50.07 59.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.51 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 54.3 t80 -54.87 -21.86 12.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.756 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.2 mp -86.73 -38.11 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.369 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.25 -23.51 62.41 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.27 95.04 0.23 Allowed Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.872 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -73.7 -36.34 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.354 2.036 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -70.37 -9.06 55.2 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 108.927 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -91.91 -50.21 5.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -71.89 -64.93 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 52' ' ' ASN . 4.7 mm -91.35 108.93 32.41 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.76 73.15 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.311 2.007 . . . . 0.0 110.291 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.941 ' C ' HG21 ' A' ' 49' ' ' THR . . . 171.34 -28.97 0.11 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.924 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 71' ' ' PRO . 11.1 t -50.4 134.1 23.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.849 -1.383 . . . . 0.0 109.45 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.78 12.0 37.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.582 ' O ' ' HG3' ' A' ' 80' ' ' MET . 5.3 ptm -87.23 123.16 31.94 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.94 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 81' ' ' ILE . 37.4 mm -109.44 36.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.976 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.199 0.523 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -52.51 -42.54 64.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 109.341 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.61 87.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -30.11 70.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.683 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -75.23 -34.39 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.566 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -47.13 81.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 109.947 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -70.16 -44.21 69.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.784 HD21 ' CD2' ' A' ' 10' ' ' PHE . 1.5 mm? -71.38 -7.7 48.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.1 -1.0 . . . . 0.0 109.434 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.08 -16.93 17.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.776 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -104.11 -26.44 12.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 110.14 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.7 -45.74 9.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.146 -0.971 . . . . 0.0 110.295 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.2 38.51 3.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.699 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 36' ' ' PHE . 1.2 t30 -176.41 61.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.616 HG22 ' HD2' ' A' ' 7' ' ' LYS . 6.5 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.0 tm-20 -59.06 -24.36 62.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.383 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.2 tptm -75.12 -53.44 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 97' ' ' TYR . . . -72.18 -67.66 1.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.616 ' HD2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -39.66 -35.27 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.44 -1.035 . . . . 0.0 110.305 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.55 -44.29 57.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 0.0 109.53 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -72.42 -65.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.705 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 98' ' ' LEU . 18.3 t80 -46.05 -40.83 11.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.726 -1.234 . . . . 0.0 109.803 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' SER . 6.9 mm -62.05 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.023 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -107.51 20.12 19.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.129 -0.982 . . . . 0.0 109.842 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -126.96 -61.33 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.772 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 1.9 m -113.3 5.07 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 0.0 110.161 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -88.79 27.23 1.35 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.809 -1.182 . . . . 0.0 109.244 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.32 -61.08 1.46 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 28' ' ' THR . 5.3 m -80.02 -30.83 39.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.653 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 66.4 m-70 -102.18 173.56 6.32 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.044 0.926 . . . . 0.0 109.46 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 18' ' ' HIS . 20.9 p -161.85 92.77 0.87 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.5 m -84.14 34.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.78 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.416 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 tptt -101.23 35.89 2.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.85 -35.28 4.03 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.76 0.18 6.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 137.92 37.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.554 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -120.04 102.53 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.01 . . . . 0.0 110.475 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.72 -74.58 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.759 HG21 ' SG ' ' A' ' 17' ' ' CYS . 66.4 m -89.77 -99.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 28' ' ' THR . . . -51.73 150.62 7.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.4 Cg_endo -69.81 156.67 62.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 111.417 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.554 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -63.26 102.1 0.36 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.538 HD13 ' ND1' ' A' ' 18' ' ' HIS . 3.7 mp -79.05 71.17 5.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 109.997 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t60 -100.51 -57.71 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.044 . . . . 0.0 109.013 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -111.24 23.1 19.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.3 tt -44.25 -36.02 2.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -1.082 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 4.4 m-30 -65.81 142.1 58.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.371 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 15.28 61.47 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 5.4 tmm_? -136.76 142.77 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -1.152 . . . . 0.0 109.589 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -82.07 -171.54 3.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -92.92 -176.73 4.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.873 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' H ' HG22 ' A' ' 40' ' ' THR . . . 51.09 101.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -157.92 -77.1 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.238 . . . . 0.0 110.193 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -40.84 136.51 1.53 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.966 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.59 152.27 29.45 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.707 2.271 . . . . 0.0 110.265 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.63 -53.03 4.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.7 OUTLIER -99.35 69.86 1.7 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.421 -1.046 . . . . 0.0 108.621 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 p -67.8 97.72 0.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 30' ' ' PRO . 1.4 m-30 -53.52 -175.72 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.769 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 49' ' ' THR . 3.3 t -60.9 88.02 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -36.84 -32.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.313 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.637 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -45.13 -63.03 1.02 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.718 -0.613 . . . . 0.0 109.464 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.75 -52.99 6.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.973 . . . . 0.0 109.404 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -50.52 -42.32 54.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 109.664 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.56 -42.83 99.79 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.865 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -49.71 -21.13 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.049 -1.032 . . . . 0.0 109.272 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.3 46.48 78.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -104.05 123.12 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.531 -0.982 . . . . 0.0 110.249 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -87.71 100.9 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 7.4 m95 -40.2 116.72 0.7 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.825 0.822 . . . . 0.0 110.82 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -148.19 -154.09 6.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -77.68 -74.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.262 . . . . 0.0 109.588 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.45 -34.72 78.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 110.301 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.992 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -64.42 -56.13 16.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.274 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -64.94 -21.88 66.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 19.9 ttt -67.14 -32.66 73.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.315 -0.865 . . . . 0.0 109.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -54.42 6.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.412 -0.805 . . . . 0.0 109.794 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.667 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 4.9 t80 -54.99 -36.89 65.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.926 -1.109 . . . . 0.0 109.168 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.679 ' CD2' HD13 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -77.68 -27.85 50.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.36 -26.66 65.25 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.28 101.95 0.24 Allowed Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.586 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.6 Cg_endo -74.56 -27.09 11.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.372 2.048 . . . . 0.0 109.838 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -78.27 -19.33 53.88 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.598 -0.689 . . . . 0.0 109.371 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.578 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -97.53 -29.92 13.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.024 -1.048 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' HD2' HD11 ' A' ' 75' ' ' ILE . 3.7 t80 -80.81 -70.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 51' ' ' ALA . 1.6 mm -85.63 119.2 71.88 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.4 Cg_endo -73.25 82.83 1.54 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 110.482 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 113.02 26.24 4.16 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.7 t -43.99 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.039 -1.271 . . . . 0.0 109.293 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 10.6 mmtm -93.9 0.75 56.32 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.783 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.563 ' CE ' ' HB2' ' A' ' 82' ' ' PHE . 2.5 ptt? -118.1 119.31 34.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.07 -1.019 . . . . 0.0 109.727 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.4 mm -89.51 49.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.286 -0.883 . . . . 0.0 108.919 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.563 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 35.1 t80 . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.371 -0.831 . . . . 0.0 109.183 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.206 0.526 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.73 -39.04 57.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.584 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -70.29 -38.6 75.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -66.43 -28.89 68.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 68' ' ' LEU . 89.0 mt -73.82 -62.04 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.159 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.564 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.2 mm -61.06 -30.42 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -62.56 -48.85 77.69 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 110.35 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.65 ' HD2' HD22 ' A' ' 98' ' ' LEU . 61.3 t80 -63.53 -47.47 81.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.034 -1.042 . . . . 0.0 110.442 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 10' ' ' PHE . 2.5 mm? -63.25 -29.2 70.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.596 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -66.27 -36.8 83.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.023 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.27 -18.48 36.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.95 47.08 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.907 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 103' ' ' ASN . 6.7 t -132.85 -43.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.067 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' N ' HG23 ' A' ' 102' ' ' THR . 7.2 t-20 -63.43 -11.83 26.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 0.0 109.546 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.266 0.555 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -76.23 -31.23 58.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.651 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.7 tppt? -73.14 -55.37 6.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.73 97.45 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 3.3 ttpm? -65.06 -18.82 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -40.7 54.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.017 HG22 HD21 ' A' ' 94' ' ' LEU . 2.9 mp -67.26 -60.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' SER . 38.9 t80 -52.03 -44.78 64.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.115 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 20.2 mt -56.68 -38.01 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 24.8 12.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.043 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -130.23 -62.31 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.285 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -120.6 26.43 9.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.206 -0.934 . . . . 0.0 108.81 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 3.0 t -82.81 4.73 24.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 3.6 tp-100 -99.83 -54.52 2.89 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 108.712 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 44.7 m -83.21 -22.26 33.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -123.31 89.34 3.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.894 . . . . 0.0 109.861 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -93.42 96.28 9.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.96 -1.087 . . . . 0.0 108.806 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.2 m -85.29 31.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.384 -0.823 . . . . 0.0 109.941 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.98 7.19 2.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.017 -1.052 . . . . 0.0 109.708 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -149.47 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.01 36.73 3.92 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.16 80.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.94 159.16 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -141.04 140.77 34.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 -60.88 1.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 HG21 ' SG ' ' A' ' 17' ' ' CYS . 85.0 m -100.17 -61.28 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -93.49 156.29 22.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 29.9 Cg_endo -66.77 135.78 39.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.62 2.213 . . . . 0.0 111.335 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.62 103.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 109.534 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.35 46.1 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.466 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 46.1 t60 -96.06 69.34 2.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 108.822 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.661 ' N ' HG21 ' A' ' 102' ' ' THR . . . 117.98 16.33 5.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.547 HD12 ' NH1' ' A' ' 38' ' ' ARG . 23.0 tp -52.58 -30.69 32.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.507 -0.996 . . . . 0.0 109.872 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 3.3 m-85 -60.9 141.04 57.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.443 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.34 70.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.547 ' NH1' HD12 ' A' ' 35' ' ' LEU . 3.4 tmm_? -135.28 125.63 26.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -1.128 . . . . 0.0 109.382 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 19.1 mttp -72.3 173.39 8.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -74.05 170.26 15.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.738 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 67.03 108.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.536 ' NE2' ' HD2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -160.95 -63.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.976 -1.308 . . . . 0.0 109.91 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -41.75 150.63 0.35 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.266 -0.896 . . . . 0.0 109.906 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.4 -75.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.836 2.357 . . . . 0.0 110.587 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.72 66.02 3.96 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.639 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.58 120.97 2.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 108.998 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.545 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 40.4 t -84.07 70.55 10.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.9 m-85 -44.69 179.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.701 -0.625 . . . . 0.0 110.174 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.852 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -57.79 88.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 108.886 179.407 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.54 -41.4 66.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -51.48 -70.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 108.77 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.584 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -40.28 -47.28 2.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 110.062 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.95 -57.25 6.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.28 -33.62 75.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.533 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -14.07 6.3 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.114 -0.992 . . . . 0.0 109.824 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 40.81 97.02 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -95.29 133.34 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 0.0 110.034 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.942 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -94.54 112.48 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.617 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 10.0 m95 -54.17 101.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 110.245 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.46 -164.88 12.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -73.97 -67.67 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.01 89.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.872 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.67 -36.31 76.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.7 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -80.24 -27.28 38.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttt -57.03 -47.03 81.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 0.0 109.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.32 -51.56 20.12 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.378 -0.827 . . . . 0.0 109.823 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.617 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 51.9 t80 -54.09 -22.7 11.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 109.664 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.6 tp -90.35 -29.77 17.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.0 109.178 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.75 -24.75 65.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -175.75 102.27 0.25 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.563 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.7 Cg_endo -76.61 -37.47 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.35 2.033 . . . . 0.0 110.258 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -75.13 -17.82 60.34 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.334 -0.853 . . . . 0.0 110.266 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -94.39 -37.65 11.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.856 -1.152 . . . . 0.0 109.581 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.675 ' CE2' HD11 ' A' ' 75' ' ' ILE . 1.9 t80 -76.6 -66.06 0.86 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.869 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.768 HG22 ' CB ' ' A' ' 51' ' ' ALA . 8.1 mm -101.06 106.47 44.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.362 -0.836 . . . . 0.0 109.532 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.86 71.18 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.391 2.06 . . . . 0.0 110.024 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.687 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -173.42 -42.12 0.04 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' HG23 ' A' ' 49' ' ' THR . 14.6 t -43.49 158.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 3.69 21.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.489 -0.757 . . . . 0.0 109.411 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.58 ' O ' ' HG3' ' A' ' 80' ' ' MET . 9.8 ptm -92.87 118.14 30.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.992 . . . . 0.0 109.934 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mm -92.66 48.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB2' ' CE ' ' A' ' 80' ' ' MET . 15.3 t80 . . . . . 0 C--N 1.301 -1.5 0 CA-C-O 121.514 0.673 . . . . 0.0 110.173 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.245 0.545 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.8 ttp180 -56.6 -45.43 81.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.96 -49.38 70.54 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.235 -0.916 . . . . 0.0 109.596 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' HB3' HD13 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -59.72 -21.43 60.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.767 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.017 HD21 HG22 ' A' ' 9' ' ' ILE . 22.2 mt -72.68 -59.64 2.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -56.57 -49.79 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.403 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.94 70.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.611 -0.68 . . . . 0.0 109.633 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 4.5 t80 -53.07 -49.82 65.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.255 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 102' ' ' THR . 1.1 mt -82.65 -12.97 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 1.3 ttmt -79.34 -10.94 59.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.169 -0.957 . . . . 0.0 108.906 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -110.55 -40.06 4.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.91 -55.6 4.86 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.263 -0.898 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.661 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -99.56 30.48 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 9.3 t-20 -165.01 64.85 0.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.389 179.784 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.214 0.53 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -67.15 -40.34 86.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -49.67 -34.77 21.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -57.83 -45.11 86.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -1.138 . . . . 0.0 109.737 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.62 -27.58 60.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.636 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' A' ' 6' ' ' GLY . 51.1 mt -60.25 -53.8 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 6.9 t80 -73.76 -46.6 44.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.257 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.474 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 22.7 mm -56.42 -16.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -120.73 -6.66 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 15.8 tppt? -101.98 -65.81 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 109.858 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -112.04 29.4 7.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.8 t -89.9 -1.15 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.733 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -94.78 -35.6 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.241 -0.912 . . . . 0.0 108.724 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 16.9 m -103.43 -26.28 12.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.045 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.4 m-70 -117.51 78.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.035 -1.041 . . . . 0.0 109.649 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.1 p -78.66 94.8 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.178 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 20' ' ' VAL . 1.6 m -82.16 22.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 0.0 110.519 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -151.21 20.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.902 -1.124 . . . . 0.0 109.467 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.48 -17.97 27.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.65 -27.1 3.11 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.56 -0.94 3.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -88.34 164.68 15.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.076 -1.25 . . . . 0.0 109.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.573 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.994 -1.066 . . . . 0.0 110.234 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -71.02 -75.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 108.867 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 93.7 m -99.81 -58.89 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 108.713 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -83.2 155.53 32.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -67.88 143.36 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.498 2.132 . . . . 0.0 111.048 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.4 t-20 -56.25 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 110.075 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.045 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -85.02 55.44 3.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.403 -0.81 . . . . 0.0 109.826 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -96.99 48.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.269 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.43 62.26 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.4 tp -79.91 -31.22 40.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.395 -1.062 . . . . 0.0 109.872 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -60.32 137.21 58.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.047 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.4 27.98 73.08 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 58.1 ttp85 -139.96 123.59 17.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.983 -1.304 . . . . 0.0 109.742 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.524 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -64.45 175.59 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.156 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.466 HG21 ' N ' ' A' ' 53' ' ' LYS . 7.5 t -94.81 -173.92 3.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.11 -0.994 . . . . 0.0 109.82 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 91.61 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.637 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 2.2 pm0 -159.44 -36.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.182 -1.187 . . . . 0.0 109.807 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -70.17 137.4 86.88 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 109.566 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.35 173.98 12.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.45 2.1 . . . . 0.0 110.359 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.37 5.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -145.61 121.19 10.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.11 . . . . 0.0 109.12 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -85.04 66.16 9.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.9 m-85 -43.97 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.722 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -67.28 86.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -44.22 -34.97 2.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.17 -59.99 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.62 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 19.4 t-20 -52.85 -52.97 55.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.466 ' N ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.85 -33.44 7.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.318 -0.864 . . . . 0.0 109.297 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -77.87 -35.71 50.62 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.383 -0.823 . . . . 0.0 109.772 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -61.11 -11.96 10.59 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.072 -1.018 . . . . 0.0 109.574 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.98 35.93 78.53 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.51 125.45 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.667 -0.902 . . . . 0.0 110.324 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.834 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -87.15 95.33 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 5.3 m95 -34.87 121.79 0.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -142.87 -166.51 11.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -73.91 -65.26 0.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -1.201 . . . . 0.0 109.779 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -60.45 -38.83 85.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.946 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.33 -36.46 75.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 109.303 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -76.24 -24.09 54.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.172 -0.955 . . . . 0.0 109.347 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -42.02 78.49 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.19 -50.94 13.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 75' ' ' ILE . 23.6 t80 -49.72 -44.99 48.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.379 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -73.59 -32.15 63.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -25.8 63.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.58 84.11 0.34 Allowed Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 33.0 Cg_endo -76.4 -22.13 12.72 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.645 2.23 . . . . 0.0 109.354 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -75.59 -16.56 60.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -101.45 -38.69 7.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.457 -0.777 . . . . 0.0 109.239 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.57 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.4 t80 -73.47 -66.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.912 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.3 mm -97.53 106.72 34.77 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -77.75 83.46 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.259 1.973 . . . . 0.0 110.595 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 149.91 -14.37 1.02 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.695 ' HA ' HG23 ' A' ' 49' ' ' THR . 8.1 t -43.68 132.38 4.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.239 . . . . 0.0 109.908 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 23.8 4.37 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.3 mmm -59.17 125.4 23.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.753 -0.592 . . . . 0.0 109.81 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 81' ' ' ILE . 38.5 mm -89.09 17.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.611 -0.681 . . . . 0.0 109.929 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.341 0.591 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -67.86 -51.84 43.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.89 80.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 109.237 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 9' ' ' ILE . 96.1 m-20 -60.48 -28.96 68.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.384 -0.823 . . . . 0.0 109.592 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 18.0 mt -65.05 -51.92 58.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.566 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -59.59 -37.59 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.58 99.63 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.582 -0.699 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -66.1 -46.63 76.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.086 -1.009 . . . . 0.0 109.673 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' A' ' 97' ' ' TYR . 2.0 mm? -72.89 -15.21 61.59 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 2.0 ttpt -76.81 -32.95 57.97 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -38.83 13.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.891 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.43 -56.77 6.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.64 35.85 4.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.25 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -160.77 47.43 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.698 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.344 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.77 -41.47 37.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -40.65 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.928 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -67.11 -50.86 42.91 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -56.39 -27.2 55.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -79.25 -33.84 43.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 0.0 109.216 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.928 HD12 ' HA2' ' A' ' 6' ' ' GLY . 12.7 mt -60.98 -57.1 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 15' ' ' SER . 8.3 t80 -59.59 -46.24 89.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.093 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 15.1 mm -57.81 -22.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.807 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 ttt -122.31 10.75 9.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 22.4 tptt -122.94 -56.52 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.072 . . . . 0.0 109.591 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -118.47 22.0 12.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -84.96 2.86 41.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.986 . . . . 0.0 109.597 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -100.11 -41.66 7.05 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.871 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.468 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 13.1 m -95.18 -26.36 16.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.973 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.9 m-70 -115.09 81.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -0.891 . . . . 0.0 109.808 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 p -78.69 83.27 4.86 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.083 -1.01 . . . . 0.0 108.553 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -82.78 45.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.169 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -165.96 24.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.003 -1.06 . . . . 0.0 109.785 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 25' ' ' LYS . 42.7 tttp -100.22 -73.22 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.48 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.95 52.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 4.98 51.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 9.3 tppt? -91.21 144.86 25.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 109.213 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.435 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -133.04 114.88 14.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.901 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.92 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.328 -0.857 . . . . 0.0 109.28 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -99.9 -47.65 4.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.229 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -84.27 153.4 29.08 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 30.6 Cg_endo -68.74 133.53 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.672 2.248 . . . . 0.0 111.256 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.4 t-20 -50.92 99.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.47 0.652 . . . . 0.0 109.59 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.973 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -80.93 70.87 7.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 109.78 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 28.1 p-80 -100.59 -48.99 4.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 109.901 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 33' ' ' HIS . . . -120.96 30.78 5.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.58 -40.09 8.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -1.193 . . . . 0.0 109.043 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 65.0 m-85 -68.61 147.44 51.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.29 17.59 11.95 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NH1' ' HB3' ' A' ' 42' ' ' GLN . 7.3 ttp85 -147.2 116.08 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -1.211 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -59.39 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 108.94 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.615 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -79.53 -164.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.614 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 53' ' ' LYS . . . 53.99 101.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -154.45 -30.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.24 . . . . 0.0 110.558 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -95.38 135.93 22.9 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.719 -1.238 . . . . 0.0 109.552 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.0 Cg_endo -78.89 136.96 13.62 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.607 2.204 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.29 -24.45 13.8 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.525 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -99.2 108.63 21.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -1.053 . . . . 0.0 108.673 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -76.18 80.17 2.98 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 1.8 m-85 -47.96 -179.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.655 -0.653 . . . . 0.0 109.242 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.1 OUTLIER -58.19 88.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.13 -37.31 61.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.459 -0.776 . . . . 0.0 109.707 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.022 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -59.15 -46.29 88.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.586 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.849 ' HA ' HD12 ' A' ' 75' ' ' ILE . 21.9 t-20 -64.37 -54.55 31.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.041 . . . . 0.0 110.008 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CD ' ' HA3' ' A' ' 41' ' ' GLY . 6.2 tttt -50.81 -38.24 47.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.104 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -81.32 -24.1 37.38 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.621 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -65.31 -10.42 32.49 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.141 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.24 63.99 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.07 121.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -1.117 . . . . 0.0 110.256 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -84.66 99.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 m95 -37.82 110.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.606 0.717 . . . . 0.0 110.839 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -129.76 -168.16 12.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.91 -57.22 4.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -1.183 . . . . 0.0 109.877 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.14 -42.18 80.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.291 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.606 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -58.6 -38.39 77.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.999 -1.063 . . . . 0.0 109.286 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -71.59 -33.34 68.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 108.82 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.0 ttp -54.04 -38.22 64.96 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.408 -0.807 . . . . 0.0 109.317 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.95 -57.02 4.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 39.1 t80 -49.16 -31.27 8.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.1 mp -81.83 -38.14 25.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.052 -1.03 . . . . 0.0 109.266 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -59.08 -22.69 61.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.8 p30 -179.6 99.0 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.653 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.7 Cg_endo -74.22 -33.72 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.403 2.069 . . . . 0.0 110.257 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -13.99 60.26 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.896 . . . . 0.0 108.933 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 2.8 tptm -92.71 -45.11 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.536 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.5 t80 -72.2 -67.59 0.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.022 HG22 ' HB3' ' A' ' 51' ' ' ALA . 18.3 mm -95.74 107.48 34.08 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.57 78.12 3.63 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.244 1.963 . . . . 0.0 110.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 164.8 -23.09 0.15 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.7 t -43.63 155.49 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.008 -1.289 . . . . 0.0 109.768 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -111.04 8.49 21.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.012 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 80' ' ' MET . 5.7 ptm -96.4 118.05 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.94 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.1 mm -84.03 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.484 -0.76 . . . . 0.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.497 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 9.6 t80 . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 108.984 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -56.66 8.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 109.635 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.51 30.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.25 -42.31 99.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -0.809 . . . . 0.0 110.126 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' GLU . 6.5 mt -56.25 -44.92 80.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.553 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -65.83 -42.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.67 16.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.687 . . . . 0.0 110.004 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 20.8 t80 -73.85 -46.28 45.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.07 -1.019 . . . . 0.0 109.425 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -71.4 -4.38 26.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.321 -0.862 . . . . 0.0 109.812 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.9 -46.61 8.08 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -79.45 -33.64 42.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.472 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.81 19.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 19.3 p -104.03 -37.85 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.959 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 16.0 t30 -85.05 19.43 2.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 10.0 tt0 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.07 . . . . 0.0 109.477 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.173 0.511 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -62.28 -44.07 97.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.612 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -71.52 -32.77 68.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.775 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -56.57 19.17 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 7.5 ttmt -54.8 -26.58 35.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.302 -1.117 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.7 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.78 -36.19 65.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.296 -0.878 . . . . 0.0 108.909 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 43.4 mm -58.21 -59.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 108.718 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.653 ' CE2' HD21 ' A' ' 98' ' ' LEU . 30.6 t80 -58.66 -41.3 85.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 109.099 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -54.26 -30.97 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.112 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 ttt -114.88 7.32 15.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.245 -0.909 . . . . 0.0 110.954 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.21 -61.33 1.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.214 . . . . 0.0 110.275 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -127.44 24.71 6.2 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.065 . . . . 0.0 109.78 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 38.7 t -88.2 2.65 51.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.139 . . . . 0.0 109.824 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -100.59 -55.11 2.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.0 m -81.0 -25.52 37.19 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.038 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -119.39 89.49 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.106 -0.996 . . . . 0.0 109.766 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.7 p -78.43 83.64 4.64 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -80.9 36.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.457 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -161.6 21.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.072 -1.017 . . . . 0.0 109.244 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -73.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.88 55.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.5 18.52 67.88 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.63 132.28 45.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -1.21 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.545 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -127.09 101.04 6.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 110.069 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -70.0 -63.71 1.03 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.604 HG21 ' SG ' ' A' ' 17' ' ' CYS . 20.4 m -104.69 -76.76 0.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -71.26 159.34 53.85 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.9 Cg_endo -68.99 142.89 52.66 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.447 2.098 . . . . 0.0 110.901 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -58.86 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.833 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -81.68 73.65 8.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.459 -0.776 . . . . 0.0 109.825 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.74 -62.94 1.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.26 28.03 11.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD11 ' CD1' ' A' ' 59' ' ' TRP . 47.9 tp -49.66 -26.37 3.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -1.059 . . . . 0.0 109.835 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.622 ' CD1' HG21 ' A' ' 102' ' ' THR . 13.1 m-85 -72.78 130.92 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.24 79.64 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' NH2' HD12 ' A' ' 35' ' ' LEU . 7.1 ttp85 -133.97 126.99 31.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.136 -1.214 . . . . 0.0 109.667 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -61.82 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.722 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -97.55 -179.31 4.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -0.928 . . . . 0.0 109.769 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.44 97.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.583 ' OE1' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -160.74 -33.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.986 -1.302 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.21 138.49 96.04 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.973 -1.079 . . . . 0.0 109.601 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.45 -34.4 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.63 2.22 . . . . 0.0 110.676 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.93 49.08 1.04 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CG ' ' CD1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -160.21 128.37 4.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.027 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -86.29 54.24 3.08 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.1 m-85 -31.59 149.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.29 0.567 . . . . 0.0 110.19 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -58.76 90.76 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.6 -34.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.275 0.559 . . . . 0.0 109.556 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -56.03 -64.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.476 -0.765 . . . . 0.0 109.495 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 1.091 ' OD1' HG21 ' A' ' 75' ' ' ILE . 3.6 m120 -36.52 -40.29 0.24 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -47.12 63.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.63 -17.13 63.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -66.45 -7.09 17.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.47 49.29 33.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.791 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -116.53 145.15 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.775 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -100.93 96.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.722 ' NE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -40.91 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.419 -0.8 . . . . 0.0 110.492 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -123.22 -153.88 8.87 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.852 ' HG2' HG21 ' A' ' 95' ' ' ILE . 2.0 mt-10 -76.13 -70.83 0.42 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -1.129 . . . . 0.0 109.724 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -37.36 86.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.791 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.37 -49.17 78.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.091 -1.006 . . . . 0.0 109.511 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -67.51 -31.96 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.181 -0.949 . . . . 0.0 109.382 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -31.87 66.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -77.91 -54.95 5.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.703 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 5.4 t80 -57.98 -19.7 32.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -93.25 -34.47 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.912 -1.117 . . . . 0.0 109.842 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -58.84 -24.86 62.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 20.4 t-20 -170.6 95.67 0.45 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -74.59 -40.58 1.02 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.352 2.034 . . . . 0.0 110.257 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -8.11 41.1 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.274 -0.892 . . . . 0.0 108.922 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -104.05 -34.53 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.429 -0.794 . . . . 0.0 109.251 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -76.52 -70.0 0.48 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.543 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.091 HG21 ' OD1' ' A' ' 52' ' ' ASN . 2.7 mm -86.05 117.11 68.13 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.76 81.36 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.264 1.976 . . . . 0.0 110.742 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.7 -4.26 2.71 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.452 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.617 ' HA ' HG21 ' A' ' 49' ' ' THR . 15.2 t -54.21 163.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.784 -1.421 . . . . 0.0 109.546 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.11 21.18 7.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -58.77 109.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.04 43.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.58 ' HB3' ' HE3' ' A' ' 80' ' ' MET . 11.2 t80 . . . . . 0 N--CA 1.488 1.429 0 O-C-N 121.724 -0.61 . . . . 0.0 110.542 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.288 0.566 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -54.33 -40.8 68.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.703 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.2 96.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.914 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -34.34 75.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.028 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 91' ' ' ARG . 92.7 mt -60.83 -51.5 69.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.852 HG21 ' HG2' ' A' ' 61' ' ' GLU . 4.6 mm -67.38 -36.78 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.38 57.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.607 -0.683 . . . . 0.0 110.129 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -73.47 -43.32 60.46 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.998 -1.064 . . . . 0.0 109.948 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.653 HD21 ' CE2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -67.15 -7.22 21.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.953 . . . . 0.0 109.977 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 1.8 ttpt -96.01 -36.17 11.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.646 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 9.3 tttm -81.14 -31.63 34.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.11 2.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.21 -0.932 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 36' ' ' PHE . 6.4 t -102.41 25.27 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.054 -1.029 . . . . 0.0 110.422 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -160.94 61.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.959 -1.088 . . . . 0.0 109.533 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HG3' ' HG3' ' A' ' 100' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.282 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -48.3 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.315 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.659 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -57.09 -35.6 70.34 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.529 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -66.42 -44.37 83.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -1.068 . . . . 0.0 109.387 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -26.23 68.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.659 HD12 ' HA2' ' A' ' 6' ' ' GLY . 7.1 mt -73.53 -66.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 20' ' ' VAL . 45.3 t80 -55.68 -25.26 38.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 108.988 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 7' ' ' LYS . 7.4 mt -70.9 -40.38 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.847 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.5 ptm -107.34 18.1 22.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.593 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -120.58 -62.54 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.967 . . . . 0.0 109.536 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 30.01 6.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.122 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 1.3 t -86.1 7.34 25.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -100.98 -54.31 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 3.2 m -84.41 -32.52 24.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.875 ' ND1' HD22 ' A' ' 32' ' ' LEU . 63.2 m-70 -114.15 93.34 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.11 -0.994 . . . . 0.0 109.992 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.6 p -91.3 97.25 10.99 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.872 -1.142 . . . . 0.0 108.559 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -83.97 47.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 110.061 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 3.0 mt-10 -173.34 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.921 -1.112 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 0.56 39.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.549 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.13 -10.46 40.03 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.1 10.86 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -89.82 160.46 16.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -1.18 . . . . 0.0 109.365 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -138.44 167.9 20.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -141.37 -87.04 0.17 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.523 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 38.1 m -94.47 -25.03 17.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 108.98 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -115.6 150.49 18.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.682 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.7 Cg_endo -65.98 131.76 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.444 2.096 . . . . 0.0 111.031 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -49.98 101.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.49 -0.756 . . . . 0.0 110.198 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.875 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.01 63.41 6.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 109.717 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.731 ' O ' HG22 ' A' ' 102' ' ' THR . 2.2 t60 -94.25 -21.46 19.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.997 . . . . 0.0 109.993 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 38' ' ' ARG . . . -156.19 22.73 0.51 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 59' ' ' TRP . 5.8 tt -41.61 -35.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -1.053 . . . . 0.0 110.288 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' HD1' HD23 ' A' ' 35' ' ' LEU . 4.3 m-30 -70.36 131.7 44.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.129 -0.982 . . . . 0.0 110.545 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.02 -13.03 64.28 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -126.71 151.87 47.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.897 -1.355 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 177.83 6.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.818 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 1.019 HG21 ' HB3' ' A' ' 52' ' ' ASN . 2.6 p -64.5 -164.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.29 94.0 0.01 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.25 -47.27 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -1.148 . . . . 0.0 109.5 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -80.31 142.75 55.01 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -78.64 -90.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.691 2.26 . . . . 0.0 110.941 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.42 -33.02 0.83 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.61 111.44 18.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -1.109 . . . . 0.0 109.067 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 1.6 p -77.37 78.32 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-85 -46.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 109.668 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.66 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 109.208 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.61 -42.93 68.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -54.16 -73.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' THR . 1.9 m-20 -35.45 -40.97 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.137 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 50' ' ' ALA . 6.0 ttpp -55.36 -59.17 5.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.883 . . . . 0.0 110.049 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -64.08 -20.66 66.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.79 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -65.36 -8.16 17.13 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.64 45.47 59.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.37 117.48 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -1.014 . . . . 0.0 109.979 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -84.46 111.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.852 ' HE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -50.26 101.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.944 -1.097 . . . . 0.0 110.271 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -122.41 -167.63 13.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' OE2' ' CG2' ' A' ' 95' ' ' ILE . 19.7 mm-40 -65.47 -74.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -62.95 -35.11 79.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 110.268 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.47 -42.87 93.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.671 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.689 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -73.42 -33.79 65.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 35.7 tpp -59.11 -27.32 65.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.171 -0.956 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.41 -64.48 1.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.881 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.636 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 28.5 t80 -49.08 -28.26 4.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.956 . . . . 0.0 109.996 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -85.84 -32.79 21.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' MET . 4.0 tt0 -59.42 -24.7 63.71 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -177.25 88.69 0.25 Allowed Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -73.82 -36.53 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.32 -17.21 64.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.061 -1.024 . . . . 0.0 108.363 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 2.4 ttmt -99.57 -25.76 14.32 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -88.0 -70.26 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.249 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.746 HG21 ' N ' ' A' ' 52' ' ' ASN . 2.6 mm -99.52 106.66 41.09 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.366 -0.834 . . . . 0.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.98 83.76 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.374 2.049 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 158.42 -30.31 0.46 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.552 ' HA ' HG23 ' A' ' 49' ' ' THR . 10.0 t -44.39 160.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.955 -1.32 . . . . 0.0 109.785 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 15.98 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.401 ' HG3' ' OH ' ' A' ' 67' ' ' TYR . 7.6 mmm -59.2 118.31 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 tp -92.32 18.83 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.411 0.624 . . . . 0.0 110.133 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.209 0.528 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -62.15 -38.16 87.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.812 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.6 71.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.31 -25.58 67.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 9' ' ' ILE . 29.2 mt -69.75 -52.5 24.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.722 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.3 mm -62.26 -47.76 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.928 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.76 71.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.79 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.51 ' CD2' HD22 ' A' ' 98' ' ' LEU . 33.3 t80 -61.74 -44.63 96.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 ' OG1' ' A' ' 102' ' ' THR . 4.0 mm? -81.95 -2.7 52.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 1.6 tmmt? -97.0 -13.83 22.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.162 -0.961 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -119.97 -39.9 2.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.56 -32.78 60.52 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.28 -0.888 . . . . 0.0 110.387 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -127.87 23.19 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.05 -1.031 . . . . 0.0 110.321 -179.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' C ' ' A' ' 99' ' ' LYS . 4.1 t-20 -149.34 14.45 0.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.023 -1.048 . . . . 0.0 109.818 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.268 0.556 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.5 -12.81 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.853 . . . . 0.0 109.942 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' O ' HG12 ' A' ' 9' ' ' ILE . 23.7 mttt -91.88 -54.31 3.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.091 -1.006 . . . . 0.0 109.848 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.59 -30.18 55.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -70.32 -46.7 63.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -1.109 . . . . 0.0 109.728 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -70.48 -18.98 62.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.7 mm -73.18 -64.6 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 108.792 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 98' ' ' LEU . 11.5 t80 -49.23 -42.34 40.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 108.621 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 55.3 mt -56.23 -42.41 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.01 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' A' ' 12' ' ' MET . 3.3 ppp? -107.12 20.06 19.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.49 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.49 -54.59 1.77 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.738 -1.226 . . . . 0.0 109.866 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -133.89 25.65 3.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.136 -0.977 . . . . 0.0 109.468 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.6 t -80.12 3.39 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -56.87 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.345 -0.847 . . . . 0.0 108.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.486 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 23.1 m -82.14 -17.9 44.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.415 -0.803 . . . . 0.0 109.13 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.033 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.3 m-70 -125.15 84.03 2.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.795 -1.191 . . . . 0.0 110.239 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 15.7 p -79.29 81.53 5.54 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.52 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 4.1 m -79.84 12.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -137.0 24.33 3.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 0.0 109.867 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.7 tmtt? -98.96 -46.98 5.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.567 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.49 67.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.4 22.53 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' CB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 tptt -98.8 140.64 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 0.0 109.588 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -140.17 128.61 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.436 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -72.5 0.72 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -53.94 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.407 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -91.4 160.22 26.69 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 35.1 Cg_endo -70.53 134.36 26.2 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.367 2.045 . . . . 0.0 110.54 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 11.7 t-20 -48.27 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.033 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.32 43.59 0.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.421 -0.799 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' VAL . 2.0 t-160 -98.62 77.82 2.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -0.975 . . . . 0.0 108.827 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' HG21 ' A' ' 102' ' ' THR . . . 115.03 15.86 7.61 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -54.2 -30.53 50.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.422 -1.046 . . . . 0.0 109.727 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.4 m-85 -65.3 143.15 57.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.905 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.54 13.62 61.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 40.4 ttp85 -138.52 129.91 27.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -1.131 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -74.39 174.43 8.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -71.94 175.7 5.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.715 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 76.51 94.94 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -150.14 -73.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.32 141.25 2.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.7 Cg_endo -79.72 -92.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.691 2.261 . . . . 0.0 111.425 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.38 -29.99 0.76 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -79.78 113.01 17.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -1.057 . . . . 0.0 108.991 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -77.98 77.93 4.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-30 -46.09 178.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.608 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.846 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.71 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -43.66 -42.72 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -54.39 -70.54 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.884 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.725 ' HB3' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -38.92 -40.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 110.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -57.41 -70.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.197 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.45 -10.56 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.333 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -66.03 -7.64 18.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.83 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.14 50.66 33.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.83 118.79 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -1.059 . . . . 0.0 109.727 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.77 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -78.33 121.35 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.023 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.77 ' N ' HD13 ' A' ' 58' ' ' ILE . 9.0 m95 -64.99 95.08 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.272 -0.892 . . . . 0.0 110.007 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -115.5 -170.7 16.22 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 6.3 mt-10 -68.61 -68.39 0.4 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.089 -1.242 . . . . 0.0 109.69 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.03 -37.22 86.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.882 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.46 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.63 -49.03 79.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.074 -1.016 . . . . 0.0 109.315 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.682 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.2 tt -63.47 -32.61 74.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 109.311 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.1 ttp -56.27 -40.87 74.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.379 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.58 -54.91 13.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.318 -0.864 . . . . 0.0 109.78 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CE1' ' OD1' ' A' ' 52' ' ' ASN . 86.4 t80 -49.18 -34.08 13.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.682 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -76.3 -37.01 58.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 109.472 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.37 -23.31 62.45 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -170.41 93.0 0.48 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HB2' HG21 ' A' ' 78' ' ' THR . 35.8 Cg_endo -79.68 -43.36 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.373 2.049 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -79.27 -22.26 44.95 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -92.26 -36.19 13.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.4 t80 -73.62 -66.6 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 51' ' ' ALA . 13.6 mm -96.38 113.2 62.05 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.43 -0.793 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.76 70.24 7.04 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.255 1.97 . . . . 0.0 109.747 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.42 -46.69 0.03 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.846 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -58.09 163.75 2.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.281 . . . . 0.0 109.651 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.32 9.03 5.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.586 ' O ' ' HG3' ' A' ' 80' ' ' MET . 8.1 ptm -74.48 115.82 14.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.879 -1.129 . . . . 0.0 109.513 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 41.8 mm -94.13 35.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' HB3' ' CE ' ' A' ' 80' ' ' MET . 4.9 t80 . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.807 -0.558 . . . . 0.0 110.167 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.307 0.575 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -53.51 -43.77 68.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 109.263 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -58.73 -34.31 71.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.381 -0.824 . . . . 0.0 109.701 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.1 -28.82 66.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.117 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.452 ' CD2' HG21 ' A' ' 9' ' ' ILE . 55.7 mt -71.13 -63.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 109.418 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -59.66 -32.01 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 108.996 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -60.39 -40.71 91.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 109.873 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.2 -48.42 62.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.352 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.0 mm? -67.13 -16.29 64.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -72.49 -49.26 34.3 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.312 -0.867 . . . . 0.0 109.862 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 6.8 tttt -79.88 -27.4 40.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.31 -59.15 3.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 110.376 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -111.54 -29.89 7.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.46 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t30 -81.61 10.96 5.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.541 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.508 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.268 0.556 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -13.03 26.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' ILE . 6.9 ttmt -77.44 -63.07 1.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.28 -32.78 60.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 34.9 tttt -64.67 -33.7 76.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -77.08 -24.13 51.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 5' ' ' LYS . 17.9 mt -69.62 -55.94 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 108.838 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' SER . 9.7 t80 -62.84 -40.15 96.53 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.324 -0.86 . . . . 0.0 108.921 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 14.5 mt -58.06 -28.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.38 -0.825 . . . . 0.0 109.001 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -114.92 6.89 15.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 110.015 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -113.68 -66.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -115.07 31.18 6.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.965 -1.084 . . . . 0.0 109.459 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.8 t -90.16 8.74 31.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.2 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -101.44 -48.2 4.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 0.0 108.956 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 96.9 m -93.57 -25.52 17.52 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.419 -0.8 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.042 ' ND1' HD22 ' A' ' 32' ' ' LEU . 79.1 m-70 -113.87 82.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 110.249 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.536 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 5.1 p -78.86 88.4 4.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 108.448 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 32' ' ' LEU . 5.5 m -79.88 9.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -137.75 18.01 2.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.046 . . . . 0.0 109.433 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 4.8 tptt -88.9 -57.27 2.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.36 63.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.43 17.63 33.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.93 73.47 1.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -1.192 . . . . 0.0 109.368 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.527 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -78.47 128.9 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 109.964 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' NZ ' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -101.69 -80.39 0.5 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 96.3 m -91.8 -33.33 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.363 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -108.56 156.91 15.51 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 32.9 Cg_endo -68.68 136.33 35.68 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.543 2.162 . . . . 0.0 110.849 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 6.2 t-20 -51.38 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.812 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.042 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.64 70.25 7.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.494 -0.754 . . . . 0.0 109.456 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 102' ' ' THR . 31.3 t-80 -100.2 -49.58 4.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 109.098 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -122.81 37.67 2.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.73 ' O ' HD23 ' A' ' 35' ' ' LEU . 3.1 tt -49.52 -50.52 41.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.992 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -60.37 137.94 58.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.855 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.92 24.21 76.55 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD2' ' HG2' ' A' ' 42' ' ' GLN . 24.2 ttp85 -145.78 118.11 8.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -1.231 . . . . 0.0 109.797 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -70.68 164.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.91 169.07 4.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.866 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 73.13 83.39 0.29 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -148.61 -39.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -1.148 . . . . 0.0 109.882 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -79.84 136.35 54.87 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 109.693 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.5 Cg_endo -79.15 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.59 2.193 . . . . 0.0 110.972 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -40.13 -37.91 1.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.468 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -80.13 125.07 29.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -1.061 . . . . 0.0 108.979 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 48' ' ' TYR . 93.9 p -86.34 57.35 4.44 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m-30 -31.8 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.113 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.994 HG21 ' HA ' ' A' ' 78' ' ' THR . 31.0 p -63.19 93.4 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.642 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -36.93 -37.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -41.15 -69.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.92 ' OD1' HD13 ' A' ' 75' ' ' ILE . 28.6 m-20 -45.1 -45.26 11.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 109.852 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.7 -74.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.93 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.57 -14.03 2.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.885 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HB2' HG12 ' A' ' 75' ' ' ILE . 1.8 tptp -59.17 -13.83 8.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.0 109.926 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.94 58.78 12.39 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -133.73 120.33 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.731 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.07 102.15 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.047 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CG ' HD21 ' A' ' 35' ' ' LEU . 6.7 m95 -41.16 106.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.42 -159.87 10.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.9 -59.45 2.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.11 -1.229 . . . . 0.0 109.868 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.96 -38.12 64.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.846 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.98 -52.1 66.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.4 tt -62.94 -37.32 86.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -53.36 -37.9 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE1' ' CD1' ' A' ' 74' ' ' TYR . 7.5 tm-20 -69.87 -57.11 5.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.576 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.6 t80 -60.87 -13.41 15.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 109.526 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.674 HD13 ' CD2' ' A' ' 64' ' ' LEU . 4.9 tp -85.09 -49.79 7.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.058 . . . . 0.0 109.073 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 6.9 tt0 -59.21 -22.08 60.49 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 69' ' ' GLU . 1.2 m-80 -161.27 92.34 1.48 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.736 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -76.0 -52.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.0 110.878 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.128 -0.982 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . 15.5 mtpt -77.09 -39.91 47.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.884 ' CD2' HD12 ' A' ' 75' ' ' ILE . 22.8 t80 -68.05 -63.23 1.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.92 HD13 ' OD1' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -114.21 125.3 29.48 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 71.19 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.239 1.959 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 51' ' ' ALA . . . -160.57 -58.47 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.994 ' HA ' HG21 ' A' ' 49' ' ' THR . 9.4 t -41.81 152.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -1.132 . . . . 0.0 110.164 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.11 5.18 13.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.662 ' HE2' ' CB ' ' A' ' 82' ' ' PHE . 8.5 ptm -77.58 119.29 20.93 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.071 -1.018 . . . . 0.0 109.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.4 mt -90.11 55.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.662 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 48.7 t80 . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.579 -0.7 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -44.07 92.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.43 96.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.348 -0.845 . . . . 0.0 109.388 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.4 -37.45 62.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.09 -53.23 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 95' ' ' ILE . 19.9 mm -61.99 -79.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -33.76 -38.35 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.285 0.564 . . . . 0.0 110.698 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 1.2 t80 -56.62 -57.04 14.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 0.0 109.177 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 102' ' ' THR . 4.8 mt -74.68 -13.69 60.65 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.461 -0.774 . . . . 0.0 109.48 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -75.78 -15.81 60.21 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -112.36 -24.36 9.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.609 -0.682 . . . . 0.0 109.215 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.06 -48.78 6.07 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.133 -0.979 . . . . 0.0 110.058 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -109.59 32.03 5.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.923 . . . . 0.0 109.928 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t-20 -154.73 -46.14 0.09 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.171 -0.956 . . . . 0.0 109.376 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.65 173.75 16.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.168 -1.195 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.5 t -98.93 -49.15 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.575 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.72 -11.82 60.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.911 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.37 -52.47 5.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.893 . . . . 0.0 109.693 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.03 -34.71 62.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 2.5 ttpt -51.08 -42.11 60.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -1.156 . . . . 0.0 109.612 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 12' ' ' MET . 0.2 OUTLIER -77.08 -25.47 52.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.654 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.702 HG22 HD21 ' A' ' 94' ' ' LEU . 12.2 mt -66.58 -62.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CE1' HG13 ' A' ' 20' ' ' VAL . 54.6 t80 -62.76 -40.25 96.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.09 -1.006 . . . . 0.0 108.951 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 84.3 mt -66.52 -14.63 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.464 -0.773 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 5.0 ttt -119.07 5.17 11.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.007 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -120.79 -64.25 1.26 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.044 -1.035 . . . . 0.0 109.805 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.64 37.83 3.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 108.895 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.2 t -91.73 4.34 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.447 -0.783 . . . . 0.0 109.904 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.43 -46.67 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 108.973 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 11.0 m -90.64 -29.53 17.71 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.319 -0.863 . . . . 0.0 108.936 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.86 ' ND1' HD22 ' A' ' 32' ' ' LEU . 69.1 m-70 -114.72 84.51 2.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -84.93 97.98 10.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.931 -1.106 . . . . 0.0 109.12 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 10' ' ' PHE . 2.5 m -85.71 17.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -149.15 31.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -97.59 -77.04 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.53 52.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.23 16.62 35.04 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.85 124.01 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -1.153 . . . . 0.0 109.348 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.434 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -124.71 95.48 4.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -82.11 -73.85 0.37 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.097 -1.002 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.2 m -84.79 -63.08 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.04 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -88.48 152.18 23.14 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.68 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.3 Cg_endo -66.78 134.32 34.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.577 2.185 . . . . 0.0 110.969 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 17.2 t-20 -53.03 103.02 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 109.692 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.06 51.5 1.96 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.665 -0.647 . . . . 0.0 109.826 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.504 ' O ' HG22 ' A' ' 102' ' ' THR . 4.1 t60 -93.46 -8.54 41.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 109.468 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 102' ' ' THR . . . -162.01 31.07 0.31 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -55.48 -28.13 52.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.044 . . . . 0.0 109.85 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 29.9 m-85 -72.28 113.83 9.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.197 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.85 51.03 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -101.61 136.54 41.28 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.056 -1.261 . . . . 0.0 110.075 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' CG ' ' N ' ' A' ' 40' ' ' THR . 30.5 ttmt -82.45 167.52 18.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.024 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.889 HG23 ' CGA' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -61.72 165.18 5.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.918 . . . . 0.0 109.946 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 65.4 94.47 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.6 tp-100 -149.05 -48.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -1.216 . . . . 0.0 109.645 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -61.55 146.4 89.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 109.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.72 -60.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.776 2.317 . . . . 0.0 110.758 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.24 52.77 4.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.01 118.5 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -1.098 . . . . 0.0 108.888 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.538 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 3.9 t -83.33 70.99 10.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 30' ' ' PRO . 2.3 m-85 -44.26 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.684 -0.635 . . . . 0.0 109.747 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.803 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.56 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -50.85 -40.62 56.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.435 -0.791 . . . . 0.0 109.219 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -52.45 -72.51 0.05 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.629 ' N ' HG21 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -37.2 -49.35 0.91 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -53.79 -48.32 69.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -0.928 . . . . 0.0 110.678 -178.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -65.04 -45.18 86.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.103 -0.998 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -21.03 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.161 -0.962 . . . . 0.0 109.68 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.84 43.94 48.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.961 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -99.34 137.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.993 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.961 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -98.54 115.62 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.643 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 11.8 m95 -59.02 111.11 1.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -136.42 -158.74 8.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 95' ' ' ILE . 2.9 tt0 -75.78 -74.12 0.23 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.197 -1.178 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -36.91 78.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 110.13 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -59.33 -44.97 92.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.367 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -68.97 -24.97 64.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.242 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.8 tpp -59.75 -44.84 93.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -56.91 5.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 34.3 t80 -51.34 -28.65 12.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.987 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.032 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 2.7 tp -84.02 -31.48 25.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -58.76 -26.09 63.68 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 7.7 m120 -171.84 102.46 0.37 Allowed Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -75.42 -32.72 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.075 1.85 . . . . 0.0 110.045 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -27.97 31.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.456 -0.777 . . . . 0.0 109.734 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -83.75 -33.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -79.51 -68.41 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.914 . . . . 0.0 108.817 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.724 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.4 mm -102.96 111.18 64.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.215 -0.928 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 70.43 7.23 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.292 1.994 . . . . 0.0 109.711 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -172.98 -40.29 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.803 ' HA ' HG23 ' A' ' 49' ' ' THR . 11.2 t -42.58 151.55 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 109.843 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' HG2' ' O2D' ' A' ' 105' ' ' HEC . 6.2 mmmt -111.78 7.12 20.1 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.557 -0.715 . . . . 0.0 109.103 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.772 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 5.7 ptm -86.0 117.79 25.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.931 -1.105 . . . . 0.0 109.695 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -88.89 50.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.628 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 27.4 t80 -59.53 149.83 28.79 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.52 0.676 . . . . 0.0 110.197 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 83' ' ' VAL . 0.6 OUTLIER -76.21 149.26 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.213 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.86 143.13 48.54 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 2.2 mp -70.32 142.56 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -1.143 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -131.93 16.82 4.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 109.411 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.29 86.9 0.82 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.593 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -29.29 58.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -55.41 -52.84 62.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.322 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.39 -32.98 72.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.301 -0.874 . . . . 0.0 109.8 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.738 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.4 mmt180 -62.06 -44.86 95.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.399 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.68 79.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.979 -1.076 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB2' ' CD1' ' A' ' 9' ' ' ILE . 8.2 m-20 -65.61 -26.41 67.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 91' ' ' ARG . 28.6 mt -66.58 -59.92 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 108.856 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG21 ' HG3' ' A' ' 61' ' ' GLU . 4.8 mm -50.52 -32.53 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.428 -0.795 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.3 78.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.404 ' CD2' HD22 ' A' ' 98' ' ' LEU . 23.3 t80 -64.28 -50.33 68.33 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.092 -1.005 . . . . 0.0 109.724 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.1 mm? -64.67 -18.49 65.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.805 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 4.8 mttt -80.86 -25.68 37.48 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.001 -1.062 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 5.5 tptp -78.02 -37.66 46.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.94 -54.8 3.81 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 33' ' ' HIS . 19.3 p -92.69 16.23 12.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.055 -1.028 . . . . 0.0 111.149 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.0 t-20 -156.82 29.03 0.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.923 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.483 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.063 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 11.1 m-20 -114.77 162.93 16.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -1.152 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 4' ' ' GLU . 11.2 p -94.59 -36.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.943 . . . . 0.0 109.51 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.423 ' N ' HG13 ' A' ' 3' ' ' VAL . 14.1 mm-40 -72.21 -7.41 49.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.695 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -93.11 -55.24 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.796 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.81 -49.31 59.91 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.8 tttt -62.49 -13.63 32.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.22 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.9 mmtt -85.46 -54.14 4.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.048 -1.033 . . . . 0.0 109.355 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 70.8 mt -57.22 -53.7 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 15' ' ' SER . 10.1 t80 -60.26 -42.3 95.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 5.2 mt -58.34 -24.42 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.325 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ptm -123.35 18.25 9.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.163 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.64 -48.09 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.05 -1.031 . . . . 0.0 109.725 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.572 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -133.72 20.6 3.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.937 -1.102 . . . . 0.0 109.517 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.525 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.7 t -85.3 8.4 18.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.497 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -100.31 -43.87 6.12 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 28' ' ' THR . 35.5 m -93.39 -27.93 16.45 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.031 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.2 m-70 -112.94 84.28 1.96 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 109.798 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -78.53 84.05 4.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 108.364 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.3 m -83.93 31.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 110.692 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 22.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 109.818 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -99.85 6.04 45.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.431 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.16 -22.14 12.56 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.16 7.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 142.1 39.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.16 . . . . 0.0 109.279 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.488 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -127.22 172.77 10.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 109.659 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 -72.63 0.17 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 109.331 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 17' ' ' CYS . 16.8 m -85.28 -55.41 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.302 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -95.7 153.23 20.59 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 32.3 Cg_endo -69.1 128.25 16.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.032 1.822 . . . . 0.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 30' ' ' PRO . 14.8 t-20 -44.22 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.031 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.25 41.21 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.88 ' HA ' HG21 ' A' ' 102' ' ' THR . 55.0 t-80 -87.12 -16.64 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.336 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.96 37.93 0.81 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.834 HD11 ' CD1' ' A' ' 59' ' ' TRP . 6.6 tp -67.49 -33.98 76.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.557 -0.966 . . . . 0.0 110.167 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.2 m-85 -64.07 130.26 43.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.981 . . . . 0.0 110.09 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.23 20.81 76.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -148.0 121.1 8.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.019 -1.283 . . . . 0.0 109.783 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.06 160.02 29.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.223 -0.923 . . . . 0.0 109.148 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.731 HG21 ' HB3' ' A' ' 52' ' ' ASN . 11.3 t -65.05 -174.84 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.906 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 57.23 79.58 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -156.39 -56.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -1.203 . . . . 0.0 109.981 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -43.2 135.37 3.11 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.686 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.65 134.01 11.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.505 2.136 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 -11.55 60.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -133.71 76.22 1.65 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 109.718 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -68.56 92.24 0.45 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.768 ' OH ' ' HB2' ' A' ' 43' ' ' ALA . 5.7 m-30 -46.17 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.873 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 78' ' ' THR . 7.4 m -59.67 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.401 -0.812 . . . . 0.0 109.358 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -35.71 -31.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.883 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -32.3 -59.71 0.3 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.373 0.606 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.731 ' HB3' HG21 ' A' ' 40' ' ' THR . 51.2 t30 -62.23 -54.17 44.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 109.328 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HB2' HG23 ' A' ' 40' ' ' THR . 5.3 ttpp -41.94 -27.94 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 110.295 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 51' ' ' ALA . 7.3 p30 -94.94 -33.55 12.73 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.002 -1.061 . . . . 0.0 109.991 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 19.8 tptp -53.11 -20.02 3.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.033 -1.042 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.91 75.07 0.79 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.838 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -150.41 127.35 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 110.472 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.838 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -90.04 101.78 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.834 ' CD1' HD11 ' A' ' 35' ' ' LEU . 5.4 m95 -42.41 107.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.352 -0.843 . . . . 0.0 110.216 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.16 -154.8 7.97 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HG3' HG21 ' A' ' 95' ' ' ILE . 12.7 tt0 -76.58 -75.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -1.213 . . . . 0.0 109.703 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 65' ' ' MET . 21.2 t70 -62.32 -37.46 85.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.817 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.99 -55.2 35.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.873 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.3 tt -63.49 -19.73 65.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.328 -0.858 . . . . 0.0 109.298 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.503 ' HG2' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -64.78 -46.36 82.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -49.93 66.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.187 -0.945 . . . . 0.0 109.758 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.651 ' CG ' ' CH2' ' A' ' 59' ' ' TRP . 7.9 t80 -53.35 -41.02 65.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.105 -0.997 . . . . 0.0 109.352 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -69.98 -33.81 72.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.781 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.7 -24.13 63.72 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 21.1 t-20 -170.98 97.27 0.42 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 29.7 Cg_endo -74.75 -37.52 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.219 1.946 . . . . 0.0 110.769 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -72.84 -9.09 58.29 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.086 -1.009 . . . . 0.0 109.209 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 14.4 tptt -94.17 -57.69 2.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.572 ' CD1' ' HG2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -62.91 -62.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.883 HG22 ' CB ' ' A' ' 51' ' ' ALA . 3.2 mm -80.45 117.23 66.78 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.9 Cg_endo -75.61 74.87 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.165 1.91 . . . . 0.0 110.685 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.42 26.84 1.74 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.632 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 t -49.94 160.7 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.797 -1.414 . . . . 0.0 108.94 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.746 ' HB3' HMD2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -101.57 0.95 37.33 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 108.813 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.791 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.8 ptm -113.46 122.25 46.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' ILE . 16.0 tt -91.04 58.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.734 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 55.3 t80 -75.57 154.67 36.61 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.566 -0.709 . . . . 0.0 109.907 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 p -99.12 149.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.486 -0.759 . . . . 0.0 109.246 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.48 120.07 5.16 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.4 mt -74.51 131.58 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -1.158 . . . . 0.0 109.183 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -74.49 -48.09 29.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 109.383 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 96.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -33.12 69.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.688 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.7 -53.47 18.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.228 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG3' HD13 ' A' ' 9' ' ' ILE . 1.2 tp10 -60.31 -45.27 93.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.256 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.503 ' CD ' ' HG2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -50.0 -36.1 27.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.223 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.86 89.22 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.253 -0.905 . . . . 0.0 109.174 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.68 -35.44 42.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -65.0 -55.88 16.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.409 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.448 HG21 ' HG3' ' A' ' 61' ' ' GLU . 16.7 mm -53.51 -69.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.543 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -39.98 -39.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.81 -0.556 . . . . 0.0 110.244 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.03 -50.36 72.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 2.7 mm? -75.22 -3.48 33.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 -12.18 20.64 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.216 -0.927 . . . . 0.0 109.748 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -113.96 -43.55 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 110.123 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.96 -33.4 61.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.941 . . . . 0.0 110.267 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.88 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -128.54 46.15 2.65 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.061 -1.024 . . . . 0.0 109.957 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -177.5 45.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.303 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 0.903 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -108.48 152.69 24.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -1.097 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.4 p -73.32 -37.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.76 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 3' ' ' VAL . 16.6 mt-10 -62.62 -22.62 66.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -84.39 -49.75 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.006 . . . . 0.0 109.877 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -52.12 -45.56 57.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -59.9 -37.36 79.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.912 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -21.69 61.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 109.867 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' LYS . 32.1 mm -75.09 -63.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 20' ' ' VAL . 30.6 t80 -56.22 -45.61 79.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.213 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 18.6 mt -58.93 -30.66 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.6 ttp -116.77 21.9 13.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -134.14 -65.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.58 30.83 7.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.106 -0.996 . . . . 0.0 109.564 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 4.3 t -89.68 -14.95 33.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.918 -1.114 . . . . 0.0 109.466 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -82.43 -44.18 16.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 108.911 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.3 m -90.08 -35.08 15.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.38 -0.825 . . . . 0.0 108.869 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.842 ' ND1' HD22 ' A' ' 32' ' ' LEU . 68.6 m-70 -114.02 80.36 1.38 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.039 -1.038 . . . . 0.0 109.934 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 p -79.69 94.55 5.74 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.663 -1.273 . . . . 0.0 108.781 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 10' ' ' PHE . 2.9 m -84.57 -5.56 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -117.19 26.5 9.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -0.994 . . . . 0.0 109.773 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.3 -51.39 3.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.318 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.4 60.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.76 24.99 72.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -96.34 115.55 27.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -1.106 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' CG ' ' HD2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -131.57 89.88 2.77 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.46 -68.5 0.71 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 0.0 109.773 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 99.8 m -90.19 -59.81 2.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.722 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -90.41 149.0 19.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 31.7 Cg_endo -65.84 136.03 43.68 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.51 2.14 . . . . 0.0 111.232 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 33' ' ' HIS . 9.5 t-20 -52.4 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.774 -0.579 . . . . 0.0 110.286 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.842 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.15 70.07 9.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.729 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.457 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 14.8 t60 -88.86 -45.65 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.599 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.52 38.93 1.63 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD11 ' CD1' ' A' ' 59' ' ' TRP . 5.5 tp -54.03 -28.28 37.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -1.131 . . . . 0.0 109.601 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.6 m-85 -66.29 136.75 56.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.81 17.23 57.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 1.8 ttt-85 -133.87 135.68 43.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -1.203 . . . . 0.0 109.326 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -64.68 -174.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.877 . . . . 0.0 109.925 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' N ' ' A' ' 53' ' ' LYS . 4.6 p -53.5 -169.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.582 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -133.3 175.11 20.33 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.879 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -161.82 54.3 0.25 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.954 . . . . 0.0 108.666 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -44.34 169.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 109.666 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.844 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 35.0 Cg_endo -75.12 -66.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.64 2.226 . . . . 0.0 110.585 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.96 6.86 61.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.95 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -131.04 103.89 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -1.135 . . . . 0.0 109.403 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' TYR . 34.7 t -75.14 83.89 2.34 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-30 -44.19 176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.731 -0.606 . . . . 0.0 110.186 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.5 ' OG1' HAD1 ' A' ' 105' ' ' HEC . 0.3 OUTLIER -59.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.906 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -52.61 -38.75 60.72 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.604 -0.685 . . . . 0.0 109.227 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.26 -70.57 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.394 -0.817 . . . . 0.0 108.847 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -43.97 -54.18 5.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.603 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' N ' HG21 ' A' ' 40' ' ' THR . 10.1 tptp -40.03 -46.56 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.213 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.67 -34.47 60.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 9.6 tptt -53.65 -17.85 2.53 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.996 -1.065 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.43 54.34 32.75 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -108.24 138.42 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.997 . . . . 0.0 110.251 -179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.895 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -98.13 104.21 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.89 ' CD1' HD11 ' A' ' 35' ' ' LEU . 6.6 m95 -49.04 103.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.068 -1.02 . . . . 0.0 110.263 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.86 -164.11 11.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.92 -55.79 5.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.022 -1.281 . . . . 0.0 109.712 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -73.77 -38.93 64.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.157 -0.964 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.44 -37.86 79.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.058 -1.026 . . . . 0.0 109.521 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -77.38 -35.96 53.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.182 -0.949 . . . . 0.0 109.125 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 46.1 ttm -56.77 -28.53 61.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 108.831 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -53.22 6.07 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 75' ' ' ILE . 19.9 t80 -58.78 -17.72 25.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -96.08 -36.19 11.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 108.919 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' MET . 21.6 tt0 -59.31 -23.65 62.63 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 23.1 t-20 -176.0 88.52 0.28 Allowed Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.4 Cg_endo -74.59 -37.54 2.28 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.378 2.052 . . . . 0.0 110.274 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -67.63 -14.07 62.63 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.17 -0.956 . . . . 0.0 108.654 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 1.3 tppp? -98.74 -31.66 11.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.227 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.442 ' CD2' HD11 ' A' ' 75' ' ' ILE . 13.1 t80 -83.37 -72.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 108.629 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.5 mm -83.87 115.4 59.65 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 84.26 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.286 1.991 . . . . 0.0 110.396 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 140.18 -7.37 2.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.465 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 12.0 t -44.43 144.67 0.99 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.245 . . . . 0.0 109.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' CGD' ' A' ' 105' ' ' HEC . 0.2 OUTLIER -104.77 17.18 24.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.44 124.47 20.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.871 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.638 ' HB ' HBC2 ' A' ' 105' ' ' HEC . 6.6 mt -92.05 21.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HD1' HMC2 ' A' ' 105' ' ' HEC . 0.5 OUTLIER -59.72 160.28 7.62 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.419 0.628 . . . . 0.0 110.193 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 84' ' ' GLY . 17.3 m -86.93 -37.75 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.238 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 121.84 101.85 1.71 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 85' ' ' ILE . 28.7 mm -101.85 142.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 108.854 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.24 10.43 3.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.055 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 122.81 42.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.048 -1.032 . . . . 0.0 109.245 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -17.7 9.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.61 -61.34 2.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.68 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 -49.05 79.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.644 ' HA ' HD12 ' A' ' 94' ' ' LEU . 4.8 mtp180 -53.04 -36.13 60.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.91 -49.16 60.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.461 ' HB3' HG13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -62.92 -24.58 67.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 110.028 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 91' ' ' ARG . 75.8 mt -68.29 -59.52 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.564 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -61.74 -32.47 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.85 46.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.436 ' HB2' ' C ' ' A' ' 6' ' ' GLY . 32.7 t80 -66.84 -44.27 81.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.963 -1.086 . . . . 0.0 109.814 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.595 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 1.5 mm? -75.91 -4.01 38.54 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.56 -15.13 17.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.197 -0.939 . . . . 0.0 109.14 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 9.0 tttp -103.71 -31.1 10.02 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.23 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.59 -0.694 . . . . 0.0 110.983 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' N ' ' A' ' 103' ' ' ASN . 4.6 t -91.06 -48.62 6.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.929 -1.107 . . . . 0.0 110.855 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.585 ' N ' HG23 ' A' ' 102' ' ' THR . 7.8 t-20 -69.66 -4.26 18.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.871 -1.143 . . . . 0.0 110.029 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 8.4 mm-40 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.599 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.04 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -79.86 121.5 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -1.123 . . . . 0.0 109.497 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.82 -29.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -74.8 -45.93 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 9' ' ' ILE . 2.0 tppm? -76.97 -41.39 43.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.18 94.15 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HD3' ' CE1' ' A' ' 97' ' ' TYR . 3.2 ttpt -61.03 -32.85 72.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -1.158 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -67.44 -25.33 65.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 13' ' ' LYS . 5.2 mm -76.98 -68.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.523 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 48.8 t80 -53.35 -46.66 69.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 12' ' ' MET . 12.9 tt -56.01 -43.54 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 110.054 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.515 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.21 14.52 31.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.971 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.44 -68.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.072 -1.017 . . . . 0.0 109.592 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.603 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -113.59 37.16 3.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 2.9 t -93.51 -48.16 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.881 -1.137 . . . . 0.0 109.835 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.4 -33.79 45.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 36.4 m -98.24 -37.72 9.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.109 -0.994 . . . . 0.0 109.159 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.911 ' ND1' HD22 ' A' ' 32' ' ' LEU . 67.6 m-70 -115.51 74.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.85 -1.156 . . . . 0.0 108.992 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.4 96.83 5.45 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.696 -1.253 . . . . 0.0 109.168 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -87.53 25.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.475 -0.766 . . . . 0.0 109.879 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -140.08 9.29 2.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 0.0 109.668 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -85.23 -86.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.441 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.8 38.04 0.61 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.52 13.84 63.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -98.66 169.59 9.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -1.13 . . . . 0.0 109.269 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.31 117.51 9.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -91.41 -73.15 0.55 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.283 -0.886 . . . . 0.0 109.158 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m -93.24 -59.88 1.92 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -92.31 153.36 21.72 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.2 Cg_endo -66.57 147.57 82.19 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.403 2.069 . . . . 0.0 111.254 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 16.2 t-20 -64.61 100.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 110.328 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.911 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.88 38.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -90.91 36.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 109.093 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 102' ' ' THR . . . 161.56 37.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.763 HD11 ' CD1' ' A' ' 59' ' ' TRP . 4.2 tp -79.04 -24.39 43.64 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.356 -1.084 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 27.5 m-85 -74.4 127.28 32.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 109.549 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 14.12 82.92 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 11.7 ttt-85 -134.18 134.55 42.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.154 . . . . 0.0 109.516 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 4.0 mttt -73.78 -177.36 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.898 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -92.61 -175.5 3.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 59.48 89.05 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 1.5 tp-100 -147.98 -43.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 109.72 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -73.53 136.35 78.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.327 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 45' ' ' GLY . 35.2 Cg_endo -77.28 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.08 -30.02 0.37 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.526 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -80.59 125.53 30.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.433 -1.039 . . . . 0.0 109.109 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -86.49 57.3 4.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-85 -36.42 158.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.286 0.565 . . . . 0.0 110.066 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -61.0 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.84 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -46.03 -35.89 5.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -49.0 -61.2 2.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HG21 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -55.94 -50.62 70.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 109.592 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 52' ' ' ASN . 6.7 ttpm? -39.99 -30.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.53 0.681 . . . . 0.0 109.338 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLY . 86.1 m-20 -92.23 -39.67 11.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.448 -0.783 . . . . 0.0 109.687 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -56.9 92.72 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.934 -1.104 . . . . 0.0 108.252 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' ASN . . . -38.19 91.52 0.01 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -143.65 145.75 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 110.015 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.081 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -118.61 100.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.898 ' NE1' HG22 ' A' ' 40' ' ' THR . 6.9 m95 -37.56 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.793 0.806 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . -122.38 -164.45 12.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -67.9 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -1.146 . . . . 0.0 109.705 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.05 -27.21 66.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.88 -40.69 93.97 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.9 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.6 OUTLIER -76.26 -32.49 58.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -37.09 67.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -76.67 -56.81 4.28 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.679 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 9.5 t80 -56.07 -19.11 11.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 109.992 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.77 HD13 HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -92.33 -36.31 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.033 -1.042 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.99 -25.16 63.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 5.1 t-20 -168.8 85.46 0.67 Allowed Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -75.01 -26.39 10.95 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.462 2.108 . . . . 0.0 109.766 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 2.2 tttt -74.3 -19.18 60.57 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 43.2 tptt -88.79 -45.06 10.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.501 -0.749 . . . . 0.0 109.438 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.866 ' CD2' HD11 ' A' ' 75' ' ' ILE . 8.1 t80 -71.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.116 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.866 HD11 ' CD2' ' A' ' 74' ' ' TYR . 2.6 mm -96.2 107.81 37.5 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.703 -0.623 . . . . 0.0 109.654 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.749 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -79.13 81.68 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.375 2.05 . . . . 0.0 110.347 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.23 -18.25 0.71 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 49' ' ' THR . 9.5 t -44.97 132.21 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 109.938 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 23.76 5.01 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -59.2 120.0 8.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.607 -0.683 . . . . 0.0 109.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.507 ' HB ' HBC2 ' A' ' 105' ' ' HEC . 10.9 mt -93.29 26.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 0.3 OUTLIER -60.04 162.3 5.85 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.625 0.726 . . . . 0.0 110.663 -179.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 p -100.63 -33.11 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.35 93.82 2.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.827 HG22 ' H ' ' A' ' 87' ' ' LYS . 30.5 mt -62.15 125.9 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.156 . . . . 0.0 109.502 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -97.87 25.48 5.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.239 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.827 ' H ' HG22 ' A' ' 85' ' ' ILE . 2.5 mttt -135.55 107.13 6.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.575 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -61.03 -25.88 67.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.425 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.8 -39.38 76.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.393 -0.817 . . . . 0.0 109.772 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.81 -51.15 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -55.04 -44.75 74.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.958 . . . . 0.0 109.125 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.52 66.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.281 -0.887 . . . . 0.0 109.23 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.46 -36.63 84.81 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.264 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 66.7 mt -61.97 -29.78 70.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.317 -0.864 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.8 mm -79.15 -46.91 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.351 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.08 -46.78 65.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.219 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' CD2' HD22 ' A' ' 98' ' ' LEU . 28.1 t80 -70.66 -47.52 59.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.993 -1.067 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 102' ' ' THR . 1.1 mm? -71.7 -3.36 21.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -87.0 -55.9 3.62 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.08 -1.013 . . . . 0.0 109.261 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -28.58 61.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.59 50.28 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.389 -0.82 . . . . 0.0 109.68 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 102' ' ' THR . 3.1 t -124.38 41.41 3.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.855 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 2.9 t-20 179.78 50.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.144 -0.973 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.388 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 0.955 HMB1 HBB3 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.43 179.76 6.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -1.165 . . . . 0.0 109.346 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.571 HG22 ' HE2' ' A' ' 100' ' ' LYS . 2.1 t -81.24 -57.81 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HG2' ' HE3' ' A' ' 8' ' ' LYS . 5.8 tt0 -62.47 -27.68 69.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.663 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -58.25 -62.16 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.64 -37.17 94.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 1.6 ttmm -58.47 -26.45 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -1.176 . . . . 0.0 109.811 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HE3' ' HG2' ' A' ' 4' ' ' GLU . 32.2 mttt -82.2 -40.5 21.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 109.994 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.812 HG22 HD21 ' A' ' 94' ' ' LEU . 12.9 mm -61.48 -58.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.94 . . . . 0.0 110.123 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HE2' HD23 ' A' ' 32' ' ' LEU . 18.8 t80 -62.12 -41.06 97.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.005 -1.06 . . . . 0.0 109.758 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 18.3 mm -68.21 -11.93 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.7 ttm -133.31 19.47 4.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 110.215 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 5.8 tptt -131.76 -43.25 1.0 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.053 -1.029 . . . . 0.0 109.199 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -134.07 25.33 3.91 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.7 t -85.59 10.42 13.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -43.5 6.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 108.748 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.4 m -99.61 -22.02 15.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.478 -0.764 . . . . 0.0 109.136 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.81 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.8 m-70 -117.43 79.42 1.34 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 110.303 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -79.53 100.08 7.58 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.827 -1.17 . . . . 0.0 108.781 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.9 m -83.81 13.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.887 . . . . 0.0 109.742 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -121.94 17.95 10.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.407 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 1.2 tptp -89.37 179.44 6.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.7 53.92 4.58 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.1 7.52 76.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 1.4 ttpt -97.92 159.5 14.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.119 . . . . 0.0 109.356 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.604 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -140.33 109.27 6.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.905 . . . . 0.0 108.706 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.695 HG21 ' SG ' ' A' ' 17' ' ' CYS . 30.8 m -87.42 -96.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 28' ' ' THR . . . -50.12 158.83 1.55 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 35.5 Cg_endo -69.38 151.92 71.24 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.363 2.042 . . . . 0.0 111.427 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.0 t-20 -62.41 102.99 0.36 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -82.07 54.86 2.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.121 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -99.51 43.54 1.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 108.888 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA2' HG21 ' A' ' 102' ' ' THR . . . 132.01 48.5 0.11 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.943 HD21 ' CD1' ' A' ' 59' ' ' TRP . 3.6 tt -65.92 -33.78 76.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -1.027 . . . . 0.0 110.35 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 21.3 m-85 -60.08 140.58 56.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 0.0 109.847 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.04 20.0 74.32 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 38' ' ' ARG . 16.5 ttp85 -133.36 98.95 4.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 169.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.009 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -70.08 172.95 7.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.658 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 72.15 72.8 0.9 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.473 ' HG3' ' HG2' ' A' ' 38' ' ' ARG . 66.2 mm-40 -135.53 -53.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 109.806 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -71.11 137.96 84.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.625 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -79.73 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.696 2.264 . . . . 0.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.28 -33.73 1.41 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.62 ' CE1' ' O2D' ' A' ' 105' ' ' HEC . 0.3 OUTLIER -79.91 121.76 25.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -1.089 . . . . 0.0 109.429 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -84.64 65.4 9.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.6 m-30 -37.88 162.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.617 0.723 . . . . 0.0 111.12 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 78' ' ' THR . 45.1 p -68.44 88.8 0.34 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 109.466 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.74 -33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.28 -65.06 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.719 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-20 -39.72 -55.08 1.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.435 -0.791 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -42.31 66.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.75 -27.33 67.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.278 -0.889 . . . . 0.0 109.852 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.574 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 6.1 tptt -73.45 -0.22 14.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.17 -0.956 . . . . 0.0 109.668 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.59 27.26 2.0 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -81.0 125.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.994 . . . . 0.0 110.085 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -94.05 100.46 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.943 ' CD1' HD21 ' A' ' 35' ' ' LEU . 17.2 m95 -37.39 109.09 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -130.76 -155.09 8.14 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.02 -60.64 2.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -1.191 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.32 -35.24 73.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.731 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -65.35 -48.56 72.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.74 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.85 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.3 tt -69.53 -32.59 71.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.103 -0.998 . . . . 0.0 109.533 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.45 ' HG2' ' HD2' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -59.88 -34.15 72.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 108.89 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -77.8 -53.4 7.55 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.518 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 38.9 t80 -57.65 -16.34 10.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -92.37 -40.34 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.563 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.95 -22.53 60.23 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 70' ' ' ASN . 22.4 p30 -172.57 95.91 0.37 Allowed Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 30.7 Cg_endo -73.34 -40.23 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.255 1.97 . . . . 0.0 110.541 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -69.41 -9.36 53.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.995 -1.065 . . . . 0.0 108.948 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -88.15 -54.41 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -69.16 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.147 -0.971 . . . . 0.0 108.837 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.8 mm -98.19 106.82 37.68 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.653 -0.654 . . . . 0.0 109.553 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.5 75.77 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.159 1.906 . . . . 0.0 109.583 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 170.36 -22.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.89 ' HA ' HG21 ' A' ' 49' ' ' THR . 13.8 t -36.96 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -1.052 . . . . 0.0 110.329 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.631 ' HB3' HMD2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -104.89 13.46 31.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.759 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.3 ptm -114.54 123.07 48.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 110.079 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 81' ' ' ILE . 52.0 mt -94.41 44.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.824 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 19.9 t80 -59.96 147.27 39.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.653 -0.654 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.37 -24.75 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.79 -171.05 13.79 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.825 HD13 ' HG3' ' A' ' 91' ' ' ARG . 2.2 mp -105.41 132.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -1.102 . . . . 0.0 109.493 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 mmtm -81.58 -41.6 21.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.322 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HG2' ' OE2' ' A' ' 89' ' ' GLU . 2.0 tptt -92.65 123.85 36.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -56.7 -55.09 38.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.228 -0.92 . . . . 0.0 109.787 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' OE2' ' HG2' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -48.08 -25.07 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 109.617 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.0 -46.49 43.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.825 ' HG3' HD13 ' A' ' 85' ' ' ILE . 10.2 ttp85 -58.52 -52.43 65.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 108.918 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.84 73.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -63.75 -30.69 71.76 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.812 HD21 HG22 ' A' ' 9' ' ' ILE . 18.3 mt -64.66 -55.75 18.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -63.43 -31.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.27 87.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' CD2' HD22 ' A' ' 98' ' ' LEU . 34.3 t80 -64.73 -49.41 70.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.017 -1.052 . . . . 0.0 109.973 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' THR . 3.4 mm? -66.34 -16.33 63.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.727 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -77.64 -51.03 11.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.121 -0.987 . . . . 0.0 109.608 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -74.8 -22.34 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.76 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.44 -55.73 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 110.222 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.736 HG21 ' HA2' ' A' ' 34' ' ' GLY . 3.3 t -110.71 -32.23 6.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.99 -1.069 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.559 ' CB ' ' HA ' ' A' ' 99' ' ' LYS . 6.7 t30 -81.4 8.41 9.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 110.017 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.32 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.072 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.04 144.59 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 109.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 14.5 p -93.78 -19.42 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.38 -10.15 59.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -96.3 -49.71 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -75.11 -33.3 54.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -69.67 -36.15 75.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -1.164 . . . . 0.0 109.605 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -32.03 58.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 HD21 ' A' ' 94' ' ' LEU . 53.9 mt -67.92 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.262 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.549 ' CD2' HD21 ' A' ' 98' ' ' LEU . 8.7 t80 -54.35 -39.16 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 15' ' ' SER . 5.0 mm -57.09 -37.91 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -107.04 10.54 30.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.065 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -109.79 -60.03 1.84 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.102 -0.999 . . . . 0.0 109.527 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -132.07 40.81 3.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 109.313 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.2 t -87.25 -1.15 57.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -100.83 -49.07 4.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.331 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' SG ' HG21 ' A' ' 28' ' ' THR . 38.3 m -87.75 -13.19 43.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.876 . . . . 0.0 109.357 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.623 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 82.2 m-70 -134.23 81.87 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 110.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.0 p -78.67 90.21 4.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.9 -1.125 . . . . 0.0 108.003 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.1 m -82.85 35.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.625 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 23.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.869 -1.144 . . . . 0.0 110.211 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -95.74 -15.63 22.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.884 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.89 -25.4 4.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 136.53 -6.26 3.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -67.21 141.17 57.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -1.126 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.482 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -112.87 115.3 28.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 109.088 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.63 -79.94 0.32 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.252 -0.905 . . . . 0.0 109.761 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.605 HG21 ' SG ' ' A' ' 17' ' ' CYS . 7.0 m -98.97 -53.54 3.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 175.14 31.99 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -73.52 125.04 9.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.823 2.349 . . . . 0.0 110.94 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 24' ' ' GLY . 15.6 t-20 -49.37 101.46 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -78.8 76.54 5.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 -66.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -110.4 27.19 11.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 59' ' ' TRP . 1.9 tt -43.56 -30.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -1.079 . . . . 0.0 109.556 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 6.1 m-85 -74.91 128.95 36.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.58 66.26 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -120.77 123.6 43.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.406 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -60.09 -177.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.399 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.727 HG22 ' NE1' ' A' ' 59' ' ' TRP . 2.3 p -80.47 178.43 8.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.179 -0.951 . . . . 0.0 109.631 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.51 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 52.83 104.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -155.16 -62.46 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.279 . . . . 0.0 110.005 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -61.08 139.33 94.32 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.95 -173.82 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.744 2.296 . . . . 0.0 110.509 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 45.99 25.25 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -157.16 112.11 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.102 . . . . 0.0 108.96 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -78.35 77.25 4.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.6 m-85 -46.77 179.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.81 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.49 88.11 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.105 -0.997 . . . . 0.0 108.871 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.12 -41.75 12.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.77 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.03 -66.75 0.33 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.301 -0.875 . . . . 0.0 108.959 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HB3' HG21 ' A' ' 40' ' ' THR . 0.1 OUTLIER -43.25 -42.36 4.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.465 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 5.5 tttt -43.41 -72.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.95 -15.79 60.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -60.42 -13.22 12.2 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.013 -1.055 . . . . 0.0 109.39 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.52 51.51 32.19 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -110.82 123.73 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.53 -0.983 . . . . 0.0 110.215 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.694 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -87.27 116.39 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.727 ' NE1' HG22 ' A' ' 40' ' ' THR . 12.6 m95 -56.55 96.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.299 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -117.68 -176.57 17.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -64.21 -59.69 4.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.108 -1.231 . . . . 0.0 110.073 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -69.45 -38.35 77.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 109.922 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.627 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.59 -35.6 74.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.658 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.77 -29.81 51.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.071 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -58.68 -35.0 71.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.33 -0.856 . . . . 0.0 109.105 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.48 -58.61 3.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CD2' HG13 ' A' ' 75' ' ' ILE . 56.1 t80 -48.69 -28.81 3.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.163 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.944 HD21 HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -87.68 -39.27 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 0.0 109.487 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 65' ' ' MET . 10.8 tt0 -60.54 -21.22 62.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' ND2' ' HG3' ' A' ' 73' ' ' LYS . 1.8 m120 -169.21 89.61 0.59 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' CD ' ' CG1' ' A' ' 83' ' ' VAL . 32.3 Cg_endo -76.76 -41.44 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.612 2.208 . . . . 0.0 110.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -31.98 57.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.34 -0.85 . . . . 0.0 109.973 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HG3' ' ND2' ' A' ' 70' ' ' ASN . 1.6 mmpt? -83.19 -26.25 31.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 75' ' ' ILE . 7.1 t80 -83.94 -72.24 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.004 -1.06 . . . . 0.0 109.045 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.855 HG22 ' HB3' ' A' ' 51' ' ' ALA . 22.4 mm -93.73 119.37 67.12 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 109.669 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.6 Cg_endo -80.8 60.22 7.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.475 2.116 . . . . 0.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.31 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.81 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -59.83 161.96 5.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 109.758 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.21 11.41 5.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.756 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 7.7 ptm -77.75 114.05 16.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.316 1.055 . . . . 0.0 109.752 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -95.16 33.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.835 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 1.3 t80 -59.69 -32.27 70.34 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.976 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.594 ' CG1' ' CD ' ' A' ' 71' ' ' PRO . 3.3 m -31.65 104.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.438 0.637 . . . . 0.0 110.809 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.67 28.89 0.14 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.5 mt -109.63 145.54 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.123 . . . . 0.0 109.346 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -144.94 37.03 1.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.173 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.52 138.42 41.32 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.241 -0.912 . . . . 0.0 109.502 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -77.89 -37.64 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.05 -22.14 66.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -81.16 -59.4 2.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -53.32 -30.17 37.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.427 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.15 -52.67 17.9 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -59.16 -22.03 60.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.61 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HG22 ' A' ' 9' ' ' ILE . 27.4 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.9 mm -57.25 -38.58 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.325 -0.859 . . . . 0.0 109.413 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.28 82.46 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.545 -0.722 . . . . 0.0 109.86 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 7' ' ' LYS . 23.4 t80 -61.99 -34.95 77.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 109.611 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.3 mm? -83.32 -13.35 55.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -95.05 -9.32 34.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.315 -0.865 . . . . 0.0 109.682 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.98 -52.08 2.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.905 . . . . 0.0 109.46 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.14 71.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.97 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -128.53 40.41 3.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.826 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 102' ' ' THR . 6.0 t-20 178.85 51.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 1.5 pt-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.038 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.91 110.97 7.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.49 -35.91 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.293 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.64 -36.9 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.595 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 9' ' ' ILE . 5.7 mmtt -74.94 -45.26 43.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 93' ' ' ASP . . . -42.27 -52.64 5.07 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 4.1 ttmm -64.16 -36.49 84.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.211 -1.17 . . . . 0.0 109.666 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.1 tptt -62.56 -23.43 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.073 -1.017 . . . . 0.0 109.915 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.72 HG22 HD21 ' A' ' 94' ' ' LEU . 17.9 mm -82.65 -67.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.892 -1.13 . . . . 0.0 109.829 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 20' ' ' VAL . 23.2 t80 -49.99 -31.55 12.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 109.524 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.548 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 3.2 tt -69.73 -40.65 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 ttm -111.77 29.61 7.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.378 -0.826 . . . . 0.0 109.973 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -140.73 -39.88 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.007 . . . . 0.0 109.951 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' HB3' ' C4B' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -146.48 16.53 1.3 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.967 -1.083 . . . . 0.0 109.938 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 28.2 t -85.44 7.94 20.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.893 -1.129 . . . . 0.0 109.594 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -100.1 -43.32 6.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 57.9 m -95.98 -32.83 12.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.841 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.4 m-70 -108.18 84.53 1.96 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 109.472 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -79.73 91.35 5.28 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.723 -1.235 . . . . 0.0 108.817 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 10' ' ' PHE . 11.8 m -85.12 8.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.433 -0.792 . . . . 0.0 110.133 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 2.6 mt-10 -146.13 24.95 1.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.894 -1.129 . . . . 0.0 110.383 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 15.1 tttt -96.74 -58.31 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.057 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.8 54.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.38 20.01 3.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -100.81 82.66 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -79.85 150.11 30.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.109 -0.994 . . . . 0.0 109.373 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -133.77 -85.37 0.44 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.927 ' O ' HMD3 ' A' ' 105' ' ' HEC . 49.8 m -81.91 -15.6 53.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -132.44 150.26 19.64 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.8 Cg_endo -66.36 131.72 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.202 . . . . 0.0 111.108 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.1 t-20 -53.17 102.79 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.494 -0.754 . . . . 0.0 109.893 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.841 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.97 42.69 0.73 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.542 -0.724 . . . . 0.0 110.166 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.444 ' HA ' HG21 ' A' ' 102' ' ' THR . 22.6 t-80 -89.0 58.43 4.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 108.993 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.85 23.67 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.494 HD11 HBA2 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -56.52 -22.19 31.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.038 -1.272 . . . . 0.0 109.237 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 19.6 m-85 -70.85 134.37 47.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.876 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.77 10.5 61.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -123.64 120.31 32.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -1.202 . . . . 0.0 109.421 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 161.64 16.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.081 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -67.45 176.37 2.37 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 61.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -157.93 -58.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.185 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' HB1' ' NE2' ' A' ' 26' ' ' HIS . . . -53.24 129.79 50.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 0.0 109.862 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.7 Cg_endo -79.56 145.14 18.23 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.598 2.198 . . . . 0.0 110.386 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.1 -47.02 3.7 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -81.24 113.83 19.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.958 . . . . 0.0 108.766 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -77.35 77.55 3.88 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.665 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.1 m-85 -46.6 177.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.647 . . . . 0.0 109.335 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.761 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.67 86.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 109.278 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -47.24 -41.67 19.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.242 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -47.8 -68.38 0.19 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -40.47 -47.12 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.688 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HA ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -48.15 -60.03 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.858 . . . . 0.0 110.044 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.2 -20.63 66.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 110.065 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -63.84 -8.75 11.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.088 -1.008 . . . . 0.0 109.96 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.08 52.56 34.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -114.29 135.77 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.51 -0.994 . . . . 0.0 110.436 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.981 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -97.98 114.45 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.617 ' N ' HD13 ' A' ' 58' ' ' ILE . 10.6 m95 -54.59 109.03 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.98 -163.15 10.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.87 -62.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.283 . . . . 0.0 109.839 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.1 93.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.098 -1.001 . . . . 0.0 109.937 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.848 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.53 -38.17 80.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.804 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.95 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.6 OUTLIER -76.32 -32.79 58.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.765 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.6 ttt -55.79 -39.55 71.44 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.166 -0.959 . . . . 0.0 109.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -75.21 -48.6 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.27 -0.894 . . . . 0.0 109.877 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 30.4 t80 -59.55 -18.33 39.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 109.737 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.877 HD21 HMB2 ' A' ' 105' ' ' HEC . 1.2 mp -92.71 -38.92 11.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -22.2 62.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.52 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . 10.3 m-20 -172.25 94.17 0.39 Allowed Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.776 ' HB2' HG21 ' A' ' 78' ' ' THR . 31.2 Cg_endo -76.26 -30.78 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 0.0 110.022 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -82.15 -26.94 33.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.381 -0.824 . . . . 0.0 109.711 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HD3' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -80.9 -44.34 18.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.259 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 t80 -72.08 -66.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 52' ' ' ASN . 31.3 mm -98.43 110.28 55.97 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.479 -0.763 . . . . 0.0 109.62 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -79.35 67.07 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.459 2.106 . . . . 0.0 109.863 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -165.65 -47.65 0.02 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.776 HG21 ' HB2' ' A' ' 71' ' ' PRO . 9.0 t -47.57 167.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -1.233 . . . . 0.0 109.692 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -134.72 11.51 3.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.78 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.6 ptm -77.65 118.83 20.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.1 tt -93.9 33.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.985 ' CE2' HD11 ' A' ' 85' ' ' ILE . 2.4 t80 -59.58 -34.46 72.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' C ' ' O ' ' A' ' 82' ' ' PHE . 2.4 m -30.42 111.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.595 0.712 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.545 ' H ' HD12 ' A' ' 85' ' ' ILE . . . 168.27 40.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.985 HD11 ' CE2' ' A' ' 82' ' ' PHE . 4.4 mp -99.65 168.56 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -1.112 . . . . 0.0 109.868 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.605 ' N ' HG22 ' A' ' 85' ' ' ILE . 2.5 tttt -166.54 29.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.395 -0.815 . . . . 0.0 108.992 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' H ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -145.6 117.11 8.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.712 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -62.19 -40.11 94.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.161 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' OE2' ' HE2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -60.56 -23.47 64.66 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.354 -0.841 . . . . 0.0 109.291 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -73.89 -53.61 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.985 ' HA ' HD12 ' A' ' 94' ' ' LEU . 1.4 mpt_? -55.44 -45.88 76.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.126 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.58 89.75 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 109.161 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' HB3' HG13 ' A' ' 9' ' ' ILE . 4.3 m-20 -57.87 -29.13 64.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.279 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.985 HD12 ' HA ' ' A' ' 91' ' ' ARG . 27.2 mt -66.96 -47.71 70.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.6 mm -65.84 -59.2 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.388 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -44.2 -42.25 6.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.904 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.01 -52.07 58.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 110.003 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 3.2 mm? -75.39 -0.42 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -95.87 -25.1 16.14 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 110.088 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -108.7 -36.41 6.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.32 67.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -136.0 49.41 2.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.998 -1.064 . . . . 0.0 110.082 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 32.9 t30 -178.14 34.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.559 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.479 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.01 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.4 177.66 5.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 0.0 109.122 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.444 HG21 ' HD2' ' A' ' 100' ' ' LYS . 2.5 p -75.09 -35.77 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 109.965 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.65 -46.75 44.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.634 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -29.05 70.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.793 -1.192 . . . . 0.0 109.758 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . -72.43 -51.08 13.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 2.7 tttp -43.84 -35.18 1.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.023 -1.281 . . . . 0.0 110.082 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -74.25 -46.05 44.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 109.965 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.802 HD12 ' CB ' ' A' ' 93' ' ' ASP . 21.1 mt -56.86 -50.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.421 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 13.3 t80 -63.56 -46.41 86.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 110.062 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -53.21 -37.23 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.087 -1.008 . . . . 0.0 109.968 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -107.29 5.72 27.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.831 -1.168 . . . . 0.0 110.448 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.7 tppt? -109.03 -69.47 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.895 -1.128 . . . . 0.0 109.733 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -117.11 40.8 2.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.146 -0.971 . . . . 0.0 108.599 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 8.2 t -87.99 -53.94 4.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.757 -1.214 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 17' ' ' CYS . 9.5 pt20 -55.95 -38.62 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.831 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 28' ' ' THR . 8.7 m -86.96 -24.52 24.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.128 -0.983 . . . . 0.0 108.978 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.829 ' ND1' HD22 ' A' ' 32' ' ' LEU . 71.7 m-70 -131.76 76.8 1.73 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.978 -1.076 . . . . 0.0 109.58 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -76.89 92.52 3.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.23 24.44 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 110.531 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 18.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.024 -1.047 . . . . 0.0 108.645 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -22.21 51.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.496 -0.753 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 121.73 -17.18 8.84 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.31 -7.24 3.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.13 155.79 21.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -1.225 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -140.67 141.71 34.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.845 . . . . 0.0 109.568 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 28' ' ' THR . 2.6 ttmt -113.7 -85.07 0.59 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.687 HG21 ' SG ' ' A' ' 17' ' ' CYS . 19.4 m -79.13 -76.68 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -74.68 155.89 48.88 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.694 ' HD3' ' C3D' ' A' ' 105' ' ' HEC . 34.3 Cg_endo -70.14 138.01 35.65 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.236 1.958 . . . . 0.0 110.74 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -48.82 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.266 -0.897 . . . . 0.0 109.604 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.829 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -82.5 53.08 2.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.743 . . . . 0.0 110.181 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -99.81 77.5 2.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 0.0 109.336 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' ' 102' ' ' THR . . . 113.41 11.69 12.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -54.01 -27.99 35.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.601 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 2.8 m-85 -61.96 150.03 38.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 109.908 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.02 17.55 23.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' CZ ' ' O ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -138.66 162.48 34.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -1.161 . . . . 0.0 109.422 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -92.93 -156.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.543 ' O ' ' CZ ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -59.65 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -145.85 -176.04 19.41 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -161.9 36.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.433 -1.039 . . . . 0.0 109.4 -179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 44' ' ' PRO . . . -41.46 160.89 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.94 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 43' ' ' ALA . 34.2 Cg_endo -76.29 154.69 36.71 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.662 2.241 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.33 20.04 20.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' HBD1 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -153.87 104.48 2.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.932 . . . . 0.0 109.054 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 82.8 p -77.67 81.47 4.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 m-85 -44.65 174.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.662 -0.649 . . . . 0.0 109.309 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -59.06 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.03 -1.044 . . . . 0.0 109.495 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -55.17 -42.03 72.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.7 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -49.27 -72.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.594 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 1.3 m120 -38.45 -48.63 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.506 -0.746 . . . . 0.0 109.615 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 13.2 tttt -42.81 -69.77 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 0.0 110.671 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 55' ' ' LYS . 38.7 p30 -63.48 -17.96 63.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -62.44 -12.17 20.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 46.02 81.74 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -105.63 134.66 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.386 -1.067 . . . . 0.0 109.804 -179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.32 96.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 0.0 108.597 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD1' HD11 ' A' ' 35' ' ' LEU . 8.0 m95 -42.06 103.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -126.12 -164.01 11.68 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.06 -70.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.0 109.383 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -61.02 -36.63 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.432 -0.792 . . . . 0.0 109.748 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.438 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.62 -36.23 75.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.5 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.08 -33.73 57.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.335 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 tpt -54.69 -38.75 67.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.98 -58.15 3.49 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.404 -0.81 . . . . 0.0 109.491 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 53.6 t80 -52.9 -18.92 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.925 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.757 HD23 ' HD2' ' A' ' 91' ' ' ARG . 1.5 tp -92.33 -38.84 11.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.557 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -59.48 -22.55 61.73 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 8.3 p30 -178.58 88.98 0.22 Allowed Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -75.55 -43.25 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.466 2.111 . . . . 0.0 110.292 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -21.69 65.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.227 -0.921 . . . . 0.0 108.833 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -89.09 -38.91 13.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.389 -0.819 . . . . 0.0 109.227 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 3.9 t80 -75.76 -68.73 0.54 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.7 HG22 ' CB ' ' A' ' 51' ' ' ALA . 12.1 mm -93.0 109.8 41.79 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.541 -0.724 . . . . 0.0 109.335 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 34.5 Cg_endo -76.23 87.8 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.218 1.945 . . . . 0.0 110.541 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 153.37 -27.14 0.78 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.482 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -42.24 145.51 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -1.099 . . . . 0.0 110.023 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG3' ' O1D' ' A' ' 105' ' ' HEC . 3.2 mttp -107.26 18.9 21.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.487 ' HE3' ' HB2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -61.59 127.28 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 110.016 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 81' ' ' ILE . 17.7 mt -95.86 27.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' HB2' ' HE3' ' A' ' 80' ' ' MET . 0.4 OUTLIER -65.38 163.74 15.06 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.546 0.689 . . . . 0.0 110.385 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 p -100.35 -27.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.516 -0.74 . . . . 0.0 109.335 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.01 68.17 0.78 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.497 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 33.9 mm -60.87 119.26 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 109.587 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -4.2 57.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.945 . . . . 0.0 109.426 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.08 111.83 4.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.21 -37.26 77.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.0 109.354 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.95 -41.54 97.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.317 -0.865 . . . . 0.0 109.691 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.49 ' OE1' ' CA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -63.89 -49.47 72.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.594 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.998 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -56.85 -40.04 75.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.2 77.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.802 ' CB ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -63.08 -32.91 74.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.829 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt -64.91 -53.15 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.702 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -60.21 -38.64 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.5 83.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.996 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -60.26 -53.41 57.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.2 -0.938 . . . . 0.0 109.571 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 98' ' ' LEU . 3.6 mm? -65.23 -15.8 62.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.389 -0.819 . . . . 0.0 109.809 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -80.56 -28.76 37.16 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.003 -1.061 . . . . 0.0 110.158 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -102.0 -56.05 2.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.866 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.79 65.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -142.85 46.76 1.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.002 -1.061 . . . . 0.0 110.151 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 7.1 t30 174.12 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.07 -1.019 . . . . 0.0 110.03 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 3.3 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.324 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 0.88 HMB1 HBB3 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.27 166.13 13.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.54 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 4' ' ' GLU . 13.1 p -92.45 -37.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.893 . . . . 0.0 109.45 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.4 mt-10 -65.26 -12.61 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.529 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.6 mttt -91.26 -54.08 4.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -55.83 -39.91 79.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 26.6 tttp -53.43 -38.27 63.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -1.2 . . . . 0.0 109.538 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -74.51 -27.77 60.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.71 ' CG2' HD21 ' A' ' 94' ' ' LEU . 80.5 mt -61.22 -63.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.14 -0.975 . . . . 0.0 109.023 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CE1' HG13 ' A' ' 20' ' ' VAL . 40.1 t80 -62.69 -42.21 99.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 108.728 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 9.2 mm -61.5 -18.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.747 . . . . 0.0 109.297 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' A' ' 12' ' ' MET . 4.6 tpt -128.52 18.54 6.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 109.618 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HG2' HBB1 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -131.64 -50.42 0.98 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -126.51 23.23 6.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.126 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.6 t -87.84 -2.28 58.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.821 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -92.28 -45.79 8.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 108.488 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 5.4 m -90.94 -35.65 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.882 ' CG ' HD22 ' A' ' 32' ' ' LEU . 65.1 m-70 -110.63 85.01 2.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.063 -1.023 . . . . 0.0 110.339 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -79.84 99.39 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.75 -1.219 . . . . 0.0 108.821 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 10' ' ' PHE . 3.4 m -86.95 33.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 21.71 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.28 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -63.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.26 64.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.09 13.23 40.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -100.12 156.92 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.613 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -152.69 119.91 5.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.369 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -93.3 -86.0 0.26 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 22.2 m -87.93 -43.41 11.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.799 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -101.2 153.29 19.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.672 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 30.1 Cg_endo -66.71 132.81 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.947 2.431 . . . . 0.0 111.692 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -49.58 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.44 0.638 . . . . 0.0 109.909 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.882 HD22 ' CG ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.89 69.93 7.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.509 -0.745 . . . . 0.0 110.677 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -100.5 -59.46 1.7 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.053 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -111.76 36.72 4.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 59' ' ' TRP . 14.3 tp -48.87 -30.03 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.096 . . . . 0.0 109.768 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 76.5 m-85 -75.56 124.49 27.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.961 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.03 69.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.38 107.8 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.023 -1.281 . . . . 0.0 109.576 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 40' ' ' THR . 4.3 pttt -61.3 150.13 35.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.864 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -46.74 176.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 109.886 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 55.99 91.96 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 2.0 tp-100 -151.52 -43.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -1.169 . . . . 0.0 109.644 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -58.29 146.09 72.33 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.618 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.77 -62.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.794 2.329 . . . . 0.0 110.761 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.33 46.51 3.67 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -160.79 114.03 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.176 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.523 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 25.4 m -79.15 77.27 5.66 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 2.2 m-85 -46.23 -179.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.752 -0.593 . . . . 0.0 109.787 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.68 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.995 . . . . 0.0 108.971 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.46 -38.94 64.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -49.72 -64.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.36 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.864 ' HB3' HG21 ' A' ' 40' ' ' THR . 2.4 t-20 -53.51 -41.16 66.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.868 -1.145 . . . . 0.0 109.373 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HA ' HG23 ' A' ' 40' ' ' THR . 24.5 tttm -52.1 -37.0 52.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -82.07 -23.44 35.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 110.33 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HE2' ' CE1' ' A' ' 74' ' ' TYR . 28.9 tttt -76.4 3.07 11.87 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.985 -1.072 . . . . 0.0 109.671 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.2 11.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.739 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -103.8 132.01 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.739 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -96.67 112.41 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 108.648 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.638 ' CZ2' HAA1 ' A' ' 105' ' ' HEC . 6.1 m95 -59.95 105.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 110.047 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.99 -157.83 8.81 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 95' ' ' ILE . 45.6 tt0 -77.78 -63.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -1.118 . . . . 0.0 109.567 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -37.71 85.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.927 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -45.07 92.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.827 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.891 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.7 OUTLIER -66.78 -34.27 77.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.993 . . . . 0.0 109.271 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.514 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 2.5 tmm? -54.26 -38.41 65.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.397 -0.815 . . . . 0.0 109.403 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.01 -60.81 2.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CD1' HG12 ' A' ' 75' ' ' ILE . 39.0 t80 -54.42 -17.71 3.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.781 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.826 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.1 tp -90.74 -31.22 16.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.023 -1.048 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.74 -27.34 66.42 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -177.75 100.61 0.22 Allowed Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.6 Cg_endo -76.34 -40.71 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.356 2.037 . . . . 0.0 110.262 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 9.5 tptm -70.84 -12.11 61.35 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.368 -0.833 . . . . 0.0 109.708 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -102.32 -35.66 8.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.965 . . . . 0.0 109.314 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CE2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -76.84 -69.35 0.53 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 108.618 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.772 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -95.2 111.09 53.73 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.901 . . . . 0.0 109.214 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.15 70.24 7.21 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.289 1.993 . . . . 0.0 110.385 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 78' ' ' THR . . . -177.47 -38.3 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.576 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.4 t -44.71 158.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -108.54 -2.8 18.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.17 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.734 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.9 ptm -88.83 121.99 31.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.067 -1.021 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 81' ' ' ILE . 4.2 mp -99.24 45.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.62 ' CB ' ' HE2' ' A' ' 80' ' ' MET . 48.4 t80 -59.51 147.78 35.57 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 14.0 p -88.04 141.8 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.472 -0.768 . . . . 0.0 109.585 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.88 120.04 9.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.697 HG21 ' HB3' ' A' ' 90' ' ' GLU . 2.3 mp -62.06 128.51 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -1.159 . . . . 0.0 109.407 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 37.01 0.97 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -143.78 115.73 8.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 1.1 tppt? -64.96 -26.25 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.294 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.28 -43.92 54.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.211 -0.93 . . . . 0.0 109.769 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.697 ' HB3' HG21 ' A' ' 85' ' ' ILE . 1.3 tt0 -59.47 -38.96 82.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 109.415 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.514 ' NH1' ' HG2' ' A' ' 65' ' ' MET . 1.4 mtp180 -65.62 -47.47 75.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.168 -0.957 . . . . 0.0 109.089 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -55.15 -36.58 65.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.888 . . . . 0.0 109.28 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.01 -30.46 66.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.408 -0.807 . . . . 0.0 109.342 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.71 HD21 ' CG2' ' A' ' 9' ' ' ILE . 43.5 mt -65.46 -58.33 6.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 61' ' ' GLU . 3.3 mm -66.14 -29.09 45.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 109.221 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -61.39 -40.57 94.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.603 -0.685 . . . . 0.0 109.929 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -73.12 -52.94 12.35 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.109 -0.994 . . . . 0.0 109.245 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.852 ' O ' HG22 ' A' ' 102' ' ' THR . 1.4 mm? -60.43 -16.97 41.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.416 -0.803 . . . . 0.0 109.921 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HD2' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.76 -48.04 11.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.883 -1.135 . . . . 0.0 109.463 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.29 77.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.9 -50.03 11.06 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 98' ' ' LEU . 13.8 t -120.27 40.33 3.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.948 -1.095 . . . . 0.0 110.368 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' CA ' ' A' ' 99' ' ' LYS . 10.9 t-20 -167.97 39.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.481 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.014 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -158.17 102.98 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.889 HG21 ' HE2' ' A' ' 100' ' ' LYS . 9.9 p -79.07 -34.87 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 5' ' ' LYS . 15.4 pt-20 -53.47 -36.26 61.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 0.0 109.75 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -97.64 -14.11 21.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.06 -41.21 97.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 20.0 ttmt -61.94 -22.38 65.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.067 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -78.81 -40.41 33.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.086 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 HD21 ' A' ' 94' ' ' LEU . 42.8 mt -62.36 -50.95 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 108.798 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 98' ' ' LEU . 34.5 t80 -62.55 -39.22 92.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 6.7 mm -61.48 -22.2 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.42 -0.8 . . . . 0.0 108.872 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.04 13.28 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 4.1 tptt -126.86 -55.74 1.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.8 -1.188 . . . . 0.0 110.381 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.552 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -130.68 22.36 5.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.821 -1.174 . . . . 0.0 110.216 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 40.0 t -86.41 7.37 26.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.935 -1.103 . . . . 0.0 109.461 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -100.53 -54.58 2.81 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 10.5 m -82.85 -27.41 30.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.975 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.6 m-70 -115.2 88.8 2.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.135 -0.978 . . . . 0.0 110.059 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.2 p -78.7 83.37 4.86 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.045 -1.035 . . . . 0.0 108.457 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' VAL . 2.7 m -84.02 30.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 110.304 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.18 19.57 0.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.324 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -97.43 -61.1 1.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.23 62.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.54 16.1 54.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -92.0 144.7 25.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -1.155 . . . . 0.0 109.532 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.489 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.79 133.19 19.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.898 . . . . 0.0 109.683 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 -77.13 0.58 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.692 ' O ' HMD3 ' A' ' 105' ' ' HEC . 52.5 m -90.53 -40.14 12.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.529 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.509 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -104.99 152.63 17.33 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -68.04 133.15 28.12 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.385 2.057 . . . . 0.0 111.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.4 t-20 -49.1 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.475 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.975 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.93 67.69 8.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.545 -0.722 . . . . 0.0 109.49 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.666 ' O ' HG22 ' A' ' 102' ' ' THR . 5.4 t-160 -98.24 -6.93 30.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 109.874 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.82 61.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -78.69 -30.98 46.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.27 -1.136 . . . . 0.0 109.858 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 83.6 m-85 -67.97 124.33 23.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.98 28.62 62.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.03 120.56 9.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.523 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 173.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.962 . . . . 0.0 109.212 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.986 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -85.57 175.44 8.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 60.67 96.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.86 -55.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.853 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -44.32 133.24 4.52 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.21 139.62 15.01 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.578 2.185 . . . . 0.0 110.605 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.07 -49.96 4.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.09 104.51 12.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.462 -1.022 . . . . 0.0 108.84 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.62 80.59 4.09 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 6.6 m-30 -44.35 173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.695 HG22 HAD1 ' A' ' 105' ' ' HEC . 0.1 OUTLIER -62.89 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.129 -0.982 . . . . 0.0 108.435 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -41.52 -37.83 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -0.763 . . . . 0.0 109.856 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.669 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -39.78 -64.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.702 -0.624 . . . . 0.0 109.4 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.619 ' N ' HG23 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -45.83 -51.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.868 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.493 ' CA ' ' OG1' ' A' ' 40' ' ' THR . 25.2 tttt -49.93 -41.45 46.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -71.46 -32.17 67.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.011 -1.055 . . . . 0.0 110.127 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.75 2.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.039 -1.038 . . . . 0.0 109.736 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.27 52.58 46.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.997 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.35 132.92 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -1.019 . . . . 0.0 110.371 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.997 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -95.29 97.32 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.986 ' NE1' HG22 ' A' ' 40' ' ' THR . 10.1 m95 -37.16 122.77 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.634 0.73 . . . . 0.0 111.127 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -143.04 -164.06 10.03 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -76.08 -73.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 0.0 109.617 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.53 -33.59 72.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.691 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -47.22 86.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 108.835 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.667 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -61.69 -35.83 79.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.46 -0.775 . . . . 0.0 109.005 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ttt -55.79 -35.12 65.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.412 -0.805 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' OE2' ' CD1' ' A' ' 74' ' ' TYR . 1.9 tm-20 -71.94 -60.02 2.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.793 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 24.8 t80 -54.79 -21.17 10.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.938 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -88.02 -33.21 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.444 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.91 -23.92 66.63 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.519 ' HA ' HG11 ' A' ' 83' ' ' VAL . 9.9 t-20 -177.82 96.54 0.22 Allowed Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.61 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 32.2 Cg_endo -74.34 -30.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.446 2.097 . . . . 0.0 110.182 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -13.34 60.54 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 108.646 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -95.58 -46.32 6.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.117 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' OE2' ' A' ' 66' ' ' GLU . 13.2 t80 -71.46 -64.05 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.006 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 51' ' ' ALA . 4.2 mm -79.31 126.44 81.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.7 Cg_endo -74.98 74.24 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.122 1.882 . . . . 0.0 110.692 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.39 33.37 1.62 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.0 t -50.48 162.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.342 . . . . 0.0 108.929 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.62 12.35 35.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.949 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.755 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 6.3 ptm -130.57 128.64 41.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 81' ' ' ILE . 9.1 tp -109.41 40.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 1.042 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -59.72 -39.47 84.75 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.451 -178.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -22.77 115.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.585 0.707 . . . . 0.0 111.461 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.04 35.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.741 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 1.1 mp -111.06 174.82 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -1.139 . . . . 0.0 109.636 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 85' ' ' ILE . 4.5 mmtt -171.13 41.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -139.93 127.82 22.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.955 . . . . 0.0 109.291 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -71.45 -54.8 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.831 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.86 -42.2 68.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.973 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.1 tt0 -59.98 -39.09 84.5 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.129 -0.982 . . . . 0.0 109.565 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 87' ' ' LYS . 1.3 mmt85 -59.85 -50.67 72.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 -39.99 75.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.429 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -29.55 69.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.587 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.618 HD21 HG22 ' A' ' 9' ' ' ILE . 20.6 mt -64.25 -47.4 79.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.877 . . . . 0.0 109.186 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.648 HG21 ' HG2' ' A' ' 61' ' ' GLU . 3.6 mm -71.2 -30.84 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.137 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.03 79.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 101' ' ' ALA . 13.1 t80 -69.61 -33.59 72.89 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 108.951 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -78.63 -9.5 59.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.363 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -100.11 -16.52 17.81 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.889 ' HE2' HG21 ' A' ' 3' ' ' VAL . 3.3 mtpt -108.9 -20.14 13.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.592 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.564 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . . . -91.08 -43.45 9.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.384 -0.822 . . . . 0.0 109.935 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -104.0 -59.27 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 109.677 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 5.2 t30 -53.2 -26.76 18.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 109.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 100' ' ' LYS . 29.5 tp10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.455 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.042 HBB2 ' CE2' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -154.09 147.44 24.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.84 -51.3 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.754 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -63.87 -15.83 59.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 2' ' ' ASP . 7.0 tttm -82.15 -72.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 109.873 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' C ' ' HB2' ' A' ' 97' ' ' TYR . . . -53.77 -28.2 38.14 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 35.4 tttt -65.98 -37.77 86.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 109.858 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -75.21 -26.07 58.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.49 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' CD2' ' A' ' 94' ' ' LEU . 33.4 mm -64.3 -60.79 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.636 ' CE2' HG13 ' A' ' 20' ' ' VAL . 39.5 t80 -61.28 -38.3 86.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 49.4 mt -64.13 -22.49 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.29 -0.881 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 tpp -122.84 16.03 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.126 -0.984 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 6.6 tppt? -127.57 -49.01 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.091 -1.006 . . . . 0.0 109.553 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -131.76 28.69 4.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.982 . . . . 0.0 108.88 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.1 t -86.66 -4.16 59.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -95.23 -43.48 8.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.246 -0.908 . . . . 0.0 108.917 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 7.0 m -91.26 -44.19 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.963 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.871 ' ND1' HD22 ' A' ' 32' ' ' LEU . 59.6 m-70 -101.92 81.81 2.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.047 . . . . 0.0 109.772 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 p -79.66 95.51 5.95 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.826 -1.171 . . . . 0.0 108.877 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.636 HG13 ' CE2' ' A' ' 10' ' ' PHE . 3.0 m -82.37 13.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.867 . . . . 0.0 109.859 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.32 17.15 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 110.057 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -89.95 -23.94 21.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 109.709 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.35 60.36 0.55 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.71 9.53 52.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 3.5 tttp -91.61 130.76 37.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -1.166 . . . . 0.0 109.536 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.506 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.01 104.85 5.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 -82.03 0.13 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.13 -0.981 . . . . 0.0 110.181 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' HMD3 ' A' ' 105' ' ' HEC . 10.8 m -89.9 -30.86 17.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -108.65 150.4 17.05 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.666 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.4 Cg_endo -67.29 129.05 19.52 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.79 2.327 . . . . 0.0 111.103 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.0 t-20 -48.68 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.64 -0.663 . . . . 0.0 110.128 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.871 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -83.64 62.27 6.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 9.3 p80 -100.26 52.78 0.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.007 . . . . 0.0 109.311 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 38' ' ' ARG . . . 118.74 64.49 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -78.3 -26.42 46.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -1.071 . . . . 0.0 110.269 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 7.1 m-30 -71.88 125.63 27.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.076 . . . . 0.0 110.981 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.07 -6.51 69.19 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.203 -0.999 . . . . 0.0 111.281 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.13 134.59 54.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.658 -1.495 . . . . 0.0 110.287 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -70.76 150.42 45.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -60.95 163.77 5.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.018 . . . . 0.0 110.212 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.66 99.27 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -160.78 -34.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.258 . . . . 0.0 110.026 179.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.62 128.7 85.14 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 110.065 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.7 149.73 21.03 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.531 2.154 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.49 -14.2 55.82 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -126.02 111.64 14.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -1.073 . . . . 0.0 108.3 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.49 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 2.0 p -74.27 78.84 1.82 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.666 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.8 m-85 -48.18 179.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.833 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -58.9 87.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -46.16 -40.76 11.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.623 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -53.88 -67.85 0.23 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.449 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.605 ' N ' HG21 ' A' ' 75' ' ' ILE . 2.1 m120 -36.26 -53.8 0.82 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.443 -0.785 . . . . 0.0 111.078 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -55.37 -59.49 4.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.931 -1.106 . . . . 0.0 110.176 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.04 -12.43 11.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.347 -0.846 . . . . 0.0 110.675 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -79.31 5.75 11.68 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 120.814 -1.179 . . . . 0.0 109.861 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' LYS . . . 45.16 45.88 10.23 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.39 114.06 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -1.125 . . . . 0.0 109.868 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.62 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -77.35 108.7 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.57 ' CD1' HD11 ' A' ' 35' ' ' LEU . 4.9 m95 -46.74 113.63 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 110.684 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.52 179.24 17.24 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.1 -60.49 2.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.277 . . . . 0.0 109.535 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.49 -41.72 98.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.915 . . . . 0.0 109.676 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.58 -32.44 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.694 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.4 OUTLIER -78.58 -32.73 47.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.753 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 tpp -60.54 -35.76 76.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -54.07 7.53 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 45.6 t80 -56.13 -26.5 50.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.869 HD21 HMB2 ' A' ' 105' ' ' HEC . 1.1 tp -81.97 -39.54 23.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.427 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER -59.87 -23.18 63.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 9.3 m120 -168.33 96.22 0.58 Allowed Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.748 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.0 Cg_endo -77.08 -29.91 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.417 2.078 . . . . 0.0 110.44 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -85.29 -31.87 22.83 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.318 -0.863 . . . . 0.0 109.516 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 3.6 mmmt -78.57 -35.29 46.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.001 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 75' ' ' ILE . 22.1 t80 -75.81 -69.05 0.52 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 51' ' ' ALA . 5.6 mm -101.16 117.73 61.68 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 61.37 8.21 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.428 2.086 . . . . 0.0 110.017 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.45 -48.3 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.833 ' HB ' HG21 ' A' ' 49' ' ' THR . 7.4 t -50.68 167.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.283 . . . . 0.0 109.847 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -135.48 10.19 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.749 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 6.8 ptm -76.41 123.33 25.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 mt -97.87 35.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.87 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 4.4 t80 -59.7 -35.28 74.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.539 . . . . 0.0 109.888 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG13 ' HD3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -38.75 96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.498 -0.751 . . . . 0.0 110.085 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -156.09 20.84 0.5 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.615 HD13 ' HD2' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -105.2 163.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -1.138 . . . . 0.0 109.242 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -143.36 16.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.434 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.98 123.08 36.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 0.0 109.639 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -37.56 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 109.419 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -56.85 -39.67 74.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.672 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.5 -49.26 72.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -52.62 -45.19 66.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 0.0 109.04 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.61 79.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 109.213 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 89' ' ' GLU . 13.2 m-20 -59.37 -35.9 74.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 91' ' ' ARG . 38.1 mt -58.67 -46.42 87.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.612 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.2 mm -67.85 -49.03 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 0.0 110.039 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.19 -39.19 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.435 -0.79 . . . . 0.0 110.394 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 36.7 t80 -70.51 -50.67 35.4 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.999 -1.063 . . . . 0.0 110.085 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 98' ' ' LEU . 2.3 mm? -72.23 -4.49 29.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.767 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -99.49 -20.46 16.41 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.157 -0.964 . . . . 0.0 109.883 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -107.28 -20.08 13.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.647 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.92 -36.34 12.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 110.003 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.414 ' HB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -130.96 47.38 2.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.638 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 6.4 t-20 -171.93 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 109.35 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.01 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -143.64 171.47 14.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -1.13 . . . . 0.0 109.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 4' ' ' GLU . 12.7 p -96.02 -46.26 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.538 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 3' ' ' VAL . 3.8 mt-10 -64.55 -19.9 65.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 9' ' ' ILE . 9.9 mttt -91.55 -33.26 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.48 -20.55 75.54 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 25.4 ttpt -70.58 -32.98 70.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -1.118 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 11' ' ' ILE . 6.6 mttp -85.46 -31.8 22.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 29.4 mm -57.62 -57.33 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.009 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.784 ' CD2' HD21 ' A' ' 98' ' ' LEU . 20.6 t80 -67.33 -41.65 84.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 108.989 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 8.7 mm -55.85 -18.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 109.108 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 ttt -119.21 -5.89 10.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.94 -62.03 1.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.586 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -126.49 41.92 3.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.028 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -95.45 -1.1 51.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.828 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.17 -35.26 9.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 108.764 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 5.7 m -99.96 -21.43 15.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 76.0 m-70 -126.15 80.42 1.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 0.0 109.742 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -79.0 90.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.514 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.7 8.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 110.394 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -164.94 23.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.927 -1.108 . . . . 0.0 109.9 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 22' ' ' LYS . 2.9 tmtp? -100.62 37.47 1.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.133 -0.979 . . . . 0.0 109.199 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.63 -30.45 8.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.19 8.64 40.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -95.32 117.63 30.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.209 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -90.69 172.05 8.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.052 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -160.01 -91.62 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.372 -0.83 . . . . 0.0 108.912 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.845 ' O ' HMD3 ' A' ' 105' ' ' HEC . 11.5 m -65.2 -59.76 3.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 108.741 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -95.86 153.9 20.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' HD3' ' C3D' ' A' ' 105' ' ' HEC . 33.2 Cg_endo -69.49 134.42 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.176 1.917 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 26' ' ' HIS . 6.9 t-20 -46.55 101.4 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -81.8 41.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 109.911 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -91.33 70.85 6.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.36 19.37 5.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.927 HD21 ' CD1' ' A' ' 59' ' ' TRP . 17.9 tp -53.77 -29.81 41.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.142 . . . . 0.0 109.508 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' HB3' ' OD1' ' A' ' 103' ' ' ASN . 14.4 m-85 -69.85 135.56 49.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.29 83.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NH1' HD12 ' A' ' 35' ' ' LEU . 31.2 ttp85 -155.21 123.75 6.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.257 . . . . 0.0 109.599 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -61.7 164.86 5.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.195 -0.94 . . . . 0.0 109.063 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.505 ' CG2' ' HB3' ' A' ' 52' ' ' ASN . 5.8 t -101.53 169.6 8.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.515 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.496 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 88.93 67.43 1.26 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' OE1' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -161.8 -32.07 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.138 -1.213 . . . . 0.0 110.739 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB2' ' OH ' ' A' ' 48' ' ' TYR . . . -36.39 141.15 0.37 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.443 -0.785 . . . . 0.0 110.331 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 35.5 Cg_endo -77.58 128.21 9.34 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.626 2.217 . . . . 0.0 110.487 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.46 -47.35 3.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -100.5 63.84 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.482 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 m -62.9 95.46 0.08 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 30' ' ' PRO . 1.5 m-30 -50.91 -179.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.756 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.941 HG21 ' C ' ' A' ' 77' ' ' GLY . 3.2 p -59.58 90.37 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.001 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -31.4 -35.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.701 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -39.7 -62.93 0.63 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.713 ' CA ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -38.78 -69.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 110.665 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.461 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 2.3 tmtt? -43.12 -38.97 2.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -66.14 -41.91 89.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 110.488 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HG2' ' CE2' ' A' ' 74' ' ' TYR . 45.4 tptt -50.68 -20.42 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 109.123 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.57 39.47 97.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.758 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -103.88 119.04 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.605 -0.938 . . . . 0.0 110.373 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -82.17 100.78 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.927 ' CD1' HD21 ' A' ' 35' ' ' LEU . 6.3 m95 -38.81 118.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 111.05 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -131.13 -159.61 9.61 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -77.41 -63.02 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.11 -1.229 . . . . 0.0 109.735 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.28 -35.79 71.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.172 -0.955 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.51 -46.27 89.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.095 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -70.22 -36.08 74.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.27 45.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.76 -50.07 59.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.51 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.646 ' CD1' HG12 ' A' ' 75' ' ' ILE . 54.3 t80 -54.87 -21.86 12.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.756 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.669 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.2 mp -86.73 -38.11 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.369 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.25 -23.51 62.41 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.27 95.04 0.23 Allowed Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.872 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.5 Cg_endo -73.7 -36.34 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.354 2.036 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -70.37 -9.06 55.2 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 108.927 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -91.91 -50.21 5.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.554 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -71.89 -64.93 0.84 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 52' ' ' ASN . 4.7 mm -91.35 108.93 32.41 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.76 73.15 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.311 2.007 . . . . 0.0 110.291 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.941 ' C ' HG21 ' A' ' 49' ' ' THR . . . 171.34 -28.97 0.11 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.924 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 71' ' ' PRO . 11.1 t -50.4 134.1 23.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.849 -1.383 . . . . 0.0 109.45 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.78 12.0 37.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.726 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 5.3 ptm -87.23 123.16 31.94 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.94 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 81' ' ' ILE . 37.4 mm -109.44 36.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -58.9 -31.88 69.03 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.976 -178.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.583 ' CG1' ' HD3' ' A' ' 71' ' ' PRO . 3.4 m -34.32 104.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.453 0.644 . . . . 0.0 110.536 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.75 -40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD11 ' CD ' ' A' ' 13' ' ' LYS . 49.0 mt -60.94 143.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.89 45.44 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.2 7.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.714 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -52.18 -28.18 17.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.17 -46.63 70.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.945 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.754 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -52.51 -42.54 64.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 109.341 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.61 87.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -30.11 70.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.683 HD13 ' N ' ' A' ' 95' ' ' ILE . 2.3 mm -75.23 -34.39 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.566 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -47.13 81.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 109.947 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -70.16 -44.21 69.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.784 HD21 ' CD2' ' A' ' 10' ' ' PHE . 1.5 mm? -71.38 -7.7 48.97 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.1 -1.0 . . . . 0.0 109.434 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -100.08 -16.93 17.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.776 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -104.11 -26.44 12.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 110.14 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.7 -45.74 9.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.146 -0.971 . . . . 0.0 110.295 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.2 38.51 3.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.699 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 36' ' ' PHE . 1.2 t30 -176.41 61.29 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.031 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER -146.34 145.74 30.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -1.205 . . . . 0.0 109.633 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.616 HG22 ' HD2' ' A' ' 7' ' ' LYS . 6.5 p -66.8 -41.62 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 3' ' ' VAL . 4.0 tm-20 -59.06 -24.36 62.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.383 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.2 tptm -75.12 -53.44 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.445 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 97' ' ' TYR . . . -72.18 -67.66 1.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.616 ' HD2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -39.66 -35.27 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.44 -1.035 . . . . 0.0 110.305 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.55 -44.29 57.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 0.0 109.53 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -72.42 -65.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.705 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 98' ' ' LEU . 18.3 t80 -46.05 -40.83 11.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.726 -1.234 . . . . 0.0 109.803 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' SER . 6.9 mm -62.05 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.023 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -107.51 20.12 19.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.129 -0.982 . . . . 0.0 109.842 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -126.96 -61.33 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.772 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 1.9 m -113.3 5.07 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 0.0 110.161 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -88.79 27.23 1.35 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.809 -1.182 . . . . 0.0 109.244 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.32 -61.08 1.46 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 28' ' ' THR . 5.3 m -80.02 -30.83 39.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.845 ' HD1' HD13 ' A' ' 32' ' ' LEU . 66.4 m-70 -102.18 173.56 6.32 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.044 0.926 . . . . 0.0 109.46 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 18' ' ' HIS . 20.9 p -161.85 92.77 0.87 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.5 m -84.14 34.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.78 25.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 110.416 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.9 tptt -101.23 35.89 2.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.796 -1.19 . . . . 0.0 109.752 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.85 -35.28 4.03 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.76 0.18 6.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 137.92 37.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.554 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -120.04 102.53 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.01 . . . . 0.0 110.475 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.72 -74.58 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.759 HG21 ' SG ' ' A' ' 17' ' ' CYS . 66.4 m -89.77 -99.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 28' ' ' THR . . . -51.73 150.62 7.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 32.4 Cg_endo -69.81 156.67 62.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 111.417 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.554 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -63.26 102.1 0.36 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.845 HD13 ' HD1' ' A' ' 18' ' ' HIS . 3.7 mp -79.05 71.17 5.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 109.997 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t60 -100.51 -57.71 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.044 . . . . 0.0 109.013 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 35' ' ' LEU . . . -111.24 23.1 19.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.758 HD11 HMA3 ' A' ' 105' ' ' HEC . 1.3 tt -44.25 -36.02 2.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -1.082 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 4.4 m-30 -65.81 142.1 58.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.371 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 15.28 61.47 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 5.4 tmm_? -136.76 142.77 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -1.152 . . . . 0.0 109.589 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -82.07 -171.54 3.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.557 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -92.92 -176.73 4.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.873 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' H ' HG22 ' A' ' 40' ' ' THR . . . 51.09 101.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -157.92 -77.1 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.238 . . . . 0.0 110.193 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' GLN . . . -40.84 136.51 1.53 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.966 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.59 152.27 29.45 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.707 2.271 . . . . 0.0 110.265 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.63 -53.03 4.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 28' ' ' THR . 0.7 OUTLIER -99.35 69.86 1.7 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.421 -1.046 . . . . 0.0 108.621 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' TYR . 3.1 p -67.8 97.72 0.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 30' ' ' PRO . 1.4 m-30 -53.52 -175.72 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.769 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 49' ' ' THR . 3.3 t -60.9 88.02 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -36.84 -32.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.313 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.637 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -45.13 -63.03 1.02 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.718 -0.613 . . . . 0.0 109.464 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -43.75 -52.99 6.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.973 . . . . 0.0 109.404 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -50.52 -42.32 54.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 109.664 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.56 -42.83 99.79 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.865 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -49.71 -21.13 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.049 -1.032 . . . . 0.0 109.272 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.3 46.48 78.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -104.05 123.12 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.531 -0.982 . . . . 0.0 110.249 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -87.71 100.9 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 7.4 m95 -40.2 116.72 0.7 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.825 0.822 . . . . 0.0 110.82 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -148.19 -154.09 6.17 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -77.68 -74.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.262 . . . . 0.0 109.588 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.45 -34.72 78.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 110.301 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.992 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -64.42 -56.13 16.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.274 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.4 OUTLIER -64.94 -21.88 66.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 19.9 ttt -67.14 -32.66 73.93 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.315 -0.865 . . . . 0.0 109.021 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -54.42 6.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.412 -0.805 . . . . 0.0 109.794 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.667 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 4.9 t80 -54.99 -36.89 65.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.926 -1.109 . . . . 0.0 109.168 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.883 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 0.8 OUTLIER -77.68 -27.85 50.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.36 -26.66 65.25 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.28 101.95 0.24 Allowed Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.586 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.6 Cg_endo -74.56 -27.09 11.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.372 2.048 . . . . 0.0 109.838 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -78.27 -19.33 53.88 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.598 -0.689 . . . . 0.0 109.371 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.578 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -97.53 -29.92 13.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.024 -1.048 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' HD2' HD11 ' A' ' 75' ' ' ILE . 3.7 t80 -80.81 -70.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 51' ' ' ALA . 1.6 mm -85.63 119.2 71.88 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 33.4 Cg_endo -73.25 82.83 1.54 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 110.482 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 113.02 26.24 4.16 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 71' ' ' PRO . 14.7 t -43.99 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.039 -1.271 . . . . 0.0 109.293 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 10.6 mmtm -93.9 0.75 56.32 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.783 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.786 ' HB3' ' C1D' ' A' ' 105' ' ' HEC . 2.5 ptt? -118.1 119.31 34.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.07 -1.019 . . . . 0.0 109.727 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.4 mm -89.51 49.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.286 -0.883 . . . . 0.0 108.919 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.698 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 35.1 t80 -59.99 152.65 23.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.371 -0.831 . . . . 0.0 109.183 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 83' ' ' VAL . 12.4 p -81.71 10.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 83' ' ' VAL . . . 54.32 169.24 0.04 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.574 HG21 ' HB3' ' A' ' 90' ' ' GLU . 1.9 mp -120.65 153.44 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.272 -1.134 . . . . 0.0 109.372 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -130.1 11.79 5.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.463 ' H ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -66.15 -32.42 73.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.798 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.71 -52.57 64.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 85' ' ' ILE . 2.2 tt0 -59.98 -40.7 90.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.73 -39.04 57.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.584 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -70.29 -38.6 75.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -66.43 -28.89 68.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 68' ' ' LEU . 89.0 mt -73.82 -62.04 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.159 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.564 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.2 mm -61.06 -30.42 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -62.56 -48.85 77.69 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.613 -0.679 . . . . 0.0 110.35 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.65 ' HD2' HD22 ' A' ' 98' ' ' LEU . 61.3 t80 -63.53 -47.47 81.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.034 -1.042 . . . . 0.0 110.442 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 10' ' ' PHE . 2.5 mm? -63.25 -29.2 70.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.596 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -66.27 -36.8 83.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.134 -0.979 . . . . 0.0 109.023 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.27 -18.48 36.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.95 47.08 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.907 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 103' ' ' ASN . 6.7 t -132.85 -43.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.067 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' N ' HG23 ' A' ' 102' ' ' THR . 7.2 t-20 -63.43 -11.83 26.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 0.0 109.546 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.045 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.28 151.05 25.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -1.128 . . . . 0.0 109.42 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.17 -31.66 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -76.23 -31.23 58.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.651 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.7 tppt? -73.14 -55.37 6.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.561 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.73 97.45 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 97' ' ' TYR . 3.3 ttpm? -65.06 -18.82 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -40.7 54.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.017 HG22 HD21 ' A' ' 94' ' ' LEU . 2.9 mp -67.26 -60.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 109.541 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' SER . 38.9 t80 -52.03 -44.78 64.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.115 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 20.2 mt -56.68 -38.01 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 24.8 12.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.043 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -130.23 -62.31 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.944 . . . . 0.0 109.285 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -120.6 26.43 9.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.206 -0.934 . . . . 0.0 108.81 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 3.0 t -82.81 4.73 24.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 109.887 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 3.6 tp-100 -99.83 -54.52 2.89 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 108.712 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 44.7 m -83.21 -22.26 33.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.943 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -123.31 89.34 3.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.269 -0.894 . . . . 0.0 109.861 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.2 p -93.42 96.28 9.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.96 -1.087 . . . . 0.0 108.806 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.2 m -85.29 31.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.384 -0.823 . . . . 0.0 109.941 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.98 7.19 2.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.017 -1.052 . . . . 0.0 109.708 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -149.47 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.01 36.73 3.92 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.16 80.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.94 159.16 15.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -141.04 140.77 34.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 -60.88 1.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.229 -0.92 . . . . 0.0 109.475 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.554 ' O ' HMD3 ' A' ' 105' ' ' HEC . 85.0 m -100.17 -61.28 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -93.49 156.29 22.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 18' ' ' HIS . 29.9 Cg_endo -66.77 135.78 39.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.62 2.213 . . . . 0.0 111.335 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.62 103.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.177 -0.952 . . . . 0.0 109.534 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.943 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.35 46.1 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.466 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 46.1 t60 -96.06 69.34 2.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 108.822 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.661 ' N ' HG21 ' A' ' 102' ' ' THR . . . 117.98 16.33 5.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.937 HD21 HMA3 ' A' ' 105' ' ' HEC . 23.0 tp -52.58 -30.69 32.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.507 -0.996 . . . . 0.0 109.872 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 3.3 m-85 -60.9 141.04 57.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.443 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.34 70.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.547 ' NH1' HD12 ' A' ' 35' ' ' LEU . 3.4 tmm_? -135.28 125.63 26.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -1.128 . . . . 0.0 109.382 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 19.1 mttp -72.3 173.39 8.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -74.05 170.26 15.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.738 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 67.03 108.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.536 ' NE2' ' HD2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -160.95 -63.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.976 -1.308 . . . . 0.0 109.91 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -41.75 150.63 0.35 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.266 -0.896 . . . . 0.0 109.906 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.4 -75.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.836 2.357 . . . . 0.0 110.587 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.72 66.02 3.96 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.639 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -160.58 120.97 2.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 108.998 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.545 ' N ' ' HD1' ' A' ' 46' ' ' TYR . 40.4 t -84.07 70.55 10.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.9 m-85 -44.69 179.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.701 -0.625 . . . . 0.0 110.174 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.852 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -57.79 88.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 108.886 179.407 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.54 -41.4 66.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -51.48 -70.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 108.77 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.584 ' ND2' ' CD1' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -40.28 -47.28 2.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 110.062 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.95 -57.25 6.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.28 -33.62 75.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.533 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -14.07 6.3 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.114 -0.992 . . . . 0.0 109.824 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 40.81 97.02 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -95.29 133.34 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 0.0 110.034 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.942 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -94.54 112.48 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.617 ' CH2' ' CD2' ' A' ' 67' ' ' TYR . 10.0 m95 -54.17 101.92 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 110.245 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.46 -164.88 12.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -73.97 -67.67 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.01 89.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.872 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -59.67 -36.31 76.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.7 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -80.24 -27.28 38.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttt -57.03 -47.03 81.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 0.0 109.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.32 -51.56 20.12 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.378 -0.827 . . . . 0.0 109.823 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.617 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 51.9 t80 -54.09 -22.7 11.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 109.664 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 64' ' ' LEU . 1.6 tp -90.35 -29.77 17.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.0 109.178 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.75 -24.75 65.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -175.75 102.27 0.25 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.563 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.7 Cg_endo -76.61 -37.47 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.35 2.033 . . . . 0.0 110.258 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -75.13 -17.82 60.34 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.334 -0.853 . . . . 0.0 110.266 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -94.39 -37.65 11.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.856 -1.152 . . . . 0.0 109.581 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.675 ' CE2' HD11 ' A' ' 75' ' ' ILE . 1.9 t80 -76.6 -66.06 0.86 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.869 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.768 HG22 ' CB ' ' A' ' 51' ' ' ALA . 8.1 mm -101.06 106.47 44.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.362 -0.836 . . . . 0.0 109.532 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 35.7 Cg_endo -77.86 71.18 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.391 2.06 . . . . 0.0 110.024 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.687 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -173.42 -42.12 0.04 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' HG23 ' A' ' 49' ' ' THR . 14.6 t -43.49 158.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 3.69 21.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.489 -0.757 . . . . 0.0 109.411 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.737 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 9.8 ptm -92.87 118.14 30.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.992 . . . . 0.0 109.934 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mm -92.66 48.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.951 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 15.3 t80 -59.31 146.43 39.6 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.514 0.673 . . . . 0.0 110.173 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 84' ' ' GLY . 8.2 p -88.53 -5.12 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 82' ' ' PHE . . . 67.41 175.15 7.72 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 85' ' ' ILE . 3.8 mp -107.06 139.38 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.158 -1.201 . . . . 0.0 109.517 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -90.81 -22.03 21.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 121.18 39.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -62.6 -13.63 33.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.35 -56.12 11.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 109.723 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.38 -40.59 81.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 94' ' ' LEU . 7.8 ttp180 -56.6 -45.43 81.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.422 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.96 -49.38 70.54 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.235 -0.916 . . . . 0.0 109.596 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' HB3' HD13 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -59.72 -21.43 60.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.767 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.017 HD21 HG22 ' A' ' 9' ' ' ILE . 22.2 mt -72.68 -59.64 2.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 95' ' ' ILE . 5.3 mm -56.57 -49.79 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.403 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.94 70.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.611 -0.68 . . . . 0.0 109.633 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 4.5 t80 -53.07 -49.82 65.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.255 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 102' ' ' THR . 1.1 mt -82.65 -12.97 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 1.3 ttmt -79.34 -10.94 59.92 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.169 -0.957 . . . . 0.0 108.906 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -110.55 -40.06 4.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.91 -55.6 4.86 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.263 -0.898 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.661 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -99.56 30.48 3.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 9.3 t-20 -165.01 64.85 0.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.259 -0.9 . . . . 0.0 109.511 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.389 179.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.068 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.34 -173.72 4.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -1.123 . . . . 0.0 109.593 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -97.8 -33.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.65 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -67.15 -40.34 86.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.669 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -49.67 -34.77 21.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -57.83 -45.11 86.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -1.138 . . . . 0.0 109.737 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.62 -27.58 60.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.636 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' A' ' 6' ' ' GLY . 51.1 mt -60.25 -53.8 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 10' ' ' PHE . 6.9 t80 -73.76 -46.6 44.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.257 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 22.7 mm -56.42 -16.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -120.73 -6.66 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 15.8 tppt? -101.98 -65.81 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 109.858 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.569 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -112.04 29.4 7.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.8 t -89.9 -1.15 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.733 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -94.78 -35.6 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.241 -0.912 . . . . 0.0 108.724 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 16.9 m -103.43 -26.28 12.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.045 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.4 m-70 -117.51 78.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.035 -1.041 . . . . 0.0 109.649 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.1 p -78.66 94.8 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.967 -1.083 . . . . 0.0 108.178 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 20' ' ' VAL . 1.6 m -82.16 22.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 0.0 110.519 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -151.21 20.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.902 -1.124 . . . . 0.0 109.467 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -89.48 -17.97 27.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.65 -27.1 3.11 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.56 -0.94 3.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -88.34 164.68 15.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.076 -1.25 . . . . 0.0 109.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.573 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.994 -1.066 . . . . 0.0 110.234 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -71.02 -75.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 108.867 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 93.7 m -99.81 -58.89 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 108.713 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -83.2 155.53 32.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -67.88 143.36 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.498 2.132 . . . . 0.0 111.048 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 9.4 t-20 -56.25 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 110.075 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.045 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -85.02 55.44 3.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.403 -0.81 . . . . 0.0 109.826 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -96.99 48.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.269 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 127.43 62.26 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.469 ' CD1' ' O2A' ' A' ' 105' ' ' HEC . 5.4 tp -79.91 -31.22 40.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.395 -1.062 . . . . 0.0 109.872 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -60.32 137.21 58.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.047 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.4 27.98 73.08 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 39' ' ' LYS . 58.1 ttp85 -139.96 123.59 17.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.983 -1.304 . . . . 0.0 109.742 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.524 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -64.45 175.59 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.156 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.466 HG21 ' N ' ' A' ' 53' ' ' LYS . 7.5 t -94.81 -173.92 3.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.11 -0.994 . . . . 0.0 109.82 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 91.61 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.637 ' NE2' ' CE2' ' A' ' 48' ' ' TYR . 2.2 pm0 -159.44 -36.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.182 -1.187 . . . . 0.0 109.807 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -70.17 137.4 86.88 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 109.566 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.1 Cg_endo -79.35 173.98 12.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.45 2.1 . . . . 0.0 110.359 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.37 5.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.517 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -145.61 121.19 10.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.11 . . . . 0.0 109.12 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -85.04 66.16 9.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.9 m-85 -43.97 170.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.722 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.3 OUTLIER -67.28 86.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -44.22 -34.97 2.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -51.17 -59.99 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.62 ' ND2' ' CZ2' ' A' ' 59' ' ' TRP . 19.4 t-20 -52.85 -52.97 55.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' N ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -47.85 -33.44 7.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.318 -0.864 . . . . 0.0 109.297 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -77.87 -35.71 50.62 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.383 -0.823 . . . . 0.0 109.772 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -61.11 -11.96 10.59 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.072 -1.018 . . . . 0.0 109.574 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.98 35.93 78.53 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.834 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.51 125.45 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.667 -0.902 . . . . 0.0 110.324 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.834 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -87.15 95.33 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 5.3 m95 -34.87 121.79 0.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -142.87 -166.51 11.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' HG2' HG21 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -73.91 -65.26 0.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -1.201 . . . . 0.0 109.779 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -60.45 -38.83 85.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 0.0 109.946 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.33 -36.46 75.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 109.303 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.022 HD21 HMA1 ' A' ' 105' ' ' HEC . 0.9 OUTLIER -76.24 -24.09 54.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.172 -0.955 . . . . 0.0 109.347 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -42.02 78.49 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.19 -50.94 13.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' CE1' ' CG1' ' A' ' 75' ' ' ILE . 23.6 t80 -49.72 -44.99 48.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.379 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.542 ' CD1' HMB2 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -73.59 -32.15 63.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -25.8 63.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.58 84.11 0.34 Allowed Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 33.0 Cg_endo -76.4 -22.13 12.72 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.645 2.23 . . . . 0.0 109.354 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -75.59 -16.56 60.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -101.45 -38.69 7.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.457 -0.777 . . . . 0.0 109.239 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.57 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.4 t80 -73.47 -66.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.912 HG22 ' HB3' ' A' ' 51' ' ' ALA . 4.3 mm -97.53 106.72 34.77 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 36.2 Cg_endo -77.75 83.46 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.259 1.973 . . . . 0.0 110.595 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 149.91 -14.37 1.02 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.695 ' HA ' HG23 ' A' ' 49' ' ' THR . 8.1 t -43.68 132.38 4.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.239 . . . . 0.0 109.908 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 23.8 4.37 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.3 mmm -59.17 125.4 23.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.753 -0.592 . . . . 0.0 109.81 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.589 ' HB ' HBC2 ' A' ' 105' ' ' HEC . 38.5 mm -89.09 17.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -59.45 160.73 6.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.611 -0.681 . . . . 0.0 109.929 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 84' ' ' GLY . 22.0 m -99.96 -42.82 10.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.372 -0.83 . . . . 0.0 109.299 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 130.24 88.03 0.48 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.27 161.26 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -1.173 . . . . 0.0 109.172 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -147.44 50.93 1.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.062 -1.023 . . . . 0.0 109.917 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 116.46 15.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.121 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -18.85 65.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.817 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -35.31 60.56 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -81.57 -40.85 22.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -67.86 -51.84 43.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.386 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.89 80.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 109.237 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 9' ' ' ILE . 96.1 m-20 -60.48 -28.96 68.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.384 -0.823 . . . . 0.0 109.592 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 18.0 mt -65.05 -51.92 58.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.566 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -59.59 -37.59 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.58 99.63 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.582 -0.699 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 98' ' ' LEU . 22.6 t80 -66.1 -46.63 76.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.086 -1.009 . . . . 0.0 109.673 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' A' ' 97' ' ' TYR . 2.0 mm? -72.89 -15.21 61.59 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 2.0 ttpt -76.81 -32.95 57.97 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -38.83 13.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.891 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.43 -56.77 6.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.338 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.64 35.85 4.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.25 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -160.77 47.43 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.698 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.344 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.08 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER -122.66 149.84 43.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.593 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.32 -17.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.77 -41.47 37.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -40.65 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.928 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -67.11 -50.86 42.91 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.593 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -56.39 -27.2 55.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.134 . . . . 0.0 109.55 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -79.25 -33.84 43.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 0.0 109.216 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.928 HD12 ' HA2' ' A' ' 6' ' ' GLY . 12.7 mt -60.98 -57.1 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 15' ' ' SER . 8.3 t80 -59.59 -46.24 89.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.093 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 15.1 mm -57.81 -22.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.408 -0.807 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 ttt -122.31 10.75 9.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 22.4 tptt -122.94 -56.52 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.072 . . . . 0.0 109.591 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -118.47 22.0 12.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.4 t -84.96 2.86 41.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.986 . . . . 0.0 109.597 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -100.11 -41.66 7.05 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.871 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.468 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 13.1 m -95.18 -26.36 16.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.973 ' ND1' HD22 ' A' ' 32' ' ' LEU . 73.9 m-70 -115.09 81.53 1.59 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -0.891 . . . . 0.0 109.808 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 p -78.69 83.27 4.86 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.083 -1.01 . . . . 0.0 108.553 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -82.78 45.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 110.169 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -165.96 24.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.003 -1.06 . . . . 0.0 109.785 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 25' ' ' LYS . 42.7 tttp -100.22 -73.22 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.48 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.95 52.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.11 4.98 51.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 9.3 tppt? -91.21 144.86 25.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 109.213 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.435 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -133.04 114.88 14.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.901 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.92 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.328 -0.857 . . . . 0.0 109.28 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -99.9 -47.65 4.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.229 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -84.27 153.4 29.08 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 30.6 Cg_endo -68.74 133.53 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.672 2.248 . . . . 0.0 111.256 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 10.4 t-20 -50.92 99.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.47 0.652 . . . . 0.0 109.59 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.973 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -80.93 70.87 7.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 109.78 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 28.1 p-80 -100.59 -48.99 4.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 109.901 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' CG ' ' A' ' 33' ' ' HIS . . . -120.96 30.78 5.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.58 -40.09 8.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -1.193 . . . . 0.0 109.043 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 65.0 m-85 -68.61 147.44 51.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.29 17.59 11.95 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NH1' ' HB3' ' A' ' 42' ' ' GLN . 7.3 ttp85 -147.2 116.08 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -1.211 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -59.39 -174.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 108.94 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.615 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -79.53 -164.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.614 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 53' ' ' LYS . . . 53.99 101.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -154.45 -30.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.24 . . . . 0.0 110.558 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG2' ' A' ' 42' ' ' GLN . . . -95.38 135.93 22.9 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.719 -1.238 . . . . 0.0 109.552 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.0 Cg_endo -78.89 136.96 13.62 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.607 2.204 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.29 -24.45 13.8 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.525 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -99.2 108.63 21.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -1.053 . . . . 0.0 108.673 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -76.18 80.17 2.98 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 30' ' ' PRO . 1.8 m-85 -47.96 -179.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.655 -0.653 . . . . 0.0 109.242 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.845 HG23 ' CBD' ' A' ' 105' ' ' HEC . 0.1 OUTLIER -58.19 88.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.13 -37.31 61.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.459 -0.776 . . . . 0.0 109.707 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.022 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -59.15 -46.29 88.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.586 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.849 ' HA ' HD12 ' A' ' 75' ' ' ILE . 21.9 t-20 -64.37 -54.55 31.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.041 . . . . 0.0 110.008 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CD ' ' HA3' ' A' ' 41' ' ' GLY . 6.2 tttt -50.81 -38.24 47.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.104 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -81.32 -24.1 37.38 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.621 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -65.31 -10.42 32.49 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.141 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.24 63.99 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.07 121.36 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -1.117 . . . . 0.0 110.256 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -84.66 99.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 m95 -37.82 110.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.606 0.717 . . . . 0.0 110.839 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -129.76 -168.16 12.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.91 -57.22 4.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -1.183 . . . . 0.0 109.877 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.14 -42.18 80.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.291 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.606 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -58.6 -38.39 77.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.999 -1.063 . . . . 0.0 109.286 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -71.59 -33.34 68.95 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 108.82 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.0 ttp -54.04 -38.22 64.96 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.408 -0.807 . . . . 0.0 109.317 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.95 -57.02 4.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 39.1 t80 -49.16 -31.27 8.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.869 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.1 mp -81.83 -38.14 25.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.052 -1.03 . . . . 0.0 109.266 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -59.08 -22.69 61.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.8 p30 -179.6 99.0 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.653 ' HB2' HG21 ' A' ' 78' ' ' THR . 30.7 Cg_endo -74.22 -33.72 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.403 2.069 . . . . 0.0 110.257 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -13.99 60.26 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.896 . . . . 0.0 108.933 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 2.8 tptm -92.71 -45.11 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.5 t80 -72.2 -67.59 0.53 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.022 HG22 ' HB3' ' A' ' 51' ' ' ALA . 18.3 mm -95.74 107.48 34.08 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 35.6 Cg_endo -77.57 78.12 3.63 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.244 1.963 . . . . 0.0 110.378 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 164.8 -23.09 0.15 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 71' ' ' PRO . 13.7 t -43.63 155.49 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.008 -1.289 . . . . 0.0 109.768 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -111.04 8.49 21.9 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.012 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.768 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 5.7 ptm -96.4 118.05 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.94 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.1 mm -84.03 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.484 -0.76 . . . . 0.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.74 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 9.6 t80 -99.33 150.47 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -88.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.268 -0.895 . . . . 0.0 109.266 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.67 121.57 1.17 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.561 HG21 ' CG ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -64.5 157.27 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.275 -1.132 . . . . 0.0 109.179 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -10.34 19.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.153 -0.967 . . . . 0.0 109.915 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -91.28 122.94 34.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.694 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -33.77 72.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -0.844 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 6.5 tt0 -65.53 -27.92 68.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.283 -0.886 . . . . 0.0 109.632 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' CG ' HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -73.3 -42.72 62.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -67.23 -56.66 8.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 109.635 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.51 30.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 5.5 t0 -63.25 -42.31 99.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -0.809 . . . . 0.0 110.126 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' GLU . 6.5 mt -56.25 -44.92 80.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.553 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.6 mm -65.83 -42.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.67 16.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.687 . . . . 0.0 110.004 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.593 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 20.8 t80 -73.85 -46.28 45.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.07 -1.019 . . . . 0.0 109.425 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -71.4 -4.38 26.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.321 -0.862 . . . . 0.0 109.812 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.9 -46.61 8.08 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -79.45 -33.64 42.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.472 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.81 19.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 19.3 p -104.03 -37.85 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.959 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 99' ' ' LYS . 16.0 t30 -85.05 19.43 2.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 10.0 tt0 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.07 . . . . 0.0 109.477 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.025 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.64 171.8 10.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -1.197 . . . . 0.0 109.666 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.3 t -78.89 -50.52 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -62.28 -44.07 97.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.612 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -71.52 -32.77 68.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.775 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -56.57 19.17 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 7.5 ttmt -54.8 -26.58 35.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.302 -1.117 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.7 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.78 -36.19 65.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.296 -0.878 . . . . 0.0 108.909 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 43.4 mm -58.21 -59.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 108.718 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.653 ' CE2' HD21 ' A' ' 98' ' ' LEU . 30.6 t80 -58.66 -41.3 85.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 109.099 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -54.26 -30.97 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 0.0 109.112 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 ttt -114.88 7.32 15.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.245 -0.909 . . . . 0.0 110.954 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.21 -61.33 1.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.757 -1.214 . . . . 0.0 110.275 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -127.44 24.71 6.2 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.065 . . . . 0.0 109.78 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 38.7 t -88.2 2.65 51.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.139 . . . . 0.0 109.824 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -100.59 -55.11 2.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 28' ' ' THR . 34.0 m -81.0 -25.52 37.19 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.038 ' ND1' HD22 ' A' ' 32' ' ' LEU . 72.8 m-70 -119.39 89.49 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.106 -0.996 . . . . 0.0 109.766 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.7 p -78.43 83.64 4.64 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.5 m -80.9 36.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.457 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -161.6 21.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.072 -1.017 . . . . 0.0 109.244 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -73.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.88 55.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' OD1' ' A' ' 31' ' ' ASN . . . 66.5 18.52 67.88 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.63 132.28 45.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -1.21 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.545 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -127.09 101.04 6.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 110.069 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -70.0 -63.71 1.03 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.604 HG21 ' SG ' ' A' ' 17' ' ' CYS . 20.4 m -104.69 -76.76 0.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -71.26 159.34 53.85 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 31.9 Cg_endo -68.99 142.89 52.66 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.447 2.098 . . . . 0.0 110.901 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 7.2 t-20 -58.86 98.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.833 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -81.68 73.65 8.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.459 -0.776 . . . . 0.0 109.825 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.74 -62.94 1.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.26 28.03 11.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.985 HD21 HMA3 ' A' ' 105' ' ' HEC . 47.9 tp -49.66 -26.37 3.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -1.059 . . . . 0.0 109.835 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.622 ' CD1' HG21 ' A' ' 102' ' ' THR . 13.1 m-85 -72.78 130.92 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.821 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.24 79.64 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' NH2' HD12 ' A' ' 35' ' ' LEU . 7.1 ttp85 -133.97 126.99 31.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.136 -1.214 . . . . 0.0 109.667 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -61.82 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.722 HG22 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -97.55 -179.31 4.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -0.928 . . . . 0.0 109.769 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.44 97.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' OE1' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -160.74 -33.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.986 -1.302 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.21 138.49 96.04 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.973 -1.079 . . . . 0.0 109.601 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.45 -34.4 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.63 2.22 . . . . 0.0 110.676 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.93 49.08 1.04 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CG ' ' CD1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -160.21 128.37 4.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.027 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -86.29 54.24 3.08 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.1 m-85 -31.59 149.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.29 0.567 . . . . 0.0 110.19 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -58.76 90.76 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 49' ' ' THR . . . -37.6 -34.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.275 0.559 . . . . 0.0 109.556 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -56.03 -64.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.476 -0.765 . . . . 0.0 109.495 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 1.091 ' OD1' HG21 ' A' ' 75' ' ' ILE . 3.6 m120 -36.52 -40.29 0.24 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -0.823 . . . . 0.0 109.963 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -47.12 63.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.63 -17.13 63.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -66.45 -7.09 17.25 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.47 49.29 33.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.791 HD11 ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -116.53 145.15 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.775 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -100.93 96.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.722 ' NE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -40.91 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.419 -0.8 . . . . 0.0 110.492 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -123.22 -153.88 8.87 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.852 ' HG2' HG21 ' A' ' 95' ' ' ILE . 2.0 mt-10 -76.13 -70.83 0.42 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -1.129 . . . . 0.0 109.724 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -37.36 86.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.791 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.37 -49.17 78.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.091 -1.006 . . . . 0.0 109.511 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.691 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -67.51 -31.96 72.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.181 -0.949 . . . . 0.0 109.382 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -31.87 66.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -77.91 -54.95 5.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 0.0 109.657 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.703 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 5.4 t80 -57.98 -19.7 32.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -93.25 -34.47 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.912 -1.117 . . . . 0.0 109.842 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -58.84 -24.86 62.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 20.4 t-20 -170.6 95.67 0.45 Allowed Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' CG ' HG13 ' A' ' 83' ' ' VAL . 30.7 Cg_endo -74.59 -40.58 1.02 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.352 2.034 . . . . 0.0 110.257 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -8.11 41.1 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.274 -0.892 . . . . 0.0 108.922 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 0.4 OUTLIER -104.05 -34.53 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.429 -0.794 . . . . 0.0 109.251 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' HD2' HD11 ' A' ' 75' ' ' ILE . 7.0 t80 -76.52 -70.0 0.48 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.543 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.091 HG21 ' OD1' ' A' ' 52' ' ' ASN . 2.7 mm -86.05 117.11 68.13 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.76 81.36 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.264 1.976 . . . . 0.0 110.742 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.7 -4.26 2.71 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.452 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.617 ' HA ' HG21 ' A' ' 49' ' ' THR . 15.2 t -54.21 163.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.784 -1.421 . . . . 0.0 109.546 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' HD2' HMD2 ' A' ' 105' ' ' HEC . 0.2 OUTLIER -126.11 21.18 7.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -58.77 109.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.04 43.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.74 ' HB2' HMC2 ' A' ' 105' ' ' HEC . 11.2 t80 -107.63 -45.99 3.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.724 -0.61 . . . . 0.0 110.542 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.603 HG13 ' CG ' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -24.72 106.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.434 0.635 . . . . 0.0 111.25 -179.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 85' ' ' ILE . . . -172.26 29.87 0.11 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 84' ' ' GLY . 4.5 mt -152.85 163.06 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.14 . . . . 0.0 109.627 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.22 36.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 109.335 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -106.54 148.87 27.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -75.88 -35.13 59.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.335 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.72 -29.57 70.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -57.59 3.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.883 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -54.33 -40.8 68.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.703 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.2 96.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.914 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -34.34 75.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.028 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 91' ' ' ARG . 92.7 mt -60.83 -51.5 69.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.852 HG21 ' HG2' ' A' ' 61' ' ' GLU . 4.6 mm -67.38 -36.78 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.38 57.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.607 -0.683 . . . . 0.0 110.129 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -73.47 -43.32 60.46 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.998 -1.064 . . . . 0.0 109.948 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.653 HD21 ' CE2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -67.15 -7.22 21.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.953 . . . . 0.0 109.977 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 103' ' ' ASN . 1.8 ttpt -96.01 -36.17 11.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.646 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 9.3 tttm -81.14 -31.63 34.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.05 -60.11 2.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.21 -0.932 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 36' ' ' PHE . 6.4 t -102.41 25.27 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.054 -1.029 . . . . 0.0 110.422 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -160.94 61.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.959 -1.088 . . . . 0.0 109.533 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HG3' ' HG3' ' A' ' 100' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.024 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -146.42 155.16 42.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -1.115 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.01 -26.98 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.282 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -48.3 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.315 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.659 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -57.09 -35.6 70.34 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -66.42 -44.37 83.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -1.068 . . . . 0.0 109.387 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -26.23 68.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.659 HD12 ' HA2' ' A' ' 6' ' ' GLY . 7.1 mt -73.53 -66.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 20' ' ' VAL . 45.3 t80 -55.68 -25.26 38.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 108.988 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 7' ' ' LYS . 7.4 mt -70.9 -40.38 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.847 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.5 ptm -107.34 18.1 22.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.593 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -120.58 -62.54 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.967 . . . . 0.0 109.536 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.433 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -123.76 30.01 6.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.122 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 1.3 t -86.1 7.34 25.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -100.98 -54.31 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 28' ' ' THR . 3.2 m -84.41 -32.52 24.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.875 ' ND1' HD22 ' A' ' 32' ' ' LEU . 63.2 m-70 -114.15 93.34 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.11 -0.994 . . . . 0.0 109.992 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.6 p -91.3 97.25 10.99 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.872 -1.142 . . . . 0.0 108.559 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 20' ' ' VAL . 3.0 m -83.97 47.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 110.061 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 3.0 mt-10 -173.34 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.921 -1.112 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 0.56 39.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.549 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.13 -10.46 40.03 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.1 10.86 6.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -89.82 160.46 16.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -1.18 . . . . 0.0 109.365 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -138.44 167.9 20.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -141.37 -87.04 0.17 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.78 ' O ' HMD3 ' A' ' 105' ' ' HEC . 38.1 m -94.47 -25.03 17.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 108.98 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 17' ' ' CYS . . . -115.6 150.49 18.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.682 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 31.7 Cg_endo -65.98 131.76 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.444 2.096 . . . . 0.0 111.031 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -49.98 101.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.49 -0.756 . . . . 0.0 110.198 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.875 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.01 63.41 6.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.563 -0.711 . . . . 0.0 109.717 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.731 ' O ' HG22 ' A' ' 102' ' ' THR . 2.2 t60 -94.25 -21.46 19.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.104 -0.997 . . . . 0.0 109.993 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 38' ' ' ARG . . . -156.19 22.73 0.51 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 59' ' ' TRP . 5.8 tt -41.61 -35.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -1.053 . . . . 0.0 110.288 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' HD1' HD23 ' A' ' 35' ' ' LEU . 4.3 m-30 -70.36 131.7 44.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.129 -0.982 . . . . 0.0 110.545 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.02 -13.03 64.28 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -126.71 151.87 47.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.897 -1.355 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 177.83 6.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.818 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 1.019 HG21 ' HB3' ' A' ' 52' ' ' ASN . 2.6 p -64.5 -164.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.29 94.0 0.01 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.25 -47.27 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -1.148 . . . . 0.0 109.5 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 46' ' ' TYR . . . -80.31 142.75 55.01 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.4 Cg_endo -78.64 -90.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.691 2.26 . . . . 0.0 110.941 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -41.42 -33.02 0.83 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -82.61 111.44 18.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -1.109 . . . . 0.0 109.067 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 48' ' ' TYR . 1.6 p -77.37 78.32 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-85 -46.84 179.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 109.668 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -58.66 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 109.208 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -53.61 -42.93 68.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.553 -0.717 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -54.16 -73.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' THR . 1.9 m-20 -35.45 -40.97 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.137 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 50' ' ' ALA . 6.0 ttpp -55.36 -59.17 5.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.883 . . . . 0.0 110.049 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -64.08 -20.66 66.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.79 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -65.36 -8.16 17.13 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.64 45.47 59.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -108.37 117.48 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -1.014 . . . . 0.0 109.979 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -84.46 111.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.852 ' HE1' HG22 ' A' ' 40' ' ' THR . 8.1 m95 -50.26 101.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.944 -1.097 . . . . 0.0 110.271 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -122.41 -167.63 13.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' OE2' ' CG2' ' A' ' 95' ' ' ILE . 19.7 mm-40 -65.47 -74.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -62.95 -35.11 79.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 110.268 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.469 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.47 -42.87 93.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.671 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.689 ' CD2' HD13 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -73.42 -33.79 65.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 35.7 tpp -59.11 -27.32 65.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.171 -0.956 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.41 -64.48 1.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.881 . . . . 0.0 109.907 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' CD2' ' CH2' ' A' ' 59' ' ' TRP . 28.5 t80 -49.08 -28.26 4.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.956 . . . . 0.0 109.996 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD13 ' CD2' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -85.84 -32.79 21.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' MET . 4.0 tt0 -59.42 -24.7 63.71 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -177.25 88.69 0.25 Allowed Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 30.2 Cg_endo -73.82 -36.53 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.32 -17.21 64.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.061 -1.024 . . . . 0.0 108.363 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HB3' ' CG ' ' A' ' 70' ' ' ASN . 2.4 ttmt -99.57 -25.76 14.32 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 75' ' ' ILE . 11.8 t80 -88.0 -70.26 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.249 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.746 HG21 ' N ' ' A' ' 52' ' ' ASN . 2.6 mm -99.52 106.66 41.09 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.366 -0.834 . . . . 0.0 109.098 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 74' ' ' TYR . 36.2 Cg_endo -77.98 83.76 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.374 2.049 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' THR . . . 158.42 -30.31 0.46 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.552 ' HA ' HG23 ' A' ' 49' ' ' THR . 10.0 t -44.39 160.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.955 -1.32 . . . . 0.0 109.785 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 15.98 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.401 ' HG3' ' OH ' ' A' ' 67' ' ' TYR . 7.6 mmm -59.2 118.31 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.799 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.742 HG22 HBC2 ' A' ' 105' ' ' HEC . 1.6 tp -92.32 18.83 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.812 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -60.07 161.97 6.25 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.411 0.624 . . . . 0.0 110.133 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 84' ' ' GLY . 33.7 m -99.77 -41.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.343 -0.848 . . . . 0.0 109.366 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 83' ' ' VAL . . . 118.56 81.18 0.75 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.6 mm -67.17 136.15 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -1.202 . . . . 0.0 109.231 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.89 50.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -127.84 106.8 9.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.255 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -34.73 74.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.872 . . . . 0.0 110.1 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.15 -43.78 94.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.876 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.79 -42.22 81.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.905 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -62.15 -38.16 87.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.812 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.8 -50.6 71.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.31 -25.58 67.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 9' ' ' ILE . 29.2 mt -69.75 -52.5 24.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.722 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 95' ' ' ILE . 3.3 mm -62.26 -47.76 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.928 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.76 71.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.79 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.51 ' CD2' HD22 ' A' ' 98' ' ' LEU . 33.3 t80 -61.74 -44.63 96.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 ' OG1' ' A' ' 102' ' ' THR . 4.0 mm? -81.95 -2.7 52.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' ILE . 1.6 tmmt? -97.0 -13.83 22.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.162 -0.961 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -119.97 -39.9 2.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.56 -32.78 60.52 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.28 -0.888 . . . . 0.0 110.387 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -127.87 23.19 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.05 -1.031 . . . . 0.0 110.321 -179.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HB3' ' C ' ' A' ' 99' ' ' LYS . 4.1 t-20 -149.34 14.45 0.88 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.023 -1.048 . . . . 0.0 109.818 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.082 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.81 170.1 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -1.115 . . . . 0.0 109.325 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -100.36 -44.45 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.5 -12.81 59.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.853 . . . . 0.0 109.942 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' O ' HG12 ' A' ' 9' ' ' ILE . 23.7 mttt -91.88 -54.31 3.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.091 -1.006 . . . . 0.0 109.848 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.59 -30.18 55.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -70.32 -46.7 63.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -1.109 . . . . 0.0 109.728 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -70.48 -18.98 62.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 21.7 mm -73.18 -64.6 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 108.792 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 98' ' ' LEU . 11.5 t80 -49.23 -42.34 40.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 108.621 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 55.3 mt -56.23 -42.41 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.01 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' A' ' 12' ' ' MET . 3.3 ppp? -107.12 20.06 19.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.49 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.49 -54.59 1.77 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.738 -1.226 . . . . 0.0 109.866 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.568 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -133.89 25.65 3.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.136 -0.977 . . . . 0.0 109.468 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 1.6 t -80.12 3.39 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -56.87 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.345 -0.847 . . . . 0.0 108.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.486 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 23.1 m -82.14 -17.9 44.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.415 -0.803 . . . . 0.0 109.13 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.033 ' ND1' HD22 ' A' ' 32' ' ' LEU . 75.3 m-70 -125.15 84.03 2.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.795 -1.191 . . . . 0.0 110.239 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 15.7 p -79.29 81.53 5.54 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.52 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 4.1 m -79.84 12.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -137.0 24.33 3.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 0.0 109.867 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.7 tmtt? -98.96 -46.98 5.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.567 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.49 67.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.4 22.53 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' CB ' ' HD2' ' A' ' 22' ' ' LYS . 8.0 tptt -98.8 140.64 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 0.0 109.588 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -140.17 128.61 22.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.436 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -72.5 0.72 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -53.94 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.407 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -91.4 160.22 26.69 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CB ' ' CZ ' ' A' ' 48' ' ' TYR . 35.1 Cg_endo -70.53 134.36 26.2 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.367 2.045 . . . . 0.0 110.54 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 11.7 t-20 -48.27 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.033 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -83.32 43.59 0.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.421 -0.799 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' VAL . 2.0 t-160 -98.62 77.82 2.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -0.975 . . . . 0.0 108.827 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' HG21 ' A' ' 102' ' ' THR . . . 115.03 15.86 7.61 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.561 HD13 HD11 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -54.2 -30.53 50.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.422 -1.046 . . . . 0.0 109.727 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.4 m-85 -65.3 143.15 57.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.905 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 66.54 13.62 61.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 40.4 ttp85 -138.52 129.91 27.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -1.131 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' O ' ' NH1' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -74.39 174.43 8.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -71.94 175.7 5.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.715 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 76.51 94.94 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -150.14 -73.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 46' ' ' TYR . . . -44.32 141.25 2.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.7 Cg_endo -79.72 -92.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.691 2.261 . . . . 0.0 111.425 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -42.38 -29.99 0.76 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -79.78 113.01 17.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -1.057 . . . . 0.0 108.991 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -77.98 77.93 4.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CZ ' ' CB ' ' A' ' 30' ' ' PRO . 1.7 m-30 -46.09 178.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.608 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.846 HG21 ' HB ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -59.71 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' TYR . . . -43.66 -42.72 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 108.984 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 75' ' ' ILE . . . -54.39 -70.54 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.884 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.725 ' HB3' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -38.92 -40.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 110.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -57.41 -70.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.197 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.45 -10.56 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.333 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -66.03 -7.64 18.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.83 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.14 50.66 33.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.83 118.79 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -1.059 . . . . 0.0 109.727 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.77 HD13 ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -78.33 121.35 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.07 -1.019 . . . . 0.0 109.023 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.77 ' N ' HD13 ' A' ' 58' ' ' ILE . 9.0 m95 -64.99 95.08 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.272 -0.892 . . . . 0.0 110.007 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -115.5 -170.7 16.22 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 6.3 mt-10 -68.61 -68.39 0.4 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.089 -1.242 . . . . 0.0 109.69 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.03 -37.22 86.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.882 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.46 ' CG2' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -59.63 -49.03 79.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.074 -1.016 . . . . 0.0 109.315 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.682 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.2 tt -63.47 -32.61 74.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 109.311 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.1 ttp -56.27 -40.87 74.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.379 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.58 -54.91 13.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.318 -0.864 . . . . 0.0 109.78 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CE1' ' OD1' ' A' ' 52' ' ' ASN . 86.4 t80 -49.18 -34.08 13.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.803 HD11 HMB2 ' A' ' 105' ' ' HEC . 1.0 OUTLIER -76.3 -37.01 58.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.351 -0.843 . . . . 0.0 109.472 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.37 -23.31 62.45 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -170.41 93.0 0.48 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' CD ' HG13 ' A' ' 83' ' ' VAL . 35.8 Cg_endo -79.68 -43.36 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.373 2.049 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -79.27 -22.26 44.95 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -92.26 -36.19 13.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.122 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.4 t80 -73.62 -66.6 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 51' ' ' ALA . 13.6 mm -96.38 113.2 62.05 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.43 -0.793 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.76 70.24 7.04 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.255 1.97 . . . . 0.0 109.747 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.42 -46.69 0.03 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.846 ' HB ' HG21 ' A' ' 49' ' ' THR . 9.7 t -58.09 163.75 2.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.281 . . . . 0.0 109.651 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.32 9.03 5.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.736 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.1 ptm -74.48 115.82 14.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.879 -1.129 . . . . 0.0 109.513 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 41.8 mm -94.13 35.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.78 ' CZ ' HBB2 ' A' ' 105' ' ' HEC . 4.9 t80 -59.33 -34.62 72.57 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.807 -0.558 . . . . 0.0 110.167 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG13 ' CD ' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -29.51 104.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.44 0.638 . . . . 0.0 111.209 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.86 25.43 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.521 HD11 ' HZ ' ' A' ' 82' ' ' PHE . 6.9 mt -103.43 160.16 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.93 43.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.372 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 89' ' ' GLU . 9.4 ttmm -162.12 115.27 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -52.63 -37.03 57.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 87' ' ' LYS . 3.0 mm-40 -60.6 -38.32 84.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.64 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -62.9 -49.24 75.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 109.513 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -53.51 -43.77 68.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 109.263 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -58.73 -34.31 71.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.381 -0.824 . . . . 0.0 109.701 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -69.1 -28.82 66.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.117 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' CD2' HG21 ' A' ' 9' ' ' ILE . 55.7 mt -71.13 -63.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 109.418 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 1.1 mp -59.66 -32.01 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 108.996 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 92' ' ' ALA . . . -60.39 -40.71 91.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 109.873 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.2 -48.42 62.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.352 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 10' ' ' PHE . 2.0 mm? -67.13 -16.29 64.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -72.49 -49.26 34.3 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.312 -0.867 . . . . 0.0 109.862 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HA ' ' CB ' ' A' ' 104' ' ' GLU . 6.8 tttt -79.88 -27.4 40.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.109 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.31 -59.15 3.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 110.376 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -111.54 -29.89 7.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.46 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t30 -81.61 10.96 5.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.073 -1.017 . . . . 0.0 110.241 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.541 ' CB ' ' HA ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 109.508 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 1.068 HBC3 HMC1 ' A' ' 105' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.506 ' CB ' ' HB2' ' A' ' 5' ' ' LYS . 1.8 m-20 -85.51 166.8 16.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -1.105 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -95.81 -60.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -13.03 26.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 2' ' ' ASP . 6.9 ttmt -77.44 -63.07 1.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 9' ' ' ILE . . . -56.28 -32.78 60.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 97' ' ' TYR . 34.9 tttt -64.67 -33.7 76.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -77.08 -24.13 51.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 5' ' ' LYS . 17.9 mt -69.62 -55.94 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 108.838 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' SER . 9.7 t80 -62.84 -40.15 96.53 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.324 -0.86 . . . . 0.0 108.921 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 14.5 mt -58.06 -28.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.38 -0.825 . . . . 0.0 109.001 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -114.92 6.89 15.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 110.015 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' HBB1 ' A' ' 105' ' ' HEC . 0.0 OUTLIER -113.68 -66.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.8 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' HB3' ' CHC' ' A' ' 105' ' ' HEC . 0.0 OUTLIER -115.07 31.18 6.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.965 -1.084 . . . . 0.0 109.459 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 1.8 t -90.16 8.74 31.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.2 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -101.44 -48.2 4.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 0.0 108.956 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.496 ' O ' ' CA ' ' A' ' 29' ' ' GLY . 96.9 m -93.57 -25.52 17.52 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.419 -0.8 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.042 ' ND1' HD22 ' A' ' 32' ' ' LEU . 79.1 m-70 -113.87 82.75 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 110.249 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.536 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 5.1 p -78.86 88.4 4.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 108.448 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 32' ' ' LEU . 5.5 m -79.88 9.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -137.75 18.01 2.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.046 . . . . 0.0 109.433 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 25' ' ' LYS . 4.8 tptt -88.9 -57.27 2.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.36 63.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.43 17.63 33.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.93 73.47 1.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -1.192 . . . . 0.0 109.368 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.527 ' HB3' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -78.47 128.9 34.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 109.964 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' NZ ' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -101.69 -80.39 0.5 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.933 ' O ' HMD3 ' A' ' 105' ' ' HEC . 96.3 m -91.8 -33.33 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.363 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 17' ' ' CYS . . . -108.56 156.91 15.51 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 32.9 Cg_endo -68.68 136.33 35.68 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.543 2.162 . . . . 0.0 110.849 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' HIS . 6.2 t-20 -51.38 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.812 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.042 HD22 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -80.64 70.25 7.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.494 -0.754 . . . . 0.0 109.456 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 102' ' ' THR . 31.3 t-80 -100.2 -49.58 4.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 109.098 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -122.81 37.67 2.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.948 HD11 HMA3 ' A' ' 105' ' ' HEC . 3.1 tt -49.52 -50.52 41.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.992 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -60.37 137.94 58.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.855 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.92 24.21 76.55 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD2' ' HG2' ' A' ' 42' ' ' GLN . 24.2 ttp85 -145.78 118.11 8.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -1.231 . . . . 0.0 109.797 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -70.68 164.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.91 169.07 4.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.295 -0.878 . . . . 0.0 109.866 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . 73.13 83.39 0.29 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -148.61 -39.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -1.148 . . . . 0.0 109.882 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . . . -79.84 136.35 54.87 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 109.693 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 45' ' ' GLY . 36.5 Cg_endo -79.15 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.59 2.193 . . . . 0.0 110.972 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 44' ' ' PRO . . . -40.13 -37.91 1.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.468 ' CG ' ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -80.13 125.07 29.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -1.061 . . . . 0.0 108.979 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 48' ' ' TYR . 93.9 p -86.34 57.35 4.44 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m-30 -31.8 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.113 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.994 HG21 ' HA ' ' A' ' 78' ' ' THR . 31.0 p -63.19 93.4 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.642 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' ALA . . . -36.93 -37.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -41.15 -69.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.92 ' OD1' HD13 ' A' ' 75' ' ' ILE . 28.6 m-20 -45.1 -45.26 11.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 109.852 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.7 -74.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.93 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.57 -14.03 2.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.885 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HB2' HG12 ' A' ' 75' ' ' ILE . 1.8 tptp -59.17 -13.83 8.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.749 -1.219 . . . . 0.0 109.926 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.94 58.78 12.39 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -133.73 120.33 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.731 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.07 102.15 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.047 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CG ' HD21 ' A' ' 35' ' ' LEU . 6.7 m95 -41.16 106.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -124.42 -159.87 10.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.9 -59.45 2.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.11 -1.229 . . . . 0.0 109.868 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.96 -38.12 64.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.846 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.98 -52.1 66.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.4 tt -62.94 -37.32 86.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -53.36 -37.9 62.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE1' ' CD1' ' A' ' 74' ' ' TYR . 7.5 tm-20 -69.87 -57.11 5.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.6 t80 -60.87 -13.41 15.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.021 -1.05 . . . . 0.0 109.526 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.947 HD11 HMB2 ' A' ' 105' ' ' HEC . 4.9 tp -85.09 -49.79 7.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.058 . . . . 0.0 109.073 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 6.9 tt0 -59.21 -22.08 60.49 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 69' ' ' GLU . 1.2 m-80 -161.27 92.34 1.48 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.736 ' HB2' HG21 ' A' ' 78' ' ' THR . 32.8 Cg_endo -76.0 -52.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.42 2.08 . . . . 0.0 110.878 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.128 -0.982 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . 15.5 mtpt -77.09 -39.91 47.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.884 ' CD2' HD12 ' A' ' 75' ' ' ILE . 22.8 t80 -68.05 -63.23 1.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.92 HD13 ' OD1' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -114.21 125.3 29.48 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 71.19 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.239 1.959 . . . . 0.0 109.966 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 51' ' ' ALA . . . -160.57 -58.47 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.994 ' HA ' HG21 ' A' ' 49' ' ' THR . 9.4 t -41.81 152.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -1.132 . . . . 0.0 110.164 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.11 5.18 13.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.766 ' HB3' ' CHD' ' A' ' 105' ' ' HEC . 8.5 ptm -77.58 119.29 20.93 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.071 -1.018 . . . . 0.0 109.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.4 mt -90.11 55.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.763 ' CE2' HBB2 ' A' ' 105' ' ' HEC . 48.7 t80 -79.46 148.56 31.84 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.579 -0.7 . . . . 0.0 109.964 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.08 -158.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 109.262 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.04 122.82 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.466 ' CD1' HD11 ' A' ' 94' ' ' LEU . 13.4 mt -75.17 134.38 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -1.173 . . . . 0.0 109.157 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.76 -34.14 22.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.693 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' CB ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -70.12 105.94 3.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.144 -0.972 . . . . 0.0 109.701 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.25 68.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.03 -53.84 53.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.421 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' OE1' ' CB ' ' A' ' 87' ' ' LYS . 29.4 mt-10 -62.83 -32.7 73.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.234 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -44.07 92.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.43 96.78 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.348 -0.845 . . . . 0.0 109.388 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.4 -37.45 62.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 85' ' ' ILE . 41.5 mt -66.09 -53.23 40.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 95' ' ' ILE . 19.9 mm -61.99 -79.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 95' ' ' ILE . . . -33.76 -38.35 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.285 0.564 . . . . 0.0 110.698 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 1.2 t80 -56.62 -57.04 14.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.115 -0.99 . . . . 0.0 109.177 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 102' ' ' THR . 4.8 mt -74.68 -13.69 60.65 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.461 -0.774 . . . . 0.0 109.48 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -75.78 -15.81 60.21 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -112.36 -24.36 9.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.609 -0.682 . . . . 0.0 109.215 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.06 -48.78 6.07 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.133 -0.979 . . . . 0.0 110.058 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -109.59 32.03 5.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.923 . . . . 0.0 109.928 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' LYS . 8.9 t-20 -154.73 -46.14 0.09 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.171 -0.956 . . . . 0.0 109.376 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HEC . . . . . 0.948 HMA3 HD11 ' A' ' 35' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_